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Summary 
 
The Structural Maintenance of Chromosome (SMC) family of proteins are 
required to regulate almost all aspects of chromosome biology and are critical 
for genomic stability. The SMC5/6 complex, a member of this family, is 
composed of two SMC heterodimers and six additional Non-SMC Elements 1-
6. The components of SMC5/6 possess activities including ATPases, ubiquitin 
and SUMO ligases. SMC5/6 is required in homologous recombination and for 
accurate chromosome segregation. Loss of SMC5/6 is lethal in yeasts, 
embryonic lethal in mice and mutations in NSMCE2 leads to primordial dwarfism 
and insulin resistance.  
 
This thesis focuses on a mutation in NSMCE3, found in American and Dutch 
families, that results in a novel chromosomal breakage syndrome characterized 
by fatal pulmonary disease. Another focus is the development, execution and 
validation of a microscopy based synthetic sick/lethal screen using cells with 
knockdown of NSMCE4a. Studies of SMC5/6 in yeasts predict that 
compromising SMC5/6 function would lead to a dependence on other DNA 
repair pathways. The results combined with patient data confirm that SMC5/6 is 
important in the absence of repair by non-homologous end joining and is 
particularly important under conditions of replication stress. 
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1.0 - Introduction  
	 2	
1.1 –  Introduction to DNA repair 
The genetic code of an organism encodes the information for its development, 
function, reproduction and metabolism. It must be faithfully copied from 
generation to generation. The genetic code is made up of deoxyribonucleic 
acid (DNA) and is wrapped around histones that form nucleosomes(Fernandez-
Capetillo, Lee, Nussenzweig, et al., 2004). The DNA must be unwound then 
replicated to duplicate its content before creating a new cell, or transcribed by 
the appropriate polymerases to create new proteins. Damage to the genetic 
material and/or failure to faithfully segregate the genetic code has been 
implicated in a large number of diseases and cancer(Macheret & Halazonetis, 
2015) 
 
The risk of developing cancer at some point in our lifetime is 1 in 2 (Ahmad, 
Ormiston-Smith & Sasieni, 2015). The identification of new targets for cancer 
therapy is at the forefront of research. There are many ways to identify potential 
therapeutic targets and this thesis will focus on the identification of synthetic 
sick/lethal interaction screen and the characterization of patient cells with a 
mutation in a subunit of a key DNA repair complex known as SMC5/6.   
 
1.1.1 – Sources of DNA damage.  
The requirement for accurate and efficient maintenance of DNA is absolute, 
however, the inherent structure of DNA and the modifications needed to allow 
normal cellular activities, including transcription and replication, make it liable to 
chemical attack from both endogenous and exogenous sources(Gupta & Lutz, 
1999; Lindahl, 1993; Marnett, Riggins & West, 2003).  
 
1.1.1.1 – Endogenous sources of DNA damage.  
1.1.1.1.1 – DNA replication.  
Replication of the genome occurs once in every cell cycle during S phase 
(Macheret & Halazonetis, 2015). Once origins of replication have been licensed 
replication can begin(Nasheuer, Smith & Bauerschmidt, 2002). Three 
polymerases are specifically required for replication; DNA polymerase α, DNA 
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polymerase δ, and DNA polymerase ε. DNA pol α is required to start DNA 
synthesis and synthesizes short RNA primers for both leading and lagging 
strands. Once DNA synthesis is primed Pol α is replaced by Pol ε or Pol δ for 
leading or lagging strand synthesis, respectively. These polymerases have 
proofreading capabilities and are used for bulk DNA synthesis (Kawasaki & 
Sugino, 2001; Fragkos, Ganier, Coulombe, et al., 2015). Whilst polymerases 
have a high fidelity they can incorporate the incorrect base during DNA 
synthesis. DNA polymerases make errors once every 104-105 nucleotides 
polymerised. These mismatches if unrepaired can lead to permanent mutations 
in the genome. It is therefore not surprising that mutations in polymerases have 
been associated with disorders such as Alpers disease, neurodegenerative 
diseases such as Alzheimer’s or Parkinson’s and of course cancer (Loeb & 
Monnat, 2008)) 
 
1.1.1.1.2 – Reactive oxygen species 
Reactive oxygen species (ROS) are a source of DNA damage. Twenty one 
percent O2 has been known to cause deleterious effects in primary cells (Floyd, 
West & Hensley, 2001; Chance, Sies & Boveris, 1979; Jackson & Loeb, 2001; 
Calcerrada, Peluffo & Radi, 2011; Marnett, Riggins & West, 2003; Lee, Niles, 
Wishnok, et al., 2002). Oxidative stress results in the formation of highly reactive 
free radicals that can cause damage to biomolecules within the cell, including, 
DNA, proteins, lipids and sugars (Lee, Niles, Wishnok, et al., 2002; Chance, Sies 
& Boveris, 1979) (Calcerrada, Peluffo & Radi, 2011). Reactive oxygen species 
have been implicated in over 200 clinical disorders, including heart failure, 
endothelial dysfunction and atherosclerosis as well as many cardiovascular 
disorders(Tariq, 2009). Reactive oxygen species are developed under normal 
physiological conditions and play a role in cellular metabolic processes including 
various enzymatic cascades and transcriptional factors (Marnett, Riggins & 
West, 2003).  
 
Through its definition, oxidative distress is an imbalance that favours the 
productions of ROS over the host organisms own antioxidant defence. There are 
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a number of ROS, such as the superoxide anion (•O2-), hydrogen peroxide (H2O2) 
and the hydroxyl radical (•OH), these are generated by number of conditions in 
vivo and by several exogenous means (Floyd, West & Hensley, 2001; Jackson & 
Loeb, 2001). Inside the cell the main producer of ROS are the mitochondria, even 
under non-pathological conditions. ROS are formed through the course of 
normal cellular metabolism through leakage of electrons from the electron 
transport chain(Marnett, Riggins & West, 2003). The resulting moderate level of 
ROS plays a role in several physiological functions within the cells including gene 
expression and signal transduction. Oxidative stress can damage nucleic acids, 
deoxyribose residues or the phosphodiester backbone of DNA. If unrepaired, 
these lesions can lead to DNA base transitions and transcription stalling, causing 
both single and double-stranded breaks which can lead to cell death and 
disease(Lee, Niles, Wishnok, et al., 2002; Chance, Sies & Boveris, 1979; Jackson 
& Loeb, 2001; Marnett, Riggins & West, 2003).  
 
1.1.1.1.3 – DNA Methylation.  
Whilst it is known that reactive oxygen species and nitrogen species are the main 
cause of endogenous DNA damage within the cell, they are not the only threat 
that the cell has to face(Holliday & Ho, 1998a; 1998b). Many cellular enzymes 
within metabolic pathways can also impact upon the fragile state of the DNA. S 
Adenosyl methionine (SAM) is a small molecular co-substrate consisting of ATP 
and methionine and is most commonly used in the methylation reactions of DNA, 
an epigenetic mechanism used in the control of gene expression(Rydberg & 
Lindahl, 1982). However, SAM can cause the non-enzymatic methylation of 
DNA, which can in turn become mutagenic, leading to cytotoxic lesions blocking 
replication(Tudek, Bioteux & Laval, 1992).  
 
1.1.1.1.4 – Hydrolysis of DNA.  
Given the chemical make-up of DNA, the N-glycosidic bond linking the base to 
the sugar phosphate backbone is labile under conditions including heating, 
alkylation of bases or cleavage by enzymes known as glycosylases (Lindahl, 
1993). Whilst glycosylases are required for base excision repair, cleavage of the 
	 5	
glycosidic bond can be deleterious (Jacobs & Schär, 2011). Cleavage of the 
bond leads to generation of an abasic side (AP). Lindahl in 1993 estimated that 
approximately 10,000 lesions per human cell per day occur and AP sites are one 
of the most frequently found lesion with depurination of base occurring 
approximately 20 times more frequently than depyrimidination (Lindahl & 
Karlström, 1973) (Lindahl, 1993). If left unrepaired, AP sites can induce 
substitutions or frame-shift mutations leading to perturbed DNA synthesis and 
mutagenesis(Jackson & Loeb, 2001; Jackson, Chen & Loeb, 1998). This is due 
to preferential incorporation of adenine by polymerases next to an AP site during 
replication(Lawrence, Borden, Banerjee, et al., 1990).  
 
1.1.1.2 – Exogenous sources of DNA Damage.  
1.1.1.2.1 – UV light damage. 
Damage induced by UV light can be split into two types, UV-A and UV-B. UV-A 
damage is caused indirectly by producing reactive oxygen species within the 
cell. UV-B causes direct damage by inducing a variety of mutagenic and 
cytotoxic DNA lesions, such as cyclobutane pyrimidine dimers (CPDs) and 6-4, 
photoproducts (6-4PPs). These can interfere with base pairing during replication 
(Otoshi, Yagi, Mori, et al., 2000). Translesion synthesis polymerases possess the 
ability to by-pass this damage during replication, however these polymerases 
are known to exhibit low fidelity and are prone to inserting adenine, thus causing 
a G:C-A:T transitions during replication (Sale, 2013).  
 
1.1.1.2.2 – Ionizing radiation.  
DNA damage from ionizing radiation comes from charged particles which may 
be an electron or ion that can pass through and ionize the DNA directly, known 
as direct action, or it can ionize water molecules in the vicinity of the DNA 
producing highly reactive •OH radicals that react with DNA through an indirect 
action (Santivasi & Xia, 2014). Sources of ionizing radiation can come from man 
made or natural sources. Types of ionizing radiation can be categorised into two 
groups: High linear energy transfer (HLET) such as alpha particles and low LET 
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(LLET) particles that arise from  gamma (g) or X-rays (Santivasi & Xia, 2014; Maier, 
Hartmann, Wenz, et al., 2016).  
 
Approximately 3000 damaged bases, 1000 single-strand breaks and 40 double 
strand breaks occur per 1 Gray (Gy) of X-ray damage. Base damage and single-
strand breaks are of minor relevance for cell survival since these types of breaks 
are repaired by highly efficient base excision repair (BER) steps (Caldecott, 
2014).The vast majority of double strand breaks induced by low-LET radiation 
are also repaired, however a small fraction (of approximately <5%) induced by 
low-LET radiation cannot be repaired due to their complexity, this can lead to 
cell death, senescence, mutation or genomic instability. Double strand breaks 
produced by high-LET radiation form most of the complex breaks and cells 
struggle to repair this type of damage(Maier, Hartmann, Wenz, et al., 2016).  
 
1.1.1.3 – Chemical sources of DNA damage.  
1.1.1.3.1 – Methylmethane sulphonate (MMS). 
MMS in an alkylating agent and carcinogen, despite this it has been used in 
cancer treatment (Lundin, 2005). Its method of action has been debated however 
it is known that HR deficient cells are sensitive to MMS. One of the proposed 
methods of action is that MMS methylates DNA predominantly on N7-
deoxyguanosine and N3-deoxyadenosine (Lundin, 2005). Originally this action 
was imagined to directly lead to DNA double strand breaks, however it is now 
believed that HR deficient cells are particularly sensitive to MMS because it 
leads to stalled replication forks and cells with deficient homologous 
recombination have issues repairing the damaged forks(Lundin, 2005).  
 
1.1.1.3.2 – Mitomycin C (MMC). 
Mitomycin C (MMC) is administered as a prodrug and requires an enzymatic 
bioreduction to exert its effects. Following reduction, MMC is converted to a 
highly reactive bis-electrophilic intermediate that alkylates cellular 
nucleophiles(Paz, Zhang, Lu, et al., 2012). Alkylation of DNA is known to be the 
most favoured mechanism of action for MMC. MMC has also been shown to 
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target thioredoxin reductase (TrxR), the mechanism of action has been proposed 
to be a stepwise process beginning with the reduction of the quinone ring of 
MMC by the selenothiol active site of TrxR and a subsequent alkylation of the 
active site by the now activated drug(Paz, Zhang, Lu, et al., 2012).  
 
1.1.1.3.3 – Camptothecin (CPT). 
Camptothecin (CPT) is a cytotoxic quinolone alkaloid that binds and inhibits 
topoisomerase I (TOP1) (Liu, Desai, Li, et al., 2000). CPT binds to TOP1 as its 
bound to DNA resulting in a ternary complex and stabilizes the interaction 
preventing the re-ligation of DNA after topo I cleavage. CPT primarily kills cells 
by causing S-phase specific damage (Liu, Desai, Li, et al., 2000).  
 
The reversible TOP1-CPT-DNA cleavable complexes are nonlethal by 
themselves, however their collision with advancing replication fork causes DNA 
damage, leading to cell death(Liu, Desai, Li, et al., 2000). The collision is 
potentially lethal only if the cleavable complex is formed on the strand which is 
complementary to the leading strand of DNA synthesis. At high concentration, 
CPT causes damage to non-S phase cells, however S-phase specific 
cytotoxicity is unaffected by inhibition of DNA replication and involvement of 
transcription has been suggested (Liu, Desai, Li, et al., 2000).  
 
1.1.1.3.4 – Hydroxyurea (HU). 
HU lowers the level of deoxyribonucleotides through inhibition of ribonucleotide 
reductase(Petermann, Orta, Issaeva, et al., 2010a). During S phase, HU has been 
shown to inhibit the replication fork causing it to stall. Stalled replication forks 
eventually collapse leading to DSBs. Damage through hydroxyurea treatment is 
mostly conserved to S phase and results in synchronisation of the fraction of 
cells that survive(Petermann, Orta, Issaeva, et al., 2010a; Fox, 2004). 
 
Whilst there are a number of ways in which genomic integrity can be 
compromised, cells have developed intricate systems to identify and repair DNA 
damage in a timely and efficient manner (Iyama & Wilson, 2013; Bernstein, R, 
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Nfonsam, et al., 2013). This process is termed the DNA damage response and 
consists of over 600 proteins (Bernstein, R, Nfonsam, et al., 2013; Ghospurkar, 
Wilson, Severson, et al., 2015). 
 
1.1.2 – Mechanisms of DNA repair.  
1.1.2.1 – DNA-damage signalling.  
The most common chromatin modification associated with the DNA damage 
response is phosphorylation of the histone variant H2A.X (gH2A.X) (Fernandez-
Capetillo, Lee, Nussenzweig, et al., 2004). It is used to recruit various DDR 
factors to the vicinity of lesions to accelerate repair and also used to initiate and 
sustain a signalling network that activates cell cycle checkpoints preventing 
further genomic instability (Fernandez-Capetillo, Lee, Nussenzweig, et al., 2004). 
ATM and ATR are serine, threonine kinases used in the DNA damage 
response(Jeggo & Downs, 2014). They exert cell cycle control in part through 
phosphorylating checkpoint kinases including Chk1, Chk2 and the transcription 
factor p53. ATR is activated following UV light induced damage, whereas ATM 
is activated in response to DSBs(Helt, Cliby, Keng, et al., 2005). Both ATM and 
ATR can phosphorylate H2A.X to create gH2A.X. gH2A.X is used to recruit 
various DDR factors to the vicinity of lesions to accelerate the repair and to 
initiate and sustain a signalling network.  
 
ATR-Interacting protein (ATRIP) binds to single-stranded DNA coated with RPA 
and interacts with ATR resulting in its accumulation at sites of DNA damage (Ball, 
Myers & Cortez, 2005).  Binding of ATRIP to RPA-ssDNA is dependent on 
TOPBP1 and RAD17-dependent loading of the 9-1-1 complex (composed of 
Rad9, Rad1 and Hus1) which activates signalling at the site of damage (Burrows 
& Elledge, 2008).  
 
1.1.2.2 – DNA Double Strand Breaks.  
DNA DSBs are the most toxic type of lesion to the cells and have two main repair 
pathways, homologous recombination and non-homologous end-joining.  
 
	 9	
1.1.2.2.1 – Homologous recombination.  
Homologous recombination uses a DNA template from a sister chromatid and 
as a results only occurs in replicating cells during S and G2 phases of the cell 
cycle(Krejci, Altmannova, Spirek, et al., 2012).  
 
Once the DSB has occurred, the MRN complex is recruited to sites of DNA 
damage where it binds to both sides of the break through MRE11 (Figure 1.1). 
RAD50 then tethers the broken ends of DNA and NBS1 activates ATM through 
phosphorylation, which leads to ATM autophosphorylation (Marechal & Zou, 
2013). ATM phosphorylates gH2A.X leading to signalling and recruitment and 
assembly of repair factors. Chromatin is relaxed and restructured, allowing 
repair proteins to access the damage. DNA is resected by MRE11, CtIP and 
EXO1 exposing single-stranded DNA(Krejci, Altmannova, Spirek, et al., 2012; 
Panier & Boulton, 2013). RPA coats and protects the single-stranded DNA. 
RAD51 then binds and replaces the RPA, mediated by RAD52 and 
BRCA2(Krejci, Altmannova, Spirek, et al., 2012). The RAD51-DNA nucleoprotein 
is made up of RAD51-DNA monomers and begins the process of strand invasion 
searching for sequences similar to that of the 3’ overhang. Strand invasions 
mediated by BRCA1 leads to the formation of displacement loops (D-loop) (San 
Filippo, Sung & Klein, 2008). DNA synthesis occurs using the invaded strand as 
template and Ligase I seals the nicks creating a double Holliday junction. 
Holliday junctions are then resolved using MUS81/EME1 and SLX1/SLX4 or 
GEN1 resolvase, creating crossover products, or dissolved by TOPO3a, RMI1 
and BLM RecQ helicase to generate non-crossover products.  
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Figure	1.1.	The	two	main	DNA	double-strand	break	pathways	NHEJ	and	HR.	The	process	
of	NHEJ	is	initiated	when	KU70/80	binds	to	both	ends	of	a	DSB.	This	is	followed	by	the	
recruitment	 of	 DNA-PKCS.	 This	 functions	 to	 tether	 the	 ends	 and	 recruits	 other	 end	
processing	factors	such	as	Artemis.	These	enzymes	prepare	the	DNA	ends	for	re-ligation	
by	the	XRCC4-XLF-DNA	LIG4	complex.	NHEJ	can	function	in	all	stages	of	the	cell	cycle.	
HR-	directed	DSB	repair	is	restricted	to	late	S	and	G2	stage	of	the	cell	cycle	and	is	much	
more	complex.	DNA	damage	 is	detected	by	MRN	(MRE11-RAD50-NBS1)	complex	and	
followed	 by	 end	 resection.	 The	 resection	 step	 is	 highly	 regulated	 and	 requires	 the	
activity	 of	 several	 nucleases	 including	 CtIP	 (CtBP-interacting	 protein).	 Resection	
generates	long	stretches	of	3’	single-stranded	DNA	which	is	coated	by	RPA	before	being	
replaced	 by	 RAD51	 to	 create	 a	 RAD51-ssDNA	 nucleofilament.	 The	 nucleofilament	
searches	for,	finds	and	binds	with	a	homologous	sequence	elsewhere	in	the	genome	to	
form	 a	 displacement	D-loop,	 in	which	DNA	 synthesis	 is	 initiated	 to	 replace	 the	DNA	
surrounding	the	break	site.	The	D-loop	is	resolved	either	through	dissociation	of	one	of	
the	 invading	 strand,	 through	 synthesis-dependent	 single	 strand	 annealing	 (SDSA)	 or	
through	migrating	double	Holliday	junction	intermediates	that	are	cleaved	through	the	
use	of	resolvases	or	dissolved	by	the	BLM-RMI-TOP3α	complex.	(Figure	adapted	from	
Panier	et	al.,	2014)	
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1.1.2.2.2 – Non-homologous end-joining (NHEJ).  
NHEJ occurs in both proliferating and in terminally differentiated cells and unlike 
HR, does not require a sister chromatid as a template. Instead NHEJ alters the 
two broken ends by various nucleases (Lees-Miller, 2003) (Lieber, Gu, Lu, et al., 
2009), so that they become compatible i.e. a 3’-hydroxyl and 5’-phosphate end 
is available for ligation. The ends are then re-ligated through the use of Ligase 
IV. The steps involved are outlined in (Figure 1.1).  It begins with the Ku70/Ku80 
heterodimer binding to both ends of the break (Rivera-Calzada, Spagnolo, Pearl, 
et al., 2006; Walker, Corpina & Goldberg, 2001). This aligns the ends of the DNA 
through binding of the sugar phosphate backbone. These proteins form a 
complex with DNA-PK and its catalytic subunit (DNA-PKCS). The ends are 
processed by Artemis (Goodarzi, Yu, Riballo, et al., 2006), XRCC4, DNA Ligase 
IV and XLF which facilitates the ligation of the DNA ends(Ahnesorg, Smith & 
Jackson, 2006a; Riballo, Woodbine, Stiff, et al., 2008). There is a slight difference 
between classic and alternate NHEJ. Classical NHEJ involves the direct ligation 
of free DNA ends. However, alt-NHEJ may require end trimming that makes it 
less accurate. The choice between classic and the alternate pathway is 
regulated by 53BP1 and PARP1 (Moshous, Callebaut, de Chasseval, et al., 
2001). 53BP1 promotes classic NHEJ and PARP1 alternate NHEJ. Alt-NHEJ 
involves increased resection of the free ends to allow micro-homologies to be 
found, this makes alt-NHEJ less accurate and more likely to result in large 
deletions or translocations. Classic NHEJ is initiated by the binding of KU70/80 
to protect the ends before recruiting DNA-PKCS, Artemis and others to allow 
more efficient ligation. These factors limit resection and promote ligation of 
broken ends involving little or no micro-homology. Defects in classic NHEJ 
channels DSBs towards alt-NHEJ where PARP1 binds to the free ends instead 
of the KU complex. Alt-NHEJ requires resection by MRN and CtIP, this resection 
exposes micro-homologies to promote pairing of broken ends which are then 
ligated by Lig III/XRCC1. Suppression of Alt-NHEJ is achieved by 53BP1 which 
restricts end-processing by MRN/CtIP (Shaheen, Allen, Nickoloff, et al., 2011).  
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Compared with HR, NHEJ is error-prone and though it is the main DNA repair 
pathway in human cells, it can lead to genomic rearrangements, deletions and 
mutations which can lead to cell death. Deficiencies in HR and NHEJ has been 
linked to various disorders (O’Driscoll & Jeggo, 2006).  
 
1.1.2.3 – Repair of Altered Bases 
Though double strand breaks are the most deleterious forms of DNA damage 
single strand breaks also occur. These are discontinuities in one strand of the 
DNA which if left unrepaired can turn into double strand breaks. There are many 
different pathways to repair single strand breaks (Caldecott, Abrahams & 
Geschwind, 2008).  
 
1.1.2.3.1 – Nucleotide Excision Repair (NER). 
NER deals with the major UV photoproducts in DNA as well as DNA adducts. 
NER works through a multi-step ‘cut and patch’ type reaction(Ogi, 
Limsirichaikul, Overmeer, et al., 2010). There are two sub-pathways in NER, the 
first is the global genome NER (GG-NER) which prevents mutagenesis by 
probing the genome for helix distorting lesions and the other is transcriptional 
coupled NER (TC-NER) which removes transcription-blocking lesions to permit 
unperturbed gene expression (Marteijn, Lans, Vermeulen, et al., 2014). 
Interestingly defects in GG-NER results in cancer predisposition and defects in 
TC-NER cause a variety of diseases such as Xeroderma pigmentosum and 
Cockayne syndrome (Rapin, Lindenbaum, Dickson, et al., 2000). The difference 
between the two sub-pathways is at the point of damage recognition. In GG-
NER XPC-RAD23B finds bulky distortions in the helix structures, whereas TC-
NER involves the recruitment of CSB, CDSA and XAB2 to arrested RNA 
polymerases. Once the site of damage is identified the pathways come together 
to form a common repair process. TFIIH, a complex consisting of a 7 subunit 
core (XPD, XPB, P62, P52, P44, P34 and TTDA) and a 3 subunit (CDK7, Cyclin 
H and Mat1) cyclin activating kinase complex (CAK) is recruited to the site of 
damage(Dijk, Typas, Mullenders, et al., 2014). XPB and XPD, 5’-3’ and 3’-5’ DNA 
helicases, found in the TFIIH complex unwind the helix in proximity to the lesion 
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located in the DNA(Rapin, Lindenbaum, Dickson, et al., 2000). Following 
unwinding, recruitment of XPA and RPA results in the dissociation of the CAK 
complex and protection of the single stranded DNA. This allows the full opening 
of the DNA around the lesion to occur. This favours the recruitment of XPG and 
XPF endonucleases to incise and remove a short stretch of single-stranded DNA 
of about 25-30 nucleotides containing the lesion. Polymerases are then recruited 
through PCNA, RPA and the clamp loader RCF to fill in the excised fragment 
(Dijk, Typas, Mullenders, et al., 2014; Rapin, Lindenbaum, Dickson, et al., 2000). 
LigI-FEN1 in S phase, or Lig IIIa-XRCC1 throughout the remainder of the cell 
cycle are recruited to seal the phosphate backbone and restore the integrity of 
the DNA(Caldecott, 2014).  
 
1.1.2.3.2 – Mismatch Repair (MMR). 
Correct structure of the helical DNA and maintenance of genetic integrity is 
dependent on the fidelity of DNA replication and the need to follow the Watson-
Crick base pairing sequence. This means that in the DNA sequence, Guanine 
must pair with Cytosine and Adenine must pair with Thymine. MMR is 
responsible for scanning and maintaining this sequence by correcting mismatch 
base substitutions and insertion-deletion mismatches. DNA replication must 
proceed with both efficiency and accuracy. To help ensure fidelity DNA 
polymerases have high nucleotide sensitivity and an ability to proof-read, a 
process that enables the polymerase to identify an incorrect base pair, reverse 
its direction by one base pair of DNA and excise and replace the mismatched 
base during DNA replication(Kunkel & Erie, 2005). Some polymerases, 
specifically translesion synthesis polymerases, increase the frequency of 
mismatch bases (Sale, Lehmann & Woodgate, 2012). Furthermore 
microsatellites can lead to polymerase slippage which can cause insertions and 
deletions (Goellner, Tester & Thibodeau, 1997; Kunkel, 2003; Lange, Takata & 
Wood, 2011).  
 
Mismatched bases are identified by MutS, one of two major heterodimeric 
mismatch repair complexes. MutS consists of MutSa and MutSb. The 
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identification and binding of MutS results in recruitment of multiple MutL 
complexes. MutL consists of MutLa, MutLb and MutLg (Kunkel & Erie, 2005). 
Once the mismatch repair pathway is activated PCNA binds and MutL’s 
endonuclease activity creates a nick in the DNA backbone (Modrich, 1994; 
Kunkel & Erie, 2005). After the nick is created EXO1 can remove the stretch 
containing the mismatch leading to a region of ssDNA, which ends when EXO1 
collides with an Okazaki fragment (Genschel, Bazemore & Modrich, 2002) or a 
second MutL created nick. RPA coats the newly exposed ssDNA until replicative 
polymerases and the relevant ligases repair the DNA.  
 
1.1.2.3.3 – Base Excision Repair (BER) 
Base excision repair removes small non-helix distorting base lesions which are 
often caused by deamination, oxidation and alkylation (Lindahl, 1999). The base 
damage is recognized and removed by glycosylases, either specific mono- or 
bi- functional proteins that results in a single-strand DNA break. The single-
strand break is repaired by the single-strand break repair pathway(Dianov & 
Hübscher, 2013).  
 
There are many different known DNA glycosylases that fall into one of six known 
super families (Brooks, Adhikary, Rubinson, et al., 2013). They are divided into 
structural super families based upon their substrate action though their mode of 
action is shared throughout. The mode of action encompasses a flipping action 
of the damaged base, basically flipping the damaged base into the glycosylases 
active pocket(Jacobs & Schär, 2011). The cleavage mechanism is divided into 
mono- and bi-functional enzymes. Once the damaged base has been identified 
the N-glycosidic bond is cleaved through nucleophilic attack leaving an abasic 
site. This cleavage activity is found in both mono- and bi- functional enzymes. 
Unlike the mono-functional enzyme the bi-functional activity also has the 
capability to convert the base lesion into a DNA single strand break that does 
not require AP endonuclease activity (Dianov & Hübscher, 2013).  Currently there 
are six mono-functional DNA glycosylases (UNG, SMUG1, MBD4, TDG, MYH 
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and MPG) and five bi-functional (OGG1, NTLH1, NEIL1, NEIL2 and NEIL3) 
(Jacobs & Schär, 2011).  
1.1.2.3.4 – Single Strand Break Repair. 
Whilst not as toxic as double-strand breaks, single-strand breaks are 
approximately one order of magnitude more frequent. Single strand breaks can 
occur as a result of direct damage caused by reactive oxygen species, collision 
with transcription machinery, due to stalled complexes of endogenous enzymes 
such as ligases and TOP1 or as mentioned previously as an intermediate of base 
excision repair (BÃ¼rkle & Virág, 2013). If single strand breaks are not repaired 
in a timely fashion this can impact the cell in multiple ways. In replicating cells, 
it can lead to replication fork collapse and double strand breaks. Collision with 
the RNA polymerase and the transcription complex can result in stalled 
transcription, premature termination of protein synthesis and incorporation of 
RNA loops(Dianov & Hübscher, 2013). 
 
Single strand break repair is a multi-step process (Caldecott, Abrahams & 
Geschwind, 2008; Caldecott, 2014). Firstly, the single-stranded break is 
detected by poly-ADP ribose polymerase (PARP). Following this PARP becomes 
activated and synthesises chains of ADP-ribose(Caldecott, 2014). Activation of 
PARP allows for chromatin remodelling and sequestering of the XRCC1 
chaperone protein. 
 
XRCC1 interacts with several end-processing enzymes such as ligase III, PNKP, 
PARP and TDP1 and this allows the damaged termini to be processed.  
 
Following detection, end-processing allows enzymes to modify the break termini 
to efficiently cleave the modification and restore the required 3’-OH and 5’-P for 
ligation (Caldecott, 2014). The next step involves gap filling, which can result in 
the divergence of this particular pathway. These are termed long patch or short 
patch repair. If only one nucleotide is required to fill the gap then this leads to 
short-gap repair where XRCC1 and LigIIIa are the main enzymes. However, long 
patch repair is involved for lesions between 2-12 nucleotides (Caldecott, 2014). 
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This results in the removal of the protrusion of single-strand DNA by FEN1, and 
gap filling by Polb, Pold or Pole before ligation. The final step in the repair 
pathway is the sealing of the phosphate backbone. This is done in an ATP 
dependent manner and varies depending on the repair pathways. If it involved 
short-patch repair then LigIIIa is used or LigI in long patch repair(Caldecott, 
2014). 
 
1.1.2.3.5 – Translesion synthesis.  
Translesion synthesis (TLS) is a DNA damage tolerance process that allows the 
DNA replication machinery to replicate past DNA lesions such as thymine dimers 
or AP sites (Sale, 2013). This process involves switching out regular DNA 
polymerases for specialised translesion polymerases, such as DNA polymerase 
IV, or V from the Y polymerase family (Sale, 2013). The polymerase switching is 
thought to be mediated by, amongst other factors, the post-translational 
modification of PCNA(Bienko, Green, Sabbioneda, et al., 2010). TLS 
polymerases often have low fidelity, that is they have a high propensity to insert 
wrong bases on undamaged templates relative to regular polymerases. From a 
cellular perspective, risking the introduction of point mutations during TLS may 
be preferable to resorting to more drastic mechanisms of DNA repair that could 
result in gross chromosomal aberrations or cell death(Kim & D’Andrea, 2012; 
Sale, 2013).  
 
1.1.2.3.6 – The Global Response to DNA Damage.  
The global response to DNA damage is the way cells act out of self-preservation. 
Cells can trigger multiple pathways of macromolecular repair, lesion bypass, 
tolerance or even apoptosis. Common features include checkpoint activation, 
transcription, cell cycle arrest and inhibition of cell division. Following DNA 
damage cell cycle checkpoints are activated, this pauses the cell cycle and 
allows repair of the damage. Checkpoint activation can arrest cells at the G1/S, 
and G2/M boundaries and coordinate events intra-S (Bartek, Lukas & Lukas, 
2004; Chen, Szakal & Castellucci, 2013). Checkpoint activation is controlled by 
two master kinases, ATM and ATR (Marechal & Zou, 2013). Both ATM and ATR 
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kinases phosphorylate downstream targets in a signal transduction cascade 
leading to cell cycle arrest (Jazayeri, Falck, Lukas, et al., 2006). An important 
downstream target of ATM/ATR is p53 and is required for inducing apoptosis 
following DNA damage (Bartkova, Horejsí, Koed, et al., 2005). The cyclin-
dependent kinase inhibitor p21 is induced by both p53-dependent and p53 
independent mechanisms and can arrest the cell cycle at the G1/S and G2/M 
checkpoints by deactivating cyclin-dependent kinase complexes.  
 
Pathological effects of poor DNA repair include genetic deficiencies, which, in 
animal models, often show decreased life span and increased cancer incidence. 
Mice deficient in telomere maintenance mechanisms or the NHEJ pathway 
develop lymphoma and infections more often resulting in shorter lifespans than 
wild-type mice. However not every DNA repair deficiency creates the predicted 
effects for example mice with deficiency in the NER pathway exhibit shortened 
lifespan without the higher rates of mutation(Harada, Shiomi, Koike, et al., 1999).  
 
Accurate DNA repair is critical to maintain genomic integrity, however accurate 
chromosome segregation during mitosis is also an important factor. To this end 
a family of macromolecular complex are employed for chromosome 
condensation, sister chromatid cohesion and accurate chromosomal 
segregation. These complexes are known as the SMC family of protein 
complexes and are made up of cohesin, condensin and the SMC5/6 complex. 
 
1.2 – Structural Maintenance of Chromosomes Family of Complexes.  
The Structural Maintenance of Chromosome (SMC) proteins regulate the 
structural and functional organization of chromosomes in organisms ranging 
from bacteria to humans (Hirano, 2006). SMC family complexes have a unique 
architecture so that they can act as dynamic linkers of the genome. A series of 
genetic screens revealed crucial roles in both mitosis and meiosis, 
chromosome-wide gene regulation and recombination repair (Hirano, 2006). The 
family currently consists of cohesin (SMC1/3), condensin (SMC2/4) and SMC5/6 
(Uhlmann, 2016). Associated with the SMC heterodimers are a number of Non-
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SMC subunits, Scc1 and Scc3 in the case of cohesin and CAP-H, CAP-D and 
CAP-G for condensin. Smc5/6 is associated with six Non-SMC Elements Nse1-
6 in yeast and NSMCE1-4 in humans(Murray & Carr, 2008; Uhlmann, 2016). 
Structural analysis of SMC proteins shows they are similar in structure with two 
long coiled coil regions with a hinge region in the middle and globular amino and 
carboxyl groups at their terminal regions (Melby, Ciampaglio, Briscoe, et al., 
1998).  
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Figure	 1.2.	 Representations	 of	 SMC	 family	 of	 complexes.	 Cohesin,	 condensin	 and	
Smc5/6.	These	complexes	share	a	common	architecture.	Two	SMC	heterodimers,	and	a	
Kleisin	subunit	are	common	features	shared	by	all	three	members	of	the	SMC	family.	
The	 Kleisin	 subunit	 bridges	 the	 heads	 of	 the	 SMC	 heterodimers	 and	 in	 the	 case	 of	
cohesin	is	cleaved	to	allow	passage	of	DNA	and	is	so	named	for	the	Greek	word	kleisimo.	
In	the	Smc5/6	image,	1,	2,	3,	4,	5	and	6	refer	to	Nse1-6	where	Nse1	is	a	ubiquitin	ligase,	
Nse2	is	a	SUMO	ligase,	Nse3	is	a	MAGE	protein,	Nse4	is	the	Kleisin	subunit	and	Nse5/6	
are	HEAT	repeat	proteins.	(Figure	adapted	from	Murray	and	Carr	2008).	 
 
1.2.1 – Cohesin 
The core cohesin complex contains two SMC proteins, SMC1 and SMC3 and 
two non-SMC proteins: Scc3 in yeast/ STAG1,2, 3 (SA1, 2, 3) in human cells and 
a Kleisin subunit (Scc1(yeast) /RAD21/RAD21L or REC8 in humans). The 
composition depends on where the complex is localised as SA1 is found mainly 
at telomeric regions and SA2 at centromeres. SA3 is found in meiosis(Brooker & 
Berkowitz, 2014; Nasmyth & Haering, 2009) where the kleisin is REC8. The 
SMC1/3 subunits are flexible coiled-coil proteins that link tail to tail at the hinge 
and head to head at their ATPase heads to form a heterodimer. The Scc1 protein 
bridges the SMC1 and SMC3 heads which stabilises their interaction and 
recruits the remaining Scc3 (SA1, 2, 3), Pds5 and Wapl subunits (Haering, Löwe, 
Hochwagen, et al., 2002). Together these subunits form a ring-like complex that 
is proposed to physically interacts with the sister chromatids by topological 
	 21	
embrace from S phase of the cell cycle until the metaphase to anaphase 
transition(Nasmyth & Haering, 2009; Ocampo-Hafalla & Uhlmann, 2011).  
 
Cohesin must bind to chromosomes before the onset of DNA replication as this 
allows cohesin to establish functional linkages and its loading is dependent on 
the Scc2/4 loader(Bermudez, Farina, Higashi, et al., 2012). The mechanism in 
which cohesin binds to DNA has long been debated but it is thought to mediate 
sister chromatid cohesion by encircling the sister strands. Cleavage of the Scc1 
subunit by the protease separase at the metaphase to anaphase transition 
opens the ring and releases the sister chromatids to allow segregation into 
daughter cells (Sun, Kucej, Fan, et al., 2009).  
 
 
 
 
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1.3.	Cohesin	is	removed	from	DNA	in	two	distinct	mechanisms.	Phosphorylation	
of	STAG	and	the	presence	of	Wapl	degrades	cohesion	and	cleavage	of	Scc1	by	separase	
which	initiates	the	final	separation.		
	
The cohesin complex has been shown to play a crucial role in chromosome 
condensation and during the repair of double-stranded DNA by HR between 
sister chromatids(Mizuguchi, Mizuguchi, Fudenberg, et al., 2014; Wu & Yu, 
SA2	phosphorylation
Scc1	cleavage
Separase
Wapl
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2012). During S phase cohesion between sister chromatids is established and 
depends on Sororin, Esco1 and Esco2. Cohesin is removed from DNA in two 
distinct mechanisms, the first during prophase involves the phosphorylation of 
either STAG1 or STAG2 depending on the localisation of the cohesin. The 
second step involves the cleavage of Scc1 (RAD21) by separase (Sun, Kucej, 
Fan, et al., 2009). This is restricted to the metaphase/anaphase transition, and is 
inhibited by the spindle assembly checkpoint until all the chromosomes are 
correctly aligned at the metaphase plate. Inhibition is achieved through 
phosphorylation of serine 1126 of separase, by securin binding to separase and 
lastly through the bulk of separase being excluded from the nucleus (Sun, Kucej, 
Fan, et al., 2009).  
 
1.2.1.1 – The Scc2-Scc4 Cohesin Loader Complex.  
The Scc2/4 loader complex is conserved throughout many organisms 
(Bermudez, Farina, Higashi, et al., 2012). The mechanism of loading is thought 
to be by opening the cohesin ring through regulation of the ATPase domains in 
the SMC1-3 heads. Bermudez et al, 2012 shows that cohesin and Scc2/4 are 
bound weakly to chromatin normally, however following replication cohesin 
stably interacted with DNA whereas Scc2/4 does not. Loss of Scc1 (Kleisin) 
stops Scc2/4 interacting with centromeres from anaphase until late G1. Cohesin 
appears to trigger its own loading by enabling Scc2/4 to connect with 
chromosomal landmarks marked by the Ctf19 kinetochore subcomplex in 
budding yeast and CENP-P in humans (Fernius, Nerusheva, Galander, et al., 
2013). In humans, mutation of the loader complex in one allele does not appear 
to affect levels of cohesin however it can lead to the severe developmental 
disorder Cornelia de Lange syndrome (CdLS) (Xu, Sowa, Cardenas, et al., 2015; 
Kikuchi, Borek, Otwinowski, et al., 2016; Gard, Light, Xiong, et al., 2009).  
 
1.2.1.2 – Cohesin complex and developmental disorders.  
Disruption of normal cohesin activity during human development causes 
associated disorders known as Cohesinopathies. The most common of these is 
known as Cornelia de Lange Syndrome (CdLS), this affects between 1/10,000 
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and 1/30,000 live births(Xu, Sowa, Cardenas, et al., 2015). CdLS patients show 
a large degree of phenotypic variation which can include craniofacial 
abnormalities, microcephaly, developmental delay, hirsutism and upper limb 
abnormalities. Heterozygous mutations in NIPBL are the most common cause 
of CdLS accounting for almost 65 % of cases. The remaining percentage of 
cases have been attributed to mutations in SMC1A, SMC3, HDAC8 and RAD21. 
Cell lines from CdLS patients shows a signature change in expression levels of 
Scc2/4 as well as reduced levels of cohesin association in the promoter region 
of many of the affected genes(Bermudez, Farina & Higashi, 2012; Ocampo-
Hafalla & Uhlmann, 2011; Gard, Light, Xiong, et al., 2009). Another similar, but 
extremely rare disorder termed Roberts syndrome (RBS) is caused by recessive 
mutation in ESCO2 which acetylates SMC3. Roberts syndrome patients exhibit 
many similar phenotypes as CdLS patients(Xu, Lu & Gerton, 2014).  
 
1.2.1.3 – Cohesin complex and cancer.  
Mutations in cohesin associated with cancer were first reported in 2008 when 
Barber et al, identified heterozygous somatic missense mutations in genes 
encoding SMC1A, SMC3, NIPBL and STAG3 (a component of meiotic cohesin) 
associated with colon cancers (Barber, McManus, Yuen, et al., 2008; Hill, Kim & 
Waldman, 2016). Individual deletions of RAD21 and STAG2 were reported in 
2010 to be found in chronic myelomonocytic (CML) and acute myeloid 
leukaemia (AML) amongst others(Xu, Balakrishnan, Malaterre, et al., 2010; Deb, 
Xu, Tuynman, et al., 2014). Since the initial discovery of cohesin mutations in 
colon cancer numerous studies have demonstrated that cohesin gene 
inactivation is a common and important event in the pathogenesis of diverse 
human cancers including bladder cancer, Ewing sarcoma and myeloid 
malignancies as well as glioblastoma multiforme, endometrial carcinoma and 
other tumour types(Hill, Kim & Waldman, 2016). The most commonly mutated of 
these is STAG2, with other cohesin genes including RAD21, SMC1A, SMC3 and 
NIPBL at a lower level suggesting STAG2 is a tumour suppressor (Hill, Kim & 
Waldman, 2016). It is likely that in the coming years a dramatic improvement in 
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the understanding of key cancer-relevant biochemical effects and phenotypes 
of cohesin inactivation in the pathogenesis of cancer will emerge. 
 
1.2.2 – Condensin 
Another member of the SMC superfamily is condensin and, as the name 
suggests, this plays a central role in chromosome condensation and segregation 
during both mitosis and meiosis(Piazza, Haering & Rutkowska, 2013). There are 
two forms of condensin in human cells, condensin I and condensin II. Both forms 
are comprised of five subunits, however they both have a pair of core subunits, 
SMC2 and SMC4 (Hirano, 2006). Each of the complexes contains a distinct set 
of Non-SMC regulatory subunits, a pair of HEAT-repeat subunits and a Kleisin 
subunit to bridge the SMC2/4 heads. Condensin I contains CAP-D2 and CAP-G 
as their HEAT repeats and CAP-H as the Kleisin. Condensin II contains CAP-D3 
and CAP-G2 as its HEAT repeats and CAP-H2 as its Kleisin(Hirano, 2005). 
Condensin I is conserved from yeast to humans, but yeasts have no condensin 
II. Loss of members of the condensin complex leads to embryonic lethality, 
knockdown of SMC2 using siRNA show modest defects in condensation in 
metaphase but become severe in anaphase(Sutani, Sakata, Nakato, et al., 2015). 
 
In cells condensin I and condensin II have different activities depending on the 
stage of the cell cycle. In mammalian cells, condensin I is sequestered in the 
cytoplasm during interphase and only gains access to chromosomes after 
nuclear envelope breakdown (NEBD) in prometaphase(Hirano, 2012; Yokoyama, 
Zhu, Zhang, et al., 2015). Condensin II on the other hand is localised to 
chromosomes from interphase through prophase and participates in the early 
stages of chromosome condensation within the prophase nucleus. After NEBD 
both condensin I and condensin II collaborate to support proper assembly of 
chromosomes in which sister chromatids are well resolved by metaphase.  
 
Altering levels of condensin in various cells can have effects on the morphology 
of chromosomes, however this varies depending on the organism. In Xenopous 
extracts there is a 5:1 ratio of condensin I to condensin II, in HeLa cells there is 
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a 1:1 ratio. Altering levels of condensin I to 1:1 with condensin II in Xenopous 
extracts leads to shorter and thicker chromosomes (Green, Kalitsis, Chang, et 
al., 2012). When condensin II was depleted to 1:0 the chromosomes appeared 
longer. This strongly suggested condensin II primarily contributes to axial 
shortening of chromatids, whereas condensin I supports their lateral 
compaction(Yokoyama, Zhu, Zhang, et al., 2015).   
 
1.2.2.1 – Cell cycle regulators of Condensins. 
Attempting to understand the cell cycle regulation of condensin is very difficult 
given the multi-subunit architecture of both condensins and their diverse 
functionality in chromosome dynamics(Hirano, 2005). There are a wide range of 
regulatory signals imposed on condensin subunits that control their localization, 
loading/unloading, activation/inactivation and fine-tuning these events. The 
regulators of condensin are wide and varied, a multitude of mitotic kinases such 
as Ckd1, Aurora B and Polo-like kinases have been shown to phosphorylate and 
regulate condensins though their contribution is dependent on different 
organisms(Piazza, Haering & Rutkowska, 2013; Sutani, Sakata, Nakato, et al., 
2015).  
 
 
1.2.3 – The SMC5/6 Complex. 
1.2.3.1 – Discovery of SMC5/6  
smc6 was first identified in 1975 as rad18 in fission yeast in a screen for mutants 
sensitive to DNA damage (Nasim & Smith, 1975) and cloned and characterised 
in 1995 (Lehmann, Walicka, Griffiths, et al., 1995). The rad18-X mutant was 
shown to have increased sensitivity to both UV and gamma irradiation 
(Lehmann, Walicka, Griffiths, et al., 1995). The homologue in Saccharomyces 
cerevisiae RHC18 was also identified. Both rad18 and RHC18 were found to be 
required for DNA repair and gene deletion showed both were essential for cell 
viability (Lehmann, Walicka, Griffiths, et al., 1995). Five years later the rad18 
partner in S. pombe, spr18, was identified and also found to be essential 
(Fousteri & Lehmann, 2000). Sequence analysis revealed both Rad18 and Spr18 
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to be members of the SMC superfamily. To avoid confusion with the S. 
cerevisiae post replication repair protein Rad18 and to highlight the conservation 
with other SMC proteins, Rad18 and Spr18 were later named smc6 and smc5, 
respectively, and this nomenclature is used across organisms in an effort to 
improve clarity.  
 
1.2.3.2 – Composition of SMC5/6  
Smc5 and Smc6, like other SMC proteins, have globular N- and C- terminal 
domains that are involved in ATP hydrolysis and Mg2+ binding(Lehmann, 
Walicka, Griffiths, et al., 1995). They also contain two extended α-helical coiled 
coil domains separated by a hinge region that is essential for the interaction 
between Smc5 and Smc6. The coiled coils fold back at the hinge region creating 
two 50 nm structures. As with the other members of the SMC superfamily, 
cohesin and condensin, SMC5/6 was found to form a complex made of the core 
Smc5 and Smc6 proteins and Non-SMC-Elements. In yeasts these are referred 
to as NSE’s whilst in humans they are referred to as NSMCE’s (Sergeant, Taylor, 
Palecek, et al., 2005). See Table 1.1 for a list of genes and proteins that form the 
complex across various species. In 2001 human homologues of Smc5 and Smc6 
were characterised(Taylor, Moghraby, Lees, et al., 2001). In 2008 the other 
members of the SMC5/6 complex in humans were identified (Taylor, Copsey, 
Hudson, et al., 2008a). Smc5/6 is associated with six Non-SMC Elements, Nse1-
6 in yeast and NSMCE1-4 in humans(Murray & Carr, 2008; Uhlmann, 2016). Nse1 
resembles a RING-finger ubiquitin E3 ligase, Nse2 functions as an E3 SUMO 
ligase, Nse3 forms a MAGE domain, Nse4 resembles a kleisin subunit to bridge 
the heads of Smc5 and Smc6 and Nse5 and Nse6 also associate with the head 
domains. 
 
siRNA knockdown of members of the SMC5/6 complex showed that knockdown 
of any of the components drastically reduced the protein levels of other member 
of the complex, with the exception of NSMCE2. Similarly, knockdown of 
NSMCE2 resulted in reduced levels of NSMCE2 but not as significant a loss of 
the other components. These results suggest that all the components except for 
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NSMCE2 are necessary for the stability of the complex and in the absence of 
the complex the components are degraded (Taylor, Copsey, Hudson, et al., 
2008a).  
 
	
Table	1.1.	SMC5/6	complex	components	across	human,	yeasts	and	mouse.		
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1.2.3.2.1 – SMC6  
Mutations in Smc5/6 results in defects in growth and defective DNA repair. 
Deletion mutants of Smc6 are lethal and therefore hypomorphic mutations are 
most commonly used to explore phenotypes. The two first hypomorphic 
mutants to be identified in fission yeast, smc6-74 and smc6-X, have been 
extensively characterised (Lehmann, Walicka, Griffiths, et al., 1995; Verkade, 
Bugg, Lindsay, et al., 1999; Irmisch, Ampatzidou, Mizuno, et al., 2009; 
Ampatzidou, Irmisch, O'Connell, et al., 2006). Both mutations are sensitive to 
DNA damage and have defects in homologous recombination (Verkade, Bugg, 
Lindsay, et al., 1999; Ampatzidou, Irmisch, O'Connell, et al., 2006; Irmisch, 
Ampatzidou, Mizuno, et al., 2009). The smc6-X mutation (R706C) maps close to 
the hinge region. The smc6-74 mutation (A151T) is within a highly conserved 
arginine finger in the ATP-binding pocket of the N-terminal globular domain. This 
suggests smc6-74 might affect DNA-dependent ATP binding/hydrolysis as 
mutations which affect the ATP binding sites are lethal (Verkade, Bugg, Lindsay, 
et al., 1999; Fousteri & Lehmann, 2000; Irmisch, Ampatzidou, Mizuno, et al., 
2009). Defects in smc6-74 but not smc6-X can be suppressed through 
overexpression of a multi-BRCT domain protein Brc1 (Verkade, Bugg, Lindsay, 
et al., 1999). Both mutants are defective in resolving HR-dependent 
intermediates that develop after collapsed replication forks (Ampatzidou, 
Irmisch, O'Connell, et al., 2006). Therefore, the Smc5/6 complex has a function 
processing HR intermediates generated at collapsed replication forks.  
 
1.2.3.2.2 – NSE2  
Nse2 supports both functions of Smc5/6 in cell growth and DNA repair, through 
docking to the arm region of Smc5. There are two distinct regions of Nse2. The 
N-terminal which is dedicated to Smc5 binding through formation of a helix 
bundle with a coiled-coil region of Smc5. Its C-terminal half includes the SUMO 
ligase domain, which adopts a RING E3 structure. Structural and mutational 
analysis show the interaction of Nse2 and Smc5 are required for cell growth and 
resistance to DNA damage. However, the RING domain confers specificity to 
the unique SUMO E2-E3 interaction. The Nse2 subunit is essential, but its 
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activities can be separated out as mutations that ablate the SUMO ligase can 
grow at a reasonable rate (Zhao & Blobel, 2005; Andrews, Palecek, Sergeant, et 
al., 2005; Sergeant, Taylor, Palecek, et al., 2005). The fission yeast nse2-SA 
mutant, harbouring mutation in the SP-RING domain that ablates the SUMO 
ligase activity, causes sensitivity to HU and MMS, however no sensitivity to UV 
is observed(Andrews, Palecek, Sergeant, et al., 2005). Mutations in Nse1 (C199S 
and C216S) can suppress the sensitivity of Nse2-SA (Tapia-Alveal & O'Connell, 
2011a; Andrews, Palecek, Sergeant, et al., 2005).  
In mice the NSMCE2 subunit suppresses recombination and micronuclei 
formation and is critical to prevent the onset of cancer and aging in 
mice(Jacome, Gutierrez-Martinez, Schiavoni, et al., 2015). Payne et al 2014 
demonstrated an association between compound heterozygosity for rare 
frameshift mutations in NSMCE2 in humans and primordial dwarfism, extreme 
insulin resistance and primary gonadal failure. 
 
1.2.3.2.3 – NSE1  
Nse1 contains a variant RING (Really Interesting New Gene) domain. Strains with 
cysteine to alanine mutations in the RING finger domain are viable but show DNA 
repair defects. Deletion of the RING finger domain is similarly defective in repair 
and inhibits the recruitment or retention of Smc5/6 to nuclear foci induced by 
DNA damage (Pebernard, McDonald, Pavlova, et al., 2004). Nse1’s RING finger 
domain has sequence similarity with an E3 ubiquitin ligase and has been 
demonstrated using recombinant proteins (McDonald, 2003; Pebernard, Perry, 
Tainer, et al., 2008). The activity is stimulated through its interaction with Nse3 
(Doyle, Gao, Wang, et al., 2010; Pebernard, Perry, Tainer, et al., 2008). Smc5/6 
is unique in that it is the only member of the SMC superfamily whose subunits 
have their own enzymatic functions and whilst it is attractive to have both SUMO 
and E3 ubiquitin ligase functions in one complex it has also been shown that 
both the SUMO and E3 ubiquitin ligase is required for SMC5/6 
function(Pebernard, McDonald, Pavlova, et al., 2004; McDonald, 2003). Nse1 
also has been shown to stabilize the interaction of Nse4 with Nse3 in the Nse1-
3-4 subcomplex. Nse1-C216S also suppresses phenotypes associated with 
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smc6-X and smc6-74 through post-replicative repair (PRR).(Tapia-Alveal & 
O'Connell, 2011b).  
 
1.2.3.2.4 – NSE3 
Nse3/NSMCE3 is related to the Melanoma Associated Antigen (MAGE) family of 
proteins. There are 55 MAGE genes in the human genome subdivided into 
different classes based on their protein structures. Many of them are expressed 
only in tumour cells or germ line cells. NSMCE3 maps to chromosome 15q, close 
to the autistic susceptibility region but it not involved in these disorders. It is 
closely related to MAGEF1 and expressed in all tissues (Taylor, Copsey, Hudson, 
et al., 2008a; Doyle, Gao, Wang, et al., 2010) 
 
1.2.3.2.5 – NSE4  
In SMC5/6, the Kleisin subunit is Nse4/NSMCE4 and bridges the head between 
SMC5 and SMC6, it is structurally similar to that of other kleisins. Cohesin’s 
kleisin, Scc1/RAD21 has an N-terminal helix-turn-helix which interacts with the 
SMC3 head whilst its C-terminal interacts with the two most C-terminal beta 
sheets of SMC1(Palecek, Vidot, Feng, et al., 2006). Nse4 possesses conserved 
hydrophobic patterns similar to other Kleisins.  Sequence threading algorithms 
revealed similar structural organisation compared to Scc1. Point mutations in 
Nse4 can disrupt interactions with Nse3 and Smc5 and some point mutations 
can disrupt the interaction with only Smc5 and still maintain an interaction with 
Nse3. Nse4’s interaction with SMC5 can be abolished by deletion of the 55 aa 
sequence of the SMC5 C-terminal. In cohesin Scc1 is cleaved prior to anaphase 
by separase, however removal of Nse4 does not follow this method and levels 
of Nse4 does not change during the cell cycle (Palecek, Vidot, Feng, et al., 2006). 
In humans there are two isoforms of NSMCE4, a and b, NSMCE4b is only found 
expressed in the male testis whereas NSMCE4a is expressed throughout the 
body(Bavner, 2005; Taylor, Copsey, Hudson, et al., 2008b). 
 
1.2.3.2.6 – NSE5 and NSE6  
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Finally, there are two additional components of Smc5/6 complex, Nse5 and 
Nse6. These are essential in budding yeast but non-essential in fission yeast 
(Pebernard, Wohlschlegel, McDonald, et al., 2006; Stephan, Kliszczak & 
Morrison, 2011) and not part of the core SMC5/6 complex in human cells (Taylor, 
Copsey, Hudson, et al., 2008a). Nse5 and Nse6 both interact with full length 
Smc5 and Smc6(Pebernard, Wohlschlegel, McDonald, et al., 2006). The 
interaction of Nse5 with Smc5 and Smc6 can be ablated through deletion of the 
globular heads of both. Deletion of the 55 aa of Smc5 that ablates the Nse4-
Smc5 interaction does not affect the interaction of Nse5-Smc5 showing that 
Nse5 binds Smc5 and Smc6 but at a site not shared by Nse4 (Palecek, Vidot, 
Feng, et al., 2006).This is also observed in Nse6 though at slightly different sites 
(Palecek, Vidot, Feng, et al., 2006). 
 
The Nse5 subunit of Smc5/6 interacts with SUMO pathway components. Using 
temperature sensitive alleles in budding yeast, Bustard et al 2016 were able to 
show that Nse5 physically associates with Ubc9 through SUMO (Branzei, Sollier, 
Liberi, et al., 2006; Bustard, Ball & Cobb, 2016). Cells carrying the Nse5-ts1 allele 
or lacking SIZ1 and SIZ2 results in a reduction of Smc5 SUMOylation after MMS 
treatment and a redundancy for SUMO mediated events in the presence of DNA 
damage. This suggests one new function of the Smc5/6 complex might be as a 
scaffold to allow SUMOylation events (Bustard, Ball & Cobb, 2016).   
 
 
1.2.3.3 – SMC5/6 localization on Chromatin.  
Smc5/6 has been found to be associated with chromatin in both budding and 
fission yeast, Xenopus laevis egg extracts and human cells (Zabrady, Adamus, 
Vondrova, et al., 2016; Verver, Hwang, Jordan, et al., 2015). Loading of Smc5/6 
onto chromatin is likely to be coupled with replication (Gallego-Paez, Tanaka, 
Bando, et al., 2014). ChIP analysis has shown some interesting overlap between 
localization between budding and fission yeast (Pebernard, Schaffer, Campbell, 
et al., 2008). In fission yeast it appears to localize throughout chromosomes 
(Pebernard, Schaffer, Campbell, et al., 2008), however in budding yeasts it is 
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enriched at intergenic regions and the relative abundance of Smc5/6 appears to 
increase as chromosome size increases (Potts, 2009). In both budding and 
fission yeast it is localized to centromeres and telomeres. The stage of the cell 
cycle affects the localization of Smc5/6 as S. cerevisiae shows maximal 
occupancy at centromeres during G2/M phase, where in S. pombe Smc5/6 
maximal occupancy is during S phase. This may be due to the lack of 
centromeric heterochromatin in budding yeast compared to fission yeast. In 
fission yeast Smc5/6 localization to centromeres is abolished in the absence of 
silencing. It is enriched at rDNA repeats in both budding and fission yeast. 
Enrichment at rDNA in both S. pombe and S. cerevisiae is hypothesised to be 
due to the difficulty in replicating these regions. Treatment with HU which 
induces replication stress and S phase arrest results in increased localisation of 
Smc5/6 to rDNA in S. pombe (Pebernard, Schaffer, Campbell, et al., 2008). In S. 
cerevisiae HU treatment diminishes the rDNA localisation. The reason for this is 
unclear but it is consistent with the fact that Smc5/6 shows maximal centromere 
localisation in G2/M rather than S phase (Pebernard, Schaffer, Campbell, et al., 
2008). In mouse and human cells SMC6 is translocated away from 
chromosomes during mitotic division, however, in budding yeast Smc6 is 
reported to be located at the centromeres (Gomez, Jordan, Viera, et al., 2013; 
Betts Lindroos, Ström, Itoh, et al., 2006; Yong-Gonzales, Hang, Castellucci, et 
al., 2012). Smc5/6 has also been showed to be enriched at genomic loci which 
are prone to replication fork stalling and collapse (Pebernard, Schaffer, 
Campbell, et al., 2008). 
 
1.2.3.4 – SMC5/6 Complex Promotes DNA DSB Repair.  
In both S. cerevisiae and S. pombe hypomorphic mutations in Smc5/6 results in 
sensitivity to a broad range of DNA damage agents. Inhibition of Smc5/6 in an 
HR-defective rad51 mutant background does not result in increased sensitivity, 
showing Smc5/6 to function in HR repair in both yeasts. Hypomorphic mutations 
of Smc5/6 in S. cerevisiae have been shown to result in increased number of 
translocations, gross chromosomal rearrangements confirming the complex is 
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required for genome maintenance and stability (Hwang, Smith, Ceschia, et al., 
2008). 
 
It was originally proposed that in humans the SMC5/6 complex promoted sister 
chromatid homologous recombination by recruiting the cohesin complex to 
double-strand breaks (Potts, Porteus & Yu, 2006a). Cohesin is thought to 
promote HR through maintaining the close proximity of sister chromatids to 
DSBs (Potts, Porteus & Yu, 2006b). However, this was subsequently shown to 
be the results of off target effects of the SMC5/6 complex siRNAs used by the 
group (Wu, Kong, Ji, et al., 2012) 
 
RNAi mediated knockdown of SMC5/6 complex components in DT40 cells 
increases the efficiency of gene targeting due to a specific requirement of 
SMC5/6 in sister chromatid HR (Stephan, Kliszczak, Dodson, et al., 2011). 
Knockdown of SMC5/6 complex components decreases sister chromatid HR, 
but does not reduce NHEJ or intra-chromatid, homologue or extrachromosomal 
HR (Potts, Porteus & Yu, 2006b). SMC5/6 itself is recruited to nuclease induced 
DSBs. SUMOylation of cohesin SCC1 by NSMCE2 was shown to counteract the 
action of Wapl, a negative regulator of cohesin loading (Wu & Yu, 2012). ChIP 
analysis of mouse B cells showed SMC5 co-localizes with RPA and BRCA1 
(Barlow, Faryabi, Callén, et al., 2013). RPA is a single-strand binding protein 
required in DNA replication and repair (Liu, Doty, Gibson, et al., 2010) whilst 
BRAC1 is a protein involved in DSB repair (Roy, Chun & Powell, 2012). This 
suggests SMC5/6 binds to ssDNA substrates created during HR and DNA 
replication (Barlow, Faryabi, Callén, et al., 2013).  
 
The SMC5/6 complex has been shown to be recruited to sites of DSBs following 
laser-induced DNA lesions. Räschle et al 2015 explored how SMC5/6 is 
physically recruited to DNA lesions. A RAD18-SLF1-SLF2 recruitment pathway 
for the SMC5/6 complex to RNF8/RNF168-generated ubiquitylation sites at 
damaged DNA sites was found. SLF2 appears to be a distant ortholog of yeast 
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NSE6. Depletion of SL1 or SLF2 led to a reduction in cell survival(Räschle, 
Smeenk, Hansen, et al., 2015). 
 
1.2.3.5 – SMC5/6 in Meiosis.  
Meiosis is the process used in the production of egg and sperm cells for sexual 
reproduction(Youds & Boulton, 2011). The amount of DNA is halved and then 
restored when the sperm and egg unite to form a single cell in the offspring. It is 
a specialised cell division resulting in the generation of unique haploid cells. 
Similar to the mitotic cell cycle the steps involved include the normal G1, S and 
G2 stages. Meiosis differs from mitosis in that the cells undergo two cell 
divisions rather than the one observed in mitosis. Before the first division during 
S phase chromosomes are replicated and organised together as sister 
chromatids(Hirano, 2015). During mitosis identical sister chromatids undergo bi-
orientation and are pulled to the opposite poles of the cell thereby separating 
two identical set of chromosomes and giving rise to daughter cells that are 
identical to the mother cell. In meiosis, however, sister chromatids are mono-
orientated and separation of homologous chromosomes occurs instead in the 
first of two tandem division events (Argunhan, 2016). Before the first division 
event, homologous chromosomes pair and exchange genetic material. During 
the second division event, more like mitosis, sister chromatids undergo bi-
orientation, at 90 degrees compared to the previous division, and are pulled to 
opposite poles of the cell. As a result of the exchange of genetic material and 
the variation in chromosome separation compared to mitosis, meiosis results in 
the production of four unique daughter cells each with one set of chromosomes.  
 
Some specialized processes during meiosis I are used to facilitate the reduction 
in ploidy(Petronczki, Siomos & Nasmyth, 2003). Reciprocal recombination 
between nonsister chromatids of homologous chromosomes leads to the 
formation of chiasmata. The resulting exchange of genetic material can be 
advantageous for natural selection but also allows the homologous 
chromosome pairs to act as a single unit whilst aligning correctly on the 
metaphase plate during metaphase I(Petronczki, Siomos & Nasmyth, 2003). The 
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kinetochores of sister chromatids attach to spindles from the same pole through 
mono-orientation. Conversely, the kinetochores of homologues rather than 
sister chromatids attach to spindles from opposite poles of the cells, this is 
known as bi-orientation(Youds & Boulton, 2011). Therefore, homologous 
chromosomes as opposed to sister chromatids come under tension during 
meiosis I. Arm cohesion as opposed to centromeric cohesion is ablated at the 
onset of anaphase I. Loss of arm cohesion and resolution of chiasmata as 
crossover or noncrossover products liberates homologues from one another and 
leads to their separation in anaphase (Youds & Boulton, 2011). At this point 
centromeric cohesion is still maintained until the onset of anaphase II, where 
removal of cohesin allows for the separation of sister chromatids. Through this 
meiosis prevents the number of chromosome from doubling upon fertilisation 
and keeps the ploidy of a species with each successive generation.  
 
HR is integral to meiosis. Meiotic HR differs slightly in comparison to the 
recombination that occurs in mitotic cells. Meiotic HR occurs in the context of 
the synaptonemal complex (SC). This complex adheres homologues along their 
length and components of the SC promote HR specifically between homologous 
chromosomes as opposed to sister chromatids (Lao and Hunter 2010). Meiotic 
HR is induced early on in prophase I by programmed DSBs which must be 
repaired before chromosomes migrate to the metaphase plate and segregate in 
anaphase I. The breaks have to be repaired before chromosomes segregate 
otherwise genetic material may be lost and result in meiotic catastrophe.  
 
The Smc5/6 complex has been shown to be required to coordinate the formation 
and resolution of joint molecules to ensure meiotic divisions(Lilienthal, Kanno & 
SjÃ gren, 2013). During meiosis the SMC complex are required for two of the 
major functions of meiosis, recombination and chromosome segregation. Both 
cohesin and condensin’s function have been investigated; however, the role of 
SMC5/6 has remained ambiguous.  
 
	 36	
Copsey et al 2013 showed specific essential meiotic functions where Smc5/6 is 
required in the recombination step and for the regulation of cohesin(Copsey, 
Tang, Jordan, et al., 2013). Data suggests Smc5/6 is required for specific 
recombination and chromosomal processes throughout meiosis and that in its 
absence attempts at cell division with unresolved joint molecule and residual 
cohesin leads to severe recombination induced meiotic catastrophe. smc5 and 
nse4 meiosis-specific shut off mutants in S. cerevisiae cells still try to undergo 
chromosome separation and this results in meiotic catastrophe. Smc5/6 
mutants accumulate unresolved joint molecules and fail to stall meiosis in order 
to resolve these structures(Copsey, Tang, Jordan, et al., 2013).  
 
Pebernard et al 2004 showed nse1, nse2 and nse3 are essential for meiosis in 
fission yeast (Pebernard, McDonald, Pavlova, et al., 2004). nse1 mutants 
displays meiotic DNA segregation and HR defects and nse2 and nse3 mutants 
had issues with mutant spore viability being reduced. The frequency of meiotic 
crossovers is vastly reduced in nse1 mutants whereas nse2 and nse3 mutants 
appear to be unaffected(Pebernard, McDonald, Pavlova, et al., 2004). These 
meiotic studies using the nse mutants were performed using hypomorphic 
mutants rather than depletion suggesting that the differences observed in the 
nse2 and nse3 mutants may be due to residual function in the alleles. It is also 
possible the Nse- subunits play a role in both recombination dependent and 
independent pathways of meiosis. From the data it suggests Nse1 plays a role 
in both, whilst Nse2 and Nse3 play role only in the independent 
pathways(Pebernard, McDonald, Pavlova, et al., 2004). 
 
1.2.3.6 – SMC5/6 in ALT Pathway.  
In comparison to many bacteria and archaea the eukaryotic nuclear genome is 
made up of linear chromosomes(Henson, Neumann & Yeager, 2002; Cesare & 
Reddel, 2010). Linear chromosomes pose a technical problem as their telomeres 
must be distinguished from chromosome breaks to avoid repair pathways being 
activated which may result in end-to-end fusions. Moreover, they have an issue 
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in that their ends cannot be completely replicated therefore the telomeres 
shorten following each round of DNA replication.  
 
For a cell to live forever it must, amongst many other things counteract the 
telomere shortening that accompanies DNA replication. In human cancers this 
typically occurs through two mechanisms, either reactivation of telomerase 
activity or in approximately 15 % of cancers through the alternative lengthening 
of telomeres (ALT) pathway. This pathway is dependent on homologous 
recombination and is therefore important for targeting in cancer therapy(Henson, 
Neumann & Yeager, 2002).  
 
Telomeres normally consist of a repetitive hexameric sequence (5’-TTAGGG-3’) 
which are intertwined around the Shelterin complex. The telomeres form a 
protective cap at the end of each chromosome. As this sequence is highly 
repetitive, new telomeric DNA can be generated by copying another molecule 
that contains the same sequence through the use of HR(Brouwer, Schimmel, 
Wiegant, et al., 2009). Interestingly, one of the main characteristics of ALT cancer 
cells is that the telomeric DNA is frequently dissociated from chromosomes. The 
extrachromosomal telomeric DNA can take many forms such as double-
stranded telomeric circles (t-circles) or single-stranded C-circles if it’s 
predominantly C rich or G-circles if it’s predominantly G-rich(Cesare & Reddel, 
2010). The extrachromosomal sequences appear to as serve as the template for 
ALT-mediated telomere elongation. The template can be taken from the end of 
a sister chromatid, the same telomere looping back on itself or even another 
telomere(Potts & Yu, 2007).  
 
Cells can use the ALT pathway during the stages of embryonic development or 
in the reprogramming of murine somatic cells into induced pluripotent stem 
cells. Attempting to target the ALT pathway has been challenging. Unlike 
reactivation of telomerase, the ALT pathway has no known specific and unique 
enzymatic activity, the enzymes which could be targeted all have an essential 
role in normal cellular pathways(Henson, Neumann & Yeager, 2002). The 
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presence of ALT activity is characterised by presence of ALT-associated 
promyelocytic leukaemia (PML) nuclear bodies or APBs, which indicate the 
abnormal presence of telomeres inside a complex formed from normally 
distributed nuclear proteins. The levels of C,G or t-circles in cells have been 
shown to accurately reflect the level of ALT activity(Henson, Neumann & Yeager, 
2002).  
 
Recombination-dependent telomere elongation. It’s generally agreed that 
telomere elongation in ALT cells require a DNA recombination step, the 
mechanism of which is uncertain(Draskovic, Arnoult, Steiner, et al., 2009). Two 
suggested methods include the unequal T-SCE model or homologous 
recombination-dependent DNA replication model. In the HR-dependent DNA 
replication model, ALT can result from the recombination mediated synthesis of 
telomeric DNA using existing telomeric sequence(Henson, Neumann & Yeager, 
2002; Cesare & Reddel, 2010).  
 
SMC5, SMC6 and NSMCE2 have been found to be required for ALT. SMC5/6 is 
required for HR so it should come as no surprise that repeated transfection of 
SMC5 and NSMCE2 siRNA resulted in gradual telomere shortening consistent 
with inhibition of telomere lengthening(Potts & Yu, 2007). However, since the 
siRNAs used in this study have subsequently been shown to have off target 
effects (Wu, Kong, Ji, et al., 2012) this study needs to be re-evaluated. Potts et 
al, 2006, showed, by overexpression of NSMCE2, NSMCE2-mediated 
SUMOylation of Shelterin complex components. NSMCE2 can SUMOylate 
TRF1, TRF2, TRF1-interacting nuclear protein and RAP1. The catalytic activity 
of NSMCE2 was necessary for the formation of APB. The exact mechanism of 
SMC5/6’s requirement in ALT is unknown, however, given that APBs are 
structural centres for telomere extension in ALT cells, SMC5/6 may be required 
for telomere recruitment to APBs through SUMOylation of Shelterin complex 
components (Potts & Yu, 2007). SMC5/6 may also function up or downstream 
of MRN through recruiting telomeres to APBs in which MRN may initiate 
recombination or through promoting telomere extension in APBs following MRN-
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dependent strand invasion respectively. SMC5/6 was observed to localise to 
PML bodies in ALT cells. 75 % of PML foci contained SMC5/6 complex and 
SMC5/6 colocalized with TRF2 in these PML bodies. This was observed in ALT 
positive cells, but not telomerase positive cells (Potts & Yu, 2007). 
 
1.3 – RNA interference  
The introduction of RNA into cells can be used to interfere with the function of 
endogenous gene expression. Andrew Fire and Craig Mello published that RNA 
interference (RNAi), as it would come to be known, exists in Caenorhabditis 
elegans to manipulate gene expression (Fire, Xu, Montgomery, et al., 1998). 
Activation of the RNAi pathway is controlled by activation of the RISC complex 
and is initiated by dsRNA in cell cytoplasm when it interacts with Argonaute. 
RNA can be introduced through exogenous and endogenous means(Bagasra & 
Prilliman, 2004).  
 
Endogenous RNAi is activated as dsRNA pre-mircoRNA which is expressed 
from RNA coding genes(Hamilton, Voinnet, Chappell, et al., 2002). Primary RNA 
transcripts are first processed to create the characteristic stem-loop of the pre-
mircoRNA in the nucleus which is then exported out of the nucleus and once it 
becomes part of the RISC complex is imported back into the nucleus. 
Exogenous RNAi can be delivered through naturally occurring viruses or 
experimentally in the lab using viruses or various transfection reagents before 
being processed by Dicer. Both exogenous and endogenous RNA pathways 
converge at the RISC step(MacRae, Zhou, Li, et al., 2006; Ye, Chen, Lian, et al., 
2015) (Figure 1.4).  
 
Pre-miRNA is genomically encoded non-coding RNAs that help to regulate gene 
expression (Carthew & Sontheimer, 2009). Mature miRNAs are structurally 
similar to siRNA, however prior to becoming mature they must undergo 
extensive post-transcriptional modification(Carthew & Sontheimer, 2009). 
miRNA is expressed from a much longer RNA-coding gene as a primary 
transcript known as a pre-miRNA which is processed in the cell nucleus to a 70-
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nucleotide stem-loop by the microprocessor complex(Moffat & Sabatini, 2006). 
This complex consists of RNase III enzyme called Drosha and a dsRNA binding 
protein DGCR8(Moffat & Sabatini, 2006). Typically, miRNAs have incomplete 
base pairing to a target and inhibits the translation of many different mRNAs with 
similar sequences. In contrast, siRNAs typically base-pair perfectly and induce 
mRNA cleavage in only a single, specific target. In different organisms, such as 
Drosophila and C. elegans, miRNA and siRNA are processed by different and 
distinct argonaute and dicer enzymes. The dsRNA protein is cleaved by Dicer to 
produce the mature miRNA that is then integrated into the RISC complex, thus 
siRNA and miRNA share the same downstream cellular machinery(MacRae, 
Zhou, Li, et al., 2006; Ye, Chen, Lian, et al., 2015). 
 
Once the dsRNA has been created it needs to be unwound and only one strand 
can be bound by Argonaute and direct gene silencing(Ye, Chen, Lian, et al., 
2015). As the dsRNA forms two strands, one is known as the guide strand and 
the other the anti-guide or passenger strand(Kacsinta & Dowdy, 2015). The anti-
strand is often degraded. It is not known how the activated RISC complex 
locates complementary mRNAs within the cell, however, it is believed this is 
related to translation(Kacsinta & Dowdy, 2015; Echeverri & Perrimon, 2006).  
 
Exogenous activation of RNAi occurs when dsRNA is detected and bound to an 
effector protein, which in C. elegans is known as RDE-4 and in Drosophila R2D2, 
and this stimulates Dicer activity. TRBP (TAR RNA binding protein), which 
recruits Dicer to Ago2 for microRNA processing and facilitates the transfer of 
cleaved siRNAs into the RISC complex (Chendrimada, Gregory, Kumaraswamy, 
et al., 2005).  
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Figure	1.4.	Schematic	showing	how	RNA	interference	is	carried	out.	In	the	case	of	shRNA	
RNA	PolIII	 is	used	 to	 create	dsRNA	with	a	hairpin	 loop.	The	hairpin	 is	 then	 isolated	by	
Drosha	and	exported	from	the	nucleus	using	Exportin	5.	 	Following	this	the	pathway	is	
very	 similar	 between	 shRNA	 and	 siRNA,	 the	 RNAi	 pathway	 is	 initiated	 by	 the	 enzyme	
DICER,	which	cleaves	long	dsRNA	molecules	into	short	double	stranded	fragments.	Each	
siRNA	is	then	unwound	into	two	single	stranded	(ssRNAs)	known	as	the	passenger	and	
guide	strand.	Unless	it	can	be	used	the	passenger	strand	is	degraded	and	the	guide	strand	
incorporated	 into	the	RISC	complex.	RNAi	 is	used	for	 is	gene	silencing.	This	 is	achieved	
when	the	guide	RNA	molecule	pairs	with	a	complimentary	sequence	in	a	mRNA	molecule	
and	 through	 this	 induces	 cleavage	 by	Argonaute,	 the	 catalytic	 component	 of	 the	 RISC	
complex,	highlighted	here	by	AGO2.	After	this	is	achieved	the	process	begins	again	with	
RISC	complex	turnover	resulting	in	efficient	knockdown	despite	the	relatively	low	molar	
volume	of	RNA	used.		 
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1.3.1 – Regulation of genes using RNAi 
RNAi has many applications, the main one being gene regulation. Endogenously 
expressed miRNA are most important in translational repression and in the 
regulation of development especially on the timing of morphogenesis and 
maintenance of undifferentiated or incompletely differentiated cell types such as 
stem cells(Ye, Chen, Lian, et al., 2015; Carthew & Sontheimer, 2009). Use of 
RNAi in downregulation of genes was first described in 1993 in C. elegans using 
miRNA. This was also observed in plants when a specific miRNA in A. thaliana 
was shown to be involved in the regulation of several genes that control plant 
shape. In many organisms, including humans, miRNA expression is linked to the 
formation of tumours and dysregulation of the cell cycle. miRNAs, by that logic, 
can function as both oncogenes and tumour suppressors(Luo, Emanuele, Li, et 
al., 2009).  
 
In addition to downregulation, RNAi can be used to upregulate genes (Luo, 
Emanuele, Li, et al., 2009). The precise mechanism is unknown, however, Dicer 
and Argonaute are involved, possibly through histone demethylation(Wang, Lu, 
Wientjes, et al., 2010). siRNA and miRNA complementary to parts of the 
promoter region can increase gene transcription, dubbed RNA 
inactivation(Carthew & Sontheimer, 2009). miRNA have been proposed to 
upregulate their target genes upon cell cycle arrest, however, the mechanisms 
are unknown.  
 
1.3.2 – Use of RNAi in research 
In experimental biology, RNAi is most often exploited to study the function of 
genes in cell culture and model organisms(Mohr, Smith, Shamu, et al., 2014). 
dsRNA is synthesised with a sequence complementary to part of a gene of 
interest and then introduced into a cell or organisms whereupon it is recognised 
as exogenous genetic material and activates the RNAi pathway (Figure 1.4). 
Frequently, RNAi may not totally abolish expression of the gene, this technique 
is referred to as ‘knockdown’ rather than ‘knockout’ where expression of the 
gene is entirely eliminated. Exogenous RNAi can have off target effects so 
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extensive efforts have been directed toward the design of successful dsRNA 
reagents that maximise knockdown of the target whilst minimising the off-target 
effect. Off-target effects occur most frequently when the dsRNA contain 
repetitive sequence(Moffat & Sabatini, 2006; Luo, Emanuele, Li, et al., 2009).  
 
Knockdown of proteins can be achieved in a number of ways. Normally protein 
levels are affected through delivery of siRNA (a 21-27 double stranded 
oligonucleotide with a two nucleotide 3’ overhang). Experimentally, RNAi can be 
delivered to cells in a number of ways(Mohr, Smith, Shamu, et al., 2014). 
Transfection of siRNA into cells can be used to cause transient knockdown in 
the short term. Long term RNAi can be achieved through the expression of 
shRNA which is delivered through ectopic expression as stem-loop, hairpin 
structures that resemble pre-microRNA, the endogenous substrate of DICER.  
 
Introduction of RNAi into cells and whole organisms can be achieved in a 
number of ways. In whole organisms such as C. elegans RNAi delivery can be 
achieved by feeding bacteria, such as E. coli that carry the dsRNA, to worms 
and the RNA payload is transferred via the intestinal tract (Sharma & Rao, 2009; 
Liu, Long, Xiong, et al., 2014). This is just as effective at inducing gene silencing 
as other mechanisms such as soaking the worms in dsRNA solution or injecting 
dsRNA into the worms gonads(Liu, Long, Xiong, et al., 2014).  
 
Delivery of RNAi into cell culture models depends on the purpose of the 
experiment. The site of siRNA therapeutic effect is in the cytosol(Wang, Lu, 
Wientjes, et al., 2010). Transfection of DNA or RNA molecules into mammalian 
cells in culture can be accomplished using various different protocols and 
reagents(Wang, Lu, Wientjes, et al., 2010). Chemical methods include liposome-
mediated, non-liposomal lipids, polyamines and dendrimers. Physical methods 
include electroporation or even microinjection. Viral-based systems can include 
retrovirus, adenovirus or lentivirus(Garvey, Spiller, Lindsay, et al., 2016; Wang, 
Lu, Wientjes, et al., 2010).  
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Lipid-based carriers use the formation of liposomes, micelles, microemulsions 
and solid lipid nanoparticles(Wang, Lu, Wientjes, et al., 2010). These liposomes 
are globular vesicles with an aqueous core and phospholipid bilayer which is 
comprised of lipids or sterols. Due to their relative simplicity and well understood 
pharmaceutical properties liposomes are commonly used as siRNA 
carriers(Wang, Lu, Wientjes, et al., 2010). They are synthetic analogues to mimic 
the phospholipid bilayer(Wang, Lu, Wientjes, et al., 2010). Transfection 
compounds share a number of characteristics with their natural counterparts 
including the presence of both a hydrophobic and hydrophilic region. This allows 
the formation of spheroid molecules with the presence of free DNA or RNA. The 
DNA or RNA is sequestered into the middle of the liposome with the hydrophobic 
region coating the outside. The complex passes through the cell membrane and 
allows the nucleic acids to be released into the cytoplasm. Electroporation is 
one of the fastest and potentially most efficient technique for delivering 
exogenous nucleic acids to suspension or non-adherent cells(Moffat & Sabatini, 
2006). It uses a pulse of electricity to create transient pores in the cellular 
membrane to enable to uptake of charged nucleic acid molecules. These are 
normally transient transfection methods; however, they can be used to establish 
stable cell lines also. Other common transfection methods from stable 
integration can include microinjection and virus-mediated gene delivery 
(transduction) (Liu, Long, Xiong, et al., 2014). Microinjection requires targeting 
specific cells within a population for gene delivery through microinjecting 
specific DNA sequences into the nuclei of target cells. A limitation however is 
that the number of cells that can be transfected is limited by the skill and time of 
the person performing the microinjection. Viruses can be used to deliver RNAi. 
Exogenous genes or probes can be introduced through viral transduction 
techniques such as using viruses as carriers. Viral delivery is most useful for 
stably transfecting primary cell culture. Once the genetic material is integrated 
into the host genome, transcription is dependent on the host cell for 
expression(Perrimon & Mathey-Prevot, 2006).  
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RNAi’s use in biotechnology is widespread from food, other crops, insecticides 
and transgenic plants. One of the biggest roles in biotechnology is genome scale 
RNAi using high-throughput screening technology (HTS). This allows the 
creation of genome-wide loss-of-function screening and broadly used in the 
identification of genes associated with specific phenotypes. RNAi HTS has the 
ability to interrogate thousands of genes with the capability to generate 
thousands of data points per experiment.  
 
1.4 – Screening  
By definition cellular phenotypes are observable characteristics of cells that arise 
as a result of interactions caused by intrinsic and extrinsic chemical or 
biochemical factors. Genetic screens have long been used to classify mutations 
on the basis of their visual phenotypes. One of the first screens was carried out 
in 1910 by Thomas Hunt Morgan who identified spontaneous mutations in 
Drosophila melanogaster that resulted in white eyes instead of red eyes (Kohler, 
1994). Morgan et al, followed this up by not only mapping the mutation to a 
chromosome but also by using X-ray radiation to induce mutations and then 
analysing the phenotypic consequences and inheritance patterns(Kohler, 1994). 
Laying the foundation of modern genetics and genetic screening.  
 
Image-based screens can explore a large number of basal or perturbed 
conditions that can be used to study the influences of these factors on cellular 
phenotypes (Zhang, 2011). Huge amounts of images can be taken of cells and 
these can be used to study hundreds of thousands of phenotypic descriptors in 
a vast array of experimental conditions. The use of normal phenotypic screening 
normally gives an arbitrary read out of cell viability(Bougen-Zhukov, Loh, Lee, et 
al., 2016). A 50 % reduction in cell viability after exposure to condition ‘x’ can be 
interpreted as either 1) the cell doubling time was twice as long compared to 
control population or 2) twice as many cells died compared to the control 
population(Bougen-Zhukov, Loh, Lee, et al., 2016).   
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1.4.1 – Synthetic lethality screens 
Synthetic lethality was first described almost 100 years ago in 1922 and named 
approximately 20 years later by Calvin Bridges and his colleague Theodore 
Dobzhansky. This was following the observation of a combination of mutations 
in Drosophila melanogaster which lead to death(Bridges, 1922; Dobzhansky, 
1946). Synthetic lethality arises when the combination of genetic perturbations 
leads to an increase in cell death, whilst the individual perturbations do not. To 
break it down further there are a range of outcomes following mutation or 
loss/knockdown of a gene. As shown in (Figure 1.5) synthetic lethality is the 
effect of mutating or knocking down/out both Gene A and Gene B resulting in 
cell death (Figure 1.5.E), whereas loss of one of these genes does not affect cell 
viability (Figure 1.5.B/D). If Gene A and B are both affected and viability is 
improved, then this is termed synthetic viable (Figure 1.5.F). However, if loss of 
both genes does not affect cell viability or exacerbate a phenotype then they can 
be said to be neutral (Figure 1.5.C).  
 
Synthetic lethal genetic interactions exist due to the way in which cells and 
organisms maintain their internal homeostasis (Kacsinta & Dowdy, 2015; 
Hopkins, McGregor, Murray, et al., 2016). Cells or organisms with strong internal 
homeostasis have strong genetic robustness. This is achieved through the 
establishment of several buffering mechanisms such as proteins with functional 
redundancy known as capacitors (Fece de la Cruz, Gapp & Nijman, 2015). 
Functional redundancy is defined as the situation where a given biochemical 
function is redundantly encoded by two or more genes and this means that if 
one gene is affected then the other takes over to ensure no loss in viability.  
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Much of the knowledge gained from exploring synthetic lethality has been 
acquired from experiments carried out in yeast(Forsburg, 2001). In yeasts, the 
large scale quantitative mapping of potential interaction has reached genome 
wide scales. The resulting information provides genetic interaction networks and 
are an invaluable source of knowledge about the function of genes (Dixon, 
Costanzo, Baryshnikova, et al., 2009). Drug-gene synthetic lethality has been 
employed extensively to characterise the mechanism of action of drugs and also 
their interactions (Barbour & Xiao, 2006). This can facilitate the development of 
new treatments using existing drugs. Clinical drugs with relatively unknown 
mechanisms of action include paracetamol and derivatives of thalidomide 
including thalidomide itself. Thalidomide, traditionally used to treat morning 
sickness but with catastrophic side effects and has been rebranded to treat 
cancer(Rajkumar & Kyle, 2005) but yet, their mechanisms remains elusive. 
A B C
D E F
Figure	 1.5.	 Schematic	 outlining	 the	 concept	 of	 synthetic	 lethality.	 A	 is	 a	 normal	
situation	where	the	presence	of	Gene	A	and	Gene	B	 is	unchanged	and	the	cells	are	
viable.	B	shows	when	Gene	A	is	affected	but	Gene	B	still	in	effect	within	the	pathway	
the	cell	 is	able	to	compensate	and	remain	viable.	C	shows	a	neutral	outcome	when	
both	Gene	A	and	Gene	B	are	affected	but	there	is	no	effect	on	the	cells	indicating	there	
is	no	crossover	in	function	between	the	two.	D	shows	a	similar	effect	to	A	where	Gene	
B	 is	 affected	 but	 Gene	 A,	 still	 being	 present,	 is	 able	 to	 overcome	 the	 stress	 and	
continue.	E	shows	a	synthetic	lethality/sick	outcome	where	the	knockout/knockdown	
or	mutation	 in	Gene	A	and	Gene	B	 show	 lethality,	 indicating	 there	 is	an	 overlap	 in	
function	 in	 these	 genes	 and	 loss	 of	 both	 is	 lethal	 to	 the	 cell.	F	 shows	 an	 opposite	
outcome.	When	both	Gene	A	and	Gene	B	are	affected,	this	confers	a	growth	advantage	
to	the	cell,	this	is	termed	synthetic	viability.	 
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Synthetic sick/lethal interaction screens can be used to design combination 
therapies and predict potential drug combinations that sensitize cells to other 
treatments or drugs with synergistic relationships. Identifying these situations 
can be particularly important in cases of cancer or infectious diseases which can 
quickly become resistant to conventional therapies.  
 
Using synthetic sick/lethal interactions to design anti-cancer treatments and 
chemotherapeutics provides the framework to fully understand the genetic 
background required for long standing chemotherapeutics (Kim, Kim, Miyata, et 
al., 2016; Turner, Lord, Iorns, et al., 2008). Conventionally drugs were designed 
to target fast dividing cells and kill them. However, the mechanism through 
which this was achieved was not always obvious and some cells respond in a 
different way to others. Understanding the interactions that would enable the 
specific toxicity in cancer cells is imperative.  
 
One of the biggest landmarks in synthetic lethality-based cancer therapy was 
the publication of papers describing the tumour suppressor and DNA repair 
genes BRCA1 and BRCA2 and their synthetic lethality with PARP 
inhibitors(Bryant, Schultz, Thomas, et al., 2005; Farmer, McCabe, Lord, et al., 
2005; Aly & Ganesan, 2011). Patients with mutated BRCA1/BRCA2 display 
synthetic lethality with another DNA repair enzyme, Poly ADP-Ribose 
Polymerase (PARP) (Bryant, Schultz, Thomas, et al., 2005; Farmer, McCabe, 
Lord, et al., 2005; Aly & Ganesan, 2011). The mechanism by which DNA is 
repaired is dependent upon the stage of cell cycle, the damage that is 
encountered and the type of damage caused. BRCA1, BRCA2 and PALB2 are 
involved in homologous recombination which is essential during S and G2 phase 
of the cell cycle(Roy, Chun & Powell, 2012; Krejci, Altmannova, Spirek, et al., 
2012). When these genes are mutated, cells can accumulate errors in DNA repair 
pathways. This can lead to chromosomal rearrangements and transclocations, 
known hallmarks of cancer(O’Neil, van Pel & Hieter, 2013). PARP is required to 
repair DNA single strand breaks through the single strand break repair 
pathway(Krishnakumar & Kraus, 2010). If repair is inhibited, then in S phase 
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passage of the replication fork converts the single strand breaks to double 
strand breaks. Drugs that inhibit PARP work by binding PARP to DNA. As the 
DNA is being replicated the replication fork collides with the PARP-DNA complex 
inducing one-ended double strand breaks(Krishnakumar & Kraus, 2010; Aly & 
Ganesan, 2011), which must be repaired through HR. Cells deficient in BRCA1, 
BRCA2 or PALB2 cannot repair DSBs through HR. This leads to increased cell 
death (Bryant, Schultz, Thomas, et al., 2005; Farmer, McCabe, Lord, et al., 2005; 
Aly & Ganesan, 2011; Lord, Tutt & Ashworth, 2015).  
 
Most synthetic lethality screens have been carried out in yeasts where gene 
knockout collections have driven this approach (Giaever & Nislow, 2014). Whilst 
understanding gene-gene interaction is easier in the relatively small genome size 
of yeasts screens in human cells have been limited by the fact that RNAi has 
until recently been prohibitively expensive. Screens were restricted to using 
chemical compounds as a scalable approach to identify gene-gene interactions 
was not unfeasible due to cost (Luo, Emanuele, Li, et al., 2009). Recent reduction 
in cost of RNAi has made it possible to systematically identify synthetic lethal 
interactions in human cells and a variety of screening strategies have been 
developed. The development of screens involves many steps: 1) determining the 
target or marker, 2) creating a suitable cellular model, 3) finding and establishing 
the most relevant screening method, 4) determining assay kinetics and 5) 
optimisation.  
 
1.4.2 – High-throughput and high content screens  
High-throughput screens are cells based screens and measure a signal 
averaged over all cells within a microplate well then measuring the differences 
from the average(Zhang, 2011). A multitude of signals can be analysed including 
levels of a small molecule such as ATP and commonly cells can be assayed 
following perturbation of protein expression by RNAi or response after treatment 
with small molecules. Given the data is collected over the whole well it 
disregards information that may exist from individual cells(Zhang, 2011; 
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Echeverri & Perrimon, 2006). Homogenous cell-based assays are normally 
limited to one or two measures in parallel.  
 
In contrast, microscopy-based, high-content assays allow for collection of data 
showing multiple several cell phenotypes. Cells can be modified to express 
fluorescently labelled proteins or stained with fluorescent markers that allow the 
visualisation of proteins and cellular phenotypes(Conrad & Gerlich, 2010; 
Garvey, Spiller, Lindsay, et al., 2016). One of the major breakthroughs in this 
type of screen involved the technological advances made in the field of 
microscopy such as more stable light sources, faster autofocus and most 
importantly automation. Other advances in general biology such as new 
fluorescent probes and fluorescent protein variants for use as reporters and 
fusion proteins. Whilst these advances allow the generation of large number of 
data the biggest bottle-neck has been in the field of image analysis and the 
availability of standardised software(Boutros, Heigwer & Laufer, 2015).  
 
Intrinsic-phenotype screens can be used to study phenotypes by monitoring 
different intrinsic factors while keeping cells under the same extrinsic factors or 
environmental conditions. Alternatively, extrinsic-phenotype screening can be 
used to monitor phenotypes by subjecting cells to different extrinsic factors or 
environmental conditions whilst keeping the same intrinsic biomolecular 
species. Although the purpose of the screen types may be different they often 
use similar experimental and computational methods. Intrinsic factors include 
biomolecules such as DNA, RNA, proteins or metabolites produced within the 
cells. Extrinsic factors include biomolecules or chemicals that originate from 
outside the cell such as the varying the environment or introducing radiation or 
drugs(Bougen-Zhukov, Loh, Lee, et al., 2016).  
 
If the molecular target of the extrinsic perturbation is known and specific, 
extrinsic screens can be used to infer the biomolecules that are involved in 
generating a specific phenotype such as apoptosis, cellular senescence or 
autophagy. This type of screen is referred to as reverse genetic or chemical 
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genetic screening(Turner, Lord, Iorns, et al., 2008). RNAi and the CRISPR Cas9 
system are two genetic perturbation techniques used routinely. RNAi is a form 
of post-transcriptional modification used to silence or reduce the levels of gene 
transcription. This involves long double-stranded RNA molecules, introduced as 
either siRNA or shRNA that are cleaved into siRNA and mediate sequence-
specific degradation of mRNA molecules. Image based screens involving siRNA 
knockdown of specific genes have been used to identify targets involved in cell 
division, cell migration and chromosome segregation amongst many 
others(Turner, Lord, Iorns, et al., 2008).  
 
This is a procedure to construct quantitative representations (or profiles) of 
cellular phenotypes based on the images collected in large-scale phenotypic 
screens. The profiles are used to build models or templates which can be used 
to automatically screen groups of intrinsic or extrinsic factors in the 
screens(Bougen-Zhukov, Loh, Lee, et al., 2016). Constructing a phenotypic 
profile involves identifying a subset of features that could be used to classify 
proteins localised in subcellular compartments, identify the effects of small 
molecules, determine new biomolecules that mediate biological process, 
identify protein localisation patterns amongst many others.  
 
When designing an experiment and establishing conditions for subsequent high-
throughput screens often require multiple rounds of protocol optimisations. 
Many factors must be considered before moving forward(Zhang, 2011). For 
example, what type of cells should be used, what is the intended size of the 
screen and what is the suitable scope of the experiment? Other considerations 
need to be taken too, for example what needs to be experimentally evaluated by 
examining a specific range of features. In setting up an assay the overall 
scientific question addressed by the experiment often dictates the parameters 
needing to be considered such as cell type used and phenotype screened. Many 
parameters are predetermined for example the cell type often controls the 
transfection protocol and timescale. An imaging assay often requires cell fixation 
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and staining. Image-analysis steps should be implemented in parallel as this 
provides direct feedback on the suitability of the assay.  
 
The collection of data is often one of the quickest steps, however understanding 
the data takes the longest. Once the images have been obtained as a raw image 
it needs to go through a few processing steps. Firstly, the image has to go 
through noise filtering and illumination correction, secondly it must go through 
histogram based or adaptive thresholding to ensure the area of interest can be 
included whilst the remainder is excluded, finally the image then undergoes 
object identification. These steps are of massive importance and ensures a strict 
quality control over all screens. It is important to ensure that image artefacts can 
be excluded from analysis, for example difficult cell shapes, under-segmentation 
where cells are clustered together and difficult to resolve this can be overcome 
where only the cell nucleus is required to be imaged however this poses a major 
issue when imaging the cytoplasm. The opposite condition of over-segregation 
might also pose an issue as there maybe not be enough cells to screen. 
Heterogeneous illumination may also pose a problem as it means there isn’t an 
even coverage of illumination throughout the field of view. Finally, general 
artefacts such as air bubbles or dirt may also pose an issue for screening a 
population of cells(Michael, Auld, Klumpp, et al., 2008). It has been suggested 
that over 200 features can be extracted from each single cell in a high-content 
screen. The data available from each screen is vast and depending on the 
parameters and gating it can allow for many different conclusions from a single 
assay(Zhang, 2011; Conrad & Gerlich, 2010).   
 
1.5 – Aims and Objectives.  
The main aim of this thesis was to explore the SMC5/6 complex in human cells. 
The initial focus was the development, execution and validation of a synthetic 
sick/lethal screen using knockdown of NSMCE4a and consequently SMC5 and 
SMC6. However, during the course of this project a collaboration was set up to 
explore the effects of a homozygous point mutation in NSMCE3, one of the 
components of the SMC5/6 complex, which resulted in a novel human 
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chromosome breakage syndrome. My final chapter is therefore a 
characterisation of the cellular phenotypes resulting from this mutation in patient 
fibroblasts. 
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2.0 – Materials and Methods 
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2.1 – Human cells 
 
 
2.2 – E.coli Strains 
DH5a – used for isolation of DNA 
Genotype: dlacZ Delta M15 Delta(lacZYA-argF) U169 recA1 endA1 hsdR17(rK-
mK+) supE44 thi-1 gyrA96 relA1 
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2.3 – S. pombe strains and plasmids 
 
2.4 – Materials.  
Solutions were made up with distilled water unless otherwise stated. Material 
and solutions were autoclaved at 125 °C for 15 minutes for sterilisation where 
possible. Filter sterilisation was carried out through a 0.2 µm filter (Nalgene). 
Storage was at room temperature unless stated.  
 
LB Broth (Autoclaved) 
Adjusted to pH 7.5 and made to 1 L with dH2O 
10 g tryptone 
5 g yeast extract 
10 g NaCl 
 
LB Agar (Autoclaved)  
To 500 mL of the prepared LB broth 
7.5 g Agar 
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TBE (5X) – to make 1 L of 5X stock 
54 g Tris Base 
27.5 g Boric Acid 
20 mL 0.5 M EDTA pH 8.0 
 
Transfer buffer (10X) – for 1 L of 10X stock 
31 g Tris base 
144 g glycine 
Made to 1 L using dH2O 
 
Transfer buffer (1X) 
100 mL 10X transfer buffer 
100 mL MeOH 
800 mL dH2O 
 
Tris-Glycine Electrophoresis buffer (running buffer) 
31 g Tris base 
144 g glycine 
100 mL 10 % SDS 
Made to 1 L using dH2O 
 
Protein loading buffer 
40 % glycerol 
240 mM Tris-HCl pH 6.8 
8 % SDS 
0.04 % bromophenol blue  
5 % beta-mercaptoethanol – added just before use.  
 
DNA loading dye 
10 mM Tris-HCl (pH 7.6) 
0.03 % (w/v) bromophenol blue 
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0.03 % (w/v) xylene cyanol FF 
60 % glycerol 
 
Phosphate buffered saline (PBS) – (Autoclaved) 
One tablet in 200 mL dH2O yields (pH 7.4) 
10 mM Phosphate buffer 
2.7 mM KCl  
137 mM NaCl 
 
siRNA buffer – 5X buffer 
300 mM KCl 
30 mM HEPES pH 7.5 
1.0 mM MgCl2 
 
Kits 
QIAprep Spin Miniprep Kit (Qiagen – 27104) 
QIAGEN Plasmid Midi Kit (Qiagen – 12145) 
Endofree Plasmid Maxi Kit (Qiagen – 12362) 
QIAquick Gel Extraction Kit (Qiagen – 28704) 
 
Buffer I – for competent DH5a cells  
10 mM RbCl 
50 mM MnCl2.4H2O 
30 mM KOAc 
10 mM CaCl2 
15 % v/v Glycerol 
 
Buffer II – for competent DH5a cells  
10 mM RbCl 
10 mM MOPS 
75 mM CaCl2 
15 % v/v Glycerol 
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Antibiotic selection – Bacterial and Human cells  
G418 2 µg/mL - human 
Puromycin 2.5 µg/mL - human 
Ampicillin 100 µg/mL - bacteria 
Kanamycin 50 µg/mL – bacteria 
 
Methylene blue. 
1 % (w/v) Methylene blue mixed with PBS. Used at 0.1 % final concentration.  
 
2.5 – Cloning and molecular methods 
2.5.1 – PCR, Restriction digests and ligations.  
Polymerase chain reaction experiments (PCR) were carried out using KOD Hot 
Start DNA Polymerase (Merck Millipore) according to manufacturer’s guidelines. 
Amplified products were run on 1 % agarose gels using EtBr and UV light to 
illuminate the bands and purified using Qiagen Gel Purification kit.  
 
Restriction endonuclease digests were set up according to the conditions 
recommended by the manufacturer. Typically, New England Biolabs (NEB). 
Digests were allowed to incubate at 37 °C in a water bath for approximately 2 
hours before purification on a 1 % gel as described previously. Ligations were 
carried out using T4 DNA ligase (NEB) and samples were left at 16 °C overnight. 
The ligated products were then transformed into E. coli DH5a cells before 
carrying out colony PCR to check integration.  
 
2.5.2 – Site-directed mutagenesis and fusion PCR.  
Site-directed mutagenesis (SDM) reactions were carried out using a PCR based 
method. Using a template from a gene of interest, primers were designed to 
allow a mutagenic overhang which was complemented by the homologous 
primer. Restriction digests were carried out to give ligatable ends, these were 
then ligated into a destination plasmid.  
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2.5.3 – DNA plasmids created or used 
  
Table	2.2.	DNA	plasmids	created	or	used.		
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2.5.4	–	List	of	oligonucleotides	used	
	
Table	2.2.	Table	of	Oligonucleotides.	
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2.5.5 – Competent Cells and Transformations.  
2.5.5.1 – Creating Competent cells - E.coli DH5a cells.  
A streak of DH5a cells were used to inoculate 5 mL LB and sample left to 
incubate overnight at 37 °C with shaking, 225 rpm. 1 mL of this overnight culture 
was diluted into 200 mL LB at 37 °C with shaking for approx. 2.5 hours until 
OD600 is no greater than 0.5. Cells were chilled on ice for 10 minutes before being 
transferred to 4x cold sterile 50 mL falcon tubes. Cells were centrifuged at 3500 
rpm, 4 °C, for 15 minutes. The supernatant was discarded and pellet 
resuspended in 66 mL Buffer I and left on ice for 45 minutes. Cells were 
centrifuged at 3500 rpm, 4 °C, for 15 minutes and resuspended in 8 mL of Buffer 
II. This was incubated on ice for 15 minutes. Cells were aliquoted in 50 µL in cold 
sterile eppendorfs. These were snap frozen in liquid nitrogen and stored at -80 
°C.  
 
2.5.5.2 – Transformations. 
DNA was transformed into DH5a cells for cloning. 50 µL of cells were 
transformed with either 1-2 µL of prepared miniprep plasmid DNA or entirety of 
ligation product. The DNA/E.coli mixture was incubated on ice for 10 minutes 
before being heat shocked at 42 °C for 45- 60 seconds. Then placed back on 
ice for 10 minutes. 1 mL of LB broth was then added to cells and left to incubate 
at 37 °C for approximately 1 hour to allow clonal expansion. Cells were pelleted 
and 1 mL of supernatant was removed leaving approximately 50 µL of 
supernatant plus cell pellet. This was resuspended in remaining volume and 
spread onto LB agar (LB solidified with 1.5 % agar) plates containing the 
appropriate antibiotic, and left overnight at 37 °C. Ampicillin or Kanamycin was 
added to the LB agar plates at a final concentration of 100 µg/ mL.  
 
2.5.6 – Electrophoresis of DNA and Western blot analysis 
2.5.6.1 – Electrophoresis of DNA.  
DNA was resolved on a 1 % agarose gel (1 % agarose w/v dissolved in TBE) 
and stained with ethidium bromide (1/100 from stock solution). The gel was run 
at 100 V for 37 minutes in 0.5 X TBE. Samples were loaded in 1X loading buffer 
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and run alongside GeneRuler DNA ladder. DNA was visualized by UV illumination 
using a Syngene InGenius Bioimaging system. For gel extractions gels were 
placed over a UV box and band excised with a clean scalpel. Depending on size 
of DNA band required the percentage of gel was altered. 
 
2.5.6.2 – Western blotting.  
Whole cell extracts, prepared as described in the lysis method, were resolved 
via Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE), 
alongside PageRuler protein marker (10 kDa – 250 kDa). Samples were resolved 
through a 5 % acrylamide stacking gel from a 30 % acrylamide stock (National 
Diagnostics), 0.125 M Tris pH 6.8, 0.1 % (w/v) SDS, 0.1 % (w/v) ammonium 
persulphate and 0.1 % (v/v) TEMED (N,N,N’,N’ – Tetramethylethylenediamine). 
The resolving gels were made up with 6 or 10 % acrylamide from a 30 % 
acrylamide stock (National Diagnostics). The resolving gel was made with 0.375 
M Tris pH 8.8, 0.1 % (w/v) SDS, 0.1 % (w/v) ammonium persulphate and 0.04 % 
(v/v) TEMED. The ammonium persulphate and TEMED were added to mixtures 
last to allow polymerisation of the gel. Samples were denatured in a final 
concentration of 1X protein loading buffer and incubated at 99 °C for 10 minutes 
before loading. Gels were run at 150 V for 110 minutes before being transferred 
to a nitrocellulose membrane. Transfers were carried out using nitrocellulose 
membranes (0.2 µM pore size) at 30 V for 3 hours in 1X transfer buffer. 
Membranes were then stained with Ponceau S to ensure accurate transfer. 
Membranes were blocked using 3 % (w/v) non-fat dried milk (Marvel) dissolved 
in PBS and 0.1 % (v/v) Tween20 (PBST) for 30 minutes. This was followed by 
incubation with the primary antibody in 3 % non-fat milk PBST at 4 °C overnight. 
Membranes were washed 3X in 3 % non-fat milk PBST for 10 minutes. The 
appropriate horseradish peroxidase (HRP)-conjugated secondary antibody 
diluted in 3 % milk PBST was added to the membranes and allowed to incubate 
for 1 hour at room temperature. Again membranes were washed 3X for 10 
minutes with 3 % milk PBST before detection of bands with addition of ECL 
chemiluminescent reagents as per manufacturers guidelines. Emission was 
captured using autoradiograph film and developed.   
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Table 2.4 – Antibodies 
 
	
Table	2.3.	List	of	antibodies	used.	
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2.6 – S. pombe methods 
2.6.1 – S. pombe growth media 
Media was used either in liquid or solid state.  Indicated supplements were 
added to the media as required at 100 mg/L.  
 
YE media 
0.5 % w/v yeast extract  
3.0 % w/v glucose 
 
YES media 
0.5 % w/v yeast extract  
3.0 % w/v glucose 
2.5 g/L Difco Bacto Agar 
 
Phloxin containing plates using solid YES media.   
20 mg/L Phloxin B (Sigma)  
 
Edinburgh Minimal Media (EMM2) – 1L 
50 mL 20x EMM2 salts  
25 mL 20 % NH4Cl 
25 mL 0.4 M Na2HPO4 
12.5 mL 40 % Glucose 
1 mL 1000x Vitamins  
0.1 mL 10000x Trace elements 
 
20x EMM2 salts – 1L 
61.2 g Potassium hydrogen phthalate  
20.0 g Potassium chloride 
21.4 g MgCl2. 6H2O  
0.2 g Na2SO4 
0.26 g CaCl2. 2H2O 
 
	 66	
1000x Vitamins  
1.0 g/L Pantothenic acid  
10.0 g/L Nicotinic acid  
10.0 g/L Inositol 
0.01 g/L d-Biotin 
 
10000x Trace elements 
5.0 g/L H3BO3 
4.0 g/L MnSO4 
4.0 g/L ZnSO4.7H2O  
2.0 g/L FeCl3.6H2O  
1.5 g/L Na2 MoO4  
1.0g/L KI 
0.4 g/L CuSO4.5H2O  
10.0 g/L Citric acid 
 
Where necessarily supplemented with: adenine, histidine, leucine, thiamine, 
uracil at final concentration of 100 mg/L. The medium was filter sterilized after 
making. 
 
2.6.2 – Yeast transformation 
Cells were grown in YE overnight to a density of approximately 107 cells per mL 
and washed using dH2O. Cells were then washed in 5 mL of LiAc-TE (0.1 M 
lithium acetate, pH 7.5, 10 mM Tris-HCl, pH 7.5, 1 mM EDTA). Cells were then 
resuspended in LiAc-TE to a density of 2 x 109 cells per mL. 1 µL of plasmid DNA 
and 2 µL of salmon sperm DNA was added to 100 µL of cell suspension. To this 
260 µL of 40 % PEG/LiAc-TE was added. Cells were then incubated for 60 
minutes at 30 ºC. 43 µL of DMSO was added and cells were heat-shocked at 42 
ºC for 5 minutes before being washed in 1 mL of sterile water. Samples were 
then resuspended in 50 µL of sterile water and plated into relevant selection 
plates.  
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2.6.3 – Recombination mediated cassette exchange (RMCE) 
pAW8 plasmids were transformed into the appropriate S. pombe base strain as 
described in Watson et al, 2008 (Watson, Garcia, Bone, et al., 2008) and leu+ 
transformants selected. Transformants were then grown in media containing 
leucine to allow loss of the plasmid and Cre expression induced. The product of 
cassette exchange was selected for using 5’ FOA plates. Cells which still 
expressed uracil gene were killed by 5’ FOA selection. Cells which stably 
integrated the desired construct were picked, checked for lack of growth on 
plates lacking leucine or uracil, before colony PCR and sequencing was carried 
out to confirm targeted integration of alleles.  
 
2.6.4 – Colony PCR 
Colony PCR was performed to check for successful transformation of DNA. 
Samples of E. coli and S. pombe were mixed in PCR mixture and in the case of 
S. pombe boiled before PCR reaction was carried out as per manufacturer’s 
instructions.  
 
2.6.5 – Spot tests 
S. pombe strains were grown overnight in YE and harvested the following day. 
Cells were counted in a hemocytometer and diluted to 107 cells per mL with 
sterile water. Serial dilutions were created to allow plating of 17.5x105, 8.75x104, 
4.3x103, 2.1x102 and 1x101 cells in 5 µL. Cells were spotted onto plates 
containing drugs or exposed to radiation prior to plating and incubated for 96 
hours.  
 
2.6.6 – Colony survival assays 
Loops of logarithmically growing cells were inoculated in 1 mL of growth medium 
and counted using a hemocytometer before being diluted to a concentration of 
1x104 cells per mL. Equal numbers of cells were plated onto triplicate plates and 
incubated for 3-4 days at 25, 30 and 37 ºC until colonies formed. The number of 
colonies per plate was counted using a colony counter.  
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2.7 – Mammalian Cell Culture.  
2.7.1 – Maintenance of Cell Lines.  
Primary human cell lines: 1BR, 48BR, GVH02, HSC62, CJ179, AT1BR and 
411BR, were cultured at 37 °C with 5 % CO2 in Gibco Minimal Essential Media 
(MEM) supplemented with 15 % foetal calf serum (FCS), 2 mM L-glutamine, 100 
U/mL Penicillin and 100 µg/mL streptomycin. Immortalised versions of these cell 
lines were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10 % FCS, 2 mM L-glutamine, 100 U/mL Penicillin and 100 
µg/mL streptomycin. Similarly, cancerous cell lines: U2OS, MG63, A549 and 
DLD1 cells, were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10 % FCS, 2 mM L-glutamine, 100 U/mL Penicillin and 100 
µg/mL streptomycin. Tetracycline inducible U2OS cells were also cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10 % 
tetracycline free FCS, 2 mM L-glutamine, 100 U/mL Penicillin and 100 µg/mL 
streptomycin. 
 
2.7.2 – Transfection 
2.7.2.1 – Transfection of siRNA using HiperFect 
2.7.2.1.1 – Topdown method for siRNA transfection 
siRNA was used to transiently knock down proteins of interest by inhibition of 
mRNA. To do this cells were seeded in 6 well plates and allowed to adhere for 
24 hours. After 24 hours’ cells were washed with PBS and 2 mL fresh media 
applied. Transfection mixture was prepared typically using 10 µL Hiperfect 
transfection reagent, 2 µL siRNA and made to a final volume of 100 µL made up 
with Optimem. Optimem and Hiperfect were added together first and allowed to 
incubate at room temperature for 10 minutes before addition of siRNA. Samples 
allowed to incubate for a further 10 minutes before being added to relevant 6 
well plate. 100 µL was prepared per required well.  
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2.7.2.1.2 – Reverse transfection. 
Reverse transfection allows cells be to plated and transfected in one day. 
Transfection mixture was made up to 100 µL as before and added to plates 
before cells being added.  
 
2.7.2.2 – Transfection of plasmids using GeneJuice (Merck Millipore).  
To create stable cell lines or express proteins of interest, plasmids were 
transfected in using GeneJuice. As previously, cells were seeded in 6 well plates 
and allowed to adhere for 24 hours before transfection. A final volume of 100 µL 
was used as with the siRNA transfection. 1 µg of DNA per well of a 6 well dish 
was used and 3 µL of GeneJuice per 1 µg of DNA. Final volume was made up to 
100 µL using Optimem and transfection mixtures were allowed to incubate for 
15 minutes before adding to cells. If plasmid had a selection marker, selective 
antibiotic was applied after 24 hours.  
 
2.7.2.3 – Transfection of plasmids using Calcium Phosphate.  
U2OS cells from a 90% confluent T75 flask were trypsinized and diluted 1 in 10 
in fresh media and made up to 10 mL per 10 cm plate. Dishes were allowed to 
incubate overnight at 37 °C with 5 % CO2. Transfection solutions were prepared, 
2X HBS was thawed at room temperature and 500 µL aliquots were made per 
transfection. Into a separate Eppendorf 10 µg DNA, 61 µL of CaCl2 (2 mM stock) 
was added and made up to 500  µL with distilled water. Using a plugged 
aspirator to bubble the 2X HBS mixture, the DNA mixture was added dropwise. 
The final 1 mL preparation was then added dropwise to the 10 cm plate and cells 
were placed back in the incubator and left for 24 hours. The DNA precipitate is 
visible through a light microscope and potentially looks like infection, however 
this is not the case. After cells were left for 24 hours they were washed using 
PBS and fresh 10 mL of media applied.  
 
2.7.3 – Flow cytometry. 
T75 flasks were seeded with relevant cells and allowed to grow but not reach 
full confluency. If required samples were then exposed to 250 µM hydroxyurea 
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for either 2, 8 or 18 hours before being released into fresh media and prepared 
for flow cytometry. Cells were trypsinized and collected before being spun down 
at 2000 rpm for 2 minutes and washed using PBS, cells were then resuspended 
in 500 µL PBS before addition of 1 mL ice cold ethanol whilst gently vortexing 
and incubated for 30 minutes to fix. Cells were spun down and washed with 
PBS. Samples were spun down at 3500 rpm for 10 minutes and supernatant 
removed. Cells resuspended and incubated in 1 mL Triton X-100 (0.5 %) in PBS 
to permeabilise. Samples were then washed using PBS and spun down before 
being resuspended in 600 µL PBS/0.05 % Tween20 + 5 µg propidium iodide (PI) 
and 30 µL RNAse from stock solution.  
 
2.7.3.1 – FACS Analysis 
Samples were prepared as described in flow cytometry section. However, after 
fixing using 100 % ice cold EtOH the steps in the protocol varied. Once the cells 
were fixed they were prepared for BrdU labelling. Samples spun at 3500 rpm for 
10 minutes at 10 °C, supernatant was removed carefully to avoid losing the 
pellet. Samples were vortexed slowly to loosen the pellet. Whilst vortexing 1 mL 
of 2 M HCl/PBS/Triton X-100 (0.5 %) was added drop-wise. Samples were 
incubated at room temperature for 30 minutes to denature DNA and produce 
single stranded DNA. Samples were then spun at 3500 rpm for 10 minutes at 10 
°C. Supernatant was discarded and cells resuspended in 1 mL of 0.1 M Borax 
pH 8.5 to neutralise the acid. Samples were again spun as before, supernatant 
removed and pellet resuspended in 500 µL 1 % BSA/ 0.5 % Tween20/ PBS. 10 
µL of anti-BrdU-FITC antibody was added to each sample and incubated at 
room temperature for 30 minutes whilst shielding from light. Samples were again 
spun down and washed with 1 % BSA/ 0.5 % Tween20/ in PBS. Samples we 
centrifuged for a final time and resuspended in 600 µL PBS/ 0.05 % Tween20 
containing 5 µg propidium iodide (PI) + 30 µL RNAse from stock solution. 
Samples were then stored at 4 °C until required for FACs analysis.  
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2.7.4 – Colony formation assay. 
These were used to analyse cellular response after treatment with specific 
agents. Assays were set up which determined how many colonies were formed 
depending on how many cells were seeded. Initially cells were plated in 6 cm 
dishes for 24 hours prior to treatment and allowed to grow for 7-10 days’ post 
treatment before being fixed using methylene blue. The number of colonies 
counted. To analyse the data, the number of colonies formed were divided by 
the number of cells plated and multiplied by 100 to give the plating efficiency. 
The plating efficiency of the untreated control was then used as a baseline and 
the other plates compared against this.  
 
2.7.5 – Clonogenic assay using primary cell lines.  
 Another assay used to determine cellular response to DNA damaging agent. 10 
cm dishes were initially seeded with primary fibroblasts that had been exposed 
to 35 Gy ionizing radiation. Primary cells were exposed to either Camptothecin 
(CPT 1, 2, 5 or 10 µM), methylmethane sulphonate (MMS 50, 100, 150, 200, 250 
mg/mL) , mitomycin c (MMC 1, 2, 5, 10 µM), hydroxyurea (HU 0.25, 1, 5, 10 µM), 
ultraviolet radiation (UV 2, 5, 7, 10 J/m2) or ionizing radiation (IR 1, 3, 5, 7 Gy). 
Data was processed as with the colony formation assays.  
 
2.7.6 – Hydroxyurea block and restart assay.  
Primary cells were plated onto square glass coverslips in a well of a 6-well plate. 
They were allowed to adhere for 24 hours before carrying out the assay. Media 
was removed and washed using PBS before addition of 2 mL of fresh media 
with 250 µM hydroxyurea. Cells left to incubate at 37 °C for 0, 2, 8 or 18 hours 
in the presence of hydroxyurea. Media was discarded and cells washed using 
PBS. Cells were then incubated with 10 µM 5-Ethynyl-2’-deoxyuridine (EdU) with 
fresh media for 30 minutes. 
 
2.7.6.1 – EdU Labelling.  
After incubating the cells were labelled with EdU, following manufacturers 
guidelines (C10337 Life Technologies). Cells were removed from incubator, 
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media removed and washed using PBS, they were then fixed using 4 % 
paraformaldehyde (PFA) for 10 minutes at room temperature. Cells were washed 
once with PBS and permeabilised using 0.1 % Triton X-100 in PBS for 2 minutes. 
Cells were washed again using PBS and detection mixture added (50 µL per 
coverslip) and allowed to incubate for 30 minutes whilst protected from light. 
Cells were washed using PBS and coverslips mounted onto slides using Prolong 
Gold Antifade with DAPI (Thermo Fisher P36931).  
 
2.7.7 – gH2AX Assay.  
Cells were plated onto glass coverslips in a well of a 6-well plate. Cells were 
allowed to adhere and grow for approximately 24-48 hours before being 
exposed to 3 Gy ionizing radiation using a 137Cs g-ray source. The cells were 
allowed to recover at 37 °C for either 2, 8 or 14 hours. The cells were harvested 
altogether and the media removed. Cells were washed using PBS and fixed 
using 4 % PFA. They were then permeabilised using 0.1 % Triton X-100 in PBS 
for 2 minutes. Cells were washed with PBS and primary antibody added, anti-
gH2AX antibody was used to detect phosphorylated Ser139 and anti-CENPF 
antibody used to allow detection of G2 cells. Cells were incubated with primary 
antibody for 35-60 minutes at room temperature protected from light, before 
being washed 3X with PBS. Cells were left to incubate with relevant secondary 
antibody, after incubation for 45-60 minutes in the dark. Coverslips were 
mounted onto slides using Prolong Gold Antifade with DAPI (Thermo Fisher 
P36931) as before. Cells were imaged using an Olympus IX73 microscope using 
an Lumencor LED light source, a 60x 1.4NA PlanApo lens (Olympus) and Orca 
Flash CMOS camera (Hamamatsu). Images were analysed using Micro-manager 
and ImageJ (NIH) software.  
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2.7.8 – High-throughput siRNA screen. 
2.7.8.1 – Initial test screens.  
2.7.8.1.1 – Plating efficiency.  
Different ratios of either mCherry-NLS (non-silencing) or AcGFP-NLS (NSMCE4a 
shRNA) cells were plated in clear bottom 96-well plates. Between 72-120 hours 
later they were harvested, fixed using 4 % PFA, permeabilised using 0.1 % Triton 
X-100 in PBS and nuclear staining was carried out using DAPI in PBS. Cells 
incubated for 10 minutes before being washed off and the cells left under 200 
µL PBS. The cells were then scanned using Olympus IX83 ScanR microscope 
to determine resultant ratios.  
 
2.7.8.1.2 – siRNA test screen.  
Cells were plated in varying ratios of red/green and in various densities. 10 µL 
final volume of transfection mixture (0.5 µL siRNA, 2.5 µL HiperFect and 7 µL 
Optimem) per well was plated into the bottom of each well and cells added on 
top of this in relevant ratios. Cells were harvested at various time points after 
incubation at 37 °C. Cells were washed using PBS, fixed using 4 % PFA for 10 
minutes, washed with PBS and permeabilised using 0.1 % Triton X-100 for 5 
minutes. Samples were washed using PBS, incubated with 1:10,000 DAPI for 10 
minutes, washed and stored with 200 µL PBS at 4 °C until required.  
 
2.7.8.2. – Screen protocol.  
Using 6 black, clear bottom 96 well plates, 2 x 103 cells were plated in a 1:1 ratio 
and allowed to adhere for 24 hours. Cells then had media removed and washed 
using PBS. 190 µL media was then added. 10 µL transfection mixture was added 
(as described previously), mixed thoroughly and incubated for 72 hours, 
preferably over the weekend to minimise traffic and edge effect. After 72 hours 
plates were removed from the incubator and washed using 200 µL PBS, fixed 
using 200 µL 4 % PFA for 10 minutes at room temperature, washed using 200 
µL PBS, permeabilised using 100 µL 0.1 % Triton X-100 in PBS, washed using 
200 µL PBS, treated with 100 µL DAPI (as described previously), washed using 
200 µL PBS and kept under 200 µL PBS. Plates were scanned and analysed 
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using Olympus IX83 ScanR microscopy platform. Cells were imaged using 10 x 
magnification in 16 frames per well. Images underwent background reduction 
analysis using Olympus ScanR Analysis software. Images were adjusted for 
fluorescence intensities and separate GFP-positive and mCherry-positive cells. 
Results were exported and further analysed in Microsoft Excel via binning and 
correlation.  
 
2.7.9 – Micronuclei protocol 
Patient fibroblasts were grown to approximately 70 % confluency, trypsinized, 
resuspended, counted and seeded onto glass coverslips. Twenty-four hours 
later cells were fixed using 4 % paraformaldehyde (PFA) for 10 minutes at room 
temperature, washed and permeabilised with 0.1 % Triton X-100 for 1 minute 
before being mounted onto glass slides using ProLong Gold Antifade Mountant 
with DAPI (Thermo Fisher P36931). Approximately 103 cells were analysed over 
three independent experiments.  
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Chapter 3 – Development of a high-throughput high-content synthetic 
sick/lethal screen to investigate knockdown of NSMCE4a in osteosarcoma 
cells.  
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3.1 – Introduction – Synthetic Lethality Screen  
 
In this chapter the development of a synthetic sick/lethal interaction screen to 
investigate the SMC5/6 complex in human cells will be described. The aim was 
to set up a high-throughput microscopy screen that could be used as a pipeline 
for the development of translational links between the Genome Damage and 
Stability Centre and oncologists at the Brighton and Sussex Medical School and 
the Drug Discovery Group at Sussex. The screen would be set up with the 
SMC5/6 complex as the initial target but the protocol developed could then be 
applied to other complexes.  
 
The development of screens involves many steps: 1) determining the target or 
marker, 2) creating a suitable cellular model, 3) finding and establishing the most 
relevant screening method, 4) determining assay kinetics and 5) optimisation. 
The steps involved in setting up a screen to investigate the requirement of 
SMC5/6 will be described here. Briefly, the determination of the target within the 
complex, the choice of cellular model, screening method, assay kinetics and 
optimisation. The cellular model initially chosen was U2OS cells, an immortalised 
osteosarcoma cell line, which is a suitable transfection host and amenable to 
imaging. A microscopy-based method was then developed to directly compare 
the relative viability of two cell lines with different knockdowns grown in the same 
well.  This is outlined in Figure 3.1. Cells containing the target knockdown co-
expressed with nuclear GFP were plated in equal ratio with control knockdown 
cells co-expressing nuclear RFP and after incubation with a DNA damage 
response siRNA library the relative numbers of red and green cells scanned and 
analysed using the ScanR imaging platform.  
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Experimentally, RNAi can be delivered to cells in a number of ways. Transfection 
of siRNA into cells can be used to cause transient knockdown in the short term. 
Long term RNAi can be achieved through the expression of shRNA which is 
delivered through ectopic expression as stem-loop, hairpin structures that 
resemble pre-microRNA, the endogenous substrate of DICER. As long term 
Figure	 3.1.	 Schematic	 showing	 desired	methodology	 of	 screening.	 Initially	 plasmids	
were	designed	to	express	shRNA	of	choice	to	knockdown	target	of	interest	or	necessary	
controls,	 fluorophore	 and	 antibiotic	 selection.	 Cells	 with	 contrasting	 fluorophores	
would	 be	 mixed	 in	 a	 desired	 ratio,	 incubated	 with	 siRNA	 specific	 to	 DNA	 Damage	
response	 for	 a	 period	 of	 time	 and	 analysis	 of	 the	 resulting	 ratio	 carried	 out	 using	
Olympus	ScanR	microscope.		
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knockdown was required shRNA would provide the most appropriate method 
for this screen.  
 
3.2 – Results 
3.2.1 – Choice of SMC5/6 subunit to knockdown 
 
To determine the target of the screen to test the synthetic lethality of loss of the 
SMC5/6 complex with other genes the first requirement was to determine which 
subunit to target. Previously it was reported that targeting of SMC5 using siRNA 
was difficult as once the protein has been translated it is stable and resistant to 
degradation (Stephan, Kliszczak, Dodson, et al., 2011). This is consistent with 
meiotic shutoff experiments in budding yeast, where the SMC5 shutoff had a 
less severe phenotype than the NSE4 shutoff (Copsey, Tang, Jordan, et al., 
2013). In addition, studies using recombinant SMC5 and SMC6 showed SMC6 
to be much less stable than SMC5 (Alt, Dang, Wells, et al., 2016). Therefore, the 
two candidates for targeting were shortlisted: SMC6 and NSMCE4a.  
 
To initially determine which of these components of the SMC5/6 complex would 
be best suited to stably knockdown, transient knockdown using Smartpool 
(Dharmacon) siRNA was tested. Smartpool siRNA consists of a mixture of siRNA 
containing four different sequences targeting different regions of the gene. The 
siRNAs were tested in 1BR hTERT, a wild-type fibroblast and MG63, an 
immortalized osteosarcoma cell line. 5.04 – 10.04 1BR hTERT or MG63 cells was 
transfected with 20 pmol of Smartpool siRNA to SMC6, NSMCE4a or an siRNA 
control. After 24-96 hours’ cells were harvested and immunoblots analysed.  As 
predicted from previous studies, which showed that loss of any subunit resulted 
in destabilisation of the complex (Taylor, Copsey, Hudson, et al., 2008a), 
successful knockdown of SMC6 (Figure 3.2.A) and NSMCE4a (Figure 3.2.B) 
resulted in a loss of other members of the SMC5/6 complex. Loss of SMC5 was 
observed following knockdown of NSMCE4a and SMC6 but was not observed 
in controls. Equal loading was confirmed using an anti-tubulin antibody, 
quantification of knockdown is seen in (Table A.4.1.A/B).  
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Since loss of NSMCE4a resulted in loss of SMC5 and SMC6, NSMCE4a was 
chosen as the target to proceed with the screen, NSMCE4a was chosen as it 
bridges the heads between SMC5 and SMC6 and also forms interactions with 
NSMCE1 and NSMCE3. Whilst the lack of reliable antibody to NSMCE4a was a 
concern loss of SMC5 or SMC6 could be used as a measure of knockdown 
efficiency.  
 
 
 
 
 
  
Figure	3.2.	A.	Western	blot	analysis	using	cell	extracts	from	MG63	cells	treated	with	
siRNA	to	NSMCE4a	over	a	period	of	24	to	96	hours.	Cells	were	transfected	and	harvest	
before	being	lysed	using	RIPA	buffer.	Supernatant	extracts	were	loaded	on	SDS-PAGE	
gel	and	transferred	to	nitrocellulose	membrane.	Antibodies	were	used	specific	to	SMC5	
and	SMC6	which	 showed	 reduction	 in	protein	 levels	 in	 cells	 treated	with	NSMCE4a	
siRNA.	Anti-tubulin	was	used	as	a	loading	control.	B.	As	in	A,	Western	blot	analysis	of	
cell	extracts	from	MG63	cells	treated	with	siRNA	to	SMC6.	Supernatant	extracts	were	
loaded	 onto	 SDS-PAGE	 gel	 and	 transferred	 to	 nitrocellulose	membrane.	 Antibodies	
specific	to	SMC5	and	SMC6	show	reduction	in	protein	levels.	Anti-tubulin	was	used	as	
a	loading	control.		
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3.2.2 – Establishing stable cell lines expressing NSMCE4a shRNA.  
 
To establish the synthetic sick/lethality screen an shRNA that could be 
constitutively expressed in the cells at all times was chosen. The pGIPZ plasmid 
(Thermoscientific) contains a number of features that make it ideal for this. It has 
puromycin selection, turboGFP and shRNA of choice and all under the co-
cistronic expression of a single CMV promoter and enhancer (Figure 3.3.A). This 
system means the expression of fluorophore and puromycin selection should be 
directly linked with the expression of the shRNA. The short hairpin RNA used to 
target NSMCE4a is expressed on the same mRNA as the fluorophore. Therefore, 
the overall expression of fluorophore can be used as an indicator of shRNA 
expression. High level of fluorophore expression would predict high levels of 
NSMCE4a knockdown (Hopkins, McGregor, Murray, et al., 2016) (Figure 3.3.B).  
 
The next step was to create a cellular model using an immortalised 
osteosarcoma cell line, U2OS. This cell line was chosen as it is a suitable 
transfection host and amenable to imaging using microscopy. pGIPZ plasmids 
with shRNA specific to NSMCE4a, the positive controls GAPDH and EG5 and a 
non-silencing control were transfected into cells. To ensure cells stably 
integrated the plasmid, cells were cultured under puromycin selection (1.5 µg/ 
mL) for 14 days. Expression of turboGFP was checked through use of 
fluorescence microscopy (Figure 3.3.B).  
 
After 14 days Immunoblot analysis confirmed knockdown of NSMCE4a (Figure 
3.3.C). Cells expressing shRNA to NSMCE4a showed SMC5 and SMC6 levels 
were reduced in all constructs, this was confirmed using Ponceau staining as a 
loading control. Quantification of proteins levels is seen in (Table A.4.1.C). 
Surprisingly, the EG5 positive control also showed reduction of SMC5 and 
SMC6 protein levels. However, EG5 is a kinase essential in mitosis (Wojcik, 
Buckley, Richard, et al., 2013) and therefore it is likely that cells expressing EG5 
shRNA are arrested at M phase and this may affect SMC5/6 levels (Figure 
3.3.C). For this reason, EG5 knockdown cells were not taken forward. 
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Figure	3.3.	A.	Schematic	of	pGIPZ	plasmid	used	to	create	stably	transfected	cells	with	
knockdown	of	NSMCE4a,	EG5,	GAPDH	and	non-silencing	shRNA.	Plasmid	has	co-cistronic	
expression	of	turboGFP,	puromycin	resistance	and	expression	of	shRNA.	This	plasmid	
allows	 for	 the	 selection	 of	 cells	 which	 express	 fluorophore	 and	 have	 puromycin	
resistance	 as	 shRNA	 should	 be	 expressed	 as	well.	B.	 Representative	 image	 showing	
expression	of	turboGFP	fluorophore	in	U2OS	cells.	pGIPZ	plasmid	was	transfected	into	
the	 cells	 and	 expression	 checked	 after	 24	 hours.	 Cells	 were	 put	 under	 puromycin	
selection	after	72	hours	and	maintained	with	passaging	for	at	least	14	days	to	ensure	
stability.	 TurboGFP	 is	expressed	 throughout	 the	whole	 cell	making	 it	 very	difficult	 to	
distinguish	individual	cells.	The	cells	show	a	range	of	GFP	intensities	and	cells	which	have	
high	 expression	 of	 fluorophore	 have	 highest	 expression	 of	 shRNA.	 This	 allows	 the	
examination	of	phenotypes	in	a	dose	dependent	manner.	C.	Western	blot	analysis	on	
U2OS	cells	transfected	with	pGIPZ	plasmid	expressing	non-silencing,	GAPDH,	EG5	shRNA	
controls	 and	 3	NSMCE4a	 constructs.	 Cells	were	 stably	 expressing	 the	 plasmids	 for	 3	
weeks	 before	 being	 harvest,	 lysed	 and	 ran	 on	 an	 SDS-PAGE	 gel,	 transferred	 to	
nitrocellulose	 and	 probed	with	 anti	 SMC5	 and	 SMC6	 antibodies.	 All	 three	NSMCE4a	
constructs	showed	reduction	in	both	SMC5	and	SMC6	levels	consistent	with	what	was	
observed	previously	using	siRNA.	Interestingly	reduction	in	SMC5	and	SMC6	levels	was	
observed	in	EG5	positive	control.	This	could	be	explained	as	EG5	is	a	mitotic	kinase	and	
loss	of	which	stalls	cells	in	the	M	phase.	SMC5/6	is	removed	from	chromosomes	during	
M	phase	therefore	would	not	be	as	detectable	in	cycling	cells.		
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3.2.3 – Establishing stable cell lines expressing nuclear localised 
fluorophores.  
 
The screening method was designed to distinguish knockdown and control cells 
cultured together on the basis of expression of different fluorophores (Figure 
3.1). However, using the turboGFP fluorophore that was present in the pGIPZ 
plasmid proved not to be feasible. Imaging of the cells expressing turboGFP 
showed that cells above approximately 70 % confluent could not be resolved 
accurately. This was due to the overlapping of cells and the spread of 
fluorophore throughout the cell (Figure 3.3.B). This was solved by the creation 
of nuclear localised fluorophores, which allowed the cells to be accurately 
resolved. To ensure that the fluorophore did not have an effect on cellular 
viability both AcGFP and mCherry variants of NSMCE4a and controls were 
created (Figure 3.4.A). Construction of the nuclear localised fluorophores 
involved creating a CMV enhancer/promoter-AcGFP NLS construct by fusion 
PCR (see Methods table 2.2 for plasmids constructed) and cloning this into 
pCr2.1-Topo). The insert was then ligated using XbaI-NotI sites into the pGIPZ 
plasmids to replace the CMV enhancer/promoter-turboGFP. The mCherry 
variant was created through removal of the AcGFP and NLS using restriction 
enzymes SphI - NotI and ligation of the mCherry with NLS sequence in its place. 
A schematic of the cloning strategy is given in Figure 3.4.A. 
 
Constructs were transfected into U2OS cells and a pool of stable integrants 
selected as before. Western blot analysis confirmed that knockdown of the 
SMC5/6 complex is not affected by the change in fluorophore Figure 3.4.B. In 
addition, it showed that shNSMCE4a construct 1 (861) had a greater level of 
knock down of Smc5 and Smc6 than construct 2 (859) and so construct 1 was 
taken forward to the screen. Quantification of proteins levels is seen in (Table 
A.4.1.D. 
 
Comparison of cells expressing AcGFP and mCherry with nuclear localisation 
sequences (Figure 3.4.C/D) and cells with only turboGFP (Figure 3.3.B) 
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demonstrates that the NLS enables cells closer together to be differentiated due 
to the empty cytoplasmic space. It also facilitated a more accurate analysis of 
fluorophore intensity. Since expression of fluorophore and puromycin selection 
are still directly linked with the expression of the shRNA the overall expression 
of fluorophore can be used as an indicator of shRNA expression.  
 
The ability to gate cells expressing the highest levels of fluorophore using the 
ScanR Analysis software had several advantages. Firstly, as shRNAs become 
silenced over time it was possible to check expression levels. Secondly, since 
knockout of NSMCE2 is cell lethal in mouse (Jacome, Gutierrez-Martinez, 
Schiavoni, et al., 2015) it would be predicted that efficient knockdown would 
have a selective disadvantage. By screening a pool of integrants with a range of 
expression levels and gating for fluorophore intensity (rather than screening a 
clonal population) it is possible to set criteria to identify the top hits for a range 
of knockdown efficiencies.  
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Figure	3.4.	A.	Schematic	showing	altered	pGIPZ	plasmid.	turboGFP	was	replaced	with	
AcGFP	and	mCherry	tagged	with	a	nuclear	localization	sequence.	In	order	to	do	this,	the	
CMV	promoter	and	enhancer	was	also	removed	and	replaced	with	a	fragment	created	
to	contain	CMV	enhancer,	promoter,	fluorophore.	Both	GFP	and	mCherry	plasmids	were	
created	 for	 the	 Non-silencing	 control	 and	 for	 two	 NSMCE4a	 shRNA	 constructs.	 B.	
Western	blot	of	SMC5	and	SMC6	levels	in	stable	integrants	of	Non-silencing	with	nuclear	
mCherry	(NS	RFP	NLS),	non-silencing	with	nuclear	GFP	(NS	GFP-NLS),	and	two	different	
shNSMCE4a	constructs	with	nuclear	GFP	(NSMCE4a	C1	and	C2).	Tubulin	was	used	as	a	
loading	control.	Both	SMC5	and	SMC6	levels	were	reduced	in	the	shNSMCE4a	cells	but	
not	 in	the	controls.	 	C.	Representative	 images	of	U2OS	cells	containing	altered	pGIPZ	
plasmids.	Left:	AcGFP-NLS	localized	to	the	cell	nucleus,	right:	Cherry-NLS	is	also	localized	
to	the	nucleus.		
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3.2.4 – Expression of NSMCE4a shRNA does not negatively impact cell 
cycle progression.  
 
The screen was designed to compare relative numbers of GFP and mCherry-
expressing cells co-cultured in the same well. This would depend on the relative 
numbers of cells in the initial culture as well as the effects of the siRNA library 
and thus it was important to determine whether the relative plating efficiencies 
of the NSMCE4 knockdown cells compared to the scramble control. The effect 
of the different fluorophores was also checked to see whether they influenced 
plating efficiency. To determine the ratio at which the cells would be plated an 
experiment varying the ratio of cells was carried out. Cells were plated in 1:1, 
1:2, or 2:1 ratios of shNon-silencing:GFP to shNon-silencing:mCherry as a 
control for the effects of the GFP and mCherry fluorophores. Two different 
shNSMCE4a:GFP constructs were compared to shNon-silencing:mCherry in 
similar ratios and cells cultured for a period of 72 hours (Figure 3.5.A). The ratio 
of red to green cells was determined by counting the number of cells in each 
well and comparing to original plating ratio. Results comparing the initial and 
final ratios showed no significant effect of either the fluorophore or shNSMCE4a 
on the plating efficiency (Figure 3.5.B). A ratio of 1:1 was therefore taken forward 
for the screen. 
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Figure	 3.5.	 A.	 Plate	 map	 of	 an	 experiment	 to	 determine	 the	 appropriate	 plating	
efficiency	 and	 density	 required	 for	 the	 screen.	 Cells	were	 plated	 in	 quadruplicate	 in	
varying	 ratios	 and	 repeated	 using	 varying	 cell	 number.	 In	 columns	 1-3	 non-silencing	
shRNA	cells	were	analysed	in	either	1:1,	1:2,	and	2:1	ratios.	This	was	repeated	in	columns	
4-6	contained	NSMCE4a	construct	1	and	red	non-silencing	cells	and	again	in	columns	7-
9	contained	NSMCE4a	construct	2	and	red	non-silencing	cells.	Column	10	rows	A	and	B	
contained	only	non-silencing	mCherry	cells,	row	10	C	and	D	contained	only	non-silencing	
AcGFP	 cells.	 In	 columns	11	and	12	 in	 all	 4	well	 contained	NSMCE4a	 construct	 1	 and	
construct	2.	Columns	10-12	were	used	as	controls	to	ensure	the	cells	growing	on	their	
own	maintained	cell	number.	B.	Graph	showing	result	of	plating	efficiency	experiments	
and	percentage	of	cells	that	have	AcGFP	expression.	Not	shown	on	the	graph	is	the	three	
controls	 from	 columns	10-12	 shows	100	%	percentage.	 Column	1	 showed	no	AcGFP	
expression,	 however	 this	 was	 due	 to	 experimental	 error.	 Experiment	 was	 still	
considered	 successful	 as	 other	 controls	 showed	 correct	 levels	 and	 no	 significant	
deviation	from	what	was	plated.	A	ratio	of	1:1	was	chosen	to	be	taken	forward	for	the	
full	screen.	(*,	**,	***)	denote	non	significance	between	same	ratios.		
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Loss or reduction of SMC5/6 has been shown to result in delayed cell cycle 
progression and mitotic entry (Gallego-Paez, Tanaka, Bando, et al., 2014). 
Gallego Paez et al showed cell cycle progression in cells depleted of SMC5 or 
SMC6 had a significant delay, 2.5 fold, when compared with control cells 
(Gallego-Paez, Tanaka, Bando, et al., 2014). This is consistent with studies in 
yeast that showed SMC5/6 to be required for the stabilization of stalled 
replication forks and the restart of collapsed replication forks (Irmisch, 
Ampatzidou, Mizuno, et al., 2009; Ampatzidou, Irmisch, O'Connell, et al., 2006). 
Therefore, the cell cycle profiles of shNSMCE4 cells relative to the shNon-
silencing control were examined. Cells were plated into 96 well plates at a 1:1 
ratio of AcGFP:mCherry (NSMCE4a:Non-silencing) and analysed over a 72-120 
hour period (Figure 3.6.A). The cells were fixed at various time-points, 
permeabilised and DAPI stained before being analysed using the ScanR 
microscope. The resulting DAPI content was calculated and the number of cells 
binned based upon the amount of DAPI observed in each cell. Given the large 
number of cells screened, approximately 10,000 per well, an accurate profile of 
the cell cycle can be achieved. There did not appear to be an effect in cell cycle 
progression in shNSMCE4a cells compared to the non-silencing control cell line 
(Figure 3.6.B). The lack of cell cycle delay may be due to the fact that clonal 
populations were not selected but rather pools of puromycin resistant cells were 
analysed as these were what would be taken forward into the screen. The 
variable levels of knockdown, while an advantage for the screen as results could 
be gated against expression levels, would likely mask the slow growth of the 
more severe knockdowns.  
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Figure	 3.6.	 A.	 Representative	 images	 taken	 using	 Olympus	 ScanR	 microscope	 of	
shNSMCE4a:GFP	and	shNon-silencing:mCherry	cells	were	co-cultured	and	analysed	Cells	
were	mixed	together,	plated	into	96-well	plates	and	allowed	to	incubate	for	between	
72	and	120	hours.	Cells	were	 fixed,	permeabilised	and	DAPI	 stained.	Panels:	 top	 left	
DAPI,	top	right	GFP,	lower	left	mCherry,	lower	right	merge.	B.	Graph	showing	cell	cycle	
profile	based	upon	DAPI	content.	Cells	were	scanned	using	Olympus	ScanR	microscope	
and	 the	 DAPI	 intensity	 calculated.	 Scores	 were	 binned	 into	 24	 percentiles	 of	 DAPI	
intensity	and	the	number	of	cells	in	each	bin	plotted.	The	large	number	of	cell	scored	
allows	for	an	accurate	calculation	of	cell	cycle	profile.	The	peak	at	bin	7	represents	G1	
cells	and	the	peak	around	bin	15	G2	cells	and	has	twice	the	DAPI	signal	to	the	bin	7	peak.	
NSMCE4a	(blue)	and	non-silencing	(orange)	showed	no	significant	difference	in	cell	cycle	
profile.	
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3.2.5 – Choice of controls for screen 
 
Special consideration must be taken in a synthetic sick/lethal screen to ensure 
the plates are controlled both internally and throughout the screen. To this end 
the screen was designed with a number of controls in place. A mock siRNA 
needs to be used to check activation of the RISC pathway without targeting a 
protein sequence. Therefore, four scramble controls were used in each plate at 
different positions to ensure minimisation of edge effect and making sure 
position of the controls did not negatively impact the screen. Another negative 
control used in the screen was simply transfection reagent, whilst it doesn’t 
activate the RISC pathway it carries out an important function by disrupting the 
plasma membrane and can reduce viability in cells (Figure 3.7). 
 
Two positive controls were also used. The first was SMC3, a member of the 
related cohesin complex. Since cohesin and SMC5/6 hypomorphic mutants are 
synthetic lethal in yeasts it was expected this would be a positive hit in the 
screen and would be synthetic sick/lethal in combination with NSMCE4a 
knockdown (Tapia-Alveal, Lin & O'Connell, 2014). A Smartpool siRNA to GFP 
was also used to monitor transfection efficiency. siRNA to GFP was used as this 
allows the visualisation of transfection efficiency without negatively impacting 
the cells. In the screen it lowered expression of GFP to approximately 5-6 % of 
original levels and if this wasn’t observed then screen results were not taken 
forward for further processing.  
 
Throughout the screen, scramble siRNA was used as a negative control. It was 
important to ensure reproducibility throughout the screen and this was used 
during the processing of the data to make sure screens were controlled.  
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Figure	3.7.	Plate	map	that	showing	what	was	used	in	the	screen.	For	negative	controls,	
four	scramble	controls,	two	transfection	reagent	controls	and	six	untreated	controls	to	
check	plating	efficiency	accurately.	Positive	controls	were	siGFP	and	siSMC3.	siGFP	was	
used	to	ensure	transfection	efficiency.	Controls	were	in	different	wells	on	column	1	and	
column	12	to	ensure	placement	within	the	plate	did	not	affect	the	results.		
	
3.2.6 - Gathering data. 
 
Once the screen had been carried out, the images collected and processed the 
resulting data was analysed. To do this the data was compared to the scramble 
siRNA to ensure there was a difference. Each well was then given a Z-score, 
calculated using the formula (Z = ((X-µ)/σ)) in (Figure 3.8). The Z-score is the 
distance between the raw score and the population mean in units of standard 
deviation, where σ is the standard deviation of the population, µ is the mean of 
the population and X is the individual score obtained from the well. At this point 
the scramble siRNA was not used in the calculation of the mean, which was 
instead calculated from the mean of the population. Z-score significance was 
assigned if the Z-score value is +/- 2 as this correlates to a p-value of 0.05. 
Screening is a hypothesis generating tool and whilst significance may not always 
be apparent compared with other targets in the screen it allows for the 
identification of hits that previously may not have been considered.  
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3.3 – Discussion.  
 
In order to establish a synthetic sick/lethality screen many different parameters 
had to be considered. Steps involved in establishing a screen began with 
determining the target of the screen, then establishing a cell line (firstly 
determining what system of gene editing needed to be used), ensuring 
availability of the reagents and treatment type, assay kinetics and finally 
optimisation. To optimise the screen, the necessary controls needed to be 
included on the plate, the number of cells plated optimised, and how the data 
was collected and analysed assessed. 
 
In this chapter the establishment of a synthetic sick/lethality screen using U2OS 
osteosarcoma cells with a knockdown of the NSMCE4a subunit of the SMC5/6 
complex is presented. The SMC5/6 complex is the target of the screen and 
whilst it is not possible to target all members of the complex with RNAi at once 
it is possible to reduce both the levels of the complex by targeting one 
component of the complex. To this end, siRNA to SMC6 and NSMCE4a were 
tested separately and both were found to reduce other members of the SMC5/6 
complex. Following this, NSMCE4a shRNA was chosen to target the SMC5/6 
complex. Due to the lack of a reliable NSMCE4a antibody, reduction in levels of 
SMC5 and SMC6 was used as a proxy for NSMCE4a knockdown.  
 
Transfecting shRNA specific to NSMCE4a into U2OS was carried out with three 
separate targeting constructs and the supplied positive and negative controls. 
	  	 Calculating	Z	Score. 1 = 3 − µ6  
				Z	=	Z-score 
				X	=	individual	screen	value 
				µ	=	mean	of	entire	screen 
				σ	=	standard	deviation	of	entire	screen 
Figure	3.8.	Calculating	Z-score.		
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The positive controls GAPDH and EG5 were tested and it was found that the 
EG5 shRNA resulted in reduction in levels of SMC5/6 complex members. This is 
likely due to the fact that EG5 is a mitotic kinase, lack of which arrests cells at 
G2/M of the cell cycle, the stage at which SMC5/6 is thought to be removed 
from the chromosomes. The other positive control GAPDH and negative 
scramble control did not result in reduced levels of SMC5/6 complex. All three 
constructs targeting NSMCE4a resulted in reduced level of both SMC5 and 
SMC6 but to different degrees. The best targeting construct (no. 1 (861)) was 
taken forward for the full screen. 
 
Establishment of cell lines with shRNA knockdown of NSMCE4a and non-
silencing controls didn’t give a clear way to identify different cells above 
approximately 70 % confluency due to the fluorophore. The turboGFP in the 
pGIPZ plasmid spread throughout the cell and made it impossible to pick out 
individual cells. To overcome this problem turboGFP was replaced with nuclear 
AcGFP/mCherry (courtesy of Dr. Velibor Savic) with a nuclear localisation 
sequence. This allowed the individual cells to be clearly identified.  
 
Co-culturing of mCherry and AcGFP cell lines allowed the cells to be analysed 
by measuring the variation in percentage in cell number from what was originally 
plated. To ensure there was no change in ratio resulting from a growth 
advantage or disadvantage conferred on either NSMCE4a and non-silencing 
constructs it was necessary to test the cells in varying cell numbers and ratios. 
Results showed knockdown of NSMCE4a did not confer either a growth defect 
or advantage over the non-silencing construct.  
 
This screen can now be used to identify genes that are synthetically sick/lethal 
with reduction in SMC5/6 complex levels. Results will be analysed through 
comparing the numbers of red/green cells following siRNA knockdown of 
members of the DNA damage response library (Dharmacon). Once the data is 
collected the resulting ratio with be used to compare against the other members 
of the screen calculating the resultant Z-score.  
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Chapter 4.0 – Identification of genes required for survival following 
knockdown of NSMCE4a using synthetic sick/lethal screening.  
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4.1 – Introduction  
 
In the previous chapter the development of a synthetic sick/lethal interaction 
screen in human cells was described. The SMC5/6 complex was chosen as the 
initial target for a number of reasons. Smc5/6 has been shown in multiple 
organisms to regulate HR, particularly in response to replication stress (Murray 
& Carr, 2008; Bustard, Menolfi, Jeppsson, et al., 2012; Menolfi, Delamarre, 
Lengronne, et al., 2015; Ampatzidou, Irmisch, O'Connell, et al., 2006; Irmisch, 
Ampatzidou, Mizuno, et al., 2009). Compromising HR is a potential route to 
therapy, as a sensitizer, in combination therapies with drugs that compromise 
parallel pathways and potentially in mono-therapy for HR-deficient tumours. 
Consistent with a defect in HR, in DT40 cells SMC5 or NSMCE2 null cells show 
chromosome segregation defects and are sensitive to PARP inhibitors (Stephan, 
Kliszczak, Dodson, et al., 2011; Kliszczak, Stephan, Flanagan, et al., 2012).  
 
In addition to its role in HR a number of synthetic interactions identified in yeasts 
that suggested that targeting SMC5/6 would lead to lethality in a range of 
relevant tumour backgrounds. In budding yeast a genome-wide genetic 
interaction map has identified multiple synthetic interactions for the SMC5/6 
complex (Costanzo, Baryshnikova, Bellay, et al., 2010). In fission yeast Smc5/6 
complex mutants are synthetically very sick with tdp1, encoding Tyrosyl-DNA 
phosphodiesterase 1, which removes DNA bound Top1 intermediates (Heideker, 
Prudden, Perry, et al., 2011), cohesin and top2 mutants (Tapia-Alveal, Lin & 
O'Connell, 2014) and lethal with the ATR homologue but not CHK1 or CHK2 
(Murray pers. Comm.).  
 
Screens can also identify synthetic viability, where disrupting a second gene can 
result in an improved phenotype. For example, in budding yeast loss of the Mph1 
helicase (FANCM) suppresses the sensitivity of Smc5/6 hypomorphic mutants 
to MMS, suggesting that SMC5/6 is required to process recombination 
structures generated by Mph1 (Chen, Choi, Szakal, et al., 2009).  
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In this chapter the results of the screen to explore synthetic lethality/viability of 
known components of the DNA damage response library in conjunction with 
shRNA knockdown of NSMCE4a will be described.  
 
4.2 – The identification of DNA damage response factors affecting cell 
viability in NSMCE4a deficient cells  
 
446 different siRNAs specific to the DNA Damage Response (DDR) (Dharmacon 
DDR library and an additional custom library) were transfected into NSMCE4a 
deficient or Non-silencing control cells (see Figure 4.1 and Appendix section 
A.1 and A.2 for full list of siRNA sequence and plate maps). The screen was 
carried out according to the overview described in Chapter 3 (Figure 3.1). Briefly, 
2000 cells per well were co-cultured in a 1:1 ratio of AcGFP NSMCE4a and 
mCherry Non-silencing and transfected with siRNA 24 hours after seeding. Cells 
were left to incubate for 72 hours, at 37 ºC. Transfected cells were fixed using 4 
% PFA, stained with DAPI and processed using an Olympus IX83 ScanR 
microscopy platform. 16 images per well in three separate channels were 
acquired. The resultant ratios were compared against the entire screen and Z 
scores calculated (Figure 3.8) The plate was set up as indicated in (Figure 3.7) 
with controls in columns 1 and 12. Two Non-silencing control siRNAs, 
transfection reagent, GFP and SMC3 were used as two negative and two 
positive controls respectively. Raw data is shown in Appendix section A.3. 
 
Top down transfection was selected to minimise stress on cells as this works 
well for most adherent cells (Turner, Lord, Iorns, et al., 2008). To minimise the 
effects of edge effect the timing of the screen was selected to coincide with least 
amount of traffic through the tissue culture suite. Edge effect is known to occur 
when the edge wells of a 96 and 384 well plates are exposed to variation in 
temperature, CO2 and humidity (Lundholt, 2003). As such the middle of the plate 
will likely have been exposed to less conditional variability compared to the rest 
of the plate. Data showing volume of cells screened in all three screens is shown 
in (Appendix Section A.3.5).  
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Figure	4.1.	Plate	maps	of	siRNAs	used	in	the	screen.	Dark	blue	headers	indicate	siRNA	
from	the	DDR	library	and	light	blue	header	indicates	Custom	library	constructed	from	
suggestions	by	members	of	the	GDSC. 
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4.3 – Image acquisition and data analysis  
Images were obtained using DAPI, TxRed and FITC channels using the system 
described previously. Images underwent spectral un-mixing and background 
correction to ensure accuracy. They were analysed for fluorescence intensity as 
per experimental parameters, cells were gated separately for AcGFP, mCherry 
and DAPI expression/incorporation. The data was collated and exported for 
further analysis in Microsoft Excel.  
 
In this screen an average of 13,000 cells per siRNA were screened over three 
independent experiments. In each of the non-silencing control wells an average 
of 9,000 cells were screened over the three independent experiments. 
Calculation of the final ratio of AcGFP/mCherry cells highlighted the variation of 
ratio 72 hours after initial transfection. Calculating the Z-score gave the final data 
required from the screen. The Z-score is an absolute value that represents the 
distance between the raw score and the data population mean in units of 
standard deviation. The average Z-score over three independent experiments 
was calculated using the formulae (Z = ((X-µ)/σ)). This was calculated using all 
the data points in screen minus the average of the scramble siRNA score. The 
data was processed and Z-score obtained; the results were then presented in a 
waterfall graph (Figure 4.2.A). If the Z-score was less than -2 or greater than +2 
it was deemed significant as this corresponds to – or + two standard deviations 
from the mean.  
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Figure	4.2.	Graphs	of	the	data	sets	calculated	from	three	independent	screens.	A.	Shows	
calculation	of	average	Z-scores	whilst	B/C/D	are	the	individual	Z-scores	from	the	three	
screens.		
4.4 – Results of Screen  
Given the list of genes that were probed, unsurprisingly the majority of hits had 
some role in the DNA damage response. The more relevant information is the 
categories the hits fall into. Table 4.1 lists the top 60 hits in the combined screen 
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and Table 4.2 shows a selection from the top 60 synthetic lethal hits grouped 
into pathways.  
	
	
Table	4.1.	 Top	60	 Synthetic	 Lethality	Hits.	 Screening	 is	 a	hypothesis	 generating	 tool,	
traditionally	 Z-scores	 of	 <2	 or	 >2	 are	 considered	 statistically	 significant	 as	 they	
correspond	to	P-values	of	0.05	however	top	synthetic	lethal	hits	can	still	be	validated.	 
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Table	4.2.	Grouping	of	selection	from	top	60	synthetic	lethality	hits	into	pathways.	 
 
The NSMCE4a shRNA resulted in knockdown but not complete ablation of 
NSMCE4a (Figure 3.4.B). Since loss of SMC5/6 is cell lethal in mouse (Jacome, 
Gutierrez-Martinez, Schiavoni, et al., 2015), it would be predicted that further 
destabilisation of the complex by knockdown of additional subunits would lead 
to synthetic lethality and consistent with this both NSMCE4a and NSMCE3 
appear as hits in the screen. The other components may not have been identified 
due to the efficiency of the siRNA knockdown.  
 
Since SMC5/6 is required to regulate HR it would be predicted to be epistatic 
with HR factors and, indeed, RAD51 appears towards the middle of the waterfall 
plot (-0.481). However, BRCA2 came out as the top hit (-1.78). It acts through 
targeting RAD51 to ssDNA over dsDNA allowing RAD51 to replace RPA and 
stabilizing the RAD51-ssDNA complexes by blocking ATP hydrolysis. It also 
Hit.	 Pathway Appears	in	n	of	3	screen	with	
score	over		approximately	-2
NSMCE4a,	NSMCE3	 Members of	the	SMC5/6	complex NSMCE4a	– 1, NSMCE3	– 2.	
BRCA2, RBBP8,	RAD52,	EXO1,	VCP Involved in	HR BRCA2 – 2,	RBBP8	– 2,	RAD52	– 2,	EXO1	
– 0,	VCP	– 2.	
Artemis,	XLF NHEJ	and	V(D)J	 recombination Artemis – 2,	XLF	– 2.	
RRM1, RRM2 Nucleotide	synthesis. RRM1	– 1, RRM2	– 2.	
MRE11,	RAD50 Initial	response	 to	DNA	damage,	
activates ATM.	
MRE11	– 0,	RAD50 – 2.	
MAD2L2 Controls	DNA	repair	at	telomeres	and	
response to	DNA	breaks	through	
inhibition	 of	5’	end	resection.	Promotes	
NHEJ.	
MAD2L2	– 1.	
USP1, FANCB Required	for	DSB repair	and	
ubiquitination	 of	FANCD2	or	
deubiquitinates of	FANCD2.	USP1	is	
involved	 in	PCNA	mediated	TLS	through	
removal	of	ubiquitin	 of	PCNA.	Promotion	
of	HR.	
USP1 – 2,	FANCB	– 1.	
HEL308, DNA2L,	RUVBL2,	RUVBL1	 Helicases and	nucleases	 HEL308	– 2,	DNA2L	– 1,	RUVBL2	– 1,	
RUVBL1	– 1.	
APTX Resolves	abortive	DNA	ligation	during	
SSBR and	DSBR
APTX – 1.	
POLE, POLE4,	POLN,	POLD4,	PCNA,	
RFC1
DNA	replication	 POLE – 2,	POLE4	– 1,	POLN	– 1,	POLD4	–
0,	PCNA	– 2,	RFC1	– 1.	
POLR2A mRNA	synthesis	 POLR2A	– 1.	
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forms a part of the PALB2-scaffolded HR complex containing RAD51C. 
Similarly, RAD52 also appeared high in the screen and is also involved in the 
same steps as BRCA2 through interacting with RAD51 and can mediate 
assembly of RAD51 in the absence of BRCA2 though with lower efficiency(Chun, 
Buechelmaier & Powell, 2012). It also promotes, in combination with ERCC1, 
single strand annealing. Whilst more error-prone, is required in the cases of 
some breaks which would not otherwise be repairable (Stark, Pierce, Oh, et al., 
2004).  
 
SMC5/6 is required in response to replication stress. Loss of ribonucleotide 
reductase (RNR) or knockdown of replication factors induces replication stress 
and both RRM1 and RRM2 (RNR) and multiple replisome components (Pole, 
Pold, RPA, Rfc1, PCNA) were identified.  
 
Taking into account the known functions and pathways that SMC5/6 is involved 
in it is likely that knockdown of NSMCE4a would result in synthetic sick/lethal 
interactions with members of other DSB repair pathways such as the NHEJ 
pathway and two hits (Artemis and XLF) prominent in synthetic sickness were 
involved in NHEJ.  
 
Overall, these results suggest that the screen has been successful and a number 
of interesting hits were identified.  
 
4.5 Synthetic viability hits 
 
A Z-score of approximately +2 or over indicates a preferential response in cells 
with NSMCE4a shRNA compared to Non-silencing shRNA. This may indicate 
that the combination of knockdowns results in either a growth advantage in the 
NSMCE4a cells or a loss of viability in the Non-silencing shRNA cells. Most 
screens focus on trying to kill cells however identifying situations for treatments 
which confer a growth advantage to cells is important for the treatment of cancer 
or other malignancies to be able to avoid unnecessarily promoting their growth 
(Aly & Ganesan, 2011).  
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Table 4.2 lists the top 50 hits in the combined screen and Table 4.3 shows a 
selection from the top 50 synthetic viable hits grouped into pathways. Analysing 
the Z-score of each individual screen allows for the identification of potential 
false positive results. An example of a false positive is FANCD2, which presented 
with Z scores of 0.9, 6.4 and -0.27 indicating that there was a significant increase 
in NSMCE4a AcGFP cells only during screen 2 in this well. WRN is also likely to 
be a false positive with scores of 7.19, -0.27 and -1.23 in screens 1-3 
respectively. This could be the result of a number of factors. For example, during 
plates of the cell it is possible that a single cell suspension was not achieved for 
a patch of Non-silencing shRNA cells. Another possibility is that the transfection 
efficiency in the other two screens was not optimal or that there was an 
abnormally high dosage of siRNA into the cells. However as FANCD2 loss has 
been shown to result in increased severe DNA defects and enhanced cell death 
(Kais, Rondinelli, Holmes, et al., 2016) it is possible that this resulted in the death 
of the Non-silencing cells over the NSMCE4a shRNA cells.  
 
Both MMS22L and TONSL came out as synthetic viable hits. The MMS22-
TONSL complex stimulates recombination-dependent repair at stalled or 
collapsed replication forks. MMS22-TONSL also helps to promote HR and helps 
mediate the response of RAD51 filaments on ssDNA (Duro, Lundin, Ask, et al., 
2010). This suggests that the synthetic viability is due to repair no longer being 
channelled into HR-dependent pathways. 
 
Other synthetically viable hits components of the ubiquitin and sumo 
modification systems. These include UBB/UBD and UBA1. UBD is a paralog of 
UBB and both play a major role in targeting cellular components for degradation 
(Fischer, De Vos, Van Dijk, et al., 2003; Oh, Park, Lee, et al., 2013). They are 
involved in the maintenance of chromatin structure, regulation of gene 
expression and stress response. UBA1 catalyses the first step in ubiquitin 
conjugation and has functions in DNA repair. It is essential for timely DNA repair 
	 104	
and in the response to replication stress. UBA1 also promotes the recruitment 
of TP53BP1 and BRCA1 to DNA damage site (Groen & Gillingwater, 2015).  
 
Other synthetic viable hits include PIAS1, PIAS3, PIAS4 and SUMO2. PIAS 
proteins function as E3-type SUMO ligases (Mattoscio & Chiocca, 2015). PIAS1 
stabilises the interaction between UBE2I and SUMO and the SUMOylation of 
PML bodies. Telomeric DNA is found in the nuclear PML bodies and SMC5/6 is 
found associated with PML bodies(Cesare & Reddel, 2010). Knockdown of 
SMC5 and NSMCE2 using siRNA results in gradual telomere shortening 
therefore it is possible that whilst there is a momentary increase in viability this 
may not last(Potts & Yu, 2007).  
 
Three of the top synthetic viable hits are involved in telomere function. These are 
ACD, TERT and CCNA2. ACD forms one of the six core proteins in the Shelterin 
complex, which functions to maintain telomere length and protects telomere 
ends(de Lange, 2005). It promotes the binding of POT1 to telomeric ssDNA and 
modulates the inhibitory effects of POT1. Telomerase reverse transcriptase 
(TERT) maintains telomere length through addition of TTAGGG repeats (Ramlee, 
Wang, Toh, et al., 2016). Given the requirement of SMC5/6 at telomeres and its 
involvement in the ALT pathway, it is interesting that combined knockdown of 
both results in a growth advantage instead of cell death(Henson, Neumann & 
Yeager, 2002). CCNA2 encodes for Cyclin A2. This is essential for the control of 
the cell cycle at the start of G1/S and the G2/M transition in mitosis. Also 
required for the packaging of telomere ends(Gong & Ferrell, 2010). Another 
potentially telomere interacting protein is TTI1, which interacts with TELO2. This 
is involved in the regulation of the DDR and involved in the resistance to DNA 
damage stress(Jiang, Benard, Kebir, et al., 2003). 
 
A H2A histone variant, H2AFZ was another synthetic viable hit. This is of 
particular interest given results published by Tapia-Alveal et al 2014 where they 
show that chromosome segregation defects observed in Smc5/6 null mutants 
or cells treated with siRNA is suppressed in cells lacking H2A.Z suggesting 
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together, H2A.Z and the cohesin or Smc5/6 complex ensure genome integrity 
(Tapia-Alveal, Lin, Yeoh, et al., 2014).    
 
Whilst the synthetic viable hits were interesting and worth further investigation, 
the remainder of this chapter will focus on the top synthetically lethal hits of the 
screen. In this case BRCA2, the NHEJ factors and replication stress factors 
were chosen for validation. 
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Table	4.3	–	Selection	of	top	synthetically	viable	hits	with	details.	Individual	Z-scores	were	
taken	 and	 the	mean	 calculated,	 right	 hand	 column	 shows	 number	 of	 times	 each	 hit	
scored	approximately	+2.		
Hits.	 Brief Summary. Appears	in	n	of	3	screen	with	score	
over		approximately	+2
ACD,	TERT Involved	in	telomere function	and	lengthening.	 ACD	– 2,	TERT	– 1.
PIAS1 E3-SUMO	Ligase.	Stabilizes	interaction	with	UBE2I	and	
SUMO.	SUMOylates PML bodies	 to	promote	ubiquitin-
mediated	degradation.	
PIAS	– 1.
TOPBP1 Plays a	role	in	stalled	replication	forks	and	checkpoint	
control.	Binds	to	DSB	breaks	and	nicks	as	well	as	
ssDNA.	Recruits	SWI/SNF.	
TOPBP1	– 1.
UBB,	UBD,	
UBA1
Involved	in	ubiquitination to	target	for	degradation.	
UBD	is	a	paralog	of	UBB.	UBA1	catalyzes	the	first	step	
in	ubiquitin	 conjugation.	Promotes	 recruitment	of	
TP53BP1	and	BRCA1	to	DNA	damage	sites.	
UBB	– 2,	UBD - 1,	UBA1	– 1.
STRA13 Binding	component of	Fanconi Anaemia complex	
involved	 in	DNA	damage	repair	and	genome	
maintenance.	Recruited	to	stalled	forks	by	interstrand
cross-link	and	required	 for	resistance	to	lesions.		
STRA13	– 2.
TTI1 Involved	in	regulation	of	 the	DDR.	Part	of	the	TTT
complex	required	to	stabilize	proteins	levels	of	the	PIKK	
family	kinases.	
TTI2	– 2.	
CCNA2 Essential	for	the	control	of	the	cell	cycle	at	the	start	of	
G1/S and	the	G2/M	transition	 in	mitosis.	Also	required	
for	the	packaging	of	telomere	ends.	
CCNA2	– 2.
DDX11 Involved	in	cellular	proliferation.	Has	ATPase and	
Helicase	activities.	Stimulates	FEN1.	Required	for	sister	
chromatid	cohesion.	
DDX11 – 1.	
ACTL6A Similar	to	Actin.	Involved	in	vesicular	transport,	 spindle	
orientation,	nuclear	migration	and	chromatin
remodeling.	Related	to	SWI/SNF	in	S.	cerevisae and	
Drosophila.	
ACTL6A – 2.	
WRN Part	of	the	RecQ subfamily	of	DNA	and	RNA	helicases.	
Involved	in	transcription,	 recombination	and	repair.	
Interacts	with	Ku70/80,	involved	 in	DSB	repair.	
WRN – 1.	
MMS22L Part	of	the	TONSL	protein complex.	Recognizes	and	
repairs	DNA	DSBs.	Stimulates	the	recombination	
dependent	 repair	of	stalled	or	collapsed	replication	
forks.	Promotes	HR.	
MMS22L – 2.	
ANKRD28 Involved	in	PP6-mediated	dephosphorylation of	NFKBIE
opposing	 its	degradation	in	response	 to	TNF-α.	Inhibits	
the	phosphatase	activity	of	PPP1C.
ANKRD28 – 2.	
FANCD2 Part of	the	Fanconi Anaemia complex.	
Monoubiquitinated by	FANCB.	Localizes	to	nuclear	foci	
with	BRCA1	and	BRCA2.	Promotes	BRCA2/FANCD1	
loading	on	to	damaged	chromatin.	
FANCD2 – 1.	
H2AFZ Variant of	H2A	that	appears	to	alter	nucleosome	
stability.	It	is	partially	redundant	with	nucleosome	
remodeling	 complexes	and	is	involved	in	
transcriptional	control.	
H2AFZ	– 2.	
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4.6 Validation of synthetic lethality hits  
 
The next step was to validate the hits. This is important to ensure the top hits 
are not false positives. Whilst siRNA libraries are a useful tool for high throughput 
screens, unless characterised further it is possible that the results could be due 
to off target effects of the siRNAs used or and lack of effect due to not lowering 
levels of the targeted protein. 
	 
4.6.1 Confirmation of NSMCE4a shRNA knockdown in later passage cells  
After the screen was carried out it was important to check there was still a 
reduction in SMC5 and SMC6 levels in the NSMCE4a shRNA cells. Western 
blotting was carried out and showed a slight reduction in SMC5 and SMC6 
levels. Loading was confirmed using anti-tubulin antibody (Figure 4.3). Levels 
were not as reduced as what was initially observed in the previous chapter 
(compare Figures 4.3 and 3.4), quantification of these levels is seen in (Table 
A.4.2.A). This is likely due to cells overcoming the knockdown with time, 
despite constant puromycin selection. Validation of hits was carried out in 
these cells but it is likely that a stronger phenotype would be observed in cells 
with stronger knockdown and this could have been achieved through use of 
the gating feature on the ScanR microscope.  
 
4.6.2 – BRCA2 is a top candidate in the synthetic sick/lethal screen  
 
BRCA2 appears as a top hit in the screen whereas BRCA1 does not. Both are 
involved in homologous recombination. BRCA2-deficient cells exhibit increased 
Figure	4.3.	Western	blot	confirming	knockdown	of	SMC5	and	SMC6	in	NSMCE4a	shRNA	
cells	after	the	screen	had	been	carried	out.		 
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sensitivity to ionizing radiation, however cell cycle checkpoint and apoptotic 
responses to DNA damage remain intact. BRCA2 regulates the intracellular 
localisation and function of the recombinase RAD51(Tarsounas, Davies & West, 
2003). Nuclear transport of RAD51 is impaired in BRCA2 deficient cells 
suggesting that once RPA has coated ssDNA following resection during cells 
deficient in BRCA2 cannot replace it with RAD51.  
 
BRCA1 also functions in the HR pathway however in a different capacity to 
BRCA2 (Roy, Chun & Powell, 2012). In response to DNA damage BRCA1 is 
hyper-phosphorylated and localizes to sites of DNA damage. In response to 
ionizing radiation BRCA1 is bound and phosphorylated by ATM (Roy, Chun & 
Powell, 2012). Both BRCA1 and BRCA2 co-localize with RAD51 to form 
complexes and co-localize with MRN appearing to function as a regulator.  
 
To validate that BRCA2 and not BRCA1 was synthetically sick with loss of 
NSMCE4a this was explored in two different approaches. Firstly, NSMCE4a 
shRNA and Non-silencing cells from the screen (Figure 4.4.A) were treated with 
siRNA Smartpools specific to BRCA1 and to BRCA2, quantification of BRCA1 
levels is seen in (Table A.4.2.D). These Smartpools are independent of the ones 
used in the screen, see Appendix section A.2 for details. The BRCA1 
knockdowns led to loss of viability in both shNSMCE4a and non-silencing cells. 
However, no statistically significant difference in viability was seen between 
shNSMCE4a AcGFP cells (19.3%) and shNon-silencing mCherry cells (23.9 %). 
Reduction of BRCA1 was confirmed through western blotting shown in (Figure 
4.4.B), equal loading was confirmed using Ponceau staining.  
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Figure	4.4.	A.	Results	of	colony	formation	assay	showing	treatment	of	NSMCE4a	shRNA	
cells	 with	 BRCA1	 siRNA	 (P-value	 0.07)	 and	 BRCA2	 siRNA	 (P-value	 0.01).	 Assay	 was	
repeated	3	 times	 in	 triplicateB.	Western	blot	 analysis	 showing	 knockdown	of	BRCA1	
following	siRNA	treatment	in	Non-silencing	mCherry	and	NSMCE4a	AcGFP	cells.		
 
A marked reduction in viability was observed in cells with dual perturbation of 
SMC5/6 and BRCA2 as shown in (Figure 4.4.A). Cell viability in the shNSMCE4a 
AcGFP cells was reduced to 23 % after exposure to BRCA2, in contrast to the 
shNon-silencing cells were viability was reduced to 48%. To confirm the 
synthetic sickness immortalised fibroblasts from wild-type (1BR hTERT), 
SMC5/6–deficient (NSMCE3-L264F, GVH02 hTERT (see Chapter 5 for further 
details of this cell line)) and BRCA2-deficient (HSC62 hTERT) individuals were 
treated with siRNA specific to NSMCE4a (Figure 4.5.A). Both WT and NSMCE3-
L264F cells showed a slight reduction in viability but the BRCA2-deficient cells 
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showed significantly increased sensitivity. In the primary patient fibroblasts after 
NSMCE4a siRNA exposure cell viability was reduced to 80.9 %, 80.3 % and 
60.9 % in WT1, NSMCE3-L264F and BRCA2 deficient cells respectively. SMC6, 
a marker of complex stability and NSMCE4a knockdown, was examined using 
western blotting (Figure 4.5.B). Equal loading was confirmed using ponceau 
staining, quantification of protein levels can be seen in (Table A.4.2.B). SMC6 is 
reduced in the untreated NSMCE3-L264F cells compared to WT (see Chapter 
5 for a full characterisation) and was also reduced in the BRCA2-deficient cell 
line. To confirm this the extract was rerun and Figure 4.5.C shows that SMC6 is 
present in the BRCA2 deficient cells and is reduced on siNSMCE4a treatment. 
After siNSMCE4a SMC6 levels reduced in WT but no changes were seen the 
other cell lines. Overall, this analysis supports results in the screen that BRCA2 
but not BRCA1 was synthetically sick with loss of NSMCE4a. It is possible that 
this is due to BRCA1 being essential in both cell types, whereas BRCA2 is only 
essential in NSMCE4a knockdown cells. However this must be investigated 
further before any such conclusion can be made.  
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Figure	4.5.	A.	Colony	formation	in	WT	(1BR	hTERT),	NSMCE3-L264F	(SMC5/6	deficient	
GVH02	hTERT),	Artemis	deficient	 (CJ176	hTERT),	 and	BRCA2-deficient	 (HSC62	hTERT)	
cells	following	treatment	with	siRNA	specific	to	NSMCE4a.	Results	indicate	a	statistically	
relevant	 reduction	 in	 cell	 viability	 of	 the	 BRCA2	 deficient	 cells	 compared	 to	 WT	 or	
SMC5/6	deficient	(p=0.005).	B.	Western	blot	showing	knockdown	of	SMC6	in	indicated	
cell	 lines.	 C.	 Initially	 SMC6	 in	 BRCA2	 cells	 were	 not	 knocked	 down,	 however	 upon	
repetition	knockdown	was	observed.		
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4.6.3 – Knockdown of NSMCE4a leads to increased sensitivity to MRE11 
inhibitor Mirin  
 
MRE11 was also a candidate for synthetic lethality as it came up in the top 60 
hits in the screen. MRE11 is part of the MRN complex, required for initiation of 
HRs and for ATM signalling (Álvarez-Quilón, Serrano-Benítez, Lieberman, et al., 
2014). To investigate this further clonogenic survival assays were carried out 
with wild-type (WT1, 1BR hTERT), NSMCE3-L264F (GVH02 hTERT), Artemis null 
(CJ176 hTERT) and BRCA2 deficient (HSC62	hTERT) mutant cells in the presence 
of 0, 5, 10, 25 and 50 µM of the MRE11 inhibitor, Mirin (Figure 4.6.B). Mirin was 
identified as a small molecule that inhibits the MRN-dependent activation of 
ATM by perturbing the nuclease activity of MRE11, (Figure 4.6.A) shows the 
structure of Mirin (Dupré, Boyer-Chatenet, Sattler, et al., 2008; Kuroda, Urata & 
Fujiwara, 2012). WT1 cells showed cell survival of 100, 39, 17, 6 and 2 % 
respectively. NSMCE3-L264F cells showed 100, 36, 11, 3 and 1 %. Artemis cells 
had 100, 47, 13, 3 and 1 % and finally BRCA2 showed 100, 58, 25, 6 and 2 % 
survival after 10 days. This showed that perturbation of SMC5/6 levels and 
inhibition of MRE11 results in increased sensitivity, consistent with the reduction 
in viability observed in the screen. The reduction in viability is similar to that seen 
in the NHEJ-defective Artemis cells where an inhibition of MRE11 results in 
sensitivity.   
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Figure	 4.6.	 A.	 ChemSketch	 drawing	 of	 Mirin	 –	 MRE11	 inhibitor.	 B.	 Graph	 showing	
response	to	Mirin	exposure.	Clonogenic	survival	assays	were	carried	out	with	wild-type	
(WT1,	 1BR	 hTERT),	 NSMCE3-L264F	 (GVH02	 hTERT),	 Artemis	 null	 (CJ176	 hTERT)	 and	
BRCA2	deficient	(HSC62	hTERT)	mutant	cells	in	the	presence	of	0,	5,	10,	25	and	50	µM	
of	 the	MRE11	 inhibitor,	Mirin.	 NSMCE3-L264F	 cells	 showed	 increased	 sensitivity,	 as	
observed	in	Artemis	cells,	this	was	not	observed	in	BRCA2-deficient	cells.		
 
4.6.4 – Knockdown of NSMCE4a is synthetic lethal with loss of NHEJ 
factors.   
NHEJ plays a major role in the DNA damage response and is the main pathway 
used in human cells (Lieber, Gu, Lu, et al., 2009). Whist error prone in 
comparison to HR the cell can carry out NHEJ at all phases of the cell cycle. HR 
on the other hand can only occur in late S and G2 phases of the cell cycle (Kass 
& Jasin, 2010).  
 
The identification of XLF and Artemis as two of the most lethal interactions and 
Ligase IV in the top 60 hits indicates that NHEJ is required when SMC5/6 is 
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compromised (Schematic of NHEJ repair showing where these proteins function 
is given in Figure 1.1). In order to show that proteins required for NHEJ are 
critical to cell survival when HR is compromised though loss of NSMCE4a, wild-
type (1BR hTERT), NSMCE3-L264F (GVH02-hTERT), Artemis (CJ176 hTERT) 
and XLF (2BN hTERT) cells were transfected with NSMCE4a siRNA or a non-
silencing control and colony formation assays were performed. While viability 
after knockdown of NSMCE4a in the Artemis cell line was not significantly 
different to WT, in the XLF cells there was significant loss of viability (Figure 
4.7.B). All data from colony formation assays was normalised to 100 % in the 
scramble. WT1 cells showed 80 % survival following NSMCE4a siRNA, 
NSMCE3-L264F cells similarly showed 80 % survival and Artemis cells showed 
74 % survival. XLF treated cells dropped to a viability of 9 % compared to wild-
type, this is statistically significant with a p-value of 0.002. The lack of decreased 
viability in the Artemis cell line may be due to lack of efficient knockdown as 
SMC6 levels did not decrease (Figure 4.6.B). Reduction of SMC5/6 levels in the 
other NSMCE4a siRNA treated cells was confirmed using western blotting with 
ponceau used to confirm equal loading (Figure 4.7.C), quantification of protein 
levels is shown in (Table A.4.2.C).  
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Figure	4.7.	A.	Graph	showing	percentage	cell	survival	after	exposure	to	NSMCE4a	siRNA	
in	wild-type	(1BR	hTERT),	NSMCE3-L264F	(GVH02-hTERT),	Artemis	 (CJ176	hTERT)	and	
XLF	(2BN	hTERT)	cells.	B.	Western	blot	showing	knockdown	of	SMC5	and	SMC6	in	WT,	
NSMCE3-L264F	and	XLF	cells.		
 
4.6.5 – NSMCE4a knockdown is synthetic lethal with knockdown of RRM1 
and RRM2.  
 
Replication stress is a hallmark of cancer (Macheret & Halazonetis, 2015). 
Several hits within the screen indicated factors that were synthetically sick/lethal 
with NSMCE4a shRNA knockdown were involved in DNA replication or 
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production of dNTPs, consistent with a requirement for SMC5/6 in response to 
replication stress. 
 
In the screen siRNA specific to ribonucleotide reductase subunits (RNR) RRM1, 
RRM2 and RRM2B were assessed. Both RRM1 and RRM2 showed a synthetic 
lethal interaction with NSMCE4a shRNA however RRM2B did not. RMM2B is 
P53 inducible through DNA hypomethylation (Link, Baer, James, et al., 2008) 
and, therefore, it is likely this is the reason a lethal interaction was not observed. 
Another possibility could be that transfection efficiency was lower and 
knockdown was not achieved.  
 
Hydroxyurea (HU) is an inhibitor of RNR and arrests cells in S phase by depleting 
nucleotide pools. (A schematic of the RNR pathway is shown in Figure 4.9.A). 
To validate these hits cells were blocked in S phase by HU, released into fresh 
media in the presence of the nucleotide analogue EdU and the percentage of 
cells with EdU positive nuclei scored with and without the HU block.  
 
Cells containing shRNA to NSMCE4a or Non-silencing shRNA cells were treated 
with 250 µM HU for up to 18 hours before being released into fresh media 
containing 10 µM EdU for 30 minutes. Plates were analysed using the Olympus 
ScanR microscopy platform. The percentages of cells that incorporated EdU 
was analysed both with and without HU block and release. Cells which 
expressed Non-silencing shRNA showed 63, 83.9 and 87 % incorporation at 0, 
12 and 14 hours and NSMCE4a shRNA showed 50, 75 and 79 % respectively. 
The assay was carried out using four replicates and with three independent 
repeats. The differences at 12 and 14 hours between Non-silencing and 
NSMCE4a shRNA was statistically significant with p-values of 0.002 and 0.05 
(Figure 4.9.B).  The apparent high level of incorporation could be false positive 
however due to bleed through into the TxRed channel from the FITC channel. 
To examine this further use of an siRNA to GFP or use of an inducible knock-out 
cell line would help confirm the result. Given the reduced number of cells in S 
phase in the –HU control does not suggest that the results +HU is not significant, 
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however when gating for high EdU incorporating cells at 14 hours shows 
reduction in NSMCE4a shRNA expressing cells numbers suggesting cells with 
NSMCE4a shRNA expression are less efficient to restart replication than Non-
silencing shRNA cells (Figure 4.9.C). These results suggest that SMC5/6 is 
required under conditions of replication stress and therefore may function as a 
tumour suppressor.  
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Figure	4.8.	A.	Schematic	representation	of	RNR	pathway.	B.	Graph	of	percentage	cells	
with	incorporation	of	EdU	with	and	without	12	and	14	hour	HU	block	and	release.	P-
value	=	0.002	and	0.05	respectively.	C.	Gating	for	the	highest	EdU	incorporating	cells	
shows	 reduction	 in	 number	 of	 NSMCE4a	 shRNA	 cells	 being	 able	 to	 incorporate	 EdU	
compared	with	Non-silencing	control	P-value	0.001.		
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4.7 – Discussion.  
4.7.1 Synthetic lethality hits 
In this chapter the results of a synthetic sick/lethal screen were presented. The 
high-throughput microscopy screen was carried out in triplicate and in each 
screen analysed large numbers of cells per well. For example, an average of 768 
NSMCE4a AcGFP and 1023 Non-silencing mCherry cells were screened per 
experiment in the RRM1 well. In RRM2 an average of 965 NSMCE4a AcGFP 
cells and 1326 Non-silencing mCherry were screened.  
 
A pool of shNSMCE4a GFP cells were used with a range of expression of the 
shRNA. This had the advantage that results could be gated for GFP intensity 
(increased GFP correlating with increased knockdown) but this was not carried 
out for this analysis. While useful for the initial screen, the mixed population was 
a disadvantage for the validation. Western blot analysis showed that SMC5/6 
was still knocked down in later passage cells but not to the same degree as had 
been observed before (Figure 4.3). This may be due to the age of the cells as 
shRNA knockdown can be overcome through incorporation of mutations in cells. 
This was observed is a parallel screen (Hopkins, McGregor, Murray, et al., 2016) 
despite the presence of constant puromycin selection when the cells were not 
under screening.  
 
The results indicated that loss of SMC5/6 results in a pronounced sensitivity 
under conditions of replication stress, loss of some HR factors and some NHEJ 
factors. 
 
BRCA2 is the top hit in the screen and functions to replace RPA with RAD51. 
RAD52 has a similar role and also appears highly in the screen. MRE11 is within 
the top 60 hits. However, consistent with the epistasis seen in yeasts RAD51 is 
neutral in the screen and BRCA1 does not appear as a top hit. Therefore, within 
the HR pathway there appears to be a split in the response to NSMCE4a 
knockdown, with early steps showing synthetic lethality. In yeasts RAD52 and 
MRN genes are also synthetically sick with hypomorphic SMC5/6 mutants and 
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this has been suggested to be due to their role in single strand annealing which 
becomes essential when later stages of HR are disrupted.  An important 
question to arise is why BRCA2 appears as the top hit whereas BRCA1 does 
not, when both are involved in HR and in similar steps. It is possible that loss of 
BRCA1 is equally deleterious for both the NSMCE4a and Non-silencing shRNA 
cells.  
 
NHEJ factors also appeared as top hits within the screen but key NHEJ factors 
were not seen. Neither DNAPK-cs nor KU70 or KU80 were identified. This may 
be due to the efficiency of knockdown and consistent with this KU70 and KU80 
are very abundant proteins which are difficult to knockdown (Jeggo lab pers. 
comm.). Alternatively, the synthetic lethality seen with Artemis and XLF points to 
a requirement for end processing when SMC5/6 function is compromised.  
 
The requirement for the SMC5/6 complex in response to replication stress was 
highlighted in the screen. The RNR subunits, RRM1 and RRM2 were strong hits. 
This is consistent with the replication stress phenotype associated with the 
NSMCE3-L264F cells described in CHAPTER 5. NSMCE4a shRNA AcGFP cells 
showed a reduction in capability to restart replication in comparison with Non-
silencing mCherry cells. In fission yeast an SMC5/6 mutant have been shown to 
have shorter replication tracts after exposure to replication stress (Jo Murray, 
pers. comm). A synthetic sick/lethal interaction was also observed with 
knockdown of NSMCE4a and DNA replication factors, POLE, POLE4, POLN, 
POLD4, RFC1 and PCNA, and depletion of these factors would also cause 
problems during replication.  
 
In budding yeast the Smc5/6 complex is required to mediate replication of 
repetitive genomic regions such as rDNA and telomeres (Gallego-Paez, Tanaka, 
Bando, et al., 2014). MAD2L2, another hit in the screen, has, among other 
functions, been found to control DNA repair at telomeres and also the response 
to DNA breaks through inhibition of 5’ end resection. Depletion of MAD2L2 
results in elongated 3’ telomeric overhangs suggesting MAD2L2 inhibits 5’ end 
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resection. 5’ end resection typically results in blockage of NHEJ whilst 
committing cells to homology driven repair (Boersma, Moatti, Segura-Bayona, 
et al., 2015). MAD2L2 also promotes NHEJ-mediated repair, therefore depletion 
of MAD2L2 in NSMCE4a knockdown cells suggests breaks which would 
typically be committed to repair by NHEJ are repaired by HR during S and late 
G2 and this may prove deleterious. The associated activity of SMC5/6 and 
MAD2L2 at telomeres may also explain why SMC5/6 and MAD2L2 is synthetic 
sick/lethal (Boersma, Moatti, Segura-Bayona, et al., 2015). 
 
Another top hit is Valosin Containing Protein (VCP) (van den Boom, Wolf, 
Weimann, et al., 2016). VCP is involved in the DNA damage response where it is 
recruited to DSBs in an RNF8- and RNF168 dependent manner and promotes 
recruitment of 53BP1 to damage sites. It is also recruited to stalled replication 
forks by SPTRN (Lessel, Vaz, Halder, et al., 2014) therefore given the crossover 
in functions between VCP and SMC5/6 it is likely that affecting both results in 
cell death. Another DNA repair pathway is represented, ssDNA break repair, with 
Aprataxin, encoded by the APTX gene. This play a role through its nucleotide-
binding activity. It is also involved in DSB repair and BER where it is used to 
resolve abortive DNA ligation intermediates at base excision sites. It is also 
required at sites where DNA ligases attempted to repair non-ligatable ends 
following damage caused by reactive oxygen species(Schellenberg, Tumbale & 
Williams, 2015).  
 
Helicases are also well represented with HEL308, DNA2L, RUVBL1 and RUVBL2 
in the top 24 hits. SMC5/6 has previously been shown to have interactions with 
helicases (Chen, Choi, Szakal, et al., 2009; Xaver, Huang, Chen, et al., 2013). 
HEL308 is encoded by the HELQ gene, as the name alludes it is a helicase with 
ATPase activity. Part of the superfamily 2 helicase it is thought to function in the 
early stage of recombination following replication fork arrest (Richards, Johnson, 
Liu, et al., 2008). The principal role of HEL308 appears to be to assist in the 
repair of replication fork blocking lesions, such as interstrand DNA cross-
links(Woodman & Bolt, 2011; Tafel, Wu & McHugh, 2011). DNA2L is a key 
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enzyme required for accurate DNA replication and DNA repair. It is involved in 
Okazaki fragment processing by cleaving long flaps that FEN1 cannot deal with. 
In S. cerevisae Dna2 is also required for its nuclease activity but also checkpoint 
activation(Wanrooij & Burgers, 2015). RUVBL1 and RUVBL2 encodes for the 
human homologue of bacterial RuvB gene. In humans RUVBL1 and RUVBL2 
possesses ssDNA stimulated ATPase and an ATP-dependent DNA helicase (5’ 
to 3’ and 3’ to 5’) both interacts with the Fanconi Anaemia core complex and 
depletion leads to DNA damage sensitivity and elevated chromosomal instability 
(Rajendra, Garaycoechea, Patel, et al., 2014). This suggests loss of helicases 
and as their associated defects accumulate in a synthetic sick/lethal manner 
with knockdown of NSMCE4a.  
 
4.7.2 – Synthetic viability hits   
A number of synthetic viable hits were also identified (see Appendix section 
A.3.6 and A.3.6.1), the most interesting of which are the MMS22L-TONSL 
complex and H2A.Z. The MMS22-TONSL complex stimulates recombination 
dependent repair at stalled or collapsed replication forks (Duro, Lundin, Ask, et 
al., 2010). Given the roles of SMC5/6 in HR and the requirement for SMC5/6 in 
response to replication stress (supported by the synthetic lethal hits in this study) 
this suggests that in the absence of the MMS22L-TONSL complex lesions are 
processed by HR-independent pathways and SMC5/6 is not required. The 
identification of H2A.Z as synthetic viable is supported by a study in fission yeast 
that identified H2A.Z as a suppressor of chromosome segregation defects in 
SMC5/6 hypomorphic mutants (Tapia-Alveal, Lin, Yeoh, et al., 2014). It would be 
interesting to follow up these and other hits but this was not possible due to time 
constraints. 
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Chapter 5 – Characterisation of the cellular defects associated with 
mutation in NSMCE3, which leads to LICS syndrome.  
  
	 124	
5.1 – Introduction 
In this chapter the characterisation of the cellular defects due to mutation in 
NSMCE3, a subunit of SMC5/6, is presented. The mutation in NSMCE3 was first 
identified in two Dutch sisters, daughters of distantly related parents (Figure 
5.1.A), who both presented at hospital at about 13 months with severe lung 
failure following pneumonia (van der Crabben, Hennus, McGregor, et al., 2016). 
Karyotyping of the patients’ cells showed high levels of chromosomal 
rearrangements (Figure 5.1.C). Whole exome sequencing of the patients’ DNA 
identified a homozygous missense mutation in NSMCE3 (c. 790G>T, 
pLeu164Phe). Another family with compound heterozygous mutations in 
NSMCE3 was also identified from America (Figure 5.1.B), (c. 626C>T)  
p.Pro209Leu and (c. 790G>T) p.Leu264Phe (Figure 5.1.D). These patients 
presented with similar symptoms of lung disease, weight loss, eczema and food 
allergies. The first sibling died at a similar age to the Dutch sisters, of pulmonary 
failure following pneumonia, while the younger sibling underwent lung 
transplantation at 15 months old due to pulmonary damage but died at 31 
months old following bone marrow failure and increased susceptibility to 
infection. The syndrome has been named LICS, as it is characterised by lung 
disease, immunodeficiency and chromosome instability. 
 
NSMCE3 (also called NDNL2 or MAGEG1) is a 35 kDa protein which forms a 
subcomplex with NSMCE1 and NSMCE4a in the SMC5/6 complex in 
humans(Taylor, Copsey, Hudson, et al., 2008a; Doyle, Gao, Wang, et al., 2010). 
It is a member of the Melanoma Antigen (MAGE) protein family and has been 
shown to enhance the E3 ubiquitin ligase function of NSMCE1 in vitro (Doyle, 
Gao, Wang, et al., 2010). Its yeast homologue, Nse3, forms a similar strong 
interaction with Nse1. It is the founder and only MAGE protein present in yeast 
and most eukaryotes but in mammals the MAGE family has diversified.  
 
There are 55 MAGE genes in the human genome which have been subdivided 
into different classes based upon their protein structures(Doyle, Gao, Wang, et 
al., 2010). MAGE proteins were first identified as cell surface markers on cancer 
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cells and the focus of studies has been to examine their potential as targets in 
cancer immunotherapy (Barker & Salehi, 2002). Individual members of the MAGE 
proteins have been reported as playing important roles in neuronal development, 
apoptosis and cell cycle control(Bush & Wevrick, 2008) but a biochemical 
function is yet to be identified for many of the MAGE proteins(Taylor, Copsey, 
Hudson, et al., 2008a).  
 
Nse3 is essential in yeasts, where most research into the roles of the Smc5/6 
complex has been carried out. This chapter will focus on the characterisation of 
the cellular effects of the NSMCE3-L264F mutation in patient cells and of the 
analogous mutation in S. pombe.  
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Figure	5.1.	A.,	B.	Family	trees	from	both	Dutch	and	US	families.	The	Dutch	family	show	
consanguinity	six	generations	previously.	C.	Karyotyping	of	lymphocytes	from	one	of	the	
Dutch	patients,	samples	were	obtained	two	weeks	after	admission	to	hospital	and	show	
large	 levels	 of	 genomic	 rearrangements	 and	 supernumerary	 markers.	 D.	 Schematic	
showing	position	of	mutations	in	the	NSMCE3	gene.	Dutch	patients	show	homozygous	
mutations	c.790C>T	p.L264F.	American	patients	have	heterozygous	mutations	c.626C>T	
p.P209L	and	c.790C>T	p.L264F.	 
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5.2 Results 
	
5.2.1 – The equivalent mutation in S. pombe, nse3-L293F, does not lead to 
sensitivity to DNA damaging agents  
 
To determine the effect of the NSMCE3-L264F mutation the comparative 
orthologous mutation was modelled in S. pombe and compared against well-
characterised Smc5/6 complex mutants. Sequence alignment, using Jalview, of 
H. sapien NSMCE3, S. pombe Nse3 and S. cerevisae Nse3 proteins indicated 
the corresponding mutation was Leu293Phe (Figure 5.2.A).  
 
The sequence encoding Nse3-L293F was created by site-directed mutagenesis 
PCR (Figure 5.2.B). The mutated nse3 gene was ligated into the pAW8 plasmid 
(Watson, Garcia, Bone, et al., 2008), between flanking LoxP and LoxM3 sites 
(Figure 5.2.C). The mutated gene was integrated under the control of the 
endogenous nse3 promoter in the host genome through Recombination 
Mediated Cassette Exchange (RMCE)(Watson, Garcia, Bone, et al., 2008). The 
base strain for this integration, which consists of the nse3 gene and ura4 
selectable marker flanked by loxP and loxM3 sites, was a gift from Prof Alan 
Lehmann. RMCE is an efficient method for gene tagging and gene replacement 
using Cre recombinase (Figure 5.2.C) (Watson, Garcia, Bone, et al., 2008). 
Following integration of the cassette, positive clones were selected for by 
replacement of the ura4 marker using 5’-fluoroorotic acid (5’-FOA). Successful 
integration of the mutated gene was confirmed by colony PCR and sequencing 
(Figure 5.2.D). 
 
Creation of nse3-L293F in S. pombe showed the mutation was viable. To 
investigate the effect of the mutation, cells were compared to wild type (WT) 
cells and well characterised mutants under a range of conditions and DNA 
damaging agents.  
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Figure	 5.2.A.	 Sequence	 alignment	 of	 NSMCE3	 genes	 from	 H.	 sapiens,	 S.	 pombe,	 S.	
cerevisiae.	Sequences	were	obtained	from	Uniprot	using	accession	numbers	Q96MG7,	
Q9Y7UA	 and	 QO5541.	 Sequences	 were	 aligned	 using	 Jalview	 and	 coloured	 using	
ClustalX.	 B.	 Schematic	 of	 site-directed	 mutagenesis	 to	 create	 nse3-L293F	 mutation.	
Fusion	PCR	was	used	to	create	two	separate	fragments	and	fuse	them	together	using	
the	F1	and	R2	primers	whilst	incorporating	the	L293F	mutation	that	had	been	created	
in	the	previous	PCR.	Restriction	sites	were	incorporated	at	the	beginning	and	end	of	the	
gene	 fragment	 to	allow	 it	 to	be	 ligated	 into	destination	plasmid	pAW8.	C.	 Schematic	
representation	of	Recombination	Mediated	Cassette	Exchange.	The	gene	incorporating	
the	nse3-L293F	mutation	in	pAW8	plasmid	was	transformed	into	the	nse3	Base	Strain	
which	 contains	 LoxP	 and	 LoxM3	 sites	 flanking	 nse3-ura4+	 gene.	 Induction	 of	 Cre	
recombinase	expression	led	to	recombination	between	wild-type	nse3	in	the	genome	
and	nse3-L293F	on	the	pAW8	plasmid.	Replacement	of	the	ura4	marker	was	selected	by	
growth	on	5-FOA	plates.	D.	Confirmation	of	successful	mutagenesis	of	nse3-WT	to	nse3-
L264F.	 
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5.2.1.1 – Examining the effects of non-permissive temperatures on cells 
with mutated nse3  
 
Smc5/6 is essential in fission yeast and mutants that destabilise the complex 
lead to loss of viability or slow growth defects (Lehmann, Walicka, Griffiths, et 
al., 1995; Fousteri & Lehmann, 2000). In addition, conditionally lethal mutants 
have also been identified (Sergeant, Taylor, Palecek, et al., 2005). To determine 
whether the nse3-L293F mutation confers a sensitivity to increased/decreased 
temperature and to ensure that these cells can grow at standard conditions (30 
ºC) cells were grown at 25 ºC and 37 ºC as well as 30 ºC. Serial dilutions of cells 
(17.5x105 – 8.75x104 – 4.3x103 – 2.1x102 – 1x101) were plated onto YEA plates 
with Phloxin B, as a marker for cell viability, and grown for 4 days at the indicated 
temperatures.  Wild-type cells (WT) and the nse3 base strain (nse3-bs) were used 
as controls to show that the flanking lox sites did not contribute to the 
phenotype. Two well characterised mutants smc6-X (Lehmann, Walicka, 
Griffiths, et al., 1995) and smc6-74 (Verkade, Bugg, Lindsay, et al., 1999) were 
plated for comparison. All three isolates of nse3-L293F strains grew similarly to 
wild-type at all temperatures (Figure 5.3). In contrast and as expected, the most 
sensitive of the smc6 mutants, smc6-X, had a slight growth defect at all 
temperatures. 
 
	
Figure	5.3.	 Spot	 test	 showing	nse3-L293F	 lack	of	 sensitivity	 to	 shifting	 temperatures.	
Wild-type	(WT),	nse3	base-strain	(bs),	three	isolates	of	nse3-L293F,	smc6-74	and	smc6-
X	 cells	 were	 plated	 in	 varying	 dilutions	 and	 exposed	 to	 different	 temperatures.	 No	
sensitivity	to	different	temperatures	was	observed	except	for	smc6-X	which	had	a	slight	
defect	at	all	temperatures.	 
Temperature	Sensitivity
25	°C 30	°C 37	°C
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nse3- BS
nse3-L293F	c1
nse3-L293F	c2
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5.2.1.2 – Exposure of nse3-L293F cells to UV radiation does not show 
increased sensitivity compared to wild-type and base strain controls. 
 
Since Smc5/6 mutants in S. pombe exhibit sensitivity to DNA damaging agents 
and inhibition of replication the response of the nse3-L293F mutant was tested. 
Spot tests were carried out using the same strains as previously described 
(nse3-L293F with wild-type (WT), nse3-base strain, smc6-X and smc6-74 as 
controls).  
 
Five dilutions of cells (17.5x105 – 8.75x104 – 4.3x103 – 2.1x102 – 1x101) were 
plated onto YEA plates with Phloxin B, exposed to 50, 100, 150 or 200 J/m2 of 
UV radiation and left to incubate for 4 days. Wild-type and base strain cells were 
not sensitive to low doses of UV. Whilst smc6-74 and smc6-X showed high 
sensitivity, with smc6-X the more sensitive. This is consistent with previous 
reports (Ampatzidou, Irmisch, O'Connell, et al., 2006). nse3-L293F cells were 
slightly more sensitive than base strain cells, but not as sensitive as the smc6 
mutants (Figure 5.4.A).  
 
To examine this potential defect further a more accurate and quantitative colony 
formation assay was carried out. The nse3-L293F strain was compared to wild-
type (WT), nse3-base strain, and smc6-74. In addition, nse2-SA was included in 
the analysis. This mutation inactivates the Nse2 SUMO ligase activity and leads 
to sensitivity to DNA damage in S phase but not to UV sensitivity (Andrews, 
Palecek, Sergeant, et al., 2005). Log phase cells were plated onto YEA plates, 
UV irradiated at doses ranging from 50-200 J/m2 and the number of colonies 
formed counted.  
 
Wild-type cells showed survival of 77, 66, 28 and 3 % at 50, 100, 150 and 200 
J/m2 respectively, whilst the nse3-base strain did not show a significant increase 
in sensitivity with survival rates of 76, 51, 48 and 4 % at respective dosages 
(Figure 5.4.B). Interestingly, nse3-L293F showed no decrease in viability with 
85, 77, 77 and 3 % survival. nse2-SA showed 69, 50, 34 and 20 % survival. 
Finally, the most sensitive strain smc6-74 showed 6 % survival at the lowest 
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dose of irradiation (50 J/m2) and only 1 % at 100 J/m2. In conclusion, while smc6-
74 cells show sensitivity at low doses, there was no increase in sensitivity in 
nse3-L293F cells when compared to the base strain. Thus, the slight UV 
sensitivity of nse3-L293F cells seen in spot tests was not reproduced in the more 
quantitative colony formation assay (Figure 5.4.B). 
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Figure	5.4.	A.	Spot	test	showing	slight	sensitivity	to	UV	radiation.	Wild-type	(WT),	nse3-
base	 strain,	 three	 isolates	 of	 nse3-L293F,	 smc6-74	 and	 smc6-X	 cells	 were	 plated	 in	
varying	dilutions	and	exposed	 to	doses	of	UV	 radiation	 ranging	between	50	and	200	
J/m2.	smc6-74	and	smc6-X	showed	high	levels	of	sensitivity	to	UV.	nse3-L293F	showed	
slight	increase	in	sensitivity	to	UV	at	dosages	of	at	150	J/m2.	B.	Colony	formation	assay	
after	exposure	to	UV	radiation.	Wild-type	(501),	nse3-base	strain,	nse3-L293F,	nse2-SA	
and	smc6-74	cells	were	plated	in	triplicate	and	exposed	to	UV	radiation.	Smc6-74	cells	
were	sensitive	to	UV	at	dosages	of	50	J/m2	and	dropped	to	under	10	%	viability	whereas	
sensitivity	was	not	observed	in	all	other	strains. 
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5.2.1.3 – nse3-L293F cells do not exhibit increased sensitivity to replication 
stress 
 
Treatment using hydroxyurea (HU) results in depletion of the dNTP pool resulting 
in stalled replication forks (Petermann, Orta, Issaeva, et al., 2010b). Prolonged 
replication fork stalling can lead to collapsed replication forks and DNA double 
strand breaks. Smc5/6 mutants, smc6-74 and smc6-X, have previously been 
shown to be very sensitive to HU (Ampatzidou, Irmisch, O'Connell, et al., 2006). 
As before, wild-type (501), nse3-base strain, nse3-L293F, smc6-74 and smc6-X 
cells were plated onto YEA with Phloxin B, containing 1-10 mM hydroxyurea and 
incubated for 4 days. Sensitivity to HU was seen in both smc6-74 and smc6-X 
cells beginning at 2.5 mM HU, but no sensitivity was observed in nse3-L293F 
cells compared to wild-type and base-strain controls (Figure 5.5.A). 
 
 
 
5.2.1.4 – nse3-L293F does not result in increased sensitivity to MMS  
 
Methyl methanesulphonate (MMS) is an alkylating agent. Alkylated DNA is 
repaired by base excision repair but in S phase can lead to stalling of the 
replication fork(Lundin, 2005). smc6-X and smc6-74 cells have been shown to 
be sensitive to MMS treatment as published previously (Sheedy, 2005). As 
before wild-type (WT), nse3-base strain, nse3-L293F, smc6-X and smc6-74 cell 
were plated onto YEA with Phloxin B containing 0.0005, 0.001, 0.002, 0.005 and 
0.01 % MMS and incubated for 4 days at 30 ºC. Strong sensitivity in smc6-X 
was observed even at low doses of 0.0005 % MMS and continues to 0.01 % 
MMS. smc6-74 began to show sensitivity at 0.001 %. However, nse3-L293F did 
not show any sensitivity until 0.005 % MMS. However, this was comparable to 
the nse3-base strain suggesting any sensitivity seen was probably due to 
presence of the flanking LoxP and LoxM3 sites (Figure 5.5.B).  
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5.2.1.5 – nse3-L293F cells do not exhibit increased sensitivity to 
Camptothecin 
 
The topoisomerase inhibitor Camptothecin (CPT) is a cytotoxic quinolone 
alkaloid. It acts through inhibition of topoisomerase I (topo1) through the 
formation of the reversible topo1-CPT-DNA covalent complex resulting in a 
protein linked DNA break (Liu, Desai, Li, et al., 2000). Sensitivity to Camptothecin 
has been reported previously for smc6-X and smc6-74 (Zabrady, Adamus, 
Vondrova, et al., 2015). Wild-type (WT), nse3-base strain, nse3-L293F, smc6-X 
and smc6-74 cells were plated on YEA plates with Phloxin B and exposed to 
0.5, 5, 10, 15 and 20 µM CPT. Slight sensitivity was observed in nse3-L293F at 
15 µM CPT compared with wild-type (WT). However, the nse3-base strain was 
also as sensitive, this again suggests the sensitivity is due to the LoxP and 
LoxM3 sites flanking the nse3 gene rather than the mutation (Figure 5.5.C). 
Therefore, the nse3 mutation does not sensitise cells to CPT. Given there was 
no observed increased in sensitivity to DNA damage, replication stress or growth 
defect in nse3-L293F cells we next tested the effect the analogous mutation may 
have in mammalian cells.  
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Figure	5.5.	A.	Spot	test	showing	lack	of	sensitivity	to	replication	stress.	Wild-type	(501),	
nse3-base	strain,	three	isolates	of	nse3-L293F,	smc6-74	and	smc6-X	cells	were	plated	in	
varying	dilutions	and	exposed	to	varying	concentrations	of	hydroxyurea	(HU).	Sensitivity	
was	observed	in	smc6-74	and	smc6-X	that	was	not	observed	in	nse3-L293F.	B.	Sensitivity	
to	MMS.	Strains	as	in	A,	cells	were	exposed	to	MMS.	smc6-X	began	to	show	sensitivity	
at	0.0005	%	with	 smc6-74	 showing	 sensitivity	 at	0.001	%.	nse3-L293F	and	nse3-base	
stain	showed	slight	sensitivity	at	0.005	%	MMS.	All	strains	were	sensitive	at	0.01	%	MMS.		
C.	 Sensitivity	 to	 Camptothecin.	 Strains	 as	 in	 A,	 cells	 were	 exposed	 to	 Camptothecin	
(CPT).	Sensitivity	to	CPT	was	observed	in	smc6-74	and	smc6-X.	Slight	sensitivity	in	nse3-
L293F	was	observed	at	15	µM	CPT	however	this	was	also	observed	in	nse3-base	strain	
indicating	sensitivity	was	due	to	the	presence	of	the	LoxP	and	LoxM3	sites	flanking	nse3.	
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5.2.2 – Analysis of primary patient fibroblasts isolated from a Dutch patient 
with mutated NSMCE3  
 
5.2.2.1 – Mutation in NSMCE3 results in increased levels of chromosome 
instability  
 
The NSMCE3 patients were categorised as having a chromosomal breakage 
syndrome due to the abnormal karyotypes seen in lymphocytes (van der 
Crabben, Hennus, McGregor, et al., 2016). A known hallmark for chromosomal 
mis-segregation and instability is the presence of micronuclei. Micronuclei (MN) 
and other nuclear abnormalities such as nucleoplasmic bridges (NPBs) and 
nuclear buds (NBUDs) are biomarkers of genotoxic events and chromosomal 
instability (Figure 5.1.C). Given the high level of chromosomal instability 
observed in the NSMCE3-L264F lymphocytes and the fact that mutations in 
another subunit of SMC5/6 complex, NSMCE2, resulted in increased 
micronuclei and chromosomal bridges (Payne, Colnaghi, Rocha, et al., 2014), 
we investigated micronuclei levels in primary patient fibroblasts, compared to 
fibroblasts isolated from patients with a well-defined chromosomal breakage 
syndrome, Ataxia telangiectasia (AT)(Vral, Thierens & De Ridder, 1996; Migliore, 
Coppede, Fenech, et al., 2010; Wang, Su, Smilenov, et al., 2011). Examples of 
micronuclei scored are shown in (Figure 5.6.A). 
 
The NSMCE3-L264F patient cells (primary fibroblasts) were compared with two 
wild-type cell lines (1BR and 48BR) and ATM-/- (AT1BR, an AT patient cell line). 
Approximately 1000 cells were scored for each cell line over three independent 
repeats. Micronuclei were observed in 3 % and 6% of 1BR and 48BR fibroblasts 
(Wild-type 1/2). Unsurprisingly, a 2-4 fold increase (13 %) of micronuclei were 
seen in ATM-/- fibroblasts. Furthermore, 21 % of NSMCE3-L264F fibroblasts 
contained micronuclei, which is a 4-7 fold increase when compared to control 
cells. This indicates large levels of chromosomal instability. The results were 
statistically significant according to Students T-Test (NSMCE3-L264F to wild-
type 1 p=7.59x10-7, to wild-type 2 p=1.325x10-8) (Figure 5.6.B).  
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Due to the high levels of micronuclei observed the patient cells it was important 
to study the phenotypes associated with the NSMCE3-L264F mutation when 
exposed to various DNA damaging agents and also on the levels of the complex 
itself.  
	
	
	
	
Figure	5.6.	A.	Examples	of	micronuclei	scored	for	assay.	Primary	fibroblasts	were	plated	
into	 10	 cm	 dishes	 and	 allowed	 to	 seed	 and	 grow.	 Cells	were	 then	 fixed	 in	 4	%	 pfa,	
permeabilised	and	DAPI	 stained	before	 scoring.	 Two	wild-type	 cell	 lines,	ATM-/-	 and	
NSMCE3-L264F	cells	were	scored	and	approximately	1000	cells	were	counted	for	each	
cell	line	over	three	independent	experiments.	B.	Graph	showing	percentage	of	cells	with	
micronuclei	abnormalities.	Wild-type	1	(WT1,	1BR)	and	wild-type	2	(WT2,	48BR)	cells	
were	used	as	wild-type	controls	and	 showed	 low	 levels	of	micronuclei,	 3	%	and	6	%	
respectively.	However,	ATM-/-	(AT1BR)	exhibit	13	%	abnormalities	and	NSMCE3-L264F	
(GVH02)	show	21	%	indicating	a	very	high	level	of	chromosomal	instability	in	these	cells.	
*	denotes	 statistically	 significant	difference	according	 to	 Student’s	 T-Test	of	NSMCE-
L264F	cells	p<0.005.	+	denotes	significance	of	ATM-/-	cells	compared	with	wild-types,	p-
value	<0.05.		
  
 
5.2.2.2 – NSMCE3 is required to maintain levels of SMC5/6  
 
Modelling of the mutation in silico by Dr Tony Oliver suggested the NSMCE3-
L264F mutation destabilised the interaction of NSMCE3 with NSMCE1 and 
NSMCE4. Computational analyses of models based on the crystal structure of 
the NSMCE1-NSMCE3 dimer (Protein Data Bank [PDB] ID 3NW0; 
http://www.rcsb.org) (Doyle, Gao, Wang, et al., 2010) predicted destabilization 
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to disrupt the fold in NSMCE3 WH/B-e domain due to the presence of steric 
clashes with side chains of the adjacent helix. Purification of recombinant 
NSMCE1 and NSMCE3 proteins from E. coli resulted in an approximately 1:1 
stoichiometric ratio of NSMCE1 and NSMCE3 in both wild-type and L264F 
mutation forms(van der Crabben, Hennus, McGregor, et al., 2016). Wild-type 
NSMCE1 and NSMCE3 formed a stable dimer when analysed using size-
exclusion chromatography. The L264F variant still interacted with NSMCE1 but 
eluted over a larger volume and with a non-uniform distribution suggesting a 
non-specific interaction with the chromatography resin and longer retention on 
the column(van der Crabben, Hennus, McGregor, et al., 2016) indicating a slight 
unfolding of the complex. Yeast2Hybrid analysis confirmed this by showing loss 
of interaction between NSMCE3 and NSMCE4, whilst incorporation of the P209L 
mutation resulted in loss of interaction between NSMCE3 and NSMCE1 and 
NSMCE4.  
 
Since structural modelling and biochemical assays indicated a destabilisation of 
NSMCE3 and loss of complex formation, levels of endogenous protein from 
patient fibroblasts were analysed to study what impact this might have. Western 
blot analysis of NSMCE3-L264F fibroblasts and two wild-type control cell lines 
(1BR and 48BR) showed low levels of SMC5 and SMC6 in the NSMCE3-L264F 
cells compared to controls (Figure 5.7). Tubulin content was used as loading 
control to ensure this reduction was not due to difference in the amount of cell 
extract loaded.  
 
These results were subsequently confirmed and, in addition, cells from an 
American patient who had heterozygous mutations in NSMCE3, p.Pro209Leu 
and p.Leu264Phe, were also shown to contain substantially reduced levels of 
NSMCE3, SMC5 and SMC6 (van der Crabben, Hennus, McGregor, et al., 2016). 
The reduction in protein levels but not complete ablation is consistent with 
viability as knockout of SMC5/6 in mice shows embryonic lethality and knockout 
in yeasts is lethal.  This results indicates the mutation in NSMCE3 results in a 
reduction of total protein levels of the whole complex, quantification of protein 
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levels can be seen in (Table A.4.3.A). Such a destabilisation of the complex may 
affect the ability of the complex to carry out its cellular function at an optimal 
level.  
 
 
 
	
	
	
	
	
	
	
	
	
	
	
	
	
5.2.2.3 – Analysis of NSMCE3-L264F fibroblasts sensitivity to DNA 
damaging agents and replication stress  
 
To determine whether the NSMCE3-L264F mutation results in increased 
sensitivity to DNA damaging agents, patient fibroblasts were exposed to a 
variety of these agents and clonogenic survival assays carried out. Sensitivity to 
DNA damaging agents has been reported for a number of SMC5/6 mutants in 
yeasts and slight sensitivity to MMS has been reported in chicken DT40 cells 
with a knock-out of SMC5 (Stephan, Kliszczak, Dodson, et al., 2011).  
 
Primary fibroblasts from patients with NSMCE3-L264F and a wild-type (48BR) 
cell line were cultured and exposed to varying doses of genotoxic agents, these 
include: IR, UV, MMC, CPT, HU and MMS. Cells were grown on 10 cm dishes 
with a feeder layer of wild-type cells irradiated with 35 Gy IR to ensure assay 
cells were able to adhere to bottom of the plate.  
 
Figure	5.4.	Western	blot	analysis	comparing	SMC5/6	complex	members.	NSMCE3-
L264F	cells	show	decreased	levels	of	SMC5	and	SMC6	compared	with	wild-type	
controls.	This	was	also	confirmed	in	patient	cells	taken	from	one	of	the	American	
patients.		
SMC6	
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Tubulin	
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5.2.2.3.1 – NSMCE3-L264F fibroblasts have a slight slow growth phenotype  
 
The growth rate of NSMCE3-L264F (GVH02) cells was examined (Figure 5.8) 
and compared to two wild-type cell lines (1BR and 48BR) and an ATM-/- cell line 
(AT1BR). It was found to be marginally slower compared with the wild-type 
controls but slightly faster than the ATM-/- cells. 
 
Figure	5.5.	Growth	rates	of	NSMCE3-L264F	(GVH02)	compared	to	two	wild-type	cell	lines	
(1BR	and	48BR)	and	an	ATM-/-	cell	line	(AT1BR)	were	calculated	by	plating	104	cells	of	
each	cell	line	into	3	cm	dishes	and	incubated	at	37	ºC	for	up	to	96	hours	before	being	
trypsinised	 and	 resuspended.	 The	 number	 of	 cell	 per	 mL	 counted	 using	 a	
haemocytometer.	 
 
 
5.2.2.3.2 – NSMCE3-L264F cells show increased sensitivity to ionizing 
radiation 
 
Ionizing radiation (IR) results in DNA single and double strand breaks (DSBs). 
DSBs generated by IR are the most lethal form of damage. To examine the ability 
of NSMCE3-L264F cells to repair double strand breaks patient cells were treated 
with increasing doses of IR. 
 
Slight sensitivity was observed when NSMCE3-L264F cells were compared to 
wild-type cells after exposure to ionizing radiation (Figure 5.9.A). Cell viability 
for wild-type cells was 53, 11, 2, and 0.2 % compared with NSMCE3-L264F 35, 
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4, 0.7 and 0.05 %. Statistical significance at 1 and 3 Gy IR according to Students 
T-Test, p-values were 0.05 and 0.03 respectively.  
 
5.2.2.3.3 – NSMCE3-L264F cells show sensitivity to UV damage	
	
Smc5/6 mutants have been shown to been sensitive to UV damage in yeasts but 
in S. pombe the equivalent mutant to NSMCE3-L264F, nse3-L293F, was not 
sensitive (see Figure 5.4). However, NSMCE3 is not well conserved in this c-
terminal wing helix extension domain (see Figure 5.2) and so the mutations are 
not necessarily equivalent.  
 
In human fibroblasts, the NSMCE3-L264F mutation resulted in a slight sensitivity 
to UV radiation when compared to wild-type cells. At doses of 2, 5, 7, 10 J/m2 
of UV survivals of wild-type cells were: 55 %, 19 %, 2.8 %, and 0.5 %. NSMCE3-
L264F cells resulted in survivals of 49 %, 10 %, 1.75 %, and 0.5 %. However, 
this sensitivity is not significant at any point according to Student’s T-test and 
this is consistent with what was observed in S. pombe nse3-L293F (Figure 
5.9.B). 
 
5.2.2.3.4 – Exposure of NSMCE3-L264F cells to Mitomycin C does not result 
in increased sensitivity 
 
Mitomycin C (MMC) is used as a chemotherapeutic agent which crosslinks DNA. 
This results in blocked replication forks which causes replication arrest and cell 
death if the crosslink is not repaired(Paz, Zhang, Lu, et al., 2012). 
 
Cells were treated with doses of MMC at 2, 5 and 10 µM and results indicated a 
mild but not statistically significant sensitivity to MMC when comparing 
NSMCE3-L264F to wild-type cells. Cell viability at doses of MMC of 2, 5 and 10 
µM were 54 %, 23 % and 10 % for wild-type and 45 %, 17 % and 5 % for 
NSMCE3-L264F cells respectively (Figure 5.9.C).  
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5.2.2.3.5 – Exposure of NSMCE3-L264F cells to Camptothecin results in 
slight sensitivity 
 
Since only slight sensitivity was seen in IR and UV treated cells the next step 
was to test a more S phase specific damage. Exposing cells to Camptothecin 
will cause protein-DNA coupled induced breaks.  
 
After exposure to Camptothecin, NSMCE3-L264F cells show slight increase in 
sensitivity over wild-type cells. At doses of 1, 2.5, 5 and 10 µM CPT, NSMCE3-
L264F cells showed 33, 14, 2 and 2 % survival, whilst wild-type cells showed 
survival rates of 49, 30, 16 and 12 %. This was not statistically significant 
according to Student’s T-Test (Figure 5.9.D).  
 
 
5.2.2.3.6 – Clonogenic analysis of NSMCE3-L264F cells exposed to HU 
shows slightly increased sensitivity to replication stress 
 
Since the SMC5/6 complex is well known to be required for stabilisation of 
replication forks and for fork restart, cells were treated with hydroxyurea to 
deplete the dNTP pool. Mutations in the Smc5/6 complex have been shown 
sensitise cells to HU (Ampatzidou, Irmisch, O'Connell, et al., 2006).  
 
Clonogenic analysis of cells with NSMCE3-L264F mutation compared with wild-
type showed slight increase in sensitivity over dosages 0.25, 1 and 5 µM of HU. 
Wild-type cells showed survival of 63, 38 and 26 % compared to NSMCE3-
L264F patient cells with 52, 27 and 16 %. The only statistically significant point 
was at 0.25 µM where wild-type showed 63 % survival compared to 52 %, p-
value = 0.008. This suggests only a slight sensitivity to damage induced in S 
phase (Figure 5.9.E). 
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5.2.2.3.7 – Exposure of NSMCE3-L264F cells to MMS results in slight 
sensitivity  
 
MMS damage can lead to collapsed replication forks and double strand breaks. 
Sensitivity of Smc5/6 mutants in yeast strains to MMS has previously been 
reported, as has slight sensitivity to MMS in DT40 SMC5 knock-out cells 
(Stephan, Kliszczak, Dodson, et al., 2011).  
 
Slight sensitivity was observed in NSMCE3-L264F cells compared to wild-type 
cells. Wild-type cells showed cell viability at doses of 65 %, 19 %, 5 %, 3 % and 
2 % at MMS doses of 50, 100, 150, 200, 250 µg/mL. NSMCE3-L264F showed 
cell viability of 61 %, 13 %, 1.5 %, 0.7 % and 0.2 %. However, this was not 
statistically significant. (Figure 5.9.F). 
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Figure	5.9.	Clonogenic	analysis	of	WT	(48BR)	and	NSMCE3-L264F	(GVH02)	cells	exposed	
to	varying	doses	of	DNA	damaging	agents,	(A)	IR,	(B)	UV,	(C)	MMC,	(D)	CPT,	(E)	HU	and	
(F)	 MMS.	 Cells	 were	 plated	 in	 triplicate	 with	 an	 irradiated	 feeder	 layer	 to	 allow	
attachment	and	exposed	to	damage	before	being	allowed	to	recover	and	grow	for	21	
days.	 Graphs	 represent	 the	 surviving	 percentage	 compared	 to	 untreated	 controls.	
NSMCE3-L264F	 cells	 showed	modest	 sensitivity	 to	 IR,	CPT	and	MMS.	Results	 are	 the	
average	 of	 3	 independent	 experiments	 with	 triplicate	 plates.	 *	 denotes	 statistical	
significance	with	p-value	<0.05	according	to	students	T-Test,	2-tailed.		
	
5.2.3 – The SMC5/6 complex is required for repair in G2 in mammalian cells  
 
Sensitivity to DNA damaging agents indicates a defect in DNA repair. In order to 
determine which repair pathway was affected we induced DNA damage and 
determined how long it took to repair the damage by analyzing the rate of 
removal of DNA damage markers. Phosphorylated H2AX (ɣH2AX) foci were used 
as a surrogate marker of DNA damage and analyzed over time after exposure to 
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ionizing radiation(Löbrich, Shibata, Beucher, et al., 2014; Ivashkevich, Redon, 
Nakamura, et al., 2012). Non-homologous end-joining (NHEJ) is the major 
pathway for repair of DSBs in mammalian cells in both G1 and G2 cells but in 
G2 homologous recombination (HR) is required for repair of a subset of DSBs 
(O’Driscoll & Jeggo, 2006). Therefore, a defect in NHEJ results in a repair defect 
in both G1 and G2 but in HR a defect in recovery is only seen in the slow repair 
fraction in G2.  
	
In yeasts SMC5/6 is required for HR, which is the main DSB repair pathway in 
yeasts (Haber, Ira, Malkova, et al., 2004). Therefore, patient cells with mutations 
in SMC5/6 and/or reduced levels of SMC5/6 would be predicted to show a 
defect in repair in G2 compared to wild-type cells. Since the patient lymphocytes 
were proficient in V(D)J recombination it was hypothesised NHEJ that would be 
unaffected in the NSMCE3-L264F patient fibroblasts.  
 
To determine if there was a defect in the NHEJ or HR repair pathway ɣH2AX foci 
were quantified over a time course following IR damage. Cells were subjected 
to 3 Gy IR and samples collected over a time course of 2, 8 and 14 hours. CENPF 
staining was used to identify G2 cells and pan-nuclear ɣH2AX staining was 
indicative of cells in S phase. HR is required in S phase but as the presence of 
ɣH2AX cannot be accurately quantified at this cell cycle stage, S phase cells 
were excluded from analysis. G1 and G2 cells were analysed of	ɣH2AX levels 
(Figure 5.10.A).  
 
Patient cells were compared against wild-type (1BR), BRCA2 deficient (HSC62) 
(defective in HR), and ATM-/- (AT1BR) (defective NHEJ and HR) cells. 
Background levels of ɣH2AX were found to be an average of approximately 1 
focus in all cells screened. Maximal ɣH2AX levels were seen at two hours after 
IR radiation and were found to range from 28-36 foci in all the cells tested.  
 
In G1 cells, where NHEJ is essential for repair of DSBs, ATM-/- cells, which are 
defective in NHEJ, show slower repair kinetics compared to wild-type cells. In 
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ATM-/- cells there were 150 % more foci (Statistically significant with a p-value 
of 0.0002) at 8 hours and 300 % more foci (Statistically significant with a p-value 
of 0.002) at 14 hours compared with wild-type cells. BRCA2 deficient cells, that 
are defective in HR, show no statistically significant difference between the 
levels of foci at 8 and 14 hours compared with wild-type cells. This is consistent 
with HR not being required in the G1 phase of the cell cycle. Similarly, patient 
cells also showed no defect in repair kinetics in G1, thus confirming that SMC5/6 
does not play a major role in NHEJ (Figure 5.10.B).  
 
To analyse repair kinetics in G2, only cells containing ɣH2AX and co-stained with 
CENPF were counted. CENPF is a component of the nuclear matrix during G2 
and is therefore used as a marker of G2. At 0 hours wild-type, NSMCE3-L264F, 
ATM-/- and BRCA2 deficient cells showed on average 3, 5, 6 and 6 foci per cell 
respectively. At 2 hours post irradiation cells showed maximal levels of ɣH2AX 
with 61, 58, 56 and 52 foci per cell scored. At 8 and 14 hours post irradiation 
levels of ɣH2AX had dropped to an average of 17 and 11 foci per cell respectively 
in wild-type cells. In the HR defective cells (ATM-/- and BRCA2 deficient) the 
number of ɣH2AX foci at 8 and 14 hours post radiation dropped to 27, 18, and 
29, 21 foci per cell respectively. Compared with wild-type this rate of removal 
was statistically significant with p-values of 0.02 for the 8-hour time point for the 
ATM-/- cells and p=0.01 and 0.02 for the BRCA2 deficient cells at 8 and 14 
hours. In NSMCE3-L264F cells the level of ɣH2AX foci at later time points was 
also increased compared with wild-type cells. At 8 and 14 hours 24 and 18 foci 
were observed and was statistically significant with p-values of 0.01 and 0.02 
compared to wild-type cells. This shows NSMCE3-L264F cells show similar 
repair kinetics to the HR deficient cells and, thus, is consistent with a 
requirement for SMC5/6 in HR repair in G2.  
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Figure	5.10.	A.	 Image	showing	how	the	cells	were	stained	and	scored	for	ɣH2AX	foci	
analysis.	Cells	were	DAPI	stained,	CENPF	was	used	to	mark	G2	stage	of	the	cell	cycle,	
ɣH2AX	foci	levels	for	scoring.	B.	Analysis	of	ɣH2AX	foci	in	wild-type	(1BR),	NSMCE3-L264F	
(GVH02),	ATM-/-	(AT1BR)	and	BRCA2-deficient	(HSC62)	cells.	Cells	were	irradiated	with	3	
Gy	 IR	 and	 allowed	 to	 recover	 for	 2,	 8	 and	 14	 hours.	 NSMCE3-L264F	 cells	 shows	 no	
increase	in	foci	levels	compared	with	NHEJ	proficient	cells.	CENPF	staining	was	used	to	
pick	out	S	and	G2	cells.	Cells	without	CENPF	staining	were	scored	as	G1/G0	cells.	S	phase	
cells	with	pan-cellular	ɣH2AX	were	also	excluded.	ATM-/-	cells	show	increased	levels	of	
foci	 in	 8	 and	 14	 hours	 statistically	 significant	 compared	 with	 wild-type	 controls	
suggesting	deficiency	 in	NHEJ.	NSMCE3-L264F	does	not	appear	 to	have	defect	 in	 this	
stage	of	the	cell	cycle.	*	denotes	statistical	significance	according	to	Students	T-Test.	C.	
ɣH2AX	assay	of	cells	in	G2	stage	of	the	cell	cycle.	Cells	were	stained	with	CENPF	to	pick	
out	G2	cells	and	these	cells	scored	for	their	ɣH2AX	foci	 levels.	NSMCE3-L264F,	ATM-/-	
and	BRCA2-deficient	cells	showed	higher	levels	of	ɣH2AX	foci	compared	with	wild-type	
cells.	At	8	and	14	hours	 the	difference	between	NSMCE3-L264F	and	WT	controls	are	
statistically	 significant	 according	 to	 Students	 T-Test.	 *	 denotes	 statistical	 significance	
according	to	Students	T-Test	p-value	<0.05.	
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5.2.4 – NSMCE3 is required for replication fork restart    
 
SMC5/6 has previously been reported to be required for replication restart 
(Irmisch, Ampatzidou, Mizuno, et al., 2009). Payne et al 2014 also showed that 
cells with a mutation in the NSMCE2 subunit of SMC5/6 showed a reduced 
recovery from replication stress. To test whether the NSMCE3-L264F cells also 
had a defect in recovery from replication stress the cells were exposed to low 
levels of HU, which depletes the dNTP pools leading to stalled replication, and 
released into media containing the thymidine analogue EdU.  
 
EdU incorporation was chosen over BrdU as BrdU-labelled DNA is quantitated 
using a detection method which involves some very harsh treatments to expose 
the BrdU. This is a time consuming step and is difficult to perform consistently 
and can often affect sample integrity. The choice of EdU kit also allowed the 
potential for co-staining with BrdU. Cells were scored for EdU incorporation as 
seen in (Figure 5.11.A).  Wild-type (48BR) and NSMCE3-L264F (GVH02) cells 
were treated with/without 250 µM HU for 18 hours and allowed to recover for 30 
min in media containing 10 µM EdU. It has previously been shown that most 
forks are able to restart replication after release from a 1-2 hour HU block, with 
nucleotide incorporation in most cells resuming within 12-18 hours. However, 
most forks remained stalled after 24 hours in HU block with induction of double 
strand breaks after 18 hours (Petermann, Orta, Issaeva, et al., 2010b; Hanada, 
Budzowska, Davies, et al., 2007).  
 
Untreated wild-type cells showed 35 % of cells were currently in S phase as 
measured by their incorporation of EdU. When exposed to HU for 18 hours 42 
% of cells were able to incorporate EdU suggesting they were able to restart 
replication. In NSMCE3-L264F cells, 41 % of cells without HU were in S phase, 
however after exposure to HU only 4 % of cells were EdU positive suggesting 
they had reduced capability to restart replication following stalled replication. 
According to Student’s T-Test this was statistically significant (p=0.005) (Figure 
5.11.B). To determine whether these results were due to a reduced number of 
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cells in S phase, FACS analysis was carried out. The FACs results from HU 
treated wild-type and NSMCE3-L264F cells confirm that similar numbers of cells 
accumulated in S phase during the HU block. After 18 hours in HU both wild-
type and NSMCE3-L264F cells accumulated in S phase showing the cell cycle 
profile of both cell lines were similar (Figure 5.12). This confirms that NSMCE3-
L264F cells were able to enter S phase but had issues restarting replication. 
Since the viability of cells of NSMCE3-L264F cells on chronic exposure to HU 
(Figure 5.9) is only slightly reduced it is likely that replication restart is delayed 
rather than abolished.  
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Figure	5.11.	A.	Representative	images	highlighting	the	scoring	of	EdU	positive	cells.	Cells	
were	plated	onto	glass	 coverslips	 and	were	 treated	with/without	250	µM	HU	 for	18	
hours	before	being	released	into	fresh	media	containing	10	µM	EdU.	Cells	were	then	
either	 processed	 to	 label	 EdU	 according	 to	 manufacturer’s	 instruction.	 Cells	 which	
incorporated	 EdU	 were	 scored.	 B.	 Graph	 showing	 percentage	 of	 cells	 which	
incorporated	EdU	compared	with	number	of	cells	counted.	NSMCE3-L264F	cells	showed	
comparable	 levels	 of	 EdU	 incorporation	 when	 compared	 with	 wild-type	 0	 hour	 HU	
treatment	 but	 vastly	 reduced	 levels	 after	 18	 hours	 in	 HU.	 	 Results	 at	 18	 hours	 are	
statistically	significant	according	to	Students	T-Test,	2-tailed,	p-value	<0.05.		
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Figure	5.12.	A.	 FACS	profiles	 comparing	wild-type	 and	NSMCE3-L264F	 cells	with	 and	
without	exposure	to	250	µM	hydroxyurea	for	18	hours.	Results	indicate	cells	are	able	to	
enter	S	phase	whilst	in	HU	block.	B.	Table	showing	percentage	of	cells	in	each	respective	
gate.	C.	Graph	of	 table	 in	B,	 showing	 reduction	of	percentage	of	cells	 in	G1	allowing	
passage	into	S	phase.		 	
	 153	
5.2.5 – Complementation of patient fibroblasts with wild-type NSMCE3 
rescues S phase replication restart phenotype  
 
To determine whether the recovery defect observed in 5.2.4 was due to the 
NSMCE3-L264F mutation we examined whether the defect could be 
complemented by expression of the wild-type protein. eGFP tagged versions of 
wild-type NSMCE3, NSMCE3-L264F and eGFP vector controls were 
constructed. These constructs were transfected into hTERT immortalised 
primary NSMCE3-L264F fibroblasts and allowed to incubate for 48 hours. Cells 
were then analysed for their ability to restart replications as described previously.  
 
Patient cells complemented with wild-type NSMCE3 were able to restart 
replication showing 32 % EdU incorporation at 0 hour and 28 % after 18 hours 
in HU.  Cells expressing the NSMCE3-L264F mutation construct showed 29 and 
7 % EdU incorporation and so failed to rescue the phenotype similarly to eGFP 
vector control, which had percentage EdU incorporation of 22 % and 10 % at 0 
and 18 hours respectively (Figure 5.13). This shows that only the wild-type 
NSMCE3 was able to complement the HU recovery defect and demonstrates 
that the defect is due to the NSMCE3-L264F mutation. This confirms that the 
SMC5/6 complex that is required for replication restart. 
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Figure	5.13.	Ectopic	expression	wild-type	NSMCE3	results	in	rescue	of	replication	stress	
phenotype.	NSMCE3-L264F	cells	were	transfected	with	either	wild-type	NSMCE3-eGFP,	
NSMCE3-L264F-eGFP	or	eGFP	control	plasmid.	48	hours	after	 transfection	 cells	were	
treated	with/without	250	µM	HU	and	released	into	10	µM	EdU	as	before.	Cells	were	
fixed	and	processed	as	previously	described	and	scored	for	their	incorporation	of	EdU.	
Expression	 of	 wild-type	 NSMCE3	 resulted	 in	 the	 rescue	 of	 the	 replication	 stress	
phenotype.	Results	were	statistically	significant	according	to	2-tailed	Students	T-Test	p-
value	<0.05.		
 
 
5.3 – Discussion  
 
SMC5/6 is required for homologous recombination and accurate chromosome 
segregation. In humans homozygous and heterozygous mutations in NSMCE3, 
L264F and L264F/P209L, result in a new chromosomal breakage syndrome 
called LICS (lung disease, immunodeficiency and chromosome instability 
syndrome). The associated destructive and fatal pulmonary damage has not 
been reported in other studies of patients with a mutation in another SMC5/6 
subunit, NSMCE2. The O’Driscoll lab published a set of mutations in NSMCE2 
linked to primordial dwarfism and insulin resistance, something that is not 
observed in the NSMCE3 patients(Payne, Colnaghi, Rocha, et al., 2014). In the 
NSMCE2 syndrome linear growth and weight were severely impaired whereas 
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in the NSMCE3 patient’s linear growth and weight were only slightly affected. 
In mice NSMCE2 is required to prevent aging and cancer (Jacome, Gutierrez-
Martinez, Schiavoni, et al., 2015). No malignancies were observed in any of the 
four NSMCE3 patients in contrast to patients with AT or NBS chromosomal 
breakage syndromes, however this is likely to be due to the young age at 
which the patients died (van der Crabben, Hennus, McGregor, et al., 2016).  
 
Karyotyping of Dutch patient lymphocytes also revealed a high level of 
rearrangements and supernumerary markers and this correlated with high levels 
of micronuclei in fibroblasts (Figure 5.6) indicative of chromosomal instability. 
IgA and IgG levels were normal showing that patients did not have a defect in 
V(D)J) or class switch recombination, processes that requires NHEJ. However, 
T cell proliferation and antibody titres were reduced and there was no response 
to recall antigens indicative of primary immunodeficiency.  Again this 
immunodeficiency was not seen in the NSMCE2 patients(Payne, Colnaghi, 
Rocha, et al., 2014). 
 
To examine the effects of the Dutch patient mutation, NSMCE3-L264F, in more 
detail it was initially modelled in yeast with the equivalent mutation nse3-L293F. 
Whilst a slight sensitivity was observed in spot tests this was attributed to the 
presence of LoxP and LoxM3 sites flanking the nse3, as it was also seen in the 
base strain. There was a slight sensitivity in spot tests when cells were exposed 
to UV radiation however this was not observed in cell survival assays. A lack of 
sensitivity to DNA damaging agents could also be explained by the low level of 
sequence similarity between human NSMCE3 and S. pombe nse3 in the C-
terminal domain. Alignment of the protein sequence using UniProt and the 
program ClustalX indicate only 19.034 % sequence similarity with only 67 
identical and 97 similar positions when comparing H. sapien and S. pombe 
NSMCE3/nse3.  
 
Analysis of primary fibroblasts isolated from one of the Dutch patients revealed 
the cellular phenotypes associated with the NSMCE3-L264F mutation. The 
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mutation destabilized NSMCE3 and reduced levels of SMC5 and SMC6 showing 
the SMC5/6 complex to be destabilised. Further analysis subsequently showed 
that the levels of NSMCE3 were below detection levels in a cell extract isolated 
from a compound heterozygote (NSMCE3-L264F, NSMCE3-P209L) individual 
from the American family (van der Crabben, Hennus, McGregor, et al., 2016). 
This could be due to lack of expression of NSMCE3, however since loss of SMC6 
or NSMCE2 is lethal in early embryonic mice it is more likely that NSMCE3 is 
present at low levels. SMC5 and SMC6 levels were dramatically reduced 
showing that a stable complex cannot be maintained. Purification of the 
recombinant NSMCE3-P209L mutant protein co-expressed with NSMCE1 in 
E.coli showed destabilisation of the complex, indicating an unfolding of 
NSMCE3 that destabilised the interaction. However, the interaction between 
NSMCE3-L264F and NSMCE1 was more stable. Yeast two hybrid analysis also 
indicated a destabilisation of the interaction between both NSMCE3 mutant 
proteins and NSMCE4 (van der Crabben, Hennus, McGregor, et al., 2016).  
 
A slight sensitivity to DNA damaging agents was observed in NSMCE3-L264F 
cells. Exposure to broad range damaging agents such as ionizing or UV radiation 
indicated a slight increase in sensitivity whilst exposure to a range of drugs such 
as MMC, CPT, HU and MMS indicated a slight increase in sensitivity, specifically 
to those which create damage in S phase. This would be consistent with a 
requirement for SMC5/6 in S phase and homologous recombination. 
 
To further analyse the repair pathway affected in NSMCE3-L264F cells a ɣH2AX 
assay was used. Since SMC5/6 is required for homologous recombination in 
yeast and patients did not have a defect in V(D)J) or class switch recombination, 
processes that requires NHEJ, it was predicted that NSMCE3-L264F patient 
cells would be proficient in NHEJ repair. This was supported when analysis of 
repair kinetics after ionising radiation in G1 revealed no significant difference in 
the rate of decline of ɣH2AX foci levels in NSMCE3-L264F cells compared to 
wild-type.  
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In contrast, analysis of repair kinetics after ionising radiation in G2 revealed that 
NSMCE3-L264L cells maintained ɣH2AX foci levels for longer than wild-type 
cells. This is similar to the HR-defective BRCA2 deficient cell line and is 
consistent with a defect in HR.  
 
Consistent with a defect in homologous recombination fibroblasts showed 
failure to recover from replication stress. Treatment of NSMCE3-L264F cells 
using hydroxyurea to stall replication resulted in cells not being able to restart 
replication. FACS analysis confirmed cells not in S phase were able to enter S 
phase during the HU block. This defect was complimented by ectopic 
expression of WT-NSMCE3 showing the defect to be a direct result of the 
mutation. The lack of recovery from replication stress is also seen in cells with 
mutated NSMCE2 showing it to be a common consequence of misregulation of 
the SMC5/6 complex.  
 
In summary, the work described in this chapter shows the first examples of a 
new autosomal recessive chromosomal breakage syndrome, LICS. This results 
from either homozygous or heterozygous mutations in NSMCE3. Patients with 
LICS present with destructive and fatal pulmonary disease whilst cells with the 
NSMCE3-L264F mutation have reduced stability of SMC5/6 complex and 
defective homologous recombination with increased levels of micronuclei and 
chromosomal instability.  
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Chapter 6.0 –Discussion. 
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This thesis explores the role of the SMC5/6 complex in human cells. It examines 
the execution and validation of a synthetic sick/lethal screen using RNAi of 
NSMCE4a and describes the effects of a novel homozygous mutation in 
NSMCE3, resulting in a new chromosomal breakage disorder, which leads to a 
fatal pulmonary disease.  
 
One focus of this thesis involved the development of a synthetic sick/lethal 
screen using shRNA knockdown of NSMCE4a. As has been shown previously, 
loss or knockdown of one subunit of SMC5/6 leads to reduction in levels of other 
members of the SMC5/6 complex. In Chapter 3 data was presented that 
highlights the steps involved in setting up the screen. These steps involved 
identification of a target (NSMCE4A), choosing a cell line to knockdown the 
target (U2OS) and ensuring that cells with reduced levels of the chosen target 
were still viable. The cell line was then created and the screening protocol 
optimised. 
 
Whilst Chapter 3 describes the set up of a high-throughput screen to further 
characterise the role of the SMC5/6 complex this protocol can now be used as 
a tool to investigate synthetic lethality for multiple genes of interest and is being 
used throughout the department (Hopkins, McGregor, Murray, et al., 2016).  
 
The results indicated that targeting the NSMCE4a subunit using siRNA did not 
negatively impact the unperturbed growth rate of U2OS cells. Once this was 
established cell lines using shRNA were created. Initially the system contained 
a tGFP sequence expressed pan-cellular and single cells could not accurately 
be resolved by the microscope. To overcome this tGFP was replaced with 
AcGFP or mCherry with nuclear localisation sequences. This allowed single cell 
resolution with the microscope. 
 
Conclusions from the set up chapter laid the basis for the screen carried out in 
Chapter 4 and the main findings of this chapter were: 
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• Smartpool siRNA knockdown of NSMCE4a and SMC6 leads to loss 
of other members of the SMC5/6 complex.  
• pGIPZ expression of NSMCE4a shRNA leads to knockdown of 
SMC5/6 complex members. 
• AcGFP-NLS and mCherry-NLS replacement of native tGFP in pGIPZ 
allows cells to be resolved accurately whilst having internal controls in 
the well.  
• Using a topdown transfection method allows for cells to recover from 
plating stress and 2000 cells per well in 1:1 relationship of 
AcGFP:mCherry allows a large number of cells to be counted without 
the cells becoming over confluent.  
• Edge effect is real and requires timing and handling to minimise.  
 
The second results chapter, Chapter 4, uses the technology developed from the 
previous chapter and allows us to analyse the effects of reduced levels of 
NSMCE4 when combined with siRNA knockdown of proteins found in the DNA 
damage response pathway. Unsurprisingly, many proteins involved in the 
homologous recombination repair pathway appeared as synthetically lethal with 
NSMCE4a shRNA knockdown, suggesting that consistent with the theory 
published by Heyer et al, flux through the pathway is important and loss of 
factors at different stages can lead to the accumulation of toxic intermediates 
(Heyer, 2015). One key member of HR - BRCA2 appeared as the top hit in the 
screen and RAD52, another protein involved in homologous recombination, was 
also synthetic sick/lethal with reduction of NSMCE4. This suggested that there 
is a crossover in the functions of BRCA2 and RAD52 as both are synthetically 
lethal following reduction of SMC5/6 levels. BRCA2 and RAD52 function to 
replace RPA with RAD51 during homologous recombination(Tarsounas, Davies 
& West, 2003; Roy, Chun & Powell, 2012; Sugiyama & Kantake, 2009). BRCA1 
also interacts with RAD51 however this does not appear as a top hit in the 
screen. It is possible that the knockdown of BRCA1 is not efficient in either cell 
line types or that knockdown of NSMCE4a does not have an additive effect when 
BRCA1 is lost. RAD51 also does not appear as a top hit in the screen, consistent 
	 161	
with it being epistatic in yeasts (Gallego-Paez, Tanaka, Bando, et al., 2014). 
RAD52 was often ignored in consideration of HR in mammalian calls as the 
mouse knockout showed largely no phenotype(Lok & Powell, 2012). However, 
synthetic lethal approaches have indicated RAD52 plays a key role in cells 
lacking the BRCA1-BRCA2 pathway and it is required for single strand annealing 
(Schlacher, Christ, Siaud, et al., 2011). Following processing and end resection 
by CtIP, MRN and EXO1; BRCA1 and PALB2 facilitates the recruitment of 
BRCA2 to allow loading of RAD51 onto ssDNA.  
 
Two of the strongest synthetic lethal hits are factors involved in NHEJ. Double 
strand breaks are mainly repaired through the use of HR or NHEJ with the major 
pathway being NHEJ. Therefore, if HR is compromised it is not surprising that 
NHEJ becomes essential. Two enzymes involved in NHEJ, Artemis and XLF, 
were synthetically sick/lethal with loss of NSMCE4a and this has been further 
validated through use of patient cells with mutation in Artemis and XLF. This 
shows that NHEJ is essential when HR is perturbed.  
 
Artemis and XLF are both involved at different stages of NHEJ. Artemis deficient 
cells are more sensitive to X-rays and show larger numbers of breaks following 
irradiation(Beucher, undefined author, undefined author, et al., 2009). Artemis is 
required in the slow repair fraction of DSB repair rather than the more immediate 
fast repair(Shibata, Conrad, Birraux, et al., 2011). XLF works in the fast repair 
section and interacts with XRCC4-LigaseIV and shows a stronger lethal 
phenotype when exposed to NSMCE4a siRNA (Ahnesorg, Smith & Jackson, 
2006b).  
 
Previously it has been reported that SMC5/6 is required during S phase for repair 
of collapsed replication forks and stabilization of stalled replication forks 
(Irmisch, Ampatzidou, Mizuno, et al., 2009; Ampatzidou, Irmisch, O'Connell, et 
al., 2006). This thesis also shows that NSMCE3-L264F patient cells exposed to 
low levels of hydroxyurea show a reduced ability to restart replication (van der 
Crabben, Hennus, McGregor, et al., 2016). Data from this screen also supports 
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this idea as knockdown of RRM1 or RRM2, components of the RNR complex 
that are required to catalyse the formation of dNTPs resulted in a synthetic lethal 
interaction with NSMCE4a shRNA. RRM2B was also in the screen but was not 
observed to be lethal. This can be explained, as RRM2B is P53 inducible 
therefore it is likely that RRM2B was not being expressed during the time of the 
screen.  
 
In the screen the number of cell screened in both RRM1 and RRM2 wells 
appeared to be much lower than RRM2B, however, it is likely that this was due 
to the cells being unable to complete the cell cycle. This could be tested by with 
FACS analysis in the knockdown cell lines. The loss of viability of NSMCE4a 
shRNA cells appear to be more prominent compared with Non-silencing shRNA 
cells and supports the idea that SMC5/6 is required to restart replication and 
may function as a tumour suppressor.  
 
Synthetic viability hits also play an important role in this screen and these hits 
need to be explored further. Many of these hits appear to be involved in telomere 
maintenance such as ACD and TERT. Three hits were involved in ubiquitylation 
of proteins to target substrates for degradation by the proteasome; these are 
UBB and UBD which are paralogs and UBA1 which catalyses the first step in 
ubiquitin conjugation. UBA1 is also involved in the recruitment of TP53BP1 and 
BRCA1 to sites of DNA damage. It is possible the loss of SMC5/6 and 
ubiquitylation factors leads to cells being unable to trigger an apoptotic 
response, however the reasons remain unclear and need further investigation.  
 
MMS22L is another top hits in synthetic viability. This is part of the TONSL 
protein complex, TONSL also appear highly in the viable section, and is required 
to recognize and stimulates the recombination dependent repair of stalled or 
collapsed replication forks through promotion of HR(Duro, Lundin, Ask, et al., 
2010). This suggests that loss of proteins that promote HR bypasses the 
requirement for SMC5/6 to regulate the HR pathways.  
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One of the most interesting synthetic viable hits is that of H2AFZ. H2AFZ is a 
variant of H2A and has been shown to alter nucleosome stability(Tapia-Alveal, 
Lin, Yeoh, et al., 2014). Tapia-Alveal 2014 show that in fission yeast H2A.Z and 
both Cohesin and Smc5/6 ensure genomic integrity through accurate 
chromosome segregation (Tapia-Alveal, Lin & O'Connell, 2014). H2A.Z appears 
to operate in opposition to Smc5/6 by promoting sister chromatid cohesion 
along chromosome arms but not centromeres. Cells lacking H2A.Z show 
chromosome defects thought to be in part likely due to disruption of the cohesin 
cycle and in cells lacking both, H2A.Z suppress the mitotic defects of Smc5/6 
dysfunction. Therefore, the result that cells with knockdown of NSMCE4a and 
siRNA knockdown of H2AFZ appear to grow better than control cells shows that 
this function is conserved.  
 
One of the issues with the screen that could be addressed further involves using 
a doxycycline inducible knockdown construct to ensure strongest possible 
knockdown of NSMCE4a. Another issue involves the transfection efficiency, 
given the large amount of siRNAs used it may be that not all the siRNAs were 
able to sufficiently knockdown their target. To further confirm the screen more 
experiments with knock-out cells or even more confirmation with patient cells. 
Interestingly, expected hits from synthetic lethality screens in yeasts did not 
come out in human cells, therefore more experiments are needed to identify the 
function of SMC5/6 in human cells. 
 
Conclusions from the screen validation chapter:  
• NSMCE4a knockdown leads to synthetic lethal interaction with a host 
of HR factors including RBBP8, VCP, EXO1, BRCA2 and RAD52.  
• NHEJ is required to repair DNA damage following reduction in HR 
activity.  
• SMC5/6 complex is required during replication and loss of replication 
factors is deleterious in cells lacking SMC5/6.  
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• SMC5/6 is required in response to replication stress pointing to a vital 
role for the SMC5/6 complex in coordinating the response to 
replication stress.  
• Loss of NSMCE4a also leads to synthetic viability with knockdown of 
ANKRD28, MMS22L and UBB/UBD/UBA1 as well as factors required 
in the lengthening of telomeres. This needs to be investigated further 
to ensure that viability is not a short-term relief before leading to 
defects further on.  
• Increased cell viability with knockdown of H2AFZ confirms previously 
published work by Tapia-Alveal 2014.  
 
The last chapter describes novel homozygous and compound heterozygous 
missense mutations that have been identified in the NSMCE3 gene in Dutch and 
American families respectively. These mutations, homozygous p.Leu264Phe 
and compound heterozygous p.Leu264Phe and p.Pro209Leu, have been 
identified as the cause of a new autosomal recessive chromosome breakage 
syndrome, termed Lung Immunodeficiency and Chromosome breakage 
Syndrome (LICS). It is characterized by failure to thrive, immune deficiency 
leading to severe and eventually fatal pulmonary disease in early childhood (van 
der Crabben, Hennus, McGregor, et al., 2016). Levels of NSMCE3 protein were 
below detection levels in patient fibroblasts and levels of SMC5 and SMC6 was 
also reduced. It is possible that this could be due to a lack of expression of 
NSMCE3 which stops the formation of the complete SMC5/6 complex, however 
as loss of SMC6 or NSMCE2 is lethal in early embryonic mice it is likely that 
NSMCE3 is present at low levels in the patient cells but is below the detection 
levels of the antibodies(van der Crabben, Hennus, McGregor, et al., 2016).  
 
In vitro analysis of the mutations suggested that the Leu264Phe variant was still 
able to form a complex with NSMCE1, but has a reduced capability to interact 
with NSMCE4 and SMC6. The Pro209Leu mutation on the other hand led to a 
C-terminal truncation and disruption of the interaction with NSMCE1 and 
NSMCE4. The destabilizing effect on the SMC5/6 complex of mutations in 
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NSMCE3 is much more pronounced than what was observed in cells isolated 
from patients with truncating mutations in NSMCE2, which encodes for the 
SUMO ligase activity of SMC5/6 (Payne, Colnaghi, Rocha, et al., 2014). The 
NSMCE2 SUMO ligase is not required for all the functions of the SMC5/6 
complex and this may explain the differences in clinical features. Both 
Leu264Phe and Pro209Leu mutations disrupt the interaction with NSMCE4 
therefore it is possible that this is the root cause of the pulmonary failure 
phenotype.  
 
In Chapter 5 a ɣH2AX assay showed that in cells isolated from one of the Dutch 
patients, destabilisation of the SMC5/6 complex resulted in defective repair in 
G2 but not in G1, consistent with a defect in HR but not NHEJ. This is consistent 
with previous findings of SMC5/6 being required for HR, however whether 
SMC5/6 was required for NHEJ had not been previously reported (Irmisch, 
Ampatzidou, Mizuno, et al., 2009; Ampatzidou, Irmisch, O'Connell, et al., 2006; 
Lehmann, Walicka, Griffiths, et al., 1995; Potts, Porteus & Yu, 2006b). A 
secondary way to confirm SMC5/6 being required for HR would have involved 
the use of a HR reporter assay using GFP fragments and an I-SceI recognition 
site to examine levels of HR repair (Wang, Pan, Su, et al., 2013). However, low 
transfection efficiency precluded this analysis in the primary fibroblasts. 
 
Patient fibroblasts with the NSMCE3-L264F mutation had a defect in recovery 
from replication stress that could be complemented through expression of wild-
type NSMCE3 protein but not NSMCE3-L264F. This shows the lack of recovery 
from replication stress to be a direct consequence of the mutation. The lack of 
recovery from replication stress was also observed in cells with mutated 
NSMCE2 showing it to be a common consequence of misregulated SMC5/6 
(Payne, Colnaghi, Rocha, et al., 2014; van der Crabben, Hennus, McGregor, et 
al., 2016). FACS analysis of NSMCE3-L264F patient cells compared with wild-
type patient cells indicated no issue with entering S phase during induction of 
replication stress.  
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It is worth noting that the allele frequency of NSMCE3-L264F is low making LICS 
a rare syndrome. In both the American and Dutch families diagnosis and 
detection of the patients only occurred after the identification of a second 
patient. Since publication of the syndrome another Dutch family has been 
identified with similar disease progression. While not closely related to the first 
Dutch family they also come from the north of the country, suggesting that there 
is a hotspot for this allele in this region. There is therefore a possibility of further 
undiagnosed patients presenting with similar symptoms.  
 
In summary, the phenotypes of LICS syndrome are:  
• Affected individuals present with terminal lung damage following 
pneumonia and chromosome rearrangements in lymphocytes.  
• Patients with NSMCE3-L264F mutation show normal antibody and 
V(D)J recombination but have a defect in B and T cell expansion which 
is consistent with an HR defect and no response to recall antibodies.  
• Cells isolated from patients have increased levels of micronuclei 
consistent with chromosome missegregation.  
• Patient cells show no repair defect in G1, however they do have a 
defect in G2 that is consistent with a defect in HR.  
• Mutation in NSMCE3 destabilises SMC5/6 and a failure to recover 
from replication stress that can be complemented with ectopic 
expression of WT NSMCE3.  
 
Additional work carried out during the past four years, which is not discussed 
throughout this thesis, focused on the SMC5 subunit of the SMC5/6 complex. A 
recent publication from the Murray/Oliver/Pearl lab describes the structure of the 
SMC5/6 hinge. The Oliver lab solved the structure of the hinge at 2.8A resolution. 
A structure function analysis using S. pombe by the Murray lab then defined key 
interfaces. The hinge, like that of cohesin and condensin, is toroidal but uniquely 
is stabilised by an essential ‘latch’ on SMC5, which contacts onto SMC6. Further 
work defined a region of the hinge from the latch round a positively charged 
channel to a further regulatory region that binds single strand DNA. Defined 
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mutations in these interfaces cause a severe loss of function with increased 
sensitivity to DNA damaging agents. Mutations in the latch led to loss of viability 
in S. pombe. To explore the requirements for this region in human cells I created 
doxycycline-inducible constructs and transfected these into U2OS cells. These 
constructs either expressed eGFP-tagged wild-type SMC5 or mutant SMC5-
Y626G, the human equivalent to the S. pombe Y612G mutation. In the absence 
of doxycycline cells were viable, as judged by a trypan blue assay which 
measures inclusion of a dye by dead cells. When expression was induced 
through addition of doxycycline for 48 hours the cell viability dropped in the 
SMC5-Y626G expressing cells, showing this to be dominant negative. This 
suggests that the SMC5 ‘latch’ is an essential feature of the SMC5/6 complex 
(Alt, Dang, Wells, et al., 2016).  
 
In summary, discussed in this thesis are several new observations for the 
SMC5/6 complex in human cells. The development, execution and validation of 
a synthetic sick/lethal screen is presented. Several interesting hits from this 
screen are described including several potential interactions that need further 
investigation. Lastly, a novel chromosome breakage syndrome caused by 
mutation in NSMCE3 is presented. Patients are shown to have higher levels of 
chromosomal instability, have a defect in HR and failure to recover from 
replication stress.   
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A.0 – Appendix Section.  
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A.1 – List of siRNA sequences.  
A.1.1 – SMC6 Smartpool siRNA 
AGAAAUAGAUAAUGCGGUU  
GGACAAAGAAAUUAAUCGA  
CAGCAUAGAUGGAAGUCGA  
CUUUAAAGCCAGUGUGUAU  
A.1.2 – NSMCE4a Smartpool siRNA 
AAUGAAGUGUCCCGAGCAA  
GUGAAGUCCAAAACGGAAA  
ACACAGAGCCGUCGGAUUC  
GUGCCAAAGCCACGAGUUG  
A.1.3 – BRCA1 siRNA 
CAGCUACCCUUCCAUCAUA  
A.1.X – BRCA2 siRNA 
GUAAAGAAAUGCAGAAUUC  
A.1.4 – GFP siRNA 
GCAAGCUGACCCUGAAGUUC 
 
A.1.5 – SMC3 Smartpool siRNA 
CAACGUAGCUUACAGAGUU  
GGUGUAAAGUUCAGAAAUA  
GAGAGUAGAUGCACUGAAU  
GCAGUGCAACACAGAAUUA  
A.1.6 – Non-silencing siRNA 
UGGUUUACAUGUCGACUAA 
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A.1.7 – pGIPZ 859 shRNA 
UGAUUUCUAACUUGUGUGU 
 
A.1.8 – pGIPZ 860 shRNA 
UCUUGAUGAGAUUCUUCCA 
 
A.1.9 – pGIPZ 861 shRNA 
AUCUUAACAUGUCAAGGA 
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A.2. – siRNA Sequences used in screen.  
A.2.1 – Screen – DDR Plates.  
	
Dharmacon ON-TARGETplus® SMARTpool® siRNA Library -  Human DNA Damage Response
G-106005  Lot 11137
Plate Well Pool Catalog Duplex Catalog Gene GENEI Gene GINumb Sequence
Plate 1 A02 L-005232-00 J-005232-06 RAD50 10111 NM_133482 1992413 ACAAGGAUCUGGAUA
Plate 1 A02 L-005232-00 J-005232-07 RAD50 10111 NM_133482 1992413 UAACCUCACUGUUGG
Plate 1 A02 L-005232-00 J-005232-08 RAD50 10111 NM_133482 1992413 GAAUUGAAUCGUAAG
Plate 1 A02 L-005232-00 J-005232-09 RAD50 10111 NM_133482 1992413 GACACAAGGUCAGAA
Plate 1 A03 L-018612-02 J-018612-17 POLE2 5427 NM_002692 3218936 GCAUAAUGUUUGCUG
Plate 1 A03 L-018612-02 J-018612-18 POLE2 5427 NM_002692 3218936 CCGUGAAGACUUAGU
Plate 1 A03 L-018612-02 J-018612-19 POLE2 5427 NM_002692 3218936 AGAUGUUUCGUGAGC
Plate 1 A03 L-018612-02 J-018612-20 POLE2 5427 NM_002692 3218936 GAUCCUUUCACUACG
Plate 1 A04 L-012299-00 J-012299-05 RUVBL2 10856 NM_006666 5730022 UAACAAGGAUUGAGC
Plate 1 A04 L-012299-00 J-012299-06 RUVBL2 10856 NM_006666 5730022 CGCAGUACAUGAAGG
Plate 1 A04 L-012299-00 J-012299-07 RUVBL2 10856 NM_006666 5730022 GAAACGCAAGGGUAC
Plate 1 A04 L-012299-00 J-012299-08 RUVBL2 10856 NM_006666 5730022 GCGAGAAAGACACGA
Plate 1 A05 L-004654-00 J-004654-06 PRKCG 5582 NM_002739 4713262 GCCCGUAACCUAAUU
Plate 1 A05 L-004654-00 J-004654-07 PRKCG 5582 NM_002739 4713262 GGAGGGCGAGUAUUA
Plate 1 A05 L-004654-00 J-004654-08 PRKCG 5582 NM_002739 4713262 GGGAGCGGCUGGAA
Plate 1 A05 L-004654-00 J-004654-09 PRKCG 5582 NM_002739 4713262 CAGAAGACCCGAACG
Plate 1 A06 L-011033-00 J-011033-05 FANCC 2176 NM_000136 5611823 GGCAAAAGCUUGUUG
Plate 1 A06 L-011033-00 J-011033-06 FANCC 2176 NM_000136 5611823 GGAAUCGUCUUGGCA
Plate 1 A06 L-011033-00 J-011033-07 FANCC 2176 NM_000136 5611823 GAUGAGAUGUUCAGG
Plate 1 A06 L-011033-00 J-011033-08 FANCC 2176 NM_000136 5611823 GGUAUGCACCUAUAG
Plate 1 A07 L-010344-00 J-010344-06 FEN1 2237 NM_004111 1971877 GGUGAAGGCUGGCAA
Plate 1 A07 L-010344-00 J-010344-07 FEN1 2237 NM_004111 1971877 GGGUCAAGAGGCUGA
Plate 1 A07 L-010344-00 J-010344-08 FEN1 2237 NM_004111 1971877 CAAACUAAUUGCUGA
Plate 1 A07 L-010344-00 J-010344-09 FEN1 2237 NM_004111 1971877 CAAGUACCCUGUGCC
Plate 1 A08 L-010496-00 J-010496-05 TCEA1 6917 NM_201437 4543935 GACAAAUGCUCGAGA
Plate 1 A08 L-010496-00 J-010496-06 TCEA1 6917 NM_201437 4543935 AGACUGACUUGUUCA
Plate 1 A08 L-010496-00 J-010496-07 TCEA1 6917 NM_201437 4543935 GUACAAACCCGUAGU
Plate 1 A08 L-010496-00 J-010496-08 TCEA1 6917 NM_201437 4543935 GCAAUUACAUCGCAG
Plate 1 A09 L-013379-00 J-013379-05 RTEL1 51750 NM_016434 3008996 CCGCAGAGCACACAA
Plate 1 A09 L-013379-00 J-013379-06 RTEL1 51750 NM_016434 3008996 UAUUCAUGCCGUACA
Plate 1 A09 L-013379-00 J-013379-07 RTEL1 51750 NM_016434 3008996 GACAUUAUCCAGAUU
Plate 1 A09 L-013379-00 J-013379-08 RTEL1 51750 NM_016434 3008996 CCAAGGUCCUGGAAU
Plate 1 A10 L-009722-00 J-009722-05 GCN5L2 2648 NM_021078 1083510 AAUGGAACCUGUAAG
Plate 1 A10 L-009722-00 J-009722-06 GCN5L2 2648 NM_021078 1083510 GCGCAUGCCUAAGGA
Plate 1 A10 L-009722-00 J-009722-07 GCN5L2 2648 NM_021078 1083510 CGACGCUGAUGGAGU
Plate 1 A10 L-009722-00 J-009722-08 GCN5L2 2648 NM_021078 1083510 GAGCGUUCCUGGCAU
Plate 1 A11 L-013368-00 J-013368-05 APTX 54840 NM_175071 2832942 ACAAGAGGCUGGUAG
Plate 1 A11 L-013368-00 J-013368-06 APTX 54840 NM_175071 2832942 ACAGAAUACUUCCUA
Plate 1 A11 L-013368-00 J-013368-07 APTX 54840 NM_175071 2832942 CAAAGGCCCGUUACC
Plate 1 A11 L-013368-00 J-013368-08 APTX 54840 NM_175071 2832942 GAAAGAACAUCUCAG
Plate 1 B02 L-004591-00 J-004591-05 RAD18 56852 NM_020165 1455040 CCAAGAAACAAGCGU
Plate 1 B02 L-004591-00 J-004591-06 RAD18 56852 NM_020165 1455040 GGGAGCAGGUUAAUG
Plate 1 B02 L-004591-00 J-004591-07 RAD18 56852 NM_020165 1455040 GCUCUCUGAUCGUGA
Plate 1 B02 L-004591-00 J-004591-08 RAD18 56852 NM_020165 1455040 GAAAUGAGUGGUUCU
Plate 1 B03 L-017578-00 J-017578-05 TTRAP 51567 NM_016614 2351034 GUACAGCCCAGAUGU
Plate 1 B03 L-017578-00 J-017578-06 TTRAP 51567 NM_016614 2351034 GCAGAAGAGGGACAC
Plate 1 B03 L-017578-00 J-017578-07 TTRAP 51567 NM_016614 2351034 UCUAAGGGAUCGAGA
Plate 1 B03 L-017578-00 J-017578-08 TTRAP 51567 NM_016614 2351034 AAAGGGCUCUGAACU
Plate 1 B04 L-032021-01 J-032021-09 GTF2H5 4E+05 NM_207118 4635985 AGGAGCAUGCCACGG
Plate 1 B04 L-032021-01 J-032021-10 GTF2H5 4E+05 NM_207118 4635985 GGAGCGAGUGGGUG
Plate 1 B04 L-032021-01 J-032021-11 GTF2H5 4E+05 NM_207118 4635985 AGGUGACUGAUUAGA
Plate 1 B04 L-032021-01 J-032021-12 GTF2H5 4E+05 NM_207118 4635985 CGUCUUGAAAGGAGU
Plate 1 B05 L-020132-00 J-020132-05 POLE 5426 NM_006231 6219823 GCGAGGAACAGGCGA
Plate 1 B05 L-020132-00 J-020132-06 POLE 5426 NM_006231 6219823 GGAGGAGGGUGCUU
Plate 1 B05 L-020132-00 J-020132-07 POLE 5426 NM_006231 6219823 GGACAGGCGUUACGA
Plate 1 B05 L-020132-00 J-020132-08 POLE 5426 NM_006231 6219823 CUCGGAAGCUGGAAG
Plate 1 B06 L-009930-00 J-009930-05 UBE2B 7320 NM_003337 3296728 GGAAUGCAGUUAUAU
Plate 1 B06 L-009930-00 J-009930-06 UBE2B 7320 NM_003337 3296728 GAACCGAAUCCUAAC
Plate 1 B06 L-009930-00 J-009930-07 UBE2B 7320 NM_003337 3296728 GAGUUUCGGCCAUUG
Plate 1 B06 L-009930-00 J-009930-08 UBE2B 7320 NM_003337 3296728 UAGAUAUCCUUCAGA
Plate 1 B07 L-003506-00 J-003506-07 MDC1 9656 NM_014641 7661965 CAGAAGAGGUGCCAC
Plate 1 B07 L-003506-00 J-003506-08 MDC1 9656 NM_014641 7661965 UAACUGAAAUCCAGC
Plate 1 B07 L-003506-00 J-003506-09 MDC1 9656 NM_014641 7661965 GGUCAGCCAUUAUGC
Plate 1 B07 L-003506-00 J-003506-10 MDC1 9656 NM_014641 7661965 GAGCCCACAUCUCAG
Plate 1 B08 L-006739-00 J-006739-05 IHPK3 1E+05 NM_054111 7819179 GGAAUGAGCACACCA
Plate 1 B08 L-006739-00 J-006739-06 IHPK3 1E+05 NM_054111 7819179 ACAUGAGCGUGAUGA
Plate 1 B08 L-006739-00 J-006739-07 IHPK3 1E+05 NM_054111 7819179 UCUAUCAGUUCCUAC
Plate 1 B08 L-006739-00 J-006739-08 IHPK3 1E+05 NM_054111 7819179 GUUCAUACCGCUUCU
Plate 1 B09 L-003540-00 J-003540-09 SIRT1 23411 NM_012238 1377559 GCAAAGGAGCAGAUU
Plate 1 B09 L-003540-00 J-003540-10 SIRT1 23411 NM_012238 1377559 GCGAUUGGGUACCGA
Plate 1 B09 L-003540-00 J-003540-11 SIRT1 23411 NM_012238 1377559 GGAUAGGUCCAUAUA
Plate 1 B09 L-003540-00 J-003540-12 SIRT1 23411 NM_012238 1377559 CCACCUGAGUUGGAU
Plate 1 B10 L-013239-01 J-013239-20 TREX1 11277 NM_033629 1486138 GCCACAACCAGGAAC
Plate 1 B10 L-013239-01 J-013239-21 TREX1 11277 NM_033629 1486138 GCGCAUGGGCGUCAA
Plate 1 B10 L-013239-01 J-013239-22 TREX1 11277 NM_033629 1486138 CAGAACACGGCCCAA
Plate 1 B10 L-013239-01 J-013239-23 TREX1 11277 NM_033629 1486138 UGUCACAACCACUGC
Plate 1 B11 L-010378-00 J-010378-05 WRN 7486 NM_000553 1992417 GAUCCAUUGUGUAUA
Plate 1 B11 L-010378-00 J-010378-06 WRN 7486 NM_000553 1992417 GCACCAAAGAGCAUU
Plate 1 B11 L-010378-00 J-010378-07 WRN 7486 NM_000553 1992417 AUACGUAACUCCAGA
Plate 1 B11 L-010378-00 J-010378-08 WRN 7486 NM_000553 1992417 GAGGGUUUCUAUCUU
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Plate 1 B11 L-010378-00 J-010378-08 WRN 7486 NM_000553 1992417 GAGGGUUUCUAUCUU
Plate 1 C02 L-011843-00 J-011843-05 DDX11 1663 NM_004399 4758135 CGGCAGAACCUUUGU
Plate 1 C02 L-011843-00 J-011843-06 DDX11 1663 NM_004399 4758135 GAACUGGCCCCUUAC
Plate 1 C02 L-011843-00 J-011843-07 DDX11 1663 NM_004399 4758135 GCAGAGCUGUACCGG
Plate 1 C02 L-011843-00 J-011843-08 DDX11 1663 NM_004399 4758135 GGGAUCAACUUCUCU
Plate 1 C03 L-010237-00 J-010237-06 APEX1 328 NM_080648 1837550 CAAAGUUUCUUACGG
Plate 1 C03 L-010237-00 J-010237-07 APEX1 328 NM_080648 1837550 GAGACCAAAUGUUCA
Plate 1 C03 L-010237-00 J-010237-08 APEX1 328 NM_080648 1837550 CUUCGAGCCUGGAUU
Plate 1 C03 L-010237-00 J-010237-09 APEX1 328 NM_080648 1837550 UAACAGCAUAUGUAC
Plate 1 C04 L-003780-01 J-003780-13 TDG 6996 NM_0010084 5654914 UCGUGAAGGAGGACG
Plate 1 C04 L-003780-01 J-003780-14 TDG 6996 NM_0010084 5654914 GUUGAAAGGCAUUGA
Plate 1 C04 L-003780-01 J-003780-15 TDG 6996 NM_0010084 5654914 CUUUAAAUUAUGACG
Plate 1 C04 L-003780-01 J-003780-16 TDG 6996 NM_0010084 5654914 GGAAGUAUGGUAUUG
Plate 1 C05 L-012358-00 J-012358-08 TOPBP1 11073 NM_007027 2014394 ACAAAUACAUGGCUG
Plate 1 C05 L-012358-00 J-012358-09 TOPBP1 11073 NM_007027 2014394 ACACUAAUCGGGAGU
Plate 1 C05 L-012358-00 J-012358-10 TOPBP1 11073 NM_007027 2014394 GAGCCGAACAUCCAG
Plate 1 C05 L-012358-00 J-012358-11 TOPBP1 11073 NM_007027 2014394 CCACAGUAGUUGAGG
Plate 1 C06 L-004592-00 J-004592-05 RAD54L 8438 NM_003579 1992413 AGAAUGAUCUGCUUG
Plate 1 C06 L-004592-00 J-004592-06 RAD54L 8438 NM_003579 1992413 CGAAUUACACCCAGA
Plate 1 C06 L-004592-00 J-004592-07 RAD54L 8438 NM_003579 1992413 GCACGAUGUCCAUUA
Plate 1 C06 L-004592-00 J-004592-08 RAD54L 8438 NM_003579 1992413 AUACGGAGGACUUCU
Plate 1 C07 L-015749-01 J-015749-09 RPA1 6117 NM_002945 2007017 CCCUAGAACUGGUUG
Plate 1 C07 L-015749-01 J-015749-10 RPA1 6117 NM_002945 2007017 AAGCAGGAAUUAUGU
Plate 1 C07 L-015749-01 J-015749-11 RPA1 6117 NM_002945 2007017 CCACUGUGAUGGACG
Plate 1 C07 L-015749-01 J-015749-12 RPA1 6117 NM_002945 2007017 CAGAAUGGAAGCUCG
Plate 1 C08 L-009871-00 J-009871-05 ATF2 1386 NM_001880 2253842 GAGAAGAGCAGCUAA
Plate 1 C08 L-009871-00 J-009871-06 ATF2 1386 NM_001880 2253842 CAUGGUAGCGGAUUG
Plate 1 C08 L-009871-00 J-009871-07 ATF2 1386 NM_001880 2253842 GGAAGUACCAUUGGC
Plate 1 C08 L-009871-00 J-009871-08 ATF2 1386 NM_001880 2253842 UGAGGAGCCUUCUGU
Plate 1 C09 L-008727-00 J-008727-09 VCP 7415 NM_007126 7669552 GCAUGUGGGUGCUG
Plate 1 C09 L-008727-00 J-008727-10 VCP 7415 NM_007126 7669552 CAAAUUGGCUGGUGA
Plate 1 C09 L-008727-00 J-008727-11 VCP 7415 NM_007126 7669552 CCUGAUUGCUCGAGC
Plate 1 C09 L-008727-00 J-008727-12 VCP 7415 NM_007126 7669552 GUAAUCUCUUCGAGG
Plate 1 C10 L-032261-00 J-032261-05 ALKBH2 1E+05 NM_0010016 4871722 GACUUUGUCUUCCGG
Plate 1 C10 L-032261-00 J-032261-06 ALKBH2 1E+05 NM_0010016 4871722 CACGGGAGCUUACUA
Plate 1 C10 L-032261-00 J-032261-07 ALKBH2 1E+05 NM_0010016 4871722 GCACCGAGAUGAUGA
Plate 1 C10 L-032261-00 J-032261-08 ALKBH2 1E+05 NM_0010016 4871722 CCAGGAAGCAGGCAA
Plate 1 C11 L-028674-00 J-028674-05 GTF2H4 2968 NM_001517 5414465 CUGAGGGUGUCCUG
Plate 1 C11 L-028674-00 J-028674-06 GTF2H4 2968 NM_001517 5414465 GAACCGAGUACACCU
Plate 1 C11 L-028674-00 J-028674-07 GTF2H4 2968 NM_001517 5414465 GAUGGGAGGUGGUC
Plate 1 C11 L-028674-00 J-028674-08 GTF2H4 2968 NM_001517 5414465 GGCCAUCAAUCUCUC
Plate 1 D02 L-009344-00 J-009344-05 PMS1 5378 NM_000534 5372934 GCGAAUGGUUUCAAG
Plate 1 D02 L-009344-00 J-009344-06 PMS1 5378 NM_000534 5372934 CAUAAACAGUCGACC
Plate 1 D02 L-009344-00 J-009344-07 PMS1 5378 NM_000534 5372934 CCACAAGCGUAGAUG
Plate 1 D02 L-009344-00 J-009344-08 PMS1 5378 NM_000534 5372934 GCAAUCGAGUAAUCA
Plate 1 D03 L-003461-00 J-003461-09 BRCA1 672 NM_007298 6325287 CAACAUGCCCACAGA
Plate 1 D03 L-003461-00 J-003461-10 BRCA1 672 NM_007298 6325287 CCAAAGCGAGCAAGA
Plate 1 D03 L-003461-00 J-003461-11 BRCA1 672 NM_007298 6325287 UGAUAAAGCUCCAGC
Plate 1 D03 L-003461-00 J-003461-12 BRCA1 672 NM_007298 6325287 GAAGGAGCUUUCAUC
Plate 1 D04 L-010035-01 J-010035-09 POLM 27434 NM_013284 7019492 GGAGAGAGUUCGGC
Plate 1 D04 L-010035-01 J-010035-10 POLM 27434 NM_013284 7019492 CGGGAAGGACUGCGA
Plate 1 D04 L-010035-01 J-010035-11 POLM 27434 NM_013284 7019492 CUGCAGCUCCGAAGC
Plate 1 D04 L-010035-01 J-010035-12 POLM 27434 NM_013284 7019492 CUGGACAUAAGCUGG
Plate 1 D05 L-006302-00 J-006302-05 REV3L 5980 NM_002912 4506482 GGAGUUCUCUGCUGA
Plate 1 D05 L-006302-00 J-006302-06 REV3L 5980 NM_002912 4506482 ACACAGAAGUUGAGU
Plate 1 D05 L-006302-00 J-006302-07 REV3L 5980 NM_002912 4506482 GGAUGUAAGUCCAUG
Plate 1 D05 L-006302-00 J-006302-08 REV3L 5980 NM_002912 4506482 GAUAUGAGAUUCAGA
Plate 1 D06 L-011689-00 J-011689-05 HMGB2 3148 NM_002129 1414117 GCAAAGAAAUUGGGU
Plate 1 D06 L-011689-00 J-011689-06 HMGB2 3148 NM_002129 1414117 GAACAUCGCCCAAAG
Plate 1 D06 L-011689-00 J-011689-07 HMGB2 3148 NM_002129 1414117 GAAUAAAUGGCUAUC
Plate 1 D06 L-011689-00 J-011689-08 HMGB2 3148 NM_002129 1414117 GAAGAAGAACGAACC
Plate 1 D07 L-003893-00 J-003893-07 GADD45A 1647 NM_001924 9790904 UCAAUGGGUUCCAGU
Plate 1 D07 L-003893-00 J-003893-08 GADD45A 1647 NM_001924 9790904 CCGAAAGGAUGGAUA
Plate 1 D07 L-003893-00 J-003893-09 GADD45A 1647 NM_001924 9790904 GAUCCUGCCUUAAGU
Plate 1 D07 L-003893-00 J-003893-10 GADD45A 1647 NM_001924 9790904 CCGAUAACGUGGUGU
Plate 1 D08 L-019657-00 J-019657-05 IGHMBP2 3508 NM_002180 4504622 GAAAUACACCCGCUG
Plate 1 D08 L-019657-00 J-019657-06 IGHMBP2 3508 NM_002180 4504622 GUACGAUGCUGCUAA
Plate 1 D08 L-019657-00 J-019657-07 IGHMBP2 3508 NM_002180 4504622 GAUACUGUCCUUCGU
Plate 1 D08 L-019657-00 J-019657-08 IGHMBP2 3508 NM_002180 4504622 CCGAGAGAAUUCCUA
Plate 1 D09 L-010032-00 J-010032-05 PMS2 5395 NM_0010180 6408507 UAAUGAAGCUGUUCU
Plate 1 D09 L-010032-00 J-010032-06 PMS2 5395 NM_0010180 6408507 UCUAUGAGUUCUUUA
Plate 1 D09 L-010032-00 J-010032-07 PMS2 5395 NM_0010180 6408507 GGAUGUUGAAGGUAA
Plate 1 D09 L-010032-00 J-010032-08 PMS2 5395 NM_0010180 6408507 GGAAUAUUAAGAAGG
Plate 1 D10 L-003479-00 J-003479-10 CSNK1E 1454 NM_001894 4054939 CCACCAAGCGCCAGA
Plate 1 D10 L-003479-00 J-003479-11 CSNK1E 1454 NM_001894 4054939 CCUCCGAAUUCUCAA
Plate 1 D10 L-003479-00 J-003479-12 CSNK1E 1454 NM_001894 4054939 CGACUACUCUUACCU
Plate 1 D10 L-003479-00 J-003479-13 CSNK1E 1454 NM_001894 4054939 GAUCAGCCGCAUCGA
Plate 1 D11 L-010587-00 J-010587-05 BRIP1 83990 NM_032043 1404297 AGUCAAGAGUCAUCG
Plate 1 D11 L-010587-00 J-010587-06 BRIP1 83990 NM_032043 1404297 GAUAGUAUGGUCAAC
Plate 1 D11 L-010587-00 J-010587-07 BRIP1 83990 NM_032043 1404297 UAACCCAAGUCGCUA
Plate 1 D11 L-010587-00 J-010587-08 BRIP1 83990 NM_032043 1404297 GUGCAAAGCCUGGGA
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Plate 1 D11 L-010587-00 J-010587-08 BRIP1 83990 NM_032043 14042977 GUGCAAAGCCUGGGAUAUA
Plate 1 E02 L-006834-00 J-006834-05 CSPG6 9126 NM_005445 63054826 CAACGUAGCUUACAGAGUU
Plate 1 E02 L-006834-00 J-006834-06 CSPG6 9126 NM_005445 63054826 GGUGUAAAGUUCAGAAAUA
Plate 1 E02 L-006834-00 J-006834-07 CSPG6 9126 NM_005445 63054826 GAGAGUAGAUGCACUGAAU
Plate 1 E02 L-006834-00 J-006834-08 CSPG6 9126 NM_005445 63054826 GCAGUGCAACACAGAAUUA
Plate 1 E03 L-011760-00 J-011760-05 RAD52 5893 NM_002879 20143951 CAGAAGGUGUGCUACAUUG
Plate 1 E03 L-011760-00 J-011760-06 RAD52 5893 NM_002879 20143951 GGUCAUCGGGUAAUUAAUC
Plate 1 E03 L-011760-00 J-011760-07 RAD52 5893 NM_002879 20143951 GGCCCAGAAUACAUAAGUA
Plate 1 E03 L-011760-00 J-011760-08 RAD52 5893 NM_002879 20143951 GGAAGAGCCAGGACAUGAA
Plate 1 E04 L-021486-00 J-021486-05 FANCL 55120 NM_018062 49472818 GCGGAUACCUGCUUCAGUA
Plate 1 E04 L-021486-00 J-021486-06 FANCL 55120 NM_018062 49472818 CAGCUGAGAACAAUACUUA
Plate 1 E04 L-021486-00 J-021486-07 FANCL 55120 NM_018062 49472818 AGUGUUGCCUGAAGAUUUA
Plate 1 E04 L-021486-00 J-021486-08 FANCL 55120 NM_018062 49472818 GCAAUAGAAUCACUAAAGG
Plate 1 E05 L-016376-00 J-016376-05 FANCD2 2177 NM_001018115 66528887 UGGAUAAGUUGUCGUCUAU
Plate 1 E05 L-016376-00 J-016376-06 FANCD2 2177 NM_001018115 66528887 CAACAUACCUCGACUCAUU
Plate 1 E05 L-016376-00 J-016376-07 FANCD2 2177 NM_001018115 66528887 GGAUUUACCUGUGAUAAUA
Plate 1 E05 L-016376-00 J-016376-08 FANCD2 2177 NM_001018115 66528887 GGAGAUUGAUGGUCUACUA
Plate 1 E06 L-016262-00 J-016262-05 TRIP13 9319 NM_004237 20149561 GUACCGAUAUGGCCAAUUA
Plate 1 E06 L-016262-00 J-016262-06 TRIP13 9319 NM_004237 20149561 GCAAAUCACUGGGUUCUAC
Plate 1 E06 L-016262-00 J-016262-07 TRIP13 9319 NM_004237 20149561 ACAAUUAGACUUUCAAGCA
Plate 1 E06 L-016262-00 J-016262-08 TRIP13 9319 NM_004237 20149561 GACCAGAAAUGUGCAGUCU
Plate 1 E07 L-004717-00 J-004717-06 TYMS 7298 NM_001071 4507750 CCAAACGUGUGUUCUGGAA
Plate 1 E07 L-004717-00 J-004717-07 TYMS 7298 NM_001071 4507750 UGGGAGAUGCACAUAUUUA
Plate 1 E07 L-004717-00 J-004717-08 TYMS 7298 NM_001071 4507750 UCACAUCGAGCCACUGAAA
Plate 1 E07 L-004717-00 J-004717-09 TYMS 7298 NM_001071 4507750 GGGCAGAAUACAGAGAUAU
Plate 1 E08 L-016040-00 J-016040-05 XPC 7508 NM_004628 54607142 GCAAAUGGCUUCUAUCGAA
Plate 1 E08 L-016040-00 J-016040-06 XPC 7508 NM_004628 54607142 UGAAAUAUGAGGCCAUCUA
Plate 1 E08 L-016040-00 J-016040-07 XPC 7508 NM_004628 54607142 GAGAAGUACCCUACAAGAU
Plate 1 E08 L-016040-00 J-016040-08 XPC 7508 NM_004628 54607142 GGAGGGCGAUGAAACGUUU
Plate 1 E09 L-003267-00 J-003267-09 HUS1 3364 NM_004507 31077213 ACAAGUAAAUCCCACAAAG
Plate 1 E09 L-003267-00 J-003267-10 HUS1 3364 NM_004507 31077213 UGAAGUGCACAUAGAUAUU
Plate 1 E09 L-003267-00 J-003267-11 HUS1 3364 NM_004507 31077213 CCAUAAAGGUGAUUCCUAG
Plate 1 E09 L-003267-00 J-003267-12 HUS1 3364 NM_004507 31077213 UCAGUAACAUGAUAGCCAA
Plate 1 E10 L-013231-01 J-013231-09 RPS27L 51065 NM_015920 76563938 AGACAGUGGUUCUUUGUGU
Plate 1 E10 L-013231-01 J-013231-10 RPS27L 51065 NM_015920 76563938 GAAGGGUGUUCAUUUAGAA
Plate 1 E10 L-013231-01 J-013231-11 RPS27L 51065 NM_015920 76563938 GCAACACUAAUGAUUCAAA
Plate 1 E10 L-013231-01 J-013231-12 RPS27L 51065 NM_015920 76563938 CUGGCUAAUUUGUGUCUCA
Plate 1 E11 L-026431-01 J-026431-09 DNA2L 1763 XM_938629 89032012 AGACAAGGUUCCAGCGCCA
Plate 1 E11 L-026431-01 J-026431-10 DNA2L 1763 XM_938629 89032012 UAACAUUGAAGUCGUGAAA
Plate 1 E11 L-026431-01 J-026431-11 DNA2L 1763 XM_938629 89032012 AAGCACAGGUGUACCGAAA
Plate 1 E11 L-026431-01 J-026431-12 DNA2L 1763 XM_938629 89032012 GAGUCACAAUCGAAGGAUA
Plate 1 F02 L-003272-00 J-003272-14 MAD2L2 10459 NM_006341 6006019 GACAAGACCUCAACUUUGG
Plate 1 F02 L-003272-00 J-003272-15 MAD2L2 10459 NM_006341 6006019 GAAAUUCGUCUUUGAGAUC
Plate 1 F02 L-003272-00 J-003272-16 MAD2L2 10459 NM_006341 6006019 CAACGUGCCGGUCCAGAUG
Plate 1 F02 L-003272-00 J-003272-17 MAD2L2 10459 NM_006341 6006019 UCCAGAAACGCAAGAAGUA
Plate 1 F03 L-021955-00 J-021955-05 KIAA1596 57697 NM_020937 74959746 GGGUAGAACUGGCCGUAAA
Plate 1 F03 L-021955-00 J-021955-06 KIAA1596 57697 NM_020937 74959746 GAGAGGAACGUAUUUAUAA
Plate 1 F03 L-021955-00 J-021955-07 KIAA1596 57697 NM_020937 74959746 AAACAGACAUCGCUGAAUU
Plate 1 F03 L-021955-00 J-021955-08 KIAA1596 57697 NM_020937 74959746 GCAUGUAGCUAGGAAGUUU
Plate 1 F04 L-020013-00 J-020013-05 SETMAR 6419 NM_006515 5730038 GAUUGACCCUUGAGACUAU
Plate 1 F04 L-020013-00 J-020013-06 SETMAR 6419 NM_006515 5730038 CCAAAGAAAGGCUAGAUCA
Plate 1 F04 L-020013-00 J-020013-07 SETMAR 6419 NM_006515 5730038 CGACUCCAAUUACAUUAUA
Plate 1 F04 L-020013-00 J-020013-08 SETMAR 6419 NM_006515 5730038 GAAGGUUUGUCUGUGAAUA
Plate 1 F05 L-005030-00 J-005030-06 PRKDC 5591 NM_006904 31340617 GGAAGAAGCUCAUUUGAUU
Plate 1 F05 L-005030-00 J-005030-07 PRKDC 5591 NM_006904 31340617 GAGCAUCACUUGCCUUUAA
Plate 1 F05 L-005030-00 J-005030-08 PRKDC 5591 NM_006904 31340617 GCAGGACCGUGCAAGGUUA
Plate 1 F05 L-005030-00 J-005030-09 PRKDC 5591 NM_006904 31340617 AGAUAGAGCUGCUAAAUGU
Plate 1 F06 L-019554-00 J-019554-05 C11ORF13 8045 NM_003475 24475884 GAACGCUGCCUAAUUCGUG
Plate 1 F06 L-019554-00 J-019554-06 C11ORF13 8045 NM_003475 24475884 UGCCAGCGAUGUCCAGUUU
Plate 1 F06 L-019554-00 J-019554-07 C11ORF13 8045 NM_003475 24475884 GGUCAUCGCACUAGCCCAA
Plate 1 F06 L-019554-00 J-019554-08 C11ORF13 8045 NM_003475 24475884 CAGCAGAGCGAGCCUUGCA
Plate 1 F07 L-010127-00 J-010127-05 PARP2 10038 NM_005484 110825960 CAUCACAGGUUACAUGUUU
Plate 1 F07 L-010127-00 J-010127-06 PARP2 10038 NM_005484 110825960 AAGGAUUGCUUCAAGGUAA
Plate 1 F07 L-010127-00 J-010127-07 PARP2 10038 NM_005484 110825960 GCAAGUGACACAGGAAUUC
Plate 1 F07 L-010127-00 J-010127-08 PARP2 10038 NM_005484 110825960 CAGGUUACCAGUCUCUUAA
Plate 1 F08 L-019650-00 J-019650-05 POLI 11201 NM_007195 6005847 CCACAGUUGGUAUUAGUUA
Plate 1 F08 L-019650-00 J-019650-06 POLI 11201 NM_007195 6005847 GCACUAUGGUCGUGAGAGU
Plate 1 F08 L-019650-00 J-019650-07 POLI 11201 NM_007195 6005847 CGGGUCAUGUAUACAAUAA
Plate 1 F08 L-019650-00 J-019650-08 POLI 11201 NM_007195 6005847 GAACAUCAGGCUUUAAUAG
Plate 1 F09 L-003294-00 J-003294-09 RAD17 5884 NM_133341 19718789 AGAUUUACCUAACCAGUUU
Plate 1 F09 L-003294-00 J-003294-10 RAD17 5884 NM_133341 19718789 CAACUUACGGCCAAGGAAA
Plate 1 F09 L-003294-00 J-003294-11 RAD17 5884 NM_133341 19718789 GAGCGACAAAGUAUAACAA
Plate 1 F09 L-003294-00 J-003294-12 RAD17 5884 NM_133341 19718789 UCGAUGUCCUCUUAUAUUU
Plate 1 F10 L-004239-00 J-004239-06 TOP2A 7153 NM_001067 19913405 CGAAAGGAAUGGUUAACUA
Plate 1 F10 L-004239-00 J-004239-07 TOP2A 7153 NM_001067 19913405 GAUGAACUCUGCAGGCUAA
Plate 1 F10 L-004239-00 J-004239-08 TOP2A 7153 NM_001067 19913405 GGAGAAGAUUAUACAUGUA
Plate 1 F10 L-004239-00 J-004239-09 TOP2A 7153 NM_001067 19913405 GGUAACUCCUUGAAAGUAA
Plate 1 F11 L-011350-00 J-011350-05 PER1 5187 NM_002616 4505712 CCAAUAAGGCGGAGAGUGU
Plate 1 F11 L-011350-00 J-011350-06 PER1 5187 NM_002616 4505712 CCAGUGACCUGCUCGAACU
Plate 1 F11 L-011350-00 J-011350-07 PER1 5187 NM_002616 4505712 GGCCGAAUCGUCUACAUUU
Plate 1 F11 L-011350-00 J-011350-08 PER1 5187 NM_002616 4505712 CAACGGGCAUGAGUCUAGA
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Plate 1 F11 L-011350-00 J-011350-08 PER1 5187 NM_002616 4505712 CAACGGGCAUGAGUC
Plate 1 G02 L-009297-00 J-009297-06 ADPRTL3 10039 NM_0010039 5155872 GGUGAUACAGACCUA
Plate 1 G02 L-009297-00 J-009297-07 ADPRTL3 10039 NM_0010039 5155872 ACGCAGAAGCUCAUC
Plate 1 G02 L-009297-00 J-009297-08 ADPRTL3 10039 NM_0010039 5155872 GACCGAGACUACCAG
Plate 1 G02 L-009297-00 J-009297-09 ADPRTL3 10039 NM_0010039 5155872 GCAAGGAGAUGUUCA
Plate 1 G03 L-016345-01 J-016345-09 NEIL2 3E+05 NM_145043 2145079 GAAUGAACCUAGAGC
Plate 1 G03 L-016345-01 J-016345-10 NEIL2 3E+05 NM_145043 2145079 GGUCAUGAAGGAGGC
Plate 1 G03 L-016345-01 J-016345-11 NEIL2 3E+05 NM_145043 2145079 GGGCAGCAGUAAGAA
Plate 1 G03 L-016345-01 J-016345-12 NEIL2 3E+05 NM_145043 2145079 GCGAGGAUGAUUCUG
Plate 1 G04 L-008234-00 J-008234-05 REV1L 51455 NM_0010378 8404396 GAAGUUAAUUGAUGG
Plate 1 G04 L-008234-00 J-008234-06 REV1L 51455 NM_0010378 8404396 CAUAUCAGCUGUACA
Plate 1 G04 L-008234-00 J-008234-07 REV1L 51455 NM_0010378 8404396 GUGGAGACUUGCAGU
Plate 1 G04 L-008234-00 J-008234-08 REV1L 51455 NM_0010378 8404396 CAUCAGAGCUGUAUA
Plate 1 G05 L-008364-00 J-008364-09 SOD1 6647 NM_000454 4876294 GGAAGUCGUUUGGCU
Plate 1 G05 L-008364-00 J-008364-10 SOD1 6647 NM_000454 4876294 GCACACUGGUGGUCC
Plate 1 G05 L-008364-00 J-008364-11 SOD1 6647 NM_000454 4876294 GUGCAGGGCAUCAUC
Plate 1 G05 L-008364-00 J-008364-12 SOD1 6647 NM_000454 4876294 CAAUAAACAUUCCCU
Plate 1 G06 L-003478-01 J-003478-17 CSNK1D 1453 NM_001893 2054414 ACGAAAGGAUUAGCG
Plate 1 G06 L-003478-01 J-003478-18 CSNK1D 1453 NM_001893 2054414 CGACCUCACAGGCCG
Plate 1 G06 L-003478-01 J-003478-19 CSNK1D 1453 NM_001893 2054414 GCCAAGAAGUACCGG
Plate 1 G06 L-003478-01 J-003478-20 CSNK1D 1453 NM_001893 2054414 AGGCUACCCUUCCGA
Plate 1 G07 L-019665-00 J-019665-05 MSH3 4437 NM_002439 6830363 GCACAUAGCUACAGA
Plate 1 G07 L-019665-00 J-019665-06 MSH3 4437 NM_002439 6830363 CCCGAGAGCUCAAUA
Plate 1 G07 L-019665-00 J-019665-07 MSH3 4437 NM_002439 6830363 GGACAGGAGUUUAUG
Plate 1 G07 L-019665-00 J-019665-08 MSH3 4437 NM_002439 6830363 GAUUCGAAACGUCAA
Plate 1 G08 L-019116-00 J-019116-05 MSH4 4438 NM_002440 3694936 GAGAUUAGAUUGUGU
Plate 1 G08 L-019116-00 J-019116-06 MSH4 4438 NM_002440 3694936 CAAGAGGUUUGGAAU
Plate 1 G08 L-019116-00 J-019116-07 MSH4 4438 NM_002440 3694936 CGACUUCGUUCUAAU
Plate 1 G08 L-019116-00 J-019116-08 MSH4 4438 NM_002440 3694936 CGACCAGAAUUUACU
Plate 1 G09 L-004914-01 J-004914-09 XAB2 56949 NM_020196 5577090 ACGCAGCACUCUCGA
Plate 1 G09 L-004914-01 J-004914-10 XAB2 56949 NM_020196 5577090 CCAAAUUCAUUGCCC
Plate 1 G09 L-004914-01 J-004914-11 XAB2 56949 NM_020196 5577090 CCUUGCGGCUGCUG
Plate 1 G09 L-004914-01 J-004914-12 XAB2 56949 NM_020196 5577090 AGGAGAGCUUCAAGG
Plate 1 G10 L-011899-00 J-011899-05 FANCG 2189 NM_004629 4759335 CAGGUAAUCGAGACA
Plate 1 G10 L-011899-00 J-011899-06 FANCG 2189 NM_004629 4759335 GAGUGGAGCCUCUAA
Plate 1 G10 L-011899-00 J-011899-07 FANCG 2189 NM_004629 4759335 GGACCUGGCCUUGUU
Plate 1 G10 L-011899-00 J-011899-08 FANCG 2189 NM_004629 4759335 GCAGGGAUGUAAGUC
Plate 1 G11 L-003202-00 J-003202-19 ATR 545 NM_001184 2014397 GAGAAAGGAUUGUAG
Plate 1 G11 L-003202-00 J-003202-20 ATR 545 NM_001184 2014397 GCAACUCGCCUAACA
Plate 1 G11 L-003202-00 J-003202-21 ATR 545 NM_001184 2014397 CCACGAAUGUUAACU
Plate 1 G11 L-003202-00 J-003202-22 ATR 545 NM_001184 2014397 CCGCUAAUCUUCUAA
Plate 1 H02 L-015379-01 J-015379-09 HEL308 1E+05 NM_133636 1952573 CGACUCAAAUUAUCG
Plate 1 H02 L-015379-01 J-015379-10 HEL308 1E+05 NM_133636 1952573 GUUUGAAGAUUGCAA
Plate 1 H02 L-015379-01 J-015379-11 HEL308 1E+05 NM_133636 1952573 GCAUGAAGCUAUCUG
Plate 1 H02 L-015379-01 J-015379-12 HEL308 1E+05 NM_133636 1952573 CGUAAGGACAAUUGA
Plate 1 H03 L-017467-00 J-017467-05 RAD51L3 5892 NM_133629 1992412 CCACAUAACUCGAGA
Plate 1 H03 L-017467-00 J-017467-06 RAD51L3 5892 NM_133629 1992412 GAUCAGACAUGACCU
Plate 1 H03 L-017467-00 J-017467-07 RAD51L3 5892 NM_133629 1992412 GGCCAAAUCUUCCCG
Plate 1 H03 L-017467-00 J-017467-08 RAD51L3 5892 NM_133629 1992412 AGAAAUGUGGCUUGU
Plate 1 H04 L-008515-00 J-008515-06 UNG2 10309 NM_021147 6684138 GCUCAUCGCUUGCAA
Plate 1 H04 L-008515-00 J-008515-07 UNG2 10309 NM_021147 6684138 CUACAGACCUUCCGC
Plate 1 H04 L-008515-00 J-008515-08 UNG2 10309 NM_021147 6684138 CAUAAACAGUACUUC
Plate 1 H04 L-008515-00 J-008515-09 UNG2 10309 NM_021147 6684138 GAAUCCCGCUGUAAG
Plate 1 H05 L-011291-00 J-011291-05 GTF2H2 2966 NM_001515 3174757 GGUAGUAGAUGGAUC
Plate 1 H05 L-011291-00 J-011291-06 GTF2H2 2966 NM_001515 3174757 AGACUGACGUGUACU
Plate 1 H05 L-011291-00 J-011291-07 GTF2H2 2966 NM_001515 3174757 GAGAAGUACUAAUCA
Plate 1 H05 L-011291-00 J-011291-08 GTF2H2 2966 NM_001515 3174757 GAUUCCAGCAUGUAG
Plate 1 H06 L-010213-00 J-010213-06 YBX1 4904 NM_004559 3409894 CUGAGUAAAUGCCGG
Plate 1 H06 L-010213-00 J-010213-07 YBX1 4904 NM_004559 3409894 CGACGCAGACGCCCA
Plate 1 H06 L-010213-00 J-010213-08 YBX1 4904 NM_004559 3409894 GUAAGGAACGGAUAU
Plate 1 H06 L-010213-00 J-010213-09 YBX1 4904 NM_004559 3409894 GCGGAGGCAGCAAAU
Plate 1 H07 L-009394-00 J-009394-06 XRCC1 7515 NM_006297 5454171 CCGCAAGCCUGAAGU
Plate 1 H07 L-009394-00 J-009394-07 XRCC1 7515 NM_006297 5454171 GGAAUGAUGGCUCAG
Plate 1 H07 L-009394-00 J-009394-08 XRCC1 7515 NM_006297 5454171 AAACUCAUCCGAUAC
Plate 1 H07 L-009394-00 J-009394-09 XRCC1 7515 NM_006297 5454171 AGGCAGACACUUACC
Plate 1 H08 L-010924-00 J-010924-05 GTF2H1 2965 NM_005316 1992330 CAACAAGUCAGGACA
Plate 1 H08 L-010924-00 J-010924-06 GTF2H1 2965 NM_005316 1992330 UUACAAGAGUCCAUU
Plate 1 H08 L-010924-00 J-010924-07 GTF2H1 2965 NM_005316 1992330 GAAGUCAGAUAGGUA
Plate 1 H08 L-010924-00 J-010924-08 GTF2H1 2965 NM_005316 1992330 GUAACGGUCUAAGAU
Plate 1 H09 L-006626-00 J-006626-05 ERCC5 2073 NM_000123 5198889 GACUGAAGCCUUUCC
Plate 1 H09 L-006626-00 J-006626-06 ERCC5 2073 NM_000123 5198889 GAUCCUGGCUGUUGA
Plate 1 H09 L-006626-00 J-006626-07 ERCC5 2073 NM_000123 5198889 GCAAGAAACAAGUAG
Plate 1 H09 L-006626-00 J-006626-08 ERCC5 2073 NM_000123 5198889 CGAUAGAUAUUGAGU
Plate 1 H10 L-016143-01 J-016143-09 MUS81 80198 NM_025128 3414759 CAGCCCUGGUGGAUC
Plate 1 H10 L-016143-01 J-016143-10 MUS81 80198 NM_025128 3414759 CAUUAAGUGUGGGCG
Plate 1 H10 L-016143-01 J-016143-11 MUS81 80198 NM_025128 3414759 UGACCCACACGGUGC
Plate 1 H10 L-016143-01 J-016143-12 MUS81 80198 NM_025128 3414759 CUCAGGAGCCCGAGU
Plate 1 H11 L-006995-00 J-006995-06 RAP80 51720 NM_016290 4247612 AGAGGCAGCUCCUUA
Plate 1 H11 L-006995-00 J-006995-07 RAP80 51720 NM_016290 4247612 AGAGCAGGCUAGUGA
Plate 1 H11 L-006995-00 J-006995-08 RAP80 51720 NM_016290 4247612 AAAUGAAUCUCCCGU
Plate 1 H11 L-006995-00 J-006995-09 RAP80 51720 NM_016290 4247612 GUAAAUCCCUGGUCC
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Plate 1 H11 L-006995-00 J-006995-09 RAP80 51720 NM_016290 4247612 GUAAAUCCCUGGUCC
Plate 2 A02 L-016775-01 J-016775-09 FLJ13614 84142 NM_139076 2058996 UAUUAGUGGUAACGU
Plate 2 A02 L-016775-01 J-016775-10 FLJ13614 84142 NM_139076 2058996 ACACAAGACAAACGA
Plate 2 A02 L-016775-01 J-016775-11 FLJ13614 84142 NM_139076 2058996 GGUAGUAGUAACCAA
Plate 2 A02 L-016775-01 J-016775-12 FLJ13614 84142 NM_139076 2058996 CAGGGUACCUUUAGU
Plate 2 A03 L-005046-00 J-005046-07 TRIM28 10155 NM_005762 1497141 GAAAUGUGAGCGUGU
Plate 2 A03 L-005046-00 J-005046-08 TRIM28 10155 NM_005762 1497141 GCGAUCUGGUUAUGU
Plate 2 A03 L-005046-00 J-005046-09 TRIM28 10155 NM_005762 1497141 AGACAGCACUGGCGU
Plate 2 A03 L-005046-00 J-005046-10 TRIM28 10155 NM_005762 1497141 GAACGAGGCCUUCGG
Plate 2 A04 L-009807-00 J-009807-05 POLS 11044 NM_006999 6254886 GGAGUGACGUUGAUU
Plate 2 A04 L-009807-00 J-009807-06 POLS 11044 NM_006999 6254886 CGGAGUUCAUCAAGA
Plate 2 A04 L-009807-00 J-009807-07 POLS 11044 NM_006999 6254886 AAACAGAGACGCCGA
Plate 2 A04 L-009807-00 J-009807-08 POLS 11044 NM_006999 6254886 GCGAAUAGCCACAUG
Plate 2 A05 L-005798-00 J-005798-12 CXORF53 79184 NM_0010180 6476248 CAUAAUGGCUCAGUG
Plate 2 A05 L-005798-00 J-005798-13 CXORF53 79184 NM_0010180 6476248 CGUCAGAAUUGUUCA
Plate 2 A05 L-005798-00 J-005798-14 CXORF53 79184 NM_0010180 6476248 GAAGGACCGAGUAGA
Plate 2 A05 L-005798-00 J-005798-15 CXORF53 79184 NM_0010180 6476248 GCAUAUACUGGAACU
Plate 2 A06 L-019659-02 J-019659-17 POLG2 11232 NM_007215 7088778 CCGGAGCUGUUGACG
Plate 2 A06 L-019659-02 J-019659-18 POLG2 11232 NM_007215 7088778 GAACCUAGGAGAUCA
Plate 2 A06 L-019659-02 J-019659-19 POLG2 11232 NM_007215 7088778 GGCGUAGAGUUGCG
Plate 2 A06 L-019659-02 J-019659-20 POLG2 11232 NM_007215 7088778 GACACUAAGCAGAUA
Plate 2 A07 L-010790-00 J-010790-05 DCLRE1A 9937 NM_014881 4273431 GCAAGAGGUUAUCCG
Plate 2 A07 L-010790-00 J-010790-06 DCLRE1A 9937 NM_014881 4273431 GAUGAAGGAUUGUAU
Plate 2 A07 L-010790-00 J-010790-07 DCLRE1A 9937 NM_014881 4273431 GUAAUGAAGCAAAUG
Plate 2 A07 L-010790-00 J-010790-08 DCLRE1A 9937 NM_014881 4273431 GAAUUCAAGUUGUGG
Plate 2 A08 L-015465-00 J-015465-05 UVRAG 7405 NM_003369 2168721 CAUCUGGUCUCCAUG
Plate 2 A08 L-015465-00 J-015465-06 UVRAG 7405 NM_003369 2168721 GAGGUGGCAUUACUG
Plate 2 A08 L-015465-00 J-015465-07 UVRAG 7405 NM_003369 2168721 UGGAUGGGCUGAAAU
Plate 2 A08 L-015465-00 J-015465-08 UVRAG 7405 NM_003369 2168721 UCUACCAGCUGUUGA
Plate 2 A09 L-032280-00 J-032280-05 TREX2 11219 NM_080701 6307971 CCGGAAGGCUGGCUU
Plate 2 A09 L-032280-00 J-032280-06 TREX2 11219 NM_080701 6307971 CGACGAGUCUGGUGC
Plate 2 A09 L-032280-00 J-032280-07 TREX2 11219 NM_080701 6307971 ACAAUGGCUUUGAUU
Plate 2 A09 L-032280-00 J-032280-08 TREX2 11219 NM_080701 6307971 CCAUGUACUUGCCGC
Plate 2 A10 L-006301-00 J-006301-08 HTATIP 10524 NM_182709 3628705 CGUAAGAACAAGAGU
Plate 2 A10 L-006301-00 J-006301-09 HTATIP 10524 NM_182709 3628705 AUGAAUGGGUGACGC
Plate 2 A10 L-006301-00 J-006301-10 HTATIP 10524 NM_182709 3628705 GGACAGCUCUGAUGG
Plate 2 A10 L-006301-00 J-006301-11 HTATIP 10524 NM_182709 3628705 GACCAAGUGUGACCU
Plate 2 A11 L-013597-00 J-013597-05 RECQL 5965 NM_032941 1459190 GAGCUUAUGUUACCA
Plate 2 A11 L-013597-00 J-013597-06 RECQL 5965 NM_032941 1459190 CUACGGCUUUGGAGA
Plate 2 A11 L-013597-00 J-013597-07 RECQL 5965 NM_032941 1459190 GAUUAUAAGGCACUU
Plate 2 A11 L-013597-00 J-013597-08 RECQL 5965 NM_032941 1459190 GGGCAAGCAAUGAAU
Plate 2 B02 L-003256-00 J-003256-17 CHEK2 11200 NM_145862 5411240 GUAAGAAAGUAGCCA
Plate 2 B02 L-003256-00 J-003256-18 CHEK2 11200 NM_145862 5411240 GCAUAGGACUCAAGU
Plate 2 B02 L-003256-00 J-003256-19 CHEK2 11200 NM_145862 5411240 GUUGUGAACUCCGUG
Plate 2 B02 L-003256-00 J-003256-20 CHEK2 11200 NM_145862 5411240 CUCAGGAACUCUAUU
Plate 2 B03 L-005218-00 J-005218-09 NUDT1 4521 NM_002452 4028827 GGGCAAAGUGCAAGA
Plate 2 B03 L-005218-00 J-005218-10 NUDT1 4521 NM_002452 4028827 GGAGAGCGGUCUGAC
Plate 2 B03 L-005218-00 J-005218-11 NUDT1 4521 NM_002452 4028827 GAAAUUCCACGGGUA
Plate 2 B03 L-005218-00 J-005218-12 NUDT1 4521 NM_002452 4028827 UGUUUGAGUUCGUG
Plate 2 B04 L-011554-00 J-011554-06 MBD4 8930 NM_003925 4505120 GAAGAUUUGAUGUGU
Plate 2 B04 L-011554-00 J-011554-07 MBD4 8930 NM_003925 4505120 GGAACAGAAUGCCGU
Plate 2 B04 L-011554-00 J-011554-08 MBD4 8930 NM_003925 4505120 GAAGAUACCAUCCCA
Plate 2 B04 L-011554-00 J-011554-09 MBD4 8930 NM_003925 4505120 UAACUUUACUUCCAC
Plate 2 B05 L-007152-00 J-007152-05 RNF168 2E+05 NM_152617 3137756 GACACUUUCUCCACA
Plate 2 B05 L-007152-00 J-007152-06 RNF168 2E+05 NM_152617 3137756 CAAAGUAAGGCCUGG
Plate 2 B05 L-007152-00 J-007152-07 RNF168 2E+05 NM_152617 3137756 AGAAGAACAGGACAG
Plate 2 B05 L-007152-00 J-007152-08 RNF168 2E+05 NM_152617 3137756 GAAAUUCUCUCGUCA
Plate 2 B06 L-004668-00 J-004668-05 PRPF19 27339 NM_014502 3422231 GAUAACAACUUUGAG
Plate 2 B06 L-004668-00 J-004668-06 PRPF19 27339 NM_014502 3422231 GCACGGAUGUCCAGA
Plate 2 B06 L-004668-00 J-004668-07 PRPF19 27339 NM_014502 3422231 GUACUAAUGUGGCCA
Plate 2 B06 L-004668-00 J-004668-08 PRPF19 27339 NM_014502 3422231 GAUCUGCGCAAGCUU
Plate 2 B07 L-003008-00 J-003008-11 FRAP1 2475 NM_004958 1992429 GGCCAUAGCUAGCCU
Plate 2 B07 L-003008-00 J-003008-12 FRAP1 2475 NM_004958 1992429 CAAAGGACUUCGCCC
Plate 2 B07 L-003008-00 J-003008-13 FRAP1 2475 NM_004958 1992429 GCAGAAUUGUCAAGG
Plate 2 B07 L-003008-00 J-003008-14 FRAP1 2475 NM_004958 1992429 CCAAAGCACUACACU
Plate 2 B08 L-011759-00 J-011759-05 RAD23B 5887 NM_002874 5117373 GCAGAUAGGUCGAGA
Plate 2 B08 L-011759-00 J-011759-06 RAD23B 5887 NM_002874 5117373 GAACGAGAGCAAGUA
Plate 2 B08 L-011759-00 J-011759-07 RAD23B 5887 NM_002874 5117373 GAAGUGGUCAUAUGA
Plate 2 B08 L-011759-00 J-011759-08 RAD23B 5887 NM_002874 5117373 CAACAACCCUGACAG
Plate 2 B09 L-012013-00 J-012013-05 MJD 4287 NM_030660 6693288 ACAGGAAGGUUAUUC
Plate 2 B09 L-012013-00 J-012013-06 MJD 4287 NM_030660 6693288 GGACAGAGUUCACAU
Plate 2 B09 L-012013-00 J-012013-07 MJD 4287 NM_030660 6693288 GCACUAAGUCGCCAA
Plate 2 B09 L-012013-00 J-012013-08 MJD 4287 NM_030660 6693288 GCAGGGCUAUUCAGC
Plate 2 B10 L-004269-00 J-004269-09 DCLRE1C 64421 NM_022487 7649649 GUACGGAGCCAAAGU
Plate 2 B10 L-004269-00 J-004269-10 DCLRE1C 64421 NM_022487 7649649 GCACAACUAUGGAUA
Plate 2 B10 L-004269-00 J-004269-11 DCLRE1C 64421 NM_022487 7649649 UGAAUAAGCUAGACA
Plate 2 B10 L-004269-00 J-004269-12 DCLRE1C 64421 NM_022487 7649649 CACCAAAGCUUUUCA
Plate 2 B11 L-016941-00 J-016941-05 FANCB 2187 NM_152633 6652868 GAAAGAGUGUGUACA
Plate 2 B11 L-016941-00 J-016941-06 FANCB 2187 NM_152633 6652868 ACAAACAAGAGAAUC
Plate 2 B11 L-016941-00 J-016941-07 FANCB 2187 NM_152633 6652868 GGACUAAAGGAAUGU
Plate 2 B11 L-016941-00 J-016941-08 FANCB 2187 NM_152633 6652868 GGUCCUUAAUGGCCC
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Plate 2 B11 L-016941-00 J-016941-08 FANCB 2187 NM_152633 6652868 GGUCCUUAAUGGCCC
Plate 2 C02 L-011822-00 J-011822-05 CETN2 1069 NM_004344 4757901 GUGAGAACCUGACUG
Plate 2 C02 L-011822-00 J-011822-06 CETN2 1069 NM_004344 4757901 GAUGAAACUGGGAAG
Plate 2 C02 L-011822-00 J-011822-07 CETN2 1069 NM_004344 4757901 GCAUCAAGUUCUCAG
Plate 2 C02 L-011822-00 J-011822-08 CETN2 1069 NM_004344 4757901 CAAGAGUUCCUGCGC
Plate 2 C03 L-015098-02 J-015098-17 KUB3 91419 NM_033276 5479278 CAGACUUGUGUGCGA
Plate 2 C03 L-015098-02 J-015098-18 KUB3 91419 NM_033276 5479278 GCCAGAAUAAUAUCC
Plate 2 C03 L-015098-02 J-015098-19 KUB3 91419 NM_033276 5479278 ACAAGACUUAUGCAA
Plate 2 C03 L-015098-02 J-015098-20 KUB3 91419 NM_033276 5479278 UGAUCAUUGUCGUGC
Plate 2 C04 L-003331-00 J-003331-09 TP73 7161 NM_005427 4885644 GAGACGAGGACACGU
Plate 2 C04 L-003331-00 J-003331-10 TP73 7161 NM_005427 4885644 GCAAUAAUCUCUCGC
Plate 2 C04 L-003331-00 J-003331-11 TP73 7161 NM_005427 4885644 GAACUUUGAGAUCCU
Plate 2 C04 L-003331-00 J-003331-12 TP73 7161 NM_005427 4885644 CCACCAUCCUGUACA
Plate 2 C05 L-005147-00 J-005147-09 OGG1 4968 NM_016827 8670537 CGACAAGACCCCAUC
Plate 2 C05 L-005147-00 J-005147-10 OGG1 4968 NM_016827 8670537 GGACAAUCUUUCCGG
Plate 2 C05 L-005147-00 J-005147-11 OGG1 4968 NM_016827 8670537 GCUCAGAAAUUCCAA
Plate 2 C05 L-005147-00 J-005147-12 OGG1 4968 NM_016827 8670537 UACCCUGGCUCAACU
Plate 2 C06 L-009227-00 J-009227-06 LIG3 3980 NM_002311 7374784 GGACUUGGCUGACAU
Plate 2 C06 L-009227-00 J-009227-07 LIG3 3980 NM_002311 7374784 GACAUUGCCUCCAGG
Plate 2 C06 L-009227-00 J-009227-08 LIG3 3980 NM_002311 7374784 CAGAAGUGGUGCACA
Plate 2 C06 L-009227-00 J-009227-09 LIG3 3980 NM_002311 7374784 GAAGGGCGUAUGCCG
Plate 2 C07 L-011082-00 J-011082-05 MEN1 4221 NM_130801 1886085 CGCAAAGGCCUCUGA
Plate 2 C07 L-011082-00 J-011082-06 MEN1 4221 NM_130801 1886085 GAUCAUACAUGCGCU
Plate 2 C07 L-011082-00 J-011082-07 MEN1 4221 NM_130801 1886085 GAUCAUGCCUGGGUA
Plate 2 C07 L-011082-00 J-011082-08 MEN1 4221 NM_130801 1886085 GAACACAUCUACCCC
Plate 2 C08 L-003906-00 J-003906-09 MLH1 4292 NM_000249 2855908 GGAAGUUGUUGGCAG
Plate 2 C08 L-003906-00 J-003906-10 MLH1 4292 NM_000249 2855908 CCAGAUGGUUCGUAC
Plate 2 C08 L-003906-00 J-003906-11 MLH1 4292 NM_000249 2855908 GAAGUAGUGAUAAGG
Plate 2 C08 L-003906-00 J-003906-12 MLH1 4292 NM_000249 2855908 UAUCUUCAUUCUUCG
Plate 2 C09 L-009271-00 J-009271-05 MRE11A 4361 NM_005591 5655010 GGAGGUACGUCGUUU
Plate 2 C09 L-009271-00 J-009271-06 MRE11A 4361 NM_005591 5655010 GGAAAUGAUACGUUU
Plate 2 C09 L-009271-00 J-009271-07 MRE11A 4361 NM_005591 5655010 CGAAAUGUCACUACU
Plate 2 C09 L-009271-00 J-009271-08 MRE11A 4361 NM_005591 5655010 GAAAGGCUCUAUCGA
Plate 2 C10 L-010575-00 J-010575-05 RRM2B 50484 NM_015713 4254413 ACUCAGAGAUGUACA
Plate 2 C10 L-010575-00 J-010575-06 RRM2B 50484 NM_015713 4254413 CAGAAGAGGUCGACU
Plate 2 C10 L-010575-00 J-010575-07 RRM2B 50484 NM_015713 4254413 GCUAUAUUCUGGCUA
Plate 2 C10 L-010575-00 J-010575-08 RRM2B 50484 NM_015713 4254413 GAACUUGGAUUCUCA
Plate 2 C11 L-018757-01 J-018757-09 FLJ40869 3E+05 NM_182625 4727149 UAUGCAAACCACUCG
Plate 2 C11 L-018757-01 J-018757-10 FLJ40869 3E+05 NM_182625 4727149 GCGUAAUCUUGGUGG
Plate 2 C11 L-018757-01 J-018757-11 FLJ40869 3E+05 NM_182625 4727149 GCCCUAAGAUACAUA
Plate 2 C11 L-018757-01 J-018757-12 FLJ40869 3E+05 NM_182625 4727149 UCUAAGACCUUUGGC
Plate 2 D02 L-015780-00 J-015780-05 DCLRE1B 64858 NM_022836 2443199 GAUCCAUACUUUAUA
Plate 2 D02 L-015780-00 J-015780-06 DCLRE1B 64858 NM_022836 2443199 GCACGUCUCUUCUUC
Plate 2 D02 L-015780-00 J-015780-07 DCLRE1B 64858 NM_022836 2443199 UCAGUGCACUUAAGG
Plate 2 D02 L-015780-00 J-015780-08 DCLRE1B 64858 NM_022836 2443199 ACUCUGACCAUUCCU
Plate 2 D03 L-011028-00 J-011028-05 ERCC3 2071 NM_000122 4557562 GAUCAAGGUUAUAGC
Plate 2 D03 L-011028-00 J-011028-06 ERCC3 2071 NM_000122 4557562 CGAGAAUGCCGCUUA
Plate 2 D03 L-011028-00 J-011028-07 ERCC3 2071 NM_000122 4557562 CCCUAUGUCUCCUGA
Plate 2 D03 L-011028-00 J-011028-08 ERCC3 2071 NM_000122 4557562 CCGCGAAGAUGACAA
Plate 2 D04 L-034933-01 J-034933-05 GIYD1 5E+05 NM_0010150 6286820 GCUAAGGGCCCAUGU
Plate 2 D04 L-034933-01 J-034933-06 GIYD1 5E+05 NM_0010150 6286820 CAGAAUUAGAAGAGG
Plate 2 D04 L-034933-01 J-034933-07 GIYD1 5E+05 NM_0010150 6286820 GGACACUGAGAAAGA
Plate 2 D04 L-034933-01 J-034933-08 GIYD1 5E+05 NM_0010150 6286820 GCUGGAGACCUGAUC
Plate 2 D05 L-012806-00 J-012806-06 MUTYH 4595 NM_012222 6912519 CGGAAGAGGUGGUAU
Plate 2 D05 L-012806-00 J-012806-07 MUTYH 4595 NM_012222 6912519 UAUAUGGGCUGGCCU
Plate 2 D05 L-012806-00 J-012806-08 MUTYH 4595 NM_012222 6912519 CAUACCAUCUAUUCA
Plate 2 D05 L-012806-00 J-012806-09 MUTYH 4595 NM_012222 6912519 CCGGAUGGAUGCAGA
Plate 2 D06 L-016112-00 J-016112-05 TDP1 55775 NM_0010087 5724280 GGAGUUAAGCCAAAG
Plate 2 D06 L-016112-00 J-016112-06 TDP1 55775 NM_0010087 5724280 UCAGUUACUUGAUGG
Plate 2 D06 L-016112-00 J-016112-07 TDP1 55775 NM_0010087 5724280 GACCAUAUCUAGUAG
Plate 2 D06 L-016112-00 J-016112-08 TDP1 55775 NM_0010087 5724280 CUAGACAGUUUCAAA
Plate 2 D07 L-006454-00 J-006454-09 POLH 5429 NM_006502 5729981 GUCCAACUGUAAAGC
Plate 2 D07 L-006454-00 J-006454-10 POLH 5429 NM_006502 5729981 GAUUGAACGUGCCAG
Plate 2 D07 L-006454-00 J-006454-11 POLH 5429 NM_006502 5729981 GCCAAGCACUUACAU
Plate 2 D07 L-006454-00 J-006454-12 POLH 5429 NM_006502 5729981 GCCGAGGGAUUGAAC
Plate 2 D08 L-003895-00 J-003895-05 GADD45G 10912 NM_006705 9790905 GAGGAGAGCCGCAGC
Plate 2 D08 L-003895-00 J-003895-06 GADD45G 10912 NM_006705 9790905 GAACGACAUCGACAU
Plate 2 D08 L-003895-00 J-003895-07 GADD45G 10912 NM_006705 9790905 CGAGUCAGCCAAAGU
Plate 2 D08 L-003895-00 J-003895-08 GADD45G 10912 NM_006705 9790905 GGAAAGCGCUGCAUG
Plate 2 D09 L-011653-00 J-011653-05 EYA3 2140 NM_172098 2666724 GAUCCUAUGCCCAGA
Plate 2 D09 L-011653-00 J-011653-06 EYA3 2140 NM_172098 2666724 GAGAGCAAACUAUAA
Plate 2 D09 L-011653-00 J-011653-07 EYA3 2140 NM_172098 2666724 GUUCUUACCUGCACU
Plate 2 D09 L-011653-00 J-011653-08 EYA3 2140 NM_172098 2666724 UAUCCCACCUAUACU
Plate 2 D10 L-005067-00 J-005067-05 XPA 7507 NM_000380 3154396 CGUAAGACUUGUACU
Plate 2 D10 L-005067-00 J-005067-06 XPA 7507 NM_000380 3154396 GGAGACGAUUGUUCA
Plate 2 D10 L-005067-00 J-005067-07 XPA 7507 NM_000380 3154396 GAGCCACCUCUUAAA
Plate 2 D10 L-005067-00 J-005067-08 XPA 7507 NM_000380 3154396 GGAGGCAUGGCUAAU
Plate 2 D11 L-005231-00 J-005231-05 RAD23A 5886 NM_005053 1992413 GCUCUGAGUAUGAGA
Plate 2 D11 L-005231-00 J-005231-06 RAD23A 5886 NM_005053 1992413 GAAGAUAGAAGCUGA
Plate 2 D11 L-005231-00 J-005231-07 RAD23A 5886 NM_005053 1992413 GAUCUUGAGUGACGA
Plate 2 D11 L-005231-00 J-005231-08 RAD23A 5886 NM_005053 1992413 GAAGAACUUUGUGGU
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Plate 2 D11 L-005231-00 J-005231-08 RAD23A 5886 NM_005053 1992413 GAAGAACUUUGUGGU
Plate 2 E02 L-021038-00 J-021038-05 POLK 51426 NM_016218 7705343 GGAUGGGACUUAAUG
Plate 2 E02 L-021038-00 J-021038-06 POLK 51426 NM_016218 7705343 GAAGAGCAAUACAGC
Plate 2 E02 L-021038-00 J-021038-07 POLK 51426 NM_016218 7705343 CUACCAAAGUUAACA
Plate 2 E02 L-021038-00 J-021038-08 POLK 51426 NM_016218 7705343 CCAAGCAAGUCUUUU
Plate 2 E03 L-021353-00 J-021353-05 SHFM1 7979 NM_006304 5453639 GUUAUAAGAUGGAGA
Plate 2 E03 L-021353-00 J-021353-06 SHFM1 7979 NM_006304 5453639 AGACUGGGCUGGCUU
Plate 2 E03 L-021353-00 J-021353-07 SHFM1 7979 NM_006304 5453639 GUUACGAGCUGAACU
Plate 2 E03 L-021353-00 J-021353-08 SHFM1 7979 NM_006304 5453639 CAAUGUAGAGGAUGA
Plate 2 E04 L-020939-01 J-020939-09 NEIL3 55247 NM_018248 8922721 GCUAAUGGAUCAGAA
Plate 2 E04 L-020939-01 J-020939-10 NEIL3 55247 NM_018248 8922721 UAAUGAAGUACCCGU
Plate 2 E04 L-020939-01 J-020939-11 NEIL3 55247 NM_018248 8922721 CUAUGUAUUUCAUCG
Plate 2 E04 L-020939-01 J-020939-12 NEIL3 55247 NM_018248 8922721 AGAAGACAACAAACG
Plate 2 E05 L-009424-00 J-009424-05 UBE2A 7319 NM_181762 3296727 CUAUGCAGAUGGUAG
Plate 2 E05 L-009424-00 J-009424-06 UBE2A 7319 NM_181762 3296727 GCGUGUUUCUGCAAU
Plate 2 E05 L-009424-00 J-009424-07 UBE2A 7319 NM_181762 3296727 GGACAUACUUCAGAA
Plate 2 E05 L-009424-00 J-009424-08 UBE2A 7319 NM_181762 3296727 GAACAAACGGGAAUA
Plate 2 E06 L-007773-00 J-007773-05 HRMT1L6 55170 NM_018137 8922514 GAGCAAGACACGGAC
Plate 2 E06 L-007773-00 J-007773-06 HRMT1L6 55170 NM_018137 8922514 GCACCGGCAUUCUGA
Plate 2 E06 L-007773-00 J-007773-07 HRMT1L6 55170 NM_018137 8922514 GGAGAUCGUUGUGCA
Plate 2 E06 L-007773-00 J-007773-08 HRMT1L6 55170 NM_018137 8922514 GCAAGACGGUACUGG
Plate 2 E07 L-006900-00 J-006900-05 RNF8 9025 NM_183078 3430433 AGAAUGAGCUCCAAU
Plate 2 E07 L-006900-00 J-006900-06 RNF8 9025 NM_183078 3430433 GAGAUGGUCUGGAG
Plate 2 E07 L-006900-00 J-006900-07 RNF8 9025 NM_183078 3430433 CAACAAGAGUCUAAA
Plate 2 E07 L-006900-00 J-006900-08 RNF8 9025 NM_183078 3430433 GAGCGCGUCUGGAAC
Plate 2 E08 L-003329-00 J-003329-14 TP53 7157 NM_000546 8400737 GAAAUUUGCGUGUGG
Plate 2 E08 L-003329-00 J-003329-15 TP53 7157 NM_000546 8400737 GUGCAGCUGUGGGU
Plate 2 E08 L-003329-00 J-003329-16 TP53 7157 NM_000546 8400737 GCAGUCAGAUCCUAG
Plate 2 E08 L-003329-00 J-003329-17 TP53 7157 NM_000546 8400737 GGAGAAUAUUUCACC
Plate 2 E09 L-017058-01 J-017058-09 RPA2 6118 NM_002946 3414762 AACAUGAAGUUCUGC
Plate 2 E09 L-017058-01 J-017058-10 RPA2 6118 NM_002946 3414762 UGGAACAGUGGAUUC
Plate 2 E09 L-017058-01 J-017058-11 RPA2 6118 NM_002946 3414762 GAGCAGGACCAGGGC
Plate 2 E09 L-017058-01 J-017058-12 RPA2 6118 NM_002946 3414762 GGAAGUAGGUUUCAU
Plate 2 E10 L-017823-01 J-017823-09 MMS19L 64210 NM_022362 3154320 GCACAAUCCAGUGAC
Plate 2 E10 L-017823-01 J-017823-10 MMS19L 64210 NM_022362 3154320 AGAAGAGACUGGUGC
Plate 2 E10 L-017823-01 J-017823-11 MMS19L 64210 NM_022362 3154320 AAAUUUGACUAACGG
Plate 2 E10 L-017823-01 J-017823-12 MMS19L 64210 NM_022362 3154320 CGUACAAACCACAGG
Plate 2 E11 L-014288-01 J-014288-09 MGC2731 79035 NM_024068 3414735 CCACCCAGCACCCGA
Plate 2 E11 L-014288-01 J-014288-10 MGC2731 79035 NM_024068 3414735 CAAGACAAAGGACGG
Plate 2 E11 L-014288-01 J-014288-11 MGC2731 79035 NM_024068 3414735 AGGUUGAGGUGAGCC
Plate 2 E11 L-014288-01 J-014288-12 MGC2731 79035 NM_024068 3414735 CCAGCAACCCUGUUA
Plate 2 F02 L-021393-01 J-021393-09 POLN 4E+05 NM_181808 3269879 UGUUAAAUGCUCUGC
Plate 2 F02 L-021393-01 J-021393-10 POLN 4E+05 NM_181808 3269879 GGGCACAAGCAGAGC
Plate 2 F02 L-021393-01 J-021393-11 POLN 4E+05 NM_181808 3269879 GCAAUAACCAGCUUC
Plate 2 F02 L-021393-01 J-021393-12 POLN 4E+05 NM_181808 3269879 GGAUUAUGGUUUAUG
Plate 2 F03 L-013942-00 J-013942-05 MIZF 25988 NM_198971 3972594 CGACAAUCCUGAGUG
Plate 2 F03 L-013942-00 J-013942-06 MIZF 25988 NM_198971 3972594 CAAGUCCCAUUACCG
Plate 2 F03 L-013942-00 J-013942-07 MIZF 25988 NM_198971 3972594 GCAGGGCAUUAUUCU
Plate 2 F03 L-013942-00 J-013942-08 MIZF 25988 NM_198971 3972594 GAACGUCGCUGAACG
Plate 2 F04 L-019287-00 J-019287-05 MSH6 2956 NM_000179 4504190 CGAAGUAGCCGCCAA
Plate 2 F04 L-019287-00 J-019287-06 MSH6 2956 NM_000179 4504190 CCACAUGGAUGCUCU
Plate 2 F04 L-019287-00 J-019287-07 MSH6 2956 NM_000179 4504190 GCAGAAGGGCUAUAA
Plate 2 F04 L-019287-00 J-019287-08 MSH6 2956 NM_000179 4504190 GGGCCAAGAUGGAGG
Plate 2 F05 L-013991-00 J-013991-05 FANCE 2178 NM_021922 6687966 CCAAGUAUCAGGCUA
Plate 2 F05 L-013991-00 J-013991-06 FANCE 2178 NM_021922 6687966 GCCCAAAGCUAUCCA
Plate 2 F05 L-013991-00 J-013991-07 FANCE 2178 NM_021922 6687966 GAAUCUGGAUGAUGC
Plate 2 F05 L-013991-00 J-013991-08 FANCE 2178 NM_021922 6687966 CAACUGCCCUGACCU
Plate 2 F06 L-032783-01 J-032783-05 EME2 2E+05 NM_0010108 5819755 AGGCAGUUCAGUCGG
Plate 2 F06 L-032783-01 J-032783-06 EME2 2E+05 NM_0010108 5819755 GGGCAAACCUGGACG
Plate 2 F06 L-032783-01 J-032783-07 EME2 2E+05 NM_0010108 5819755 UCAAGGCAGUACCGG
Plate 2 F06 L-032783-01 J-032783-08 EME2 2E+05 NM_0010108 5819755 CUGCAGGUGAACAGG
Plate 2 F07 L-018493-02 J-018493-17 C2ORF13 2E+05 NM_173545 2773490 GCACAAGAUAGAAUA
Plate 2 F07 L-018493-02 J-018493-18 C2ORF13 2E+05 NM_173545 2773490 CUUCAUAUUACGUGA
Plate 2 F07 L-018493-02 J-018493-19 C2ORF13 2E+05 NM_173545 2773490 AGCAAUCAGUGGAGG
Plate 2 F07 L-018493-02 J-018493-20 C2ORF13 2E+05 NM_173545 2773490 UGAUUAUGGAGGUGU
Plate 2 F08 L-003548-00 J-003548-06 TP53BP1 7158 NM_005657 5032188 GAAGGACGGAGUACU
Plate 2 F08 L-003548-00 J-003548-07 TP53BP1 7158 NM_005657 5032188 GCUAUAUCCUUGAAG
Plate 2 F08 L-003548-00 J-003548-08 TP53BP1 7158 NM_005657 5032188 GAGCUGGGAAGUAUA
Plate 2 F08 L-003548-00 J-003548-09 TP53BP1 7158 NM_005657 5032188 GGACUCCAGUGUUGU
Plate 2 F09 L-003281-00 J-003281-17 MNAT1 4331 NM_002431 4957451 UAGAUGAGCUGGAGA
Plate 2 F09 L-003281-00 J-003281-18 MNAT1 4331 NM_002431 4957451 GUAUUUAAACCAUGU
Plate 2 F09 L-003281-00 J-003281-19 MNAT1 4331 NM_002431 4957451 CAGCCCAGUUAACCA
Plate 2 F09 L-003281-00 J-003281-20 MNAT1 4331 NM_002431 4957451 GGCUAUACUUCUUCU
Plate 2 F10 L-017846-00 J-017846-05 PMS2L5 5383 NM_174930 3134138 GGACAACGUGAUCAC
Plate 2 F10 L-017846-00 J-017846-06 PMS2L5 5383 NM_174930 3134138 UGUCAAGAAUGGUCC
Plate 2 F10 L-017846-00 J-017846-07 PMS2L5 5383 NM_174930 3134138 GCAAAACUGACUCCU
Plate 2 F10 L-017846-00 J-017846-08 PMS2L5 5383 NM_174930 3134138 GCCAUUAGCAUUGGA
Plate 2 F11 L-018408-01 J-018408-09 SMC6L1 79677 NM_024624 5269467 AGAAAUAGAUAAUGC
Plate 2 F11 L-018408-01 J-018408-10 SMC6L1 79677 NM_024624 5269467 GGACAAAGAAAUUAA
Plate 2 F11 L-018408-01 J-018408-11 SMC6L1 79677 NM_024624 5269467 CAGCAUAGAUGGAAG
Plate 2 F11 L-018408-01 J-018408-12 SMC6L1 79677 NM_024624 5269467 CUUUAAAGCCAGUGU
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Plate 2 F11 L-018408-01 J-018408-12 SMC6L1 79677 NM_024624 5269467 CUUUAAAGCCAGUGU
Plate 2 G02 L-003218-00 J-003218-09 CCNH 902 NM_001239 1773831 GGGUACGGCUUGUAU
Plate 2 G02 L-003218-00 J-003218-10 CCNH 902 NM_001239 1773831 GAGCUUGCACUUAAC
Plate 2 G02 L-003218-00 J-003218-11 CCNH 902 NM_001239 1773831 GCAAAGUAGAUGAAU
Plate 2 G02 L-003218-00 J-003218-12 CCNH 902 NM_001239 1773831 GACCCGCUAUCCCAU
Plate 2 G03 L-011376-00 J-011376-05 RBBP8 5932 NM_203292 4271801 GGAGCUACCUCUAGU
Plate 2 G03 L-011376-00 J-011376-06 RBBP8 5932 NM_203292 4271801 GAGGUUAUAUUAAGG
Plate 2 G03 L-011376-00 J-011376-07 RBBP8 5932 NM_203292 4271801 GAACAGAAUAGGACU
Plate 2 G03 L-011376-00 J-011376-08 RBBP8 5932 NM_203292 4271801 GCACGUUGCCCAAAG
Plate 2 G04 L-004361-00 J-004361-05 XRCC2 7516 NM_005431 4885656 GAGCACAGACUAUCC
Plate 2 G04 L-004361-00 J-004361-06 XRCC2 7516 NM_005431 4885656 ACACUUUACUCACUA
Plate 2 G04 L-004361-00 J-004361-07 XRCC2 7516 NM_005431 4885656 CCUAACAGCACGAUG
Plate 2 G04 L-004361-00 J-004361-08 XRCC2 7516 NM_005431 4885656 GAAAUGUUCUCAGUG
Plate 2 G05 L-019338-00 J-019338-05 RECQL5 9400 NM_0010037 5124294 GAACGCUGGUGCAGA
Plate 2 G05 L-019338-00 J-019338-06 RECQL5 9400 NM_0010037 5124294 GGACUAGAGAGGCUU
Plate 2 G05 L-019338-00 J-019338-07 RECQL5 9400 NM_0010037 5124294 CCUGGUGCCGUCUCU
Plate 2 G05 L-019338-00 J-019338-08 RECQL5 9400 NM_0010037 5124294 CUUGCUAACCCUAAA
Plate 2 G06 L-008327-00 J-008327-06 NEIL1 79661 NM_024608 1337581 UACGAAACCUAGCGG
Plate 2 G06 L-008327-00 J-008327-07 NEIL1 79661 NM_024608 1337581 GACCAGAGGUUCUUC
Plate 2 G06 L-008327-00 J-008327-08 NEIL1 79661 NM_024608 1337581 UGACAUCCCAUCCUU
Plate 2 G06 L-008327-00 J-008327-09 NEIL1 79661 NM_024608 1337581 GGACCAAGCUGCAGA
Plate 2 G07 L-014446-01 J-014446-09 FLJ12610 79840 NM_024782 1337614 GGGCUACGCUGAUUC
Plate 2 G07 L-014446-01 J-014446-10 FLJ12610 79840 NM_024782 1337614 GAGGGAGCUAGCAAC
Plate 2 G07 L-014446-01 J-014446-11 FLJ12610 79840 NM_024782 1337614 CCUUCAGAUUCUUCG
Plate 2 G07 L-014446-01 J-014446-12 FLJ12610 79840 NM_024782 1337614 AGAAAGAGUCCACGG
Plate 2 G08 L-004494-00 J-004494-07 XRCC4 7518 NM_003401 1240864 UGACCGAGAUCCAGU
Plate 2 G08 L-004494-00 J-004494-08 XRCC4 7518 NM_003401 1240864 GAACCCAGUAUAACU
Plate 2 G08 L-004494-00 J-004494-09 XRCC4 7518 NM_003401 1240864 CAGCUGAUGUAUACA
Plate 2 G08 L-004494-00 J-004494-10 XRCC4 7518 NM_003401 1240864 CCUCUUUGAUGAGAU
Plate 2 G09 L-016846-00 J-016846-05 DLG7 9787 NM_014750 2136164 AGACUAAGAUUGAUA
Plate 2 G09 L-016846-00 J-016846-06 DLG7 9787 NM_014750 2136164 GUACAGAUCUGGAUG
Plate 2 G09 L-016846-00 J-016846-07 DLG7 9787 NM_014750 2136164 GGUCUAAACUGCAGU
Plate 2 G09 L-016846-00 J-016846-08 DLG7 9787 NM_014750 2136164 UAAAGUGGGUCGUUA
Plate 2 G10 L-013120-00 J-013120-05 EXO1 9156 NM_003686 3999506 GCACGUAAUUCAAGU
Plate 2 G10 L-013120-00 J-013120-06 EXO1 9156 NM_003686 3999506 GUAAAUGGACCUACU
Plate 2 G10 L-013120-00 J-013120-07 EXO1 9156 NM_003686 3999506 CCACCUAGGACGAGA
Plate 2 G10 L-013120-00 J-013120-08 EXO1 9156 NM_003686 3999506 CGGAAGAGAAGUUUC
Plate 2 G11 L-003100-00 J-003100-09 ABL1 25 NM_005157 6236241 UCACUGAGUUCAUGA
Plate 2 G11 L-003100-00 J-003100-10 ABL1 25 NM_005157 6236241 AGAUAACACUCUAAG
Plate 2 G11 L-003100-00 J-003100-11 ABL1 25 NM_005157 6236241 AAGGGAGGGUGUACC
Plate 2 G11 L-003100-00 J-003100-12 ABL1 25 NM_005157 6236241 CAACAAGCCCACUGU
Plate 2 H02 L-016379-02 J-016379-17 C7ORF11 1E+05 NM_138701 1885957 GAUCAGGGCGUGUUA
Plate 2 H02 L-016379-02 J-016379-18 C7ORF11 1E+05 NM_138701 1885957 UGUAGUGGAUAUAAG
Plate 2 H02 L-016379-02 J-016379-19 C7ORF11 1E+05 NM_138701 1885957 GAUUUACCGUUUCCA
Plate 2 H02 L-016379-02 J-016379-20 C7ORF11 1E+05 NM_138701 1885957 GGAGGUUGGGGUAG
Plate 2 H03 L-018981-00 J-018981-05 HMGB1 3146 NM_002128 3198287 CAAACUCAUUCAUUA
Plate 2 H03 L-018981-00 J-018981-06 HMGB1 3146 NM_002128 3198287 CAAAGCAUGGGAUUA
Plate 2 H03 L-018981-00 J-018981-07 HMGB1 3146 NM_002128 3198287 CCACUUACAUUUACA
Plate 2 H03 L-018981-00 J-018981-08 HMGB1 3146 NM_002128 3198287 CGAAAUAAUUGUUGU
Plate 2 H04 L-010572-00 J-010572-05 RAD54B 25788 NM_134434 2014392 GUUUAAAUCUGCCUA
Plate 2 H04 L-010572-00 J-010572-06 RAD54B 25788 NM_134434 2014392 CACCUACACUGGCAA
Plate 2 H04 L-010572-00 J-010572-07 RAD54B 25788 NM_134434 2014392 UCAUUCGGCUCCUAA
Plate 2 H04 L-010572-00 J-010572-08 RAD54B 25788 NM_134434 2014392 AGAUUGAGCUUUAUC
Plate 2 H05 L-004888-00 J-004888-07 ERCC6 2074 NM_000124 4557564 GCAGUAACUUCUAAU
Plate 2 H05 L-004888-00 J-004888-08 ERCC6 2074 NM_000124 4557564 GAAGCAAGGUUGUAA
Plate 2 H05 L-004888-00 J-004888-09 ERCC6 2074 NM_000124 4557564 GCAUGUGUCUUACGA
Plate 2 H05 L-004888-00 J-004888-10 ERCC6 2074 NM_000124 4557564 CAAACAGAGUUGUCA
Plate 2 H06 L-011076-00 J-011076-05 LIG1 3978 NM_000234 4557718 GCAGCGAAGUAUCAU
Plate 2 H06 L-011076-00 J-011076-06 LIG1 3978 NM_000234 4557718 GAACAACUAUCAUCC
Plate 2 H06 L-011076-00 J-011076-07 LIG1 3978 NM_000234 4557718 GAAGCCCGGUUCAUC
Plate 2 H06 L-011076-00 J-011076-08 LIG1 3978 NM_000234 4557718 CGUCUGAGAUCCAGG
Plate 2 H07 L-003322-00 J-003322-09 RPA3 6119 NM_002947 5285143 CAUCUUAUGUCCAGU
Plate 2 H07 L-003322-00 J-003322-10 RPA3 6119 NM_002947 5285143 GCAACAUGAUUGAUC
Plate 2 H07 L-003322-00 J-003322-11 RPA3 6119 NM_002947 5285143 GAAGAUAGCCAUCCU
Plate 2 H07 L-003322-00 J-003322-12 RPA3 6119 NM_002947 5285143 UUACAAUGAAGCUGU
Plate 2 H08 L-019938-00 J-019938-07 CHAF1A 10036 NM_005483 5051324 CCACAGCCAUGGAUU
Plate 2 H08 L-019938-00 J-019938-08 CHAF1A 10036 NM_005483 5051324 GGGCAAGCAGCUCAA
Plate 2 H08 L-019938-00 J-019938-09 CHAF1A 10036 NM_005483 5051324 GACAUAGACUUUAGA
Plate 2 H08 L-019938-00 J-019938-10 CHAF1A 10036 NM_005483 5051324 AAACAACUGUCAUGU
Plate 2 H09 L-020043-00 J-020043-05 SPO11 23626 NM_198265 3820167 GCACCAAAGUGAAUU
Plate 2 H09 L-020043-00 J-020043-06 SPO11 23626 NM_198265 3820167 ACAGUCAACUCUUUG
Plate 2 H09 L-020043-00 J-020043-07 SPO11 23626 NM_198265 3820167 CCAAAAGGGACAUAU
Plate 2 H09 L-020043-00 J-020043-08 SPO11 23626 NM_198265 3820167 CUGAGGAGACCUUAU
Plate 2 H10 L-004605-00 J-004605-06 DNMT1 1786 NM_001379 4503350 GCACCUCAUUUGCCG
Plate 2 H10 L-004605-00 J-004605-07 DNMT1 1786 NM_001379 4503350 AUAAAUGAAUGGUGG
Plate 2 H10 L-004605-00 J-004605-08 DNMT1 1786 NM_001379 4503350 CCUGAGCCCUACCGA
Plate 2 H10 L-004605-00 J-004605-09 DNMT1 1786 NM_001379 4503350 GGACGACCCUGACCU
Plate 2 H11 L-006061-00 J-006061-07 USP1 7398 NM_0010174 6305352 GCACAAAGCCAACUA
Plate 2 H11 L-006061-00 J-006061-08 USP1 7398 NM_0010174 6305352 CAAAGCAGAUUAUGA
Plate 2 H11 L-006061-00 J-006061-09 USP1 7398 NM_0010174 6305352 CAUAGUGGCAUUACA
Plate 2 H11 L-006061-00 J-006061-10 USP1 7398 NM_0010174 6305352 GUUUGGAGUUUGAUU
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Plate 2 H11 L-006061-00 J-006061-10 USP1 7398 NM_0010174 6305352 GUUUGGAGUUUGAUU
Plate 3 A02 L-017392-00 J-017392-05 EYA1 2138 NM_172059 2666721 GCAACAAGCUACAGC
Plate 3 A02 L-017392-00 J-017392-06 EYA1 2138 NM_172059 2666721 CGACGGGUCUUUAAA
Plate 3 A02 L-017392-00 J-017392-07 EYA1 2138 NM_172059 2666721 CGGACAAACUGUGUG
Plate 3 A02 L-017392-00 J-017392-08 EYA1 2138 NM_172059 2666721 GGUCCUACGCCAACA
Plate 3 A03 L-010559-00 J-010559-05 RECQL4 9401 NM_004260 4759029 CCUAGAUCCUGGCUG
Plate 3 A03 L-010559-00 J-010559-06 RECQL4 9401 NM_004260 4759029 GCGACCACCUAUACC
Plate 3 A03 L-010559-00 J-010559-07 RECQL4 9401 NM_004260 4759029 GAAAAUACCUGCACC
Plate 3 A03 L-010559-00 J-010559-08 RECQL4 9401 NM_004260 4759029 CAAUACAGCUUACCG
Plate 3 A04 L-017410-01 J-017410-09 RAD52B 2E+05 NM_0010348 7787393 GCGAAUUACUACUUU
Plate 3 A04 L-017410-01 J-017410-10 RAD52B 2E+05 NM_0010348 7787393 ACUGUUGAUUGUUGU
Plate 3 A04 L-017410-01 J-017410-11 RAD52B 2E+05 NM_0010348 7787393 GCAUUGGCUUGGUG
Plate 3 A04 L-017410-01 J-017410-12 RAD52B 2E+05 NM_0010348 7787393 UGUCAGAUGCAUUCC
Plate 3 A05 L-009939-00 J-009939-05 MLH3 27030 NM_014381 7657336 CCAAACCAAUCGUCC
Plate 3 A05 L-009939-00 J-009939-06 MLH3 27030 NM_014381 7657336 GCUGAGAGCUUAGCA
Plate 3 A05 L-009939-00 J-009939-07 MLH3 27030 NM_014381 7657336 ACACAGAGUUCUAGG
Plate 3 A05 L-009939-00 J-009939-08 MLH3 27030 NM_014381 7657336 AGACACGUUUCCAAU
Plate 3 A06 L-012261-00 J-012261-05 CIB1 10519 NM_006384 9951921 CGGCUUAGUGCGUCU
Plate 3 A06 L-012261-00 J-012261-06 CIB1 10519 NM_006384 9951921 GAGCGAAUCUGCAGG
Plate 3 A06 L-012261-00 J-012261-07 CIB1 10519 NM_006384 9951921 CCAAAGACAGCCUUA
Plate 3 A06 L-012261-00 J-012261-08 CIB1 10519 NM_006384 9951921 UGAACUGCCUCACGG
Plate 3 A07 L-012308-00 J-012308-05 BTG2 7832 NM_006763 2887271 GAACCGACAUGCUCC
Plate 3 A07 L-012308-00 J-012308-06 BTG2 7832 NM_006763 2887271 GCAUUCGCAUCAACC
Plate 3 A07 L-012308-00 J-012308-07 BTG2 7832 NM_006763 2887271 GGUCAUAGAGCUACC
Plate 3 A07 L-012308-00 J-012308-08 BTG2 7832 NM_006763 2887271 AGACAAAGGUUACUA
Plate 3 A08 L-005146-00 J-005146-05 MPG 4350 NM_0010150 6263277 UCGUGGAGACCGAGG
Plate 3 A08 L-005146-00 J-005146-06 MPG 4350 NM_0010150 6263277 GGAUGAAGCUGUAUG
Plate 3 A08 L-005146-00 J-005146-07 MPG 4350 NM_0010150 6263277 GCGACUUCCUAAUGG
Plate 3 A08 L-005146-00 J-005146-08 MPG 4350 NM_0010150 6263277 CCACACAGCUCGUCC
Plate 3 A09 L-017809-01 J-017809-09 TNP1 7141 NM_003284 3485006 AGGAGGAGCAAGAGC
Plate 3 A09 L-017809-01 J-017809-10 TNP1 7141 NM_003284 3485006 GCAAAAGAAAAUACC
Plate 3 A09 L-017809-01 J-017809-11 TNP1 7141 NM_003284 3485006 GCCGCAAAUUAAAGA
Plate 3 A09 L-017809-01 J-017809-12 TNP1 7141 NM_003284 3485006 GCCUAUGGAAUGUGG
Plate 3 A10 L-003909-00 J-003909-07 MSH2 4436 NM_000251 4557760 GCAGAUGAAUAGUGC
Plate 3 A10 L-003909-00 J-003909-08 MSH2 4436 NM_000251 4557760 GAAGAGACCUUAACU
Plate 3 A10 L-003909-00 J-003909-09 MSH2 4436 NM_000251 4557760 CAACAUAUAUUCGAC
Plate 3 A10 L-003909-00 J-003909-10 MSH2 4436 NM_000251 4557760 GAGAAUGAUUGGUAU
Plate 3 A11 L-003530-00 J-003530-09 RAD51 5888 NM_133487 1992413 UAUCAUCGCCCAUGC
Plate 3 A11 L-003530-00 J-003530-10 RAD51 5888 NM_133487 1992413 CUAAUCAGGUGGUAG
Plate 3 A11 L-003530-00 J-003530-11 RAD51 5888 NM_133487 1992413 GCAGUGAUGUCCUGG
Plate 3 A11 L-003530-00 J-003530-12 RAD51 5888 NM_133487 1992413 CCAACGAUGUGAAGA
Plate 3 B02 L-003293-00 J-003293-09 RAD1 5810 NM_0010336 7688181 CCACGUGUUUCGCAA
Plate 3 B02 L-003293-00 J-003293-10 RAD1 5810 NM_0010336 7688181 CAAAGUGUGUGCAAG
Plate 3 B02 L-003293-00 J-003293-11 RAD1 5810 NM_0010336 7688181 GAUGAUCAGUACAGC
Plate 3 B02 L-003293-00 J-003293-12 RAD1 5810 NM_0010336 7688181 GUAUGACAAUUCACU
Plate 3 B03 L-012928-01 J-012928-09 FLJ21816 79728 NM_024675 2743690 GAGAGUGAGUCGUUG
Plate 3 B03 L-012928-01 J-012928-10 FLJ21816 79728 NM_024675 2743690 CAUAACUGCUUGCGA
Plate 3 B03 L-012928-01 J-012928-11 FLJ21816 79728 NM_024675 2743690 GUGAUUAACCCUAAG
Plate 3 B03 L-012928-01 J-012928-12 FLJ21816 79728 NM_024675 2743690 CCUGGAAGGUGACGU
Plate 3 B04 L-020327-00 J-020327-05 KIAA1018 22909 NM_014967 6219823 GAAGGGAAUUGUAAC
Plate 3 B04 L-020327-00 J-020327-06 KIAA1018 22909 NM_014967 6219823 CGUAGAAGCUUAUCA
Plate 3 B04 L-020327-00 J-020327-07 KIAA1018 22909 NM_014967 6219823 GUAAUGAUGUGGUGU
Plate 3 B04 L-020327-00 J-020327-08 KIAA1018 22909 NM_014967 6219823 AAACCGUACUUGAGA
Plate 3 B05 L-012897-00 J-012897-05 CNOT7 29883 NM_054026 1797849 CAGCUAGGACUGACA
Plate 3 B05 L-012897-00 J-012897-06 CNOT7 29883 NM_054026 1797849 GGAGAAUUCAGGAGC
Plate 3 B05 L-012897-00 J-012897-07 CNOT7 29883 NM_054026 1797849 UCAUAGCGGUUACGA
Plate 3 B05 L-012897-00 J-012897-08 CNOT7 29883 NM_054026 1797849 GUUAGAGCUGGAACG
Plate 3 B06 L-003247-00 J-003247-11 CDKN2D 1032 NM_079421 3999507 CAAUCCAUCUGGCAG
Plate 3 B06 L-003247-00 J-003247-12 CDKN2D 1032 NM_079421 3999507 AAUCUGAUCUCCAUC
Plate 3 B06 L-003247-00 J-003247-13 CDKN2D 1032 NM_079421 3999507 GUACCAGUCCAGUCC
Plate 3 B06 L-003247-00 J-003247-14 CDKN2D 1032 NM_079421 3999507 CUGCAGGUCAUGAUG
Plate 3 B07 L-012890-00 J-012890-06 DDB1 1642 NM_001923 1343535 CACUAGAUCGCGAUA
Plate 3 B07 L-012890-00 J-012890-07 DDB1 1642 NM_001923 1343535 GAAGGUUCUUUGCGG
Plate 3 B07 L-012890-00 J-012890-08 DDB1 1642 NM_001923 1343535 CAUCGACGGUGACUU
Plate 3 B07 L-012890-00 J-012890-09 DDB1 1642 NM_001923 1343535 CAUCUCGGCUCGUAU
Plate 3 B08 L-011008-00 J-011008-05 CKN1 1161 NM_0010072 5595677 GUAAAGCAGUGUGUU
Plate 3 B08 L-011008-00 J-011008-06 CKN1 1161 NM_0010072 5595677 CAGACAAUCUUAUUA
Plate 3 B08 L-011008-00 J-011008-07 CKN1 1161 NM_0010072 5595677 CAUCAUAUGUCUCCA
Plate 3 B08 L-011008-00 J-011008-08 CKN1 1161 NM_0010072 5595677 GAUUGUACUUUAUGA
Plate 3 B09 L-006656-00 J-006656-05 PARP1 142 NM_001618 1149698 GAUUUCAUCUGGUGU
Plate 3 B09 L-006656-00 J-006656-06 PARP1 142 NM_001618 1149698 GAAAACAGGUAUUGG
Plate 3 B09 L-006656-00 J-006656-07 PARP1 142 NM_001618 1149698 GUUCUUAGCGCACAU
Plate 3 B09 L-006656-00 J-006656-08 PARP1 142 NM_001618 1149698 CCAAUAGGCUUAAUC
Plate 3 B10 L-016958-00 J-016958-05 MGC3202 91442 NM_152266 2274862 GCAUCCAGCAACUGA
Plate 3 B10 L-016958-00 J-016958-06 MGC3202 91442 NM_152266 2274862 CGGGUUAGAAAUUCC
Plate 3 B10 L-016958-00 J-016958-07 MGC3202 91442 NM_152266 2274862 CCAAAGAGCCCAGUA
Plate 3 B10 L-016958-00 J-016958-08 MGC3202 91442 NM_152266 2274862 CCAGUUGGUUCAAGA
Plate 3 B11 L-014848-01 J-014848-09 MGC4189 84268 NM_032308 1414961 GUCCAUCAUCAGCGA
Plate 3 B11 L-014848-01 J-014848-10 MGC4189 84268 NM_032308 1414961 UCUAUGGGGUUGAAG
Plate 3 B11 L-014848-01 J-014848-11 MGC4189 84268 NM_032308 1414961 CUGAGGAGCCUUGUA
Plate 3 B11 L-014848-01 J-014848-12 MGC4189 84268 NM_032308 1414961 GAGCUUGCAGUUUGA
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Plate 3 B11 L-014848-01 J-014848-12 MGC4189 84268 NM_032308 1414961 GAGCUUGCAGUUUGA
Plate 3 C02 L-020856-00 J-020856-05 POLA 5422 NM_016937 8393994 GAUGGUAAAGCACGC
Plate 3 C02 L-020856-00 J-020856-06 POLA 5422 NM_016937 8393994 GACAUUAGACGUUUC
Plate 3 C02 L-020856-00 J-020856-07 POLA 5422 NM_016937 8393994 CAUGUGAGCUGUUGU
Plate 3 C02 L-020856-00 J-020856-08 POLA 5422 NM_016937 8393994 GUACUACUGCAGAGA
Plate 3 C03 L-003295-00 J-003295-11 RAD9A 5883 NM_004584 1992411 GUAAGAUCCUGAUGA
Plate 3 C03 L-003295-00 J-003295-12 RAD9A 5883 NM_004584 1992411 AUGACGACAUUGACU
Plate 3 C03 L-003295-00 J-003295-13 RAD9A 5883 NM_004584 1992411 GCGGAAGACUCACAA
Plate 3 C03 L-003295-00 J-003295-14 RAD9A 5883 NM_004584 1992411 UCAGCAAACUUGAAU
Plate 3 C04 L-011763-00 J-011763-05 RENT1 5976 NM_002911 1837567 CAGCGGAUCGUGUGA
Plate 3 C04 L-011763-00 J-011763-06 RENT1 5976 NM_002911 1837567 CAAGGUCCCUGAUAA
Plate 3 C04 L-011763-00 J-011763-07 RENT1 5976 NM_002911 1837567 GCAGCCACAUUGUAA
Plate 3 C04 L-011763-00 J-011763-08 RENT1 5976 NM_002911 1837567 GCUCGCAGACUCUCA
Plate 3 C05 L-009641-00 J-009641-06 NBS1 4683 NM_002485 6718976 CCAACUAAAUUGCCA
Plate 3 C05 L-009641-00 J-009641-07 NBS1 4683 NM_002485 6718976 GCAGAUACAUGGGAU
Plate 3 C05 L-009641-00 J-009641-08 NBS1 4683 NM_002485 6718976 GAAUAGAAACGUCUU
Plate 3 C05 L-009641-00 J-009641-09 NBS1 4683 NM_002485 6718976 AACAAUAUGUGCACU
Plate 3 C06 L-009551-00 J-009551-05 DMC1 11144 NM_007068 2323821 GGACAUUGCUGAUCG
Plate 3 C06 L-009551-00 J-009551-06 DMC1 11144 NM_007068 2323821 CCAGGAAUUUGAUAA
Plate 3 C06 L-009551-00 J-009551-07 DMC1 11144 NM_007068 2323821 AGAAUAAGCUUGCGA
Plate 3 C06 L-009551-00 J-009551-08 DMC1 11144 NM_007068 2323821 GAACAAACUAAUUGA
Plate 3 C07 L-003289-00 J-003289-15 PCNA 5111 NM_182649 3323945 GCACGUAUAUGCCGA
Plate 3 C07 L-003289-00 J-003289-16 PCNA 5111 NM_182649 3323945 AACGAGGCCUGCUGG
Plate 3 C07 L-003289-00 J-003289-17 PCNA 5111 NM_182649 3323945 GCGGAUAUGGGACAC
Plate 3 C07 L-003289-00 J-003289-18 PCNA 5111 NM_182649 3323945 CACUAAGGGCCGAAG
Plate 3 C08 L-006901-00 J-006901-06 BAZ1B 9031 NM_032408 1467039 AUAAGGAGAUAGUUC
Plate 3 C08 L-006901-00 J-006901-07 BAZ1B 9031 NM_032408 1467039 CCAAUAAGCUGCACA
Plate 3 C08 L-006901-00 J-006901-08 BAZ1B 9031 NM_032408 1467039 GCACGUAGAUCGCCA
Plate 3 C08 L-006901-00 J-006901-09 BAZ1B 9031 NM_032408 1467039 GCAUUCAGAUUGGUG
Plate 3 C09 L-004283-00 J-004283-05 ALKBH 8846 NM_006020 5174384 GGUAUAAAGAAGCGA
Plate 3 C09 L-004283-00 J-004283-06 ALKBH 8846 NM_006020 5174384 UGACCAGAAUAGCGA
Plate 3 C09 L-004283-00 J-004283-07 ALKBH 8846 NM_006020 5174384 GUGGUGACAUCAUGA
Plate 3 C09 L-004283-00 J-004283-08 ALKBH 8846 NM_006020 5174384 GAAGACCGCUCGUGU
Plate 3 C10 L-005164-00 J-005164-06 POLB 5423 NM_002690 4505930 UCACAGAACUCGCAA
Plate 3 C10 L-005164-00 J-005164-07 POLB 5423 NM_002690 4505930 UAAGAAAUUGCCUGG
Plate 3 C10 L-005164-00 J-005164-08 POLB 5423 NM_002690 4505930 GAGCCAAGCUAUCCA
Plate 3 C10 L-005164-00 J-005164-09 POLB 5423 NM_002690 4505930 GAGCGAAUGAGGCCU
Plate 3 C11 L-009345-00 J-009345-05 NTHL1 4913 NM_002528 3845539 ACACGCAUGUGCACA
Plate 3 C11 L-009345-00 J-009345-06 NTHL1 4913 NM_002528 3845539 CGUGAAGCGUCCGCG
Plate 3 C11 L-009345-00 J-009345-07 NTHL1 4913 NM_002528 3845539 GGAGCAAGGUGAAAU
Plate 3 C11 L-009345-00 J-009345-08 NTHL1 4913 NM_002528 3845539 CGAGAUCAAUGGACU
Plate 3 D02 L-011022-00 J-011022-05 DDB2 1643 NM_000107 4557514 GAUAUCAUGCUCUGG
Plate 3 D02 L-011022-00 J-011022-06 DDB2 1643 NM_000107 4557514 GCCGAUACCCAGAUC
Plate 3 D02 L-011022-00 J-011022-07 DDB2 1643 NM_000107 4557514 GAAGACCUCCGAGAU
Plate 3 D02 L-011022-00 J-011022-08 DDB2 1643 NM_000107 4557514 GGCAUCAGUUCGCUU
Plate 3 D03 L-019687-00 J-019687-06 POLD1 5424 NM_002691 4505932 AGUUGGAGAUUGACC
Plate 3 D03 L-019687-00 J-019687-07 POLD1 5424 NM_002691 4505932 CGAGAGAGCAUGUUU
Plate 3 D03 L-019687-00 J-019687-08 POLD1 5424 NM_002691 4505932 GCAAAGGCAUCUUCC
Plate 3 D03 L-019687-00 J-019687-09 POLD1 5424 NM_002691 4505932 GCACAGAAACUGGGC
Plate 3 D04 L-008856-01 J-008856-09 MGMT 4255 NM_002412 4957451 GGUUGUGAAAUUCGG
Plate 3 D04 L-008856-01 J-008856-10 MGMT 4255 NM_002412 4957451 GAUGGAUGUUUGAGC
Plate 3 D04 L-008856-01 J-008856-11 MGMT 4255 NM_002412 4957451 AAAUAAAGCUCCUGG
Plate 3 D04 L-008856-01 J-008856-12 MGMT 4255 NM_002412 4957451 UGGCCGAAACUGAGU
Plate 3 D05 L-014206-00 J-014206-05 FANCF 2188 NM_022725 4271628 CUUAUUAGCUCUUCG
Plate 3 D05 L-014206-00 J-014206-06 FANCF 2188 NM_022725 4271628 GGUCAACGUUUGCAC
Plate 3 D05 L-014206-00 J-014206-07 FANCF 2188 NM_022725 4271628 GCGCUUCAAUGGCUA
Plate 3 D05 L-014206-00 J-014206-08 FANCF 2188 NM_022725 4271628 GAACCCGGCAUCCAC
Plate 3 D06 L-011488-00 J-011488-05 PARG 8505 NM_003631 7061013 CCAGUUGGAUGGACA
Plate 3 D06 L-011488-00 J-011488-06 PARG 8505 NM_003631 7061013 GAUGGUAGUUCCUCC
Plate 3 D06 L-011488-00 J-011488-07 PARG 8505 NM_003631 7061013 UACCAGAGCAGUUUA
Plate 3 D06 L-011488-00 J-011488-08 PARG 8505 NM_003631 7061013 GGAAACGGUACUCUA
Plate 3 D07 L-011027-00 J-011027-06 ERCC2 2068 NM_000400 4006851 CAUACUUCCUUGCUC
Plate 3 D07 L-011027-00 J-011027-07 ERCC2 2068 NM_000400 4006851 GCAAGGCCGUCGUG
Plate 3 D07 L-011027-00 J-011027-08 ERCC2 2068 NM_000400 4006851 AGGAACAAGCUGCUC
Plate 3 D07 L-011027-00 J-011027-09 ERCC2 2068 NM_000400 4006851 GGAAGGACGUCGAUG
Plate 3 D08 L-017508-00 J-017508-05 TADA3L 10474 NM_133481 1974389 CCGCACACUUGAGGA
Plate 3 D08 L-017508-00 J-017508-06 TADA3L 10474 NM_133481 1974389 CCGACUGGCAGGAUA
Plate 3 D08 L-017508-00 J-017508-07 TADA3L 10474 NM_133481 1974389 UGACCGAACUGGACA
Plate 3 D08 L-017508-00 J-017508-08 TADA3L 10474 NM_133481 1974389 GAACAAGCCCUUCAG
Plate 3 D09 L-006524-00 J-006524-05 ATRX 546 NM_138270 2033620 GAUGUUAGCUGGAUG
Plate 3 D09 L-006524-00 J-006524-06 ATRX 546 NM_138270 2033620 AGUCAUAGAUGCUAA
Plate 3 D09 L-006524-00 J-006524-07 ATRX 546 NM_138270 2033620 GCUUGAGGUUUCUGA
Plate 3 D09 L-006524-00 J-006524-08 ATRX 546 NM_138270 2033620 GUACAGGCGUUAGCA
Plate 3 D10 L-010064-00 J-010064-06 UBE2V1 7335 NM_0010322 7376554 UGAAUGGAGUAAAUA
Plate 3 D10 L-010064-00 J-010064-07 UBE2V1 7335 NM_0010322 7376554 GCCGAAGCAUAGAUU
Plate 3 D10 L-010064-00 J-010064-08 UBE2V1 7335 NM_0010322 7376554 CACAUGAUCCCUCUG
Plate 3 D10 L-010064-00 J-010064-09 UBE2V1 7335 NM_0010322 7376554 CAGGACCACUAAAUG
Plate 3 D11 L-008746-00 J-008746-05 POLL 27343 NM_013274 3814610 CCAUCGGCCUGAAGC
Plate 3 D11 L-008746-00 J-008746-06 POLL 27343 NM_013274 3814610 GAAGCUGGACCAUAU
Plate 3 D11 L-008746-00 J-008746-07 POLL 27343 NM_013274 3814610 GAACGUAUGCCCAGG
Plate 3 D11 L-008746-00 J-008746-08 POLL 27343 NM_013274 3814610 GAGAAUGGUCAGCAA
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Plate 3 D11 L-008746-00 J-008746-08 POLL 27343 NM_013274 3814610 GAGAAUGGUCAGCAA
Plate 3 E02 L-029875-00 J-029875-05 GTF2H3 2967 NM_001516 2837664 GAAUUGAAUCUUCUG
Plate 3 E02 L-029875-00 J-029875-06 GTF2H3 2967 NM_001516 2837664 GACAUAAAGGGUCAA
Plate 3 E02 L-029875-00 J-029875-07 GTF2H3 2967 NM_001516 2837664 AGAAUGAACAAGGAA
Plate 3 E02 L-029875-00 J-029875-08 GTF2H3 2967 NM_001516 2837664 UCAAGGAUAUUGGUG
Plate 3 E03 L-016420-01 J-016420-09 EME1 1E+05 NM_152463 2274896 GAAUUUGCUCGCAGA
Plate 3 E03 L-016420-01 J-016420-10 EME1 1E+05 NM_152463 2274896 GUGCAGUUGUGAAUG
Plate 3 E03 L-016420-01 J-016420-11 EME1 1E+05 NM_152463 2274896 CCGCAUUGGACCAGA
Plate 3 E03 L-016420-01 J-016420-12 EME1 1E+05 NM_152463 2274896 GCUAAGCAGUGAAAG
Plate 3 E04 L-015180-01 J-015180-09 POLQ 10721 NM_199420 7688181 CAACAACCCUUAUCG
Plate 3 E04 L-015180-01 J-015180-10 POLQ 10721 NM_199420 7688181 CGACUAAGAUAGAUC
Plate 3 E04 L-015180-01 J-015180-11 POLQ 10721 NM_199420 7688181 ACACAGUAGGCGAGA
Plate 3 E04 L-015180-01 J-015180-12 POLQ 10721 NM_199420 7688181 CCUUAAGACUGUAGG
Plate 3 E05 L-010534-00 J-010534-05 RAD51C 5889 NM_002876 1740289 GUUCAGCACUAGAUG
Plate 3 E05 L-010534-00 J-010534-06 RAD51C 5889 NM_002876 1740289 GUGAAACCCUCCGAG
Plate 3 E05 L-010534-00 J-010534-07 RAD51C 5889 NM_002876 1740289 UUUGAAAUGCAGCGG
Plate 3 E05 L-010534-00 J-010534-08 RAD51C 5889 NM_002876 1740289 GCAGAAGCCUUAGAA
Plate 3 E06 L-011337-00 J-011337-05 MSH5 4439 NM_172166 2663866 GGCACGAGCAGCUGU
Plate 3 E06 L-011337-00 J-011337-06 MSH5 4439 NM_172166 2663866 GCCAGACAUUAGUGG
Plate 3 E06 L-011337-00 J-011337-07 MSH5 4439 NM_172166 2663866 GCAACGAUCUUGUCU
Plate 3 E06 L-011337-00 J-011337-08 MSH5 4439 NM_172166 2663866 GAGAAUAUGACUCGA
Plate 3 E07 L-004289-00 J-004289-05 DEPC-1 2E+05 NM_139178 2104027 CAUUAUUGCUUCACU
Plate 3 E07 L-004289-00 J-004289-06 DEPC-1 2E+05 NM_139178 2104027 CACGAGUGAUUGACA
Plate 3 E07 L-004289-00 J-004289-07 DEPC-1 2E+05 NM_139178 2104027 GAACCUGACCUUUCG
Plate 3 E07 L-004289-00 J-004289-08 DEPC-1 2E+05 NM_139178 2104027 GAAAGAAGCUGACUG
Plate 3 E08 L-004254-00 J-004254-09 LIG4 3981 NM_206937 4625505 GCACAAAGAUGGAGA
Plate 3 E08 L-004254-00 J-004254-10 LIG4 3981 NM_206937 4625505 GGGAGUGUCUCAUGU
Plate 3 E08 L-004254-00 J-004254-11 LIG4 3981 NM_206937 4625505 GGUAUGAGAUUCUUA
Plate 3 E08 L-004254-00 J-004254-12 LIG4 3981 NM_206937 4625505 GAAGAGGGAAUUAUG
Plate 3 E09 L-003201-00 J-003201-11 ATM 472 NM_138292 7348666 GCAAAGCCCUAGUAA
Plate 3 E09 L-003201-00 J-003201-12 ATM 472 NM_138292 7348666 GGUGUGAUCUUCAGU
Plate 3 E09 L-003201-00 J-003201-13 ATM 472 NM_138292 7348666 GAGAGGAGACAGCUU
Plate 3 E09 L-003201-00 J-003201-14 ATM 472 NM_138292 7348666 GAUGGGAGGCCUAG
Plate 3 E10 L-006833-00 J-006833-05 SMC1L1 8243 NM_006306 3058113 GGACAGCUCUAUUUG
Plate 3 E10 L-006833-00 J-006833-06 SMC1L1 8243 NM_006306 3058113 GCUCGUAACUUCCUC
Plate 3 E10 L-006833-00 J-006833-07 SMC1L1 8243 NM_006306 3058113 GUACAAGGGUCGACA
Plate 3 E10 L-006833-00 J-006833-08 SMC1L1 8243 NM_006306 3058113 GAACUGGCCUCAAAG
Plate 3 E11 L-003241-00 J-003241-09 CDK7 1022 NM_001799 1695065 CAUACAAGGCUUAUU
Plate 3 E11 L-003241-00 J-003241-10 CDK7 1022 NM_001799 1695065 AAACUGAUCUAGAGG
Plate 3 E11 L-003241-00 J-003241-11 CDK7 1022 NM_001799 1695065 CAACAUUGGAUCCUA
Plate 3 E11 L-003241-00 J-003241-12 CDK7 1022 NM_001799 1695065 GAUGACUCUUCAAGG
Plate 3 F02 L-019283-00 J-019283-07 FANCA 2175 NM_0010181 6687966 GGGCCAUGCUUUCUG
Plate 3 F02 L-019283-00 J-019283-08 FANCA 2175 NM_0010181 6687966 GCAGGUCACGGUUGA
Plate 3 F02 L-019283-00 J-019283-09 FANCA 2175 NM_0010181 6687966 GUAGAAGGUCCACUG
Plate 3 F02 L-019283-00 J-019283-10 FANCA 2175 NM_0010181 6687966 GUUAGAGUUUGCUCA
Plate 3 F03 L-021420-00 J-021420-05 KIAA0625 23064 NM_015046 3762015 GCACGUCAGUCAUGC
Plate 3 F03 L-021420-00 J-021420-06 KIAA0625 23064 NM_015046 3762015 GCAAUAAGCUCAUCC
Plate 3 F03 L-021420-00 J-021420-07 KIAA0625 23064 NM_015046 3762015 GCUCAACUCUCCAAA
Plate 3 F03 L-021420-00 J-021420-08 KIAA0625 23064 NM_015046 3762015 UAGCACAGGUUGUUA
Plate 3 F04 L-022320-01 J-022320-09 FLJ10719 55215 NM_018193 8283043 ACAGAGUGGUGACGA
Plate 3 F04 L-022320-01 J-022320-10 FLJ10719 55215 NM_018193 8283043 GCAGAAAGAAAUAGC
Plate 3 F04 L-022320-01 J-022320-11 FLJ10719 55215 NM_018193 8283043 GAUACUUGUCCUUCG
Plate 3 F04 L-022320-01 J-022320-12 FLJ10719 55215 NM_018193 8283043 ACGAAGACCUAGAUG
Plate 3 F05 L-008823-00 J-008823-05 UBE2V2 7336 NM_003350 1202566 GUUAAAGUUCCUCGU
Plate 3 F05 L-008823-00 J-008823-06 UBE2V2 7336 NM_003350 1202566 CAAGAGCUAAGACGU
Plate 3 F05 L-008823-00 J-008823-07 UBE2V2 7336 NM_003350 1202566 CACCAAGGACAAAUU
Plate 3 F05 L-008823-00 J-008823-08 UBE2V2 7336 NM_003350 1202566 GAGCAUACCAGUGUU
Plate 3 F06 L-012838-01 J-012838-09 SMUG1 23583 NM_014311 7657596 GCAACUACGUGACUC
Plate 3 F06 L-012838-01 J-012838-10 SMUG1 23583 NM_014311 7657596 UCUACAAUCCCGUGG
Plate 3 F06 L-012838-01 J-012838-11 SMUG1 23583 NM_014311 7657596 ACUUCUAAGGUCACG
Plate 3 F06 L-012838-01 J-012838-12 SMUG1 23583 NM_014311 7657596 AGAAGUGAGUGGUGC
Plate 3 F07 L-006832-00 J-006832-06 RAD21 5885 NM_006265 5453993 GCUCAGCCUUUGUGG
Plate 3 F07 L-006832-00 J-006832-07 RAD21 5885 NM_006265 5453993 GGGAGUAGUUCGAAU
Plate 3 F07 L-006832-00 J-006832-08 RAD21 5885 NM_006265 5453993 GACCAAGGUUCCAUA
Plate 3 F07 L-006832-00 J-006832-09 RAD21 5885 NM_006265 5453993 GCAUUGGAGCCUAUU
Plate 3 F08 L-011373-00 J-011373-05 RAD51L1 5890 NM_133510 4625503 GAGCUGUGGUGUACA
Plate 3 F08 L-011373-00 J-011373-06 RAD51L1 5890 NM_133510 4625503 GUAUUUGGCUGAGGA
Plate 3 F08 L-011373-00 J-011373-07 RAD51L1 5890 NM_133510 4625503 CCACCAACAUGGGAG
Plate 3 F08 L-011373-00 J-011373-08 RAD51L1 5890 NM_133510 4625503 CCAGUUAUCUUGACG
Plate 3 F09 L-011795-00 J-011795-05 UNG 7374 NM_080911 1971875 UUAUCAAGCUAAUGG
Plate 3 F09 L-011795-00 J-011795-06 UNG 7374 NM_080911 1971875 GAACUCGAAUGGCCU
Plate 3 F09 L-011795-00 J-011795-07 UNG 7374 NM_080911 1971875 GAAGCGGCACCAUGU
Plate 3 F09 L-011795-00 J-011795-08 UNG 7374 NM_080911 1971875 UAUAGAGGGUUCUUU
Plate 3 F10 L-003255-00 J-003255-10 CHEK1 1111 NM_001274 2012741 CAAGAUGUGUGGUAC
Plate 3 F10 L-003255-00 J-003255-11 CHEK1 1111 NM_001274 2012741 GAGAAGGCAAUAUCC
Plate 3 F10 L-003255-00 J-003255-12 CHEK1 1111 NM_001274 2012741 CCACAUGUCCUGAUC
Plate 3 F10 L-003255-00 J-003255-13 CHEK1 1111 NM_001274 2012741 GAAGUUGGGCUAUCA
Plate 3 F11 L-180657-00 J-180657-01 ATRIP 84126 NM_032166 1839034 GCUCCAGACCAGUGA
Plate 3 F11 L-180657-00 J-180657-02 ATRIP 84126 NM_032166 1839034 UGGUGAAAUUAGCCG
Plate 3 F11 L-180657-00 J-180657-03 ATRIP 84126 NM_032166 1839034 GAAUCUGGUUGCCCG
Plate 3 F11 L-180657-00 J-180657-04 ATRIP 84126 NM_032166 1839034 UCACUACAUCAGACG
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Plate 3 F11 L-180657-00 J-180657-04 ATRIP 84126 NM_032166 1839034 UCACUACAUCAGACG
Plate 3 G02 L-010258-00 J-010258-05 DUT 1854 NM_0010252 7090644 GCUCAUUUGCGAACG
Plate 3 G02 L-010258-00 J-010258-06 DUT 1854 NM_0010252 7090644 UGUAGGAGCUGGUG
Plate 3 G02 L-010258-00 J-010258-07 DUT 1854 NM_0010252 7090644 UAGAGGAAAUGUUGG
Plate 3 G02 L-010258-00 J-010258-08 DUT 1854 NM_0010252 7090644 UGCCUAUGAUUACAC
Plate 3 G03 L-006783-00 J-006783-07 PNKP 11284 NM_007254 3154341 GUGAAACAGCUGGGA
Plate 3 G03 L-006783-00 J-006783-08 PNKP 11284 NM_007254 3154341 CCGGAUAUGUCCACG
Plate 3 G03 L-006783-00 J-006783-09 PNKP 11284 NM_007254 3154341 GACCGGAAGUGCUCC
Plate 3 G03 L-006783-00 J-006783-10 PNKP 11284 NM_007254 3154341 GGAAACGGGUCGCCA
Plate 3 G04 L-007287-00 J-007287-06 BLM 641 NM_000057 4557364 CUAAAUCUGUGGAGG
Plate 3 G04 L-007287-00 J-007287-07 BLM 641 NM_000057 4557364 GAUCAAUGCUGCACU
Plate 3 G04 L-007287-00 J-007287-08 BLM 641 NM_000057 4557364 GGAUGACUCAGAAUG
Plate 3 G04 L-007287-00 J-007287-09 BLM 641 NM_000057 4557364 GCAACUAGAACGUCA
Plate 3 G05 L-013730-01 J-013730-09 APEX2 27301 NM_014481 1837550 GAGCCAUGUGUGAUG
Plate 3 G05 L-013730-01 J-013730-10 APEX2 27301 NM_014481 1837550 CAACAAUCAAACCCG
Plate 3 G05 L-013730-01 J-013730-11 APEX2 27301 NM_014481 1837550 GGACGAGCUGGAUGC
Plate 3 G05 L-013730-01 J-013730-12 APEX2 27301 NM_014481 1837550 GAGAAGGAGUUACGG
Plate 3 G06 L-003462-00 J-003462-05 BRCA2 675 NM_000059 4502450 GAAACGGACUUGCUA
Plate 3 G06 L-003462-00 J-003462-06 BRCA2 675 NM_000059 4502450 GGUAUCAGAUGCUUC
Plate 3 G06 L-003462-00 J-003462-07 BRCA2 675 NM_000059 4502450 GAAGAAUGCAGGUUU
Plate 3 G06 L-003462-00 J-003462-08 BRCA2 675 NM_000059 4502450 UAAGGAACGUCAAGA
Plate 3 G07 L-005084-00 J-005084-08 G22P1 2547 NM_001469 5109384 AUAAAGCUCUAUCGG
Plate 3 G07 L-005084-00 J-005084-09 G22P1 2547 NM_001469 5109384 CAGGGUGGGAGUCAU
Plate 3 G07 L-005084-00 J-005084-10 G22P1 2547 NM_001469 5109384 UUAGUGAUGUCCAAU
Plate 3 G07 L-005084-00 J-005084-11 G22P1 2547 NM_001469 5109384 GAUCCAGGUUUGAUG
Plate 3 G08 L-004801-00 J-004801-09 CLK2 1196 NM_001291 4771713 GCUACAGACGCAACG
Plate 3 G08 L-004801-00 J-004801-10 CLK2 1196 NM_001291 4771713 GGAGAUGCCUACUAU
Plate 3 G08 L-004801-00 J-004801-11 CLK2 1196 NM_001291 4771713 AAGCAUAAGCGACGA
Plate 3 G08 L-004801-00 J-004801-12 CLK2 1196 NM_001291 4771713 CAGACUAUCGGCAUU
Plate 3 G09 L-012649-00 J-012649-05 POLG 5428 NM_002693 4505936 GGUAUCGGCUGUCG
Plate 3 G09 L-012649-00 J-012649-06 POLG 5428 NM_002693 4505936 AGUGGGACCUGCAAG
Plate 3 G09 L-012649-00 J-012649-07 POLG 5428 NM_002693 4505936 GCUUACUAAUGCAGU
Plate 3 G09 L-012649-00 J-012649-08 POLG 5428 NM_002693 4505936 UCAGUGCAGUCGAUA
Plate 3 G10 L-010210-00 J-010210-06 BRE 9577 NM_199191 4035376 GAGGAUAACUGACUU
Plate 3 G10 L-010210-00 J-010210-07 BRE 9577 NM_199191 4035376 CGUGGAAUAUGAUGC
Plate 3 G10 L-010210-00 J-010210-08 BRE 9577 NM_199191 4035376 GCAACAAUAUCACCA
Plate 3 G10 L-010210-00 J-010210-09 BRE 9577 NM_199191 4035376 UGAUUACGUUCCUCA
Plate 3 G11 L-010491-00 J-010491-05 XRCC5 7520 NM_021141 1240865 GCAUGGAUGUGAUUC
Plate 3 G11 L-010491-00 J-010491-06 XRCC5 7520 NM_021141 1240865 CGAGUAACCAGCUCA
Plate 3 G11 L-010491-00 J-010491-07 XRCC5 7520 NM_021141 1240865 GAGCAGCGCUUUAAC
Plate 3 G11 L-010491-00 J-010491-08 XRCC5 7520 NM_021141 1240865 AAACUUCCGUGUUCU
Plate 3 H02 L-020432-00 J-020432-05 HSU24186 29935 NM_013347 9558730 GAUGAGAGUCACCGC
Plate 3 H02 L-020432-00 J-020432-06 HSU24186 29935 NM_013347 9558730 GAUAAAGCCCGUCGU
Plate 3 H02 L-020432-00 J-020432-07 HSU24186 29935 NM_013347 9558730 GAGUAUAUGUCAAAG
Plate 3 H02 L-020432-00 J-020432-08 HSU24186 29935 NM_013347 9558730 GACCCUGUGUUCAAG
Plate 3 H03 L-012067-00 J-012067-05 XRCC3 7517 NM_005432 1240864 AAACUGAAAUCGGUA
Plate 3 H03 L-012067-00 J-012067-06 XRCC3 7517 NM_005432 1240864 UGUUGGAGUGUGUG
Plate 3 H03 L-012067-00 J-012067-07 XRCC3 7517 NM_005432 1240864 GGACCUGAAUCCCAG
Plate 3 H03 L-012067-00 J-012067-08 XRCC3 7517 NM_005432 1240864 GGACCAGACUUGAAG
Plate 3 H04 L-015737-00 J-015737-05 NPM1 4869 NM_0010377 8364186 GUAGAAGACAUUAAA
Plate 3 H04 L-015737-00 J-015737-06 NPM1 4869 NM_0010377 8364186 AAUGCAAGCAAGUAU
Plate 3 H04 L-015737-00 J-015737-07 NPM1 4869 NM_0010377 8364186 ACAAGAAUCCUUCAA
Plate 3 H04 L-015737-00 J-015737-08 NPM1 4869 NM_0010377 8364186 UAAAGGCCGACAAAG
Plate 3 H05 L-020222-01 J-020222-10 ASF1A 25842 NM_014034 1154302 CGAUCAAGUUUUAGA
Plate 3 H05 L-020222-01 J-020222-11 ASF1A 25842 NM_014034 1154302 CAUUAGACCAGGUUG
Plate 3 H05 L-020222-01 J-020222-12 ASF1A 25842 NM_014034 1154302 AGCCAUAUGAUGCAG
Plate 3 H05 L-020222-02 J-020222-17 ASF1A 25842 NM_014034 1154302 GGCAUAUGUUUGUAU
Plate 3 H06 L-011682-00 J-011682-08 H2AFX 3014 NM_002105 5263033 GGGACGAAGCACUUG
Plate 3 H06 L-011682-00 J-011682-09 H2AFX 3014 NM_002105 5263033 CGACUAGAACCUUAG
Plate 3 H06 L-011682-00 J-011682-10 H2AFX 3014 NM_002105 5263033 GGAAAGAGCUGAGCC
Plate 3 H06 L-011682-00 J-011682-11 H2AFX 3014 NM_002105 5263033 GAACUGGAAUUCUGC
Plate 3 H07 L-014224-01 J-014224-13 FLJ22833 64859 NM_0010317 7253472 GGAGAUAGGACGCGU
Plate 3 H07 L-014224-01 J-014224-14 FLJ22833 64859 NM_0010317 7253472 CGUGCAAAGUAGCAG
Plate 3 H07 L-014224-01 J-014224-15 FLJ22833 64859 NM_0010317 7253472 UCGGUUGACCAGAGG
Plate 3 H07 L-014224-01 J-014224-16 FLJ22833 64859 NM_0010317 7253472 UGAGAUCGGAGGUCU
Plate 3 H08 L-003920-00 J-003920-06 UBE2N 7334 NM_003348 3757713 AACCAGGUCUUUAGA
Plate 3 H08 L-003920-00 J-003920-07 UBE2N 7334 NM_003348 3757713 UGACUGACAUGUAGG
Plate 3 H08 L-003920-00 J-003920-08 UBE2N 7334 NM_003348 3757713 AGUAUCAAGUCCUCA
Plate 3 H08 L-003920-00 J-003920-09 UBE2N 7334 NM_003348 3757713 GAUGAUCAUUGGUGU
Plate 3 H09 L-019946-00 J-019946-05 ERCC4 2072 NM_005236 4885216 CCAAACAGCUUUAUG
Plate 3 H09 L-019946-00 J-019946-06 ERCC4 2072 NM_005236 4885216 GCACCUCGAUGUUUA
Plate 3 H09 L-019946-00 J-019946-07 ERCC4 2072 NM_005236 4885216 CGGAAGAAAUUAAGC
Plate 3 H09 L-019946-00 J-019946-08 ERCC4 2072 NM_005236 4885216 UGACAAGGGUACUAC
Plate 3 H10 L-006311-00 J-006311-05 ERCC1 2067 NM_001983 4254417 CGACGUAAUUCCCGA
Plate 3 H10 L-006311-00 J-006311-06 ERCC1 2067 NM_001983 4254417 GGCGGUACCUGGAGA
Plate 3 H10 L-006311-00 J-006311-07 ERCC1 2067 NM_001983 4254417 GGAAGAAAUUUGUGA
Plate 3 H10 L-006311-00 J-006311-08 ERCC1 2067 NM_001983 4254417 GCAAUCCCGUACUGA
Plate 3 H11 L-010379-00 J-010379-06 RRM2 6241 NM_001034 4557844 GGAGUGAUGUCAAGU
Plate 3 H11 L-010379-00 J-010379-07 RRM2 6241 NM_001034 4557844 GCGAUGGCAUAGUAA
Plate 3 H11 L-010379-00 J-010379-08 RRM2 6241 NM_001034 4557844 CCACGGAGCCGAAAA
Plate 3 H11 L-010379-00 J-010379-09 RRM2 6241 NM_001034 4557844 GAAUUGCACUCUAAU
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Plate Well Pool Catalog Number Duplex Catalog Number GENE ID Gene Accession GI Number Sequence
Plate 1 A02 L-021207-01 J-021207-09 TELO2 9894 NM_016111 7705345 UGGCCAGAUUCCUGCGCGA
Plate 1 A02 L-021207-01 J-021207-10 TELO2 9894 NM_016111 7705345 UGGAGUCCCUGAAGCGGUA
Plate 1 A02 L-021207-01 J-021207-11 TELO2 9894 NM_016111 7705345 CCCUGAAAUUCCAGUACGA
Plate 1 A02 L-021207-01 J-021207-12 TELO2 9894 NM_016111 7705345 UGAUGUGCCUGGCUGUUAA
Plate 1 A03 L-008977-00 J-008977-05 RUVBL1 8607 NM_003707 4506752 AUAAGGUGGUGAACAAGUA
Plate 1 A03 L-008977-00 J-008977-06 RUVBL1 8607 NM_003707 4506752 GGGAAGGACAGCAUUGAGA
Plate 1 A03 L-008977-00 J-008977-07 RUVBL1 8607 NM_003707 4506752 CAGGAUAAGUACAUGAAGU
Plate 1 A03 L-008977-00 J-008977-08 RUVBL1 8607 NM_003707 4506752 CUCAGGAGCUGGGUAGUAA
Plate 1 A04 L-020420-01 J-020420-09 PPP6R1 22870 NM_014931 55749688 UCAAUUGGCUCAACGAGGA
Plate 1 A04 L-020420-01 J-020420-10 PPP6R1 22870 NM_014931 55749688 CAGUGUGGCCUGCGAGAUU
Plate 1 A04 L-020420-01 J-020420-11 PPP6R1 22870 NM_014931 55749688 CCUCACGCCUCCUCCGAUA
Plate 1 A04 L-020420-01 J-020420-12 PPP6R1 22870 NM_014931 55749688 GGGAGGAGAACGACCGUGU
Plate 1 A05 L-011494-00 J-011494-05 COPS3 8533 NM_003653 23238221 GCACAAGUGUAUUCAACCA
Plate 1 A05 L-011494-00 J-011494-06 COPS3 8533 NM_003653 23238221 CAAUGCAUACCACGAGUUA
Plate 1 A05 L-011494-00 J-011494-07 COPS3 8533 NM_003653 23238221 CAAACCAGCUGACCUCAAU
Plate 1 A05 L-011494-00 J-011494-08 COPS3 8533 NM_003653 23238221 GAAUUGGCAUCCUUAAGCA
Plate 1 A06 L-019488-00 J-019488-05 TIMELESS 8914 NM_003920 52851463 UCAAUCGUCUGCUUAGUGA
Plate 1 A06 L-019488-00 J-019488-06 TIMELESS 8914 NM_003920 52851463 CAGGGUAGCUUAGUCCUUU
Plate 1 A06 L-019488-00 J-019488-07 TIMELESS 8914 NM_003920 52851463 GAGGGAGACACUUACCAUA
Plate 1 A06 L-019488-00 J-019488-08 TIMELESS 8914 NM_003920 52851463 CUACUGCUGGUCAGAAAUA
Plate 1 A07 L-004176-01 J-004176-09 INO80 54617 NM_017553 38708320 GGAAUUGAGUUUCGAUAGA
Plate 1 A07 L-004176-01 J-004176-10 INO80 54617 NM_017553 38708320 GGAGUUAUUUGAACGGCAA
Plate 1 A07 L-004176-01 J-004176-11 INO80 54617 NM_017553 38708320 GAAUCAACUUUCUCGCUUA
Plate 1 A07 L-004176-01 J-004176-12 INO80 54617 NM_017553 38708320 GAGGAAACCAACCGAGUGA
Plate 1 A08 L-007244-00 J-007244-09 PARP4 143 NM_006437 11496990 GUACAAUGGUGUCGACUAC
Plate 1 A08 L-007244-00 J-007244-10 PARP4 143 NM_006437 11496990 CGUCACGUCUUAAGGAUUU
Plate 1 A08 L-007244-00 J-007244-11 PARP4 143 NM_006437 11496990 GGAUUAGCCUCAACGAUGU
Plate 1 A08 L-007244-00 J-007244-12 PARP4 143 NM_006437 11496990 GCAACUGAACCACUAUUUA
Plate 1 A09 L-004420-00 J-004420-05 DAXX 1616 NM_001350 53828721 CAGCCAAGCUCUAUGUCUA
Plate 1 A09 L-004420-00 J-004420-06 DAXX 1616 NM_001350 53828721 GAGGUUAACAGGCGCAUUG
Plate 1 A09 L-004420-00 J-004420-07 DAXX 1616 NM_001350 53828721 GCAAAACAAAGGACGCAUA
Plate 1 A09 L-004420-00 J-004420-08 DAXX 1616 NM_001350 53828721 GGAGUUGGAUCUCUCAGAA
Plate 1 A10 L-020873-01 J-020873-09 COPS7A 50813 NM_016319 7705329 GGACAUACGCUGACUACUU
Plate 1 A10 L-020873-01 J-020873-10 COPS7A 50813 NM_016319 7705329 CAUUACAUGUCAUUGAGUA
Plate 1 A10 L-020873-01 J-020873-11 COPS7A 50813 NM_016319 7705329 GGUCCAAGUCGAAUUGAAA
Plate 1 A10 L-020873-01 J-020873-12 COPS7A 50813 NM_016319 7705329 GAAUAAGCUUCGACACCUC
Plate 1 A11 L-005248-01 J-005248-09 UBA2 10054 NM_005499 50592990 GUGCAAAGAGGUCACGUAU
Plate 1 A11 L-005248-01 J-005248-10 UBA2 10054 NM_005499 50592990 GGACAAACUAUGGCGGAAA
Plate 1 A11 L-005248-01 J-005248-11 UBA2 10054 NM_005499 50592990 CAUAACCAGUCAUGAGAUA
Plate 1 A11 L-005248-01 J-005248-12 UBA2 10054 NM_005499 50592990 GCUAGAACUGUUAGACACA
Plate 1 B02 L-021219-00 J-021219-05 TERF2IP 54386 NM_018975 52627148 GAUGAGAGCCCUCCUGAUU
Plate 1 B02 L-021219-00 J-021219-06 TERF2IP 54386 NM_018975 52627148 GGAAAGCGAUGGAGAAGAG
Plate 1 B02 L-021219-00 J-021219-07 TERF2IP 54386 NM_018975 52627148 GGUGGGAGCUGCCAUUAAG
Plate 1 B02 L-021219-00 J-021219-08 TERF2IP 54386 NM_018975 52627148 GGAAGCCACCCGGGAGUUU
Plate 1 B03 L-017750-00 J-017750-05 PPP4R2 151987 NM_174907 28372530 GCGACUAUGUGAAUUGUUA
Plate 1 B03 L-017750-00 J-017750-06 PPP4R2 151987 NM_174907 28372530 ACAAAUGGGUUGCCUGAGA
Plate 1 B03 L-017750-00 J-017750-07 PPP4R2 151987 NM_174907 28372530 AAACGAAGGCCCUGUAAGU
Plate 1 B03 L-017750-00 J-017750-08 PPP4R2 151987 NM_174907 28372530 UGACUGCCGUGAAACAGAA
Plate 1 B04 L-013386-00 J-013386-05 GAR1 54433 NM_032993 77812668 GAGAGGACAUUAAGUGAAA
Plate 1 B04 L-013386-00 J-013386-06 GAR1 54433 NM_032993 77812668 UCCAGAACGUGUAGUCUUA
Plate 1 B04 L-013386-00 J-013386-07 GAR1 54433 NM_032993 77812668 CCGCGGAGGCUUUAACAAA
Plate 1 B04 L-013386-00 J-013386-08 GAR1 54433 NM_032993 77812668 GAAGAUGACAUAGUUUGUA
Plate 1 B05 L-020566-02 J-020566-17 NSMCE4A 54780 NM_017615 8923008 AAUGAAGUGUCCCGAGCAA
Plate 1 B05 L-020566-02 J-020566-18 NSMCE4A 54780 NM_017615 8923008 GUGAAGUCCAAAACGGAAA
Plate 1 B05 L-020566-02 J-020566-19 NSMCE4A 54780 NM_017615 8923008 ACACAGAGCCGUCGGAUUC
Plate 1 B05 L-020566-02 J-020566-20 NSMCE4A 54780 NM_017615 8923008 GUGCCAAAGCCACGAGUUG
Plate 1 B06 L-013319-02 J-013319-18 NHP2 55651 NM_001034833 77812673 AGGAGUACCAGGAGGCUUA
Plate 1 B06 L-013319-02 J-013319-19 NHP2 55651 NM_001034833 77812673 GCGGUGAAGCAGAAGCAGA
Plate 1 B06 L-013319-02 J-013319-20 NHP2 55651 NM_001034833 77812673 AAAUAAAGGCAGAUCCCGA
Plate 1 B06 L-013319-02 J-013319-21 NHP2 55651 NM_001034833 77812673 CCUGUGUGAUAAUGGUCAA
Plate 1 B07 L-020553-00 J-020553-05 ASF1B 55723 NM_018154 67782340 GCACUCCUAUCAAGGGCUU
Plate 1 B07 L-020553-00 J-020553-06 ASF1B 55723 NM_018154 67782340 GACAGGAGUUCAUCCGAGU
Plate 1 B07 L-020553-00 J-020553-07 ASF1B 55723 NM_018154 67782340 CGGACGACCUGGAGUGGAA
Plate 1 B07 L-020553-00 J-020553-08 ASF1B 55723 NM_018154 67782340 GCAGGGAGACACAUGUUUG
Plate 1 B08 L-004205-00 J-004205-05 POT1 25913 NM_015450 13123773 GUAGAAGCCUUACGUGUUU
Plate 1 B08 L-004205-00 J-004205-06 POT1 25913 NM_015450 13123773 GAUAAAACAUCGUGGAUUC
Plate 1 B08 L-004205-00 J-004205-07 POT1 25913 NM_015450 13123773 GCAUAUCCGUGGUUGGAAU
Plate 1 B08 L-004205-00 J-004205-08 POT1 25913 NM_015450 13123773 UAACUUGCCUGCUCUUUAG
Plate 1 B09 L-006837-00 J-006837-05 SMC4 10051 NM_001002799 50658066 GUUAAACGCUUACACAAUA
Plate 1 B09 L-006837-00 J-006837-06 SMC4 10051 NM_001002799 50658066 GAAGUUAUGGAUAGCCUUA
Plate 1 B09 L-006837-00 J-006837-07 SMC4 10051 NM_001002799 50658066 GCAAGCAUCCAGCGUUUAA
Plate 1 B09 L-006837-00 J-006837-08 SMC4 10051 NM_001002799 50658066 GCACUGGACUACAUUGUUG
Plate 1 B10 L-010362-00 J-010362-05 PDS5B 23047 NM_015928 7705287 GAAAUAUGCUUUACAGUCA
Plate 1 B10 L-010362-00 J-010362-06 PDS5B 23047 NM_015928 7705287 UGAUAAAGAUGUUCGCUUA
Plate 1 B10 L-010362-00 J-010362-07 PDS5B 23047 NM_015928 7705287 GCAUAGUGAUGGAGACUUG
Plate 1 B10 L-010362-00 J-010362-08 PDS5B 23047 NM_015928 7705287 GGUCAAUGAUCACUUACUU
Plate 1 B11 L-006941-00 J-006941-05 BAZ1A 11177 NM_182648 32967604 CAAGUUAGAUUGCCAGUUA
Plate 1 B11 L-006941-00 J-006941-06 BAZ1A 11177 NM_182648 32967604 GAACUAAGGCUGAGAGAUU
Plate 1 B11 L-006941-00 J-006941-07 BAZ1A 11177 NM_182648 32967604 GCCAUAGCCUGUACCAAUA
Plate 1 B11 L-006941-00 J-006941-08 BAZ1A 11177 NM_182648 32967604 GAAUGCGCGUUGCAAGAUA
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Plate 1 B11 L-006941-00 J-006941-08 BAZ1A 11177 NM_182648 32967604 GAAUGCGCGUUGCAAGAUA
Plate 1 C02 L-009645-00 J-009645-05 CHRAC1 54108 NM_017444 24432041 CCACGGAGCUCUUUGUUCA
Plate 1 C02 L-009645-00 J-009645-06 CHRAC1 54108 NM_017444 24432041 ACACGGCAGUGGAAAGGAA
Plate 1 C02 L-009645-00 J-009645-07 CHRAC1 54108 NM_017444 24432041 GGACGUGGUCGUGGGUAAA
Plate 1 C02 L-009645-00 J-009645-08 CHRAC1 54108 NM_017444 24432041 GACUUACAGUGAUUUAGCA
Plate 1 C03 L-008460-01 J-008460-09 POLE3 54107 NM_017443 31543422 GAGGGAUUCUGAACGACUA
Plate 1 C03 L-008460-01 J-008460-10 POLE3 54107 NM_017443 31543422 CUUGAAAUGAGACGUGCUA
Plate 1 C03 L-008460-01 J-008460-11 POLE3 54107 NM_017443 31543422 CAUAUAGGCGGGAGCAGAA
Plate 1 C03 L-008460-01 J-008460-12 POLE3 54107 NM_017443 31543422 UGGAAUGGUAUUAGUCAAA
Plate 1 C04 L-009850-02 J-009850-18 POLE4 56655 NM_019896 38455393 GAGUGAAGGCCUUGGUGAA
Plate 1 C04 L-009850-02 J-009850-19 POLE4 56655 NM_019896 38455393 GAGGAGAGACUUGGAUAAU
Plate 1 C04 L-009850-02 J-009850-20 POLE4 56655 NM_019896 38455393 ACGUGACGCUAGCGGGACA
Plate 1 C04 L-009850-02 J-009850-21 POLE4 56655 NM_019896 38455393 CUUCACCUAUGCCGGGAUA
Plate 1 C05 L-020297-00 J-020297-05 BRD7 29117 NM_013263 41350211 GUGCCAAGAUUAUCCGUAU
Plate 1 C05 L-020297-00 J-020297-06 BRD7 29117 NM_013263 41350211 GCACGUAUGGAGUUCGAAA
Plate 1 C05 L-020297-00 J-020297-07 BRD7 29117 NM_013263 41350211 GUACUAAUGCCAUGAUUUA
Plate 1 C05 L-020297-00 J-020297-08 BRD7 29117 NM_013263 41350211 GCAAGUAACUCCAGGUGAU
Plate 1 C06 L-013332-02 J-013332-17 NOP10 55505 NM_018648 77812675 UAACCAAACUCUUCGGACU
Plate 1 C06 L-013332-02 J-013332-18 NOP10 55505 NM_018648 77812675 CAACGAGCAGGGAGAUCGA
Plate 1 C06 L-013332-02 J-013332-19 NOP10 55505 NM_018648 77812675 CAUAAAGGGAACACAUUUG
Plate 1 C06 L-013332-02 J-013332-20 NOP10 55505 NM_018648 77812675 GAAGAAAUUUGACCCGAUG
Plate 1 C07 L-004898-00 J-004898-05 UBE2T 29089 NM_014176 7661807 CCUGCGAGCUCAAAUAUUA
Plate 1 C07 L-004898-00 J-004898-06 UBE2T 29089 NM_014176 7661807 GAAGGCCAGUCAGCUAGUA
Plate 1 C07 L-004898-00 J-004898-07 UBE2T 29089 NM_014176 7661807 GGAAGGAUUUGUCUGGAUG
Plate 1 C07 L-004898-00 J-004898-08 UBE2T 29089 NM_014176 7661807 GUACACAACUCAACACAGA
Plate 1 C08 L-014013-01 J-014013-09 POLD4 57804 NM_021173 379056363 CCUAUGAGGCACCACGUAA
Plate 1 C08 L-014013-01 J-014013-10 POLD4 57804 NM_021173 47271453 GGUGUCGGGCCAAGCAUAU
Plate 1 C08 L-014013-01 J-014013-11 POLD4 57804 NM_021173 379056363 AGUCAGACAUGGACAGUUG
Plate 1 C08 L-014013-01 J-014013-12 POLD4 57804 NM_021173 47271453 GGCAGGUGCUGAAGACCCA
Plate 1 C09 L-005288-00 J-005288-05 CLSPN 63967 NM_022111 21735568 GCAGAUGGGUUCUUAAAUG
Plate 1 C09 L-005288-00 J-005288-06 CLSPN 63967 NM_022111 21735568 GAGUAGAUGUUUCCAUUAA
Plate 1 C09 L-005288-00 J-005288-07 CLSPN 63967 NM_022111 21735568 GCAGAUAGUCCUUCAGAUA
Plate 1 C09 L-005288-00 J-005288-08 CLSPN 63967 NM_022111 21735568 GAAGACAGGCUCACUGCUA
Plate 1 C10 L-014207-02 J-014207-17 COPS7B 64708 NM_022730 12232384 GGACAUACCCAGAUUACAU
Plate 1 C10 L-014207-02 J-014207-18 COPS7B 64708 NM_022730 12232384 CUGCAUGAAUGGUGUGAUG
Plate 1 C10 L-014207-02 J-014207-19 COPS7B 64708 NM_022730 12232384 CGUCAAGAUGCGCUGCUUU
Plate 1 C10 L-014207-02 J-014207-20 COPS7B 64708 NM_022730 12232384 CGUGCAGGAGCUUGCGGAA
Plate 1 C11 L-018395-01 J-018395-09 ACTR5 79913 NM_024855 31542679 CCACUGUAUUCACGGCAAA
Plate 1 C11 L-018395-01 J-018395-10 ACTR5 79913 NM_024855 31542679 GCUACAUCGCUGAGGAUUA
Plate 1 C11 L-018395-01 J-018395-11 ACTR5 79913 NM_024855 31542679 CUCGAUGUGCAGUGGGCUA
Plate 1 C11 L-018395-01 J-018395-12 ACTR5 79913 NM_024855 31542679 GCGUCUGGACCGACUGCUA
Plate 1 D02 L-016441-01 J-016441-09 ACTR8 93973 NM_022899 39812114 GGUGAUACGGAGAACGGAA
Plate 1 D02 L-016441-01 J-016441-10 ACTR8 93973 NM_022899 39812114 AAUAUGGUCUCAUGCGAUA
Plate 1 D02 L-016441-01 J-016441-11 ACTR8 93973 NM_022899 39812114 GAUAGUAUGUGACGAGGGA
Plate 1 D02 L-016441-01 J-016441-12 ACTR8 93973 NM_022899 39812114 CCACCAUCCUUCAGGCGAA
Plate 1 D03 L-016208-02 J-016208-17 OBFC1 79991 NM_024928 194394164 GUAUAUAUCCGUAGAGAGA
Plate 1 D03 L-016208-02 J-016208-18 OBFC1 79991 NM_024928 194394164 GCACAAUGGAGCACUACUA
Plate 1 D03 L-016208-02 J-016208-19 OBFC1 79991 NM_024928 194394164 CAUACAGAGAAGAGCGAGA
Plate 1 D03 L-016208-02 J-016208-20 OBFC1 79991 NM_024928 194394164 GGACACGAUCCGAGUCAGA
Plate 1 D04 L-014564-01 J-014564-13 PIF1 80119 NM_025049 82546871 CAUAUCUGCUAAAGCGAAU
Plate 1 D04 L-014564-01 J-014564-14 PIF1 80119 NM_025049 82546871 GGGAAUAUGAGGACUCGGA
Plate 1 D04 L-014564-01 J-014564-15 PIF1 80119 NM_025049 82546871 GAAGACAGGUGCUCCGGAA
Plate 1 D04 L-014564-01 J-014564-16 PIF1 80119 NM_025049 82546871 GUACACAGAUUUGAGGCUA
Plate 1 D05 L-013801-00 J-013801-05 SMARCAD1 56916 NM_020159 14149729 CCACACAUGUUUAGUAGUA
Plate 1 D05 L-013801-00 J-013801-06 SMARCAD1 56916 NM_020159 14149729 GAGGAUGGCUAUAAAGGUA
Plate 1 D05 L-013801-00 J-013801-07 SMARCAD1 56916 NM_020159 14149729 GGCCAAUCAUCCUUUAUUA
Plate 1 D05 L-013801-00 J-013801-08 SMARCAD1 56916 NM_020159 14149729 GCACGUAGAAAUGAUGAUA
Plate 1 D06 L-009848-01 J-009848-09 INO80B 83444 NM_031288 323276648 GGCUGGAUGAAGACAGUAA
Plate 1 D06 L-009848-01 J-009848-10 INO80B 83444 NM_031288 323276648 AUAAUGAAGAGGAACCUAU
Plate 1 D06 L-009848-01 J-009848-11 INO80B 83444 NM_031288 13775201 UAAAUUACAUCCGGUGCAA
Plate 1 D06 L-009848-01 J-009848-12 INO80B 83444 NM_031288 323276648 GGACCUAUCAGGAGGGUUA
Plate 1 D07 L-020843-00 J-020843-09 TIPIN 54962 NM_017858 8923484 GAGAGGACUUCCAGCCUUA
Plate 1 D07 L-020843-00 J-020843-10 TIPIN 54962 NM_017858 8923484 GGACAAUCCAUGUAAUGAU
Plate 1 D07 L-020843-00 J-020843-11 TIPIN 54962 NM_017858 8923484 UGAAUUAGAUCCCUUUCUG
Plate 1 D07 L-020843-00 J-020843-12 TIPIN 54962 NM_017858 8923484 CGACUUGAUCUCCCUAUUU
Plate 1 D08 L-021146-02 J-021146-11 WRAP53 55135 NM_001143992 221136865 GCAGAAGAAGCAAACGGGA
Plate 1 D08 L-021146-02 J-021146-12 WRAP53 55135 NM_001143992 221136865 CUGAUAACAUCUUGCGAAU
Plate 1 D08 L-021146-02 J-021146-13 WRAP53 55135 NM_001143992 221136865 AGAAGAAGCGAACGGGCCA
Plate 1 D08 L-021146-02 J-021146-14 WRAP53 55135 NM_001143992 221136865 UUUGGAGACUCAACCGUUA
Plate 1 D09 L-021037-02 J-021037-17 COPS4 51138 NM_016129 38373689 CAAUAGUCCACGAAAGUGA
Plate 1 D09 L-021037-02 J-021037-18 COPS4 51138 NM_016129 38373689 CAGUCCAGGCAGAGGCUUA
Plate 1 D09 L-021037-02 J-021037-19 COPS4 51138 NM_016129 38373689 AAUGAUAACCGAAGGACGU
Plate 1 D09 L-021037-02 J-021037-20 COPS4 51138 NM_016129 38373689 CAACGUGGGAUAAGCAGAU
Plate 1 D10 L-019951-00 J-019951-05 TINF2 26277 NM_012461 6912715 AGGAAGAACAUGCGAUAUA
Plate 1 D10 L-019951-00 J-019951-06 TINF2 26277 NM_012461 6912715 CAACCCAGGUCAUAUCUAA
Plate 1 D10 L-019951-00 J-019951-07 TINF2 26277 NM_012461 6912715 GGAAGUAUAAGGGUCCAUA
Plate 1 D10 L-019951-00 J-019951-08 TINF2 26277 NM_012461 6912715 GUACUGGAGUUUCUGCGAU
Plate 1 D11 L-020341-00 J-020341-05 MYBBP1A 10514 NM_014520 7657350 UCGCAGACCUCCUGUUGAA
Plate 1 D11 L-020341-00 J-020341-06 MYBBP1A 10514 NM_014520 7657350 CGACCGCUAUGGCCUAUUG
Plate 1 D11 L-020341-00 J-020341-07 MYBBP1A 10514 NM_014520 7657350 CGACUUGAAUAUAAUACUC
Plate 1 D11 L-020341-00 J-020341-08 MYBBP1A 10514 NM_014520 7657350 CCCCAGAGAUGGACGAUUA
	 186	
 
   
Plate D11 L-020341-00 J-020341-08 MYBBP1A 10514 NM_014520 7657350 CCCCAGAGAUGGACGAU
Plate E02 L-032694-01 J-032694-05 HAUS7 55559 NM_207106 66346718 CUGUGGAGGUGUUCGG
Plate E02 L-032694-01 J-032694-06 HAUS7 55559 NM_207106 66346718 AGAUCCAAGAAAUGACG
Plate E02 L-032694-01 J-032694-07 HAUS7 55559 NM_207106 66346718 ACGACUACUCAGAGGAC
Plate E02 L-032694-01 J-032694-08 HAUS7 55559 NM_207106 66346718 UGAAGAAGCAGCAAGGC
Plate E03 L-032280-00 J-032280-05 TREX2 11219 NM_080701 63079717 CCGGAAGGCUGGCUUU
Plate E03 L-032280-00 J-032280-06 TREX2 11219 NM_080701 63079717 CGACGAGUCUGGUGCC
Plate E03 L-032280-00 J-032280-07 TREX2 11219 NM_080701 63079717 ACAAUGGCUUUGAUUAU
Plate E03 L-032280-00 J-032280-08 TREX2 11219 NM_080701 63079717 CCAUGUACUUGCCGCCU
Plate E04 L-006835-00 J-006835-05 NCAPG 64151 NM_022346 50658080 GGAGGCUGCUGUCGAU
Plate E04 L-006835-00 J-006835-06 NCAPG 64151 NM_022346 50658080 GCAGUGAGAUUUAGAGU
Plate E04 L-006835-00 J-006835-07 NCAPG 64151 NM_022346 50658080 GCAAAUUGAUGAUGUCA
Plate E04 L-006835-00 J-006835-08 NCAPG 64151 NM_022346 50658080 AUUCAUAGGUCAACAAU
Plate E05 L-012377-00 J-012377-05 TEP1 7011 NM_007110 21536370 GAACUGAAGAGCUACCU
Plate E05 L-012377-00 J-012377-06 TEP1 7011 NM_007110 21536370 GCAUGCGGGUUGCCAG
Plate E05 L-012377-00 J-012377-07 TEP1 7011 NM_007110 21536370 GAUGGAUGGUCCCUGA
Plate E05 L-012377-00 J-012377-08 TEP1 7011 NM_007110 21536370 GAGAAUGGACCACAGGU
Plate E06 L-003873-00 J-003873-09 BARD1 580 NM_000465 4557348 UGGUUUAGCCCUCGAA
Plate E06 L-003873-00 J-003873-10 BARD1 580 NM_000465 4557348 GAGCACAUCUUCUGUAG
Plate E06 L-003873-00 J-003873-11 BARD1 580 NM_000465 4557348 CGACAUACCUUCUGUUG
Plate E06 L-003873-00 J-003873-12 BARD1 580 NM_000465 4557348 UCAGAUAUGUUGUGAGU
Plate E07 L-015831-02 J-015831-18 COPS8 10920 NM_006710 40805828 GAAAUGAGUUGUAUGGU
Plate E07 L-015831-02 J-015831-19 COPS8 10920 NM_006710 40805828 GCAUAUUAGAACAAGGA
Plate E07 L-015831-02 J-015831-20 COPS8 10920 NM_006710 40805828 GAGACGGUCCAGCCAAU
Plate E07 L-015831-02 J-015831-21 COPS8 10920 NM_006710 40805828 CAAGCUGAUUCCACCAC
Plate E08 L-011237-00 J-011237-05 CDC5L 988 NM_001253 16357499 CGAGACAAGUUAAACAU
Plate E08 L-011237-00 J-011237-06 CDC5L 988 NM_001253 16357499 GAGAGGAGUUGAUUAUA
Plate E08 L-011237-00 J-011237-07 CDC5L 988 NM_001253 16357499 CGAGGAAUCUGGCAUAA
Plate E08 L-011237-00 J-011237-08 CDC5L 988 NM_001253 16357499 GCUCUCAAGUGAAGCUU
Plate E09 L-017227-02 J-017227-17 NDNL2 56160 NM_138704 29826297 GCAUUUAAUUUUCGGAG
Plate E09 L-017227-02 J-017227-18 NDNL2 56160 NM_138704 29826297 ACUUUGUGCGACAGCG
Plate E09 L-017227-02 J-017227-19 NDNL2 56160 NM_138704 29826297 UCCAGUACGUCUUCGG
Plate E09 L-017227-02 J-017227-20 NDNL2 56160 NM_138704 29826297 GCUGUAAACGCUUCAAU
Plate E10 L-018070-00 J-018070-05 NSMCE2 286053 NM_173685 27734760 GCUGUUCAAUCUACAAU
Plate E10 L-018070-00 J-018070-06 NSMCE2 286053 NM_173685 27734760 GCAACUAAACCAUUAUG
Plate E10 L-018070-00 J-018070-07 NSMCE2 286053 NM_173685 27734760 GCACUUAGAAGGGCAAU
Plate E10 L-018070-00 J-018070-08 NSMCE2 286053 NM_173685 27734760 CAACUGGUUUCAUCUCC
Plate E11 L-017244-00 J-017244-05 SMARCD1 6602 NM_139071 21264347 GGCAAUAUAUUAAGACA
Plate E11 L-017244-00 J-017244-06 SMARCD1 6602 NM_139071 21264347 UAAGUCAGAUGCCGAGG
Plate E11 L-017244-00 J-017244-07 SMARCD1 6602 NM_139071 21264347 UUAAUCAUGUCAUCAGU
Plate E11 L-017244-00 J-017244-08 SMARCD1 6602 NM_139071 21264347 GACAAUGACUGAUGUGG
Plate F02 L-018557-01 J-018557-09 MCRS1 10445 NM_00101230 59799165 GGCAUGAGCUCUCCGG
Plate F02 L-018557-01 J-018557-10 MCRS1 10445 NM_00101230 59799165 GAGGAAGAAGUUCGAUG
Plate F02 L-018557-01 J-018557-11 MCRS1 10445 NM_00101230 59799165 CUGGAAGAUAUCCCGGA
Plate F02 L-018557-01 J-018557-12 MCRS1 10445 NM_00101230 59799165 AGCUCAAGGACAUGCGA
Plate F03 L-015684-01 J-015684-09 RMI2 116028 NM_152308 24308244 UCAGAGAUGUUGAGACG
Plate F03 L-015684-01 J-015684-10 RMI2 116028 NM_152308 24308244 ACUCAAACAUUUAGACG
Plate F03 L-015684-01 J-015684-11 RMI2 116028 NM_152308 24308244 AUAACCAGUUUGCGAGU
Plate F03 L-015684-01 J-015684-12 RMI2 116028 NM_152308 24308244 GCAGGGUAGUGAUGGC
Plate F04 L-018972-00 J-018972-05 PINX1 54984 NM_017884 31982866 UGACGCAGGUAGAACGU
Plate F04 L-018972-00 J-018972-06 PINX1 54984 NM_017884 14874755 AGCCACAGAUCAUAUUA
Plate F04 L-018972-00 J-018972-07 PINX1 54984 NM_017884 14874755 UGGCCGAACUGAACACU
Plate F04 L-018972-00 J-018972-08 PINX1 54984 NM_017884 14874755 GGUCUAAAGGAAAGGGU
Plate F05 L-017522-00 J-017522-05 SMARCE1 6605 NM_003079 45827732 AAACGAAUACGAAGCAG
Plate F05 L-017522-00 J-017522-06 SMARCE1 6605 NM_003079 45827732 GAAAGGAGAACCGUACA
Plate F05 L-017522-00 J-017522-07 SMARCE1 6605 NM_003079 45827732 CCGCGUACCUUGCUUAC
Plate F05 L-017522-00 J-017522-08 SMARCE1 6605 NM_003079 45827732 CAAGAUUAUUGGUGGCA
Plate F06 L-019553-00 J-019553-05 CUL5 8065 NM_003478 67514034 GACACGACGUCUUAUAU
Plate F06 L-019553-00 J-019553-06 CUL5 8065 NM_003478 67514034 GCAAAUAGAGUGGCUAA
Plate F06 L-019553-00 J-019553-07 CUL5 8065 NM_003478 67514034 UAAACAAGCUUGCUAGA
Plate F06 L-019553-00 J-019553-08 CUL5 8065 NM_003478 67514034 CGUCUAAUCUGUUAAAG
Plate F07 L-010813-00 J-010813-05 SMARCC1 6599 NM_003074 21237801 GAGCAGACCAAUCACAU
Plate F07 L-010813-00 J-010813-06 SMARCC1 6599 NM_003074 21237801 GUACUGACAUUUACUCC
Plate F07 L-010813-00 J-010813-07 SMARCC1 6599 NM_003074 21237801 GAACAUUUACGGAUGAG
Plate F07 L-010813-00 J-010813-08 SMARCC1 6599 NM_003074 21237801 CAACACCUGUACCCAAU
Plate F08 L-005814-00 J-005814-07 COPS5 10987 NM_006837 38027922 UAGAAACGCAUGACCGA
Plate F08 L-005814-00 J-005814-08 COPS5 10987 NM_006837 38027922 GGACUAAGGAUCACCAU
Plate F08 L-005814-00 J-005814-09 COPS5 10987 NM_006837 38027922 GCAAUCGGGUGGUAUC
Plate F08 L-005814-00 J-005814-10 COPS5 10987 NM_006837 38027922 CUUGAGCUGUUGUGGA
Plate F09 L-003208-00 J-003208-10 CCNB3 85417 NM_033670 16306524 GUCUCAAGGCUGUGUA
Plate F09 L-003208-00 J-003208-11 CCNB3 85417 NM_033670 16306524 GCGCAGAUAUGCUAGG
Plate F09 L-003208-00 J-003208-12 CCNB3 85417 NM_033670 16306524 UGAACAAACUGCUGACU
Plate F09 L-003208-00 J-003208-13 CCNB3 85417 NM_033670 16306524 CAACUCACCUCGUGUGG
Plate F10 L-010638-01 J-010638-09 STAG1 10274 NM_005862 62243695 GAAUAGAGAUGUUUCGA
Plate F10 L-010638-01 J-010638-10 STAG1 10274 NM_005862 62243695 UCAAGAAAUCGGCGAGA
Plate F10 L-010638-01 J-010638-11 STAG1 10274 NM_005862 62243695 GAUUAGAGCCAUUUGUA
Plate F10 L-010638-01 J-010638-12 STAG1 10274 NM_005862 62243695 GAAUGUUGGUGAAUGU
Plate F11 L-007157-00 J-007157-05 NSMCE1 197370 NM_145080 39725702 GAACUGGAUUUGUUUAG
Plate F11 L-007157-00 J-007157-06 NSMCE1 197370 NM_145080 39725702 GGAACUGAUUAUUGACU
Plate F11 L-007157-00 J-007157-07 NSMCE1 197370 NM_145080 39725702 GGAGUCUGGUGUCUUG
Plate F11 L-007157-00 J-007157-08 NSMCE1 197370 NM_145080 39725702 GAUGACCCAUGGCGUG
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Plate 1 F11 L-007157-00 J-007157-08 NSMCE1 197370 NM_145080 39725702 GAUGACCCAUGGCGUGCUA
Plate 1 G02 L-019912-00 J-019912-05 PPP4R1 9989 NM_005134 4826933 GCCCGGAGUUUGCUCGAUA
Plate 1 G02 L-019912-00 J-019912-06 PPP4R1 9989 NM_005134 4826933 CAGGAUAGGUGUUCUUAAA
Plate 1 G02 L-019912-00 J-019912-07 PPP4R1 9989 NM_005134 4826933 GGAGAUAUUUGCAGUGUAG
Plate 1 G02 L-019912-00 J-019912-08 PPP4R1 9989 NM_005134 4826933 GAUCAGGAAUUGUAUAACU
Plate 1 G03 L-008312-00 J-008312-05 SMARCC2 6601 NM_139067 21237807 UCACUAAACUGCCGAUCAA
Plate 1 G03 L-008312-00 J-008312-06 SMARCC2 6601 NM_139067 21237807 GAGAAGCACUGGAGUAUCA
Plate 1 G03 L-008312-00 J-008312-07 SMARCC2 6601 NM_139067 21237807 GCUACUAUCCUGACAGUUA
Plate 1 G03 L-008312-00 J-008312-08 SMARCC2 6601 NM_139067 21237807 UAAGAAAGGUCCCUCAACA
Plate 1 G04 L-016462-01 J-016462-09 WDR48 57599 NM_020839 21314694 CUUAAAGGGCACACGGAUA
Plate 1 G04 L-016462-01 J-016462-10 WDR48 57599 NM_020839 21314694 CGUCAGAAGUCCACGUGAA
Plate 1 G04 L-016462-01 J-016462-11 WDR48 57599 NM_020839 21314694 ACACAUAAGGAUUACGUAA
Plate 1 G04 L-016462-01 J-016462-12 WDR48 57599 NM_020839 21314694 AAACAGAGAUGGCACGCAA
Plate 1 G05 L-017519-00 J-017519-05 HUS1B 135458 NM_148959 82659116 GGAUGACCCUGAGUAUAGA
Plate 1 G05 L-017519-00 J-017519-06 HUS1B 135458 NM_148959 82659116 GCAAAUACAUCCUACGACG
Plate 1 G05 L-017519-00 J-017519-07 HUS1B 135458 NM_148959 82659116 CAAAGGCUGUCUAGAGCUG
Plate 1 G05 L-017519-00 J-017519-08 HUS1B 135458 NM_148959 82659116 CAUGGAAGGUGUCUCGGAA
Plate 1 G06 L-013970-01 J-013970-09 ARID1B 57492 NM_175863 40068461 UGAUCAACAUGGCGGACAA
Plate 1 G06 L-013970-01 J-013970-10 ARID1B 57492 NM_175863 40068461 CCGAAUUACAAACGCCAUA
Plate 1 G06 L-013970-01 J-013970-11 ARID1B 57492 NM_175863 40068461 UCUCAAAGCAGACGGCAAA
Plate 1 G06 L-013970-01 J-013970-12 ARID1B 57492 NM_175863 40068461 ACGAGCAUCCAGAGAGAAA
Plate 1 G07 L-015461-01 J-015461-09 SMC1B 27127 NM_148674 71565159 AGGAAGAGGCAGAACGUUA
Plate 1 G07 L-015461-01 J-015461-10 SMC1B 27127 NM_148674 71565159 UCAAUAAAGGACAGCGAAA
Plate 1 G07 L-015461-01 J-015461-11 SMC1B 27127 NM_148674 71565159 UAGAGAAGUUAGAGGAGUA
Plate 1 G07 L-015461-01 J-015461-12 SMC1B 27127 NM_148674 71565159 GAGCAUGUGAAUAGGGAUU
Plate 1 G08 L-018625-01 J-018625-09 NFATC2IP 84901 NM_032815 46447822 GGAUACAGGCCACGAUAAA
Plate 1 G08 L-018625-01 J-018625-10 NFATC2IP 84901 NM_032815 46447822 GGGAUUUACACCACGCCUA
Plate 1 G08 L-018625-01 J-018625-11 NFATC2IP 84901 NM_032815 46447822 ACGUAGUGUCUGUGGACUU
Plate 1 G08 L-018625-01 J-018625-12 NFATC2IP 84901 NM_032815 46447822 GACAUUUGCUUGAGGCUUA
Plate 1 G09 L-003994-01 J-003994-09 INO80E 283899 NM_173618 27734726 CAUCAUCAGAUAACAGCGA
Plate 1 G09 L-003994-01 J-003994-10 INO80E 283899 NM_173618 27734726 CGGCAGAUGUUCAGCGAUG
Plate 1 G09 L-003994-01 J-003994-11 INO80E 283899 NM_173618 27734726 CCUUGGAUGGAGACGAUGA
Plate 1 G09 L-003994-01 J-003994-12 INO80E 283899 NM_173618 27734726 GCGCAAAGGAAAUUACUGA
Plate 1 G10 L-030080-00 J-030080-05 ANKRD52 283373 XM_370696 51471077 GGAACGAGCUGACAUCACA
Plate 1 G10 L-030080-00 J-030080-06 ANKRD52 283373 XM_370696 51471077 CAACGAGGCCGACUGUAAA
Plate 1 G10 L-030080-00 J-030080-07 ANKRD52 283373 XM_370696 51471077 GGAAUGGUCUAGCUUCUGU
Plate 1 G10 L-030080-00 J-030080-08 ANKRD52 283373 XM_370696 51471077 GAAGUGCGUUCCCUACUCU
Plate 1 G11 L-015710-01 J-015710-09 ANKRD44 91526 NM_153697 24233529 UCGCAAAUUUAUCGGUAAU
Plate 1 G11 L-015710-01 J-015710-10 ANKRD44 91526 NM_153697 24233529 CCACAGGGGCCAACGUUAA
Plate 1 G11 L-015710-01 J-015710-11 ANKRD44 91526 NM_153697 24233529 GCACUAUGCAGCUGCGAAU
Plate 1 G11 L-015710-01 J-015710-12 ANKRD44 91526 NM_153697 24233529 CUAUGGAAAUACAGCGCUU
Plate 1 H02 L-011007-00 J-011007-08 CDKN2A 1029 NM_058195 47132605 GAUCAUCAGUCACCGAAGG
Plate 1 H02 L-011007-00 J-011007-09 CDKN2A 1029 NM_058195 47132605 AAACACCGCUUCUGCCUUU
Plate 1 H02 L-011007-00 J-011007-10 CDKN2A 1029 NM_058195 47132605 UAACGUAGAUAUAUGCCUU
Plate 1 H02 L-011007-00 J-011007-11 CDKN2A 1029 NM_058195 47132605 CAGAACCAAAGCUCAAAUA
Plate 1 H03 L-021351-00 J-021351-05 STAG2 10735 NM_006603 31563530 GAAAUUUACUUGCAGCAUU
Plate 1 H03 L-021351-00 J-021351-06 STAG2 10735 NM_006603 31563530 GUAGAUGAUUGGAUAGAAU
Plate 1 H03 L-021351-00 J-021351-07 STAG2 10735 NM_006603 31563530 GGGAUUUAUUUGCUUGUAA
Plate 1 H03 L-021351-00 J-021351-08 STAG2 10735 NM_006603 31563530 CCACUGAUGUCUUACCGAA
Plate 1 H04 L-027334-00 J-027334-05 CORT 1325 NM_001302 56121821 GGAGAUUGGGCUUAAAAUA
Plate 1 H04 L-027334-00 J-027334-06 CORT 1325 NM_001302 56121821 CCAGUCAGCCCACAAGAUG
Plate 1 H04 L-027334-00 J-027334-07 CORT 1325 NM_001302 56121821 GACCUUCUCCUCCUGCAAA
Plate 1 H04 L-027334-00 J-027334-08 CORT 1325 NM_001302 56121821 GCCGAGACAGCGAGCAUAU
Plate 1 H05 L-034901-02 J-034901-17 EID3 493861 NM_001008394 56605997 CAAUAUUAGAGCCGAUGAA
Plate 1 H05 L-034901-02 J-034901-18 EID3 493861 NM_001008394 56605997 UGAAUUGGAUGGAAGGCGA
Plate 1 H05 L-034901-02 J-034901-19 EID3 493861 NM_001008394 56605997 UUGCAAACCUACUUUCGAA
Plate 1 H05 L-034901-02 J-034901-20 EID3 493861 NM_001008394 56605997 CGAACAACUCCUUAACCGA
Plate 1 H06 L-014895-00 J-014895-05 SLX4 84464 NM_032444 63252862 UCAAACGGCACUCAGAUAA
Plate 1 H06 L-014895-00 J-014895-06 SLX4 84464 NM_032444 63252862 GCGGAGACUUUGUUGAAAU
Plate 1 H06 L-014895-00 J-014895-07 SLX4 84464 NM_032444 63252862 CAAGUGAGCCCGAGGAACA
Plate 1 H06 L-014895-00 J-014895-08 SLX4 84464 NM_032444 63252862 UCAGAGCCGUCCCAAAUAA
Plate 1 H07 L-027056-00 J-027056-05 AMN1 196394 NM_207337 46559738 GAUCUACGGAGCUGCGAUA
Plate 1 H07 L-027056-00 J-027056-06 AMN1 196394 NM_207337 46559738 CGAUUUAGGUGGCUGCUUA
Plate 1 H07 L-027056-00 J-027056-07 AMN1 196394 NM_207337 46559738 GGUGUGAUUGCACUUGUUA
Plate 1 H07 L-027056-00 J-027056-08 AMN1 196394 NM_207337 46559738 CAUGGACUGUUUAUUGAUG
Plate 1 H08 L-014117-01 J-014117-09 SMC5 23137 NM_015110 24850455 CGAAAUAAUUGAUAAGCGA
Plate 1 H08 L-014117-01 J-014117-10 SMC5 23137 NM_015110 24850455 GAAAGAAUUGAACGGGUAA
Plate 1 H08 L-014117-01 J-014117-11 SMC5 23137 NM_015110 24850455 GAAACUUGUUACCGAAUUA
Plate 1 H08 L-014117-01 J-014117-12 SMC5 23137 NM_015110 24850455 GAACAGGGAAGUCGAGCAU
Plate 1 H09 L-018283-01 J-018283-09 NCAPG2 54892 NM_017760 116812585 ACGGAAGGUUUCUGACGUA
Plate 1 H09 L-018283-01 J-018283-10 NCAPG2 54892 NM_017760 40255236 CCUCAGUAGAUAAGGCGUA
Plate 1 H09 L-018283-01 J-018283-11 NCAPG2 54892 NM_017760 116812585 CUUCAUGUUCCACGGGAUA
Plate 1 H09 L-018283-01 J-018283-12 NCAPG2 54892 NM_017760 116812585 GGCCAAACUUUACACGAUU
Plate 1 H10 L-187549-00 J-187549-01 TEN1 100134934 NM_001113324 164519030 AUGAUUCAGUCCAGAGUAA
Plate 1 H10 L-187549-00 J-187549-02 TEN1 100134934 NM_001113324 164519030 GGGAGCACGCUGAGAACAU
Plate 1 H10 L-187549-00 J-187549-03 TEN1 100134934 NM_001113324 164519030 GGGAGCAGAGACUGUACAA
Plate 1 H10 L-187549-00 J-187549-04 TEN1 100134934 NM_001113324 164519030 GGUUAGUGCAGGCCAAGUU
Plate 1 H11 L-017845-01 J-017845-09 SMG6 23293 NM_017575 30425541 CCAGUGAUACAGCGAAUUA
Plate 1 H11 L-017845-01 J-017845-10 SMG6 23293 NM_017575 30425541 CAGAUUGGAUGCUCGGCUA
Plate 1 H11 L-017845-01 J-017845-11 SMG6 23293 NM_017575 30425541 GCAGCAAGCCAUUACGCAA
Plate 1 H11 L-017845-01 J-017845-12 SMG6 23293 NM_017575 30425541 UGGAGAAAACCUCGGAUAA
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Plate 2 A02 L-008692-01 J-008692-09 PBRM1 55193 NM_181042 93102368 GUUAGGAGUUGUCGGAAUA
Plate 2 A02 L-008692-01 J-008692-10 PBRM1 55193 NM_181042 93102368 AGCUAAAUUUGCCGAGUUA
Plate 2 A02 L-008692-01 J-008692-11 PBRM1 55193 NM_181042 93102368 AUAUAGAUCUCCUCGCAAA
Plate 2 A02 L-008692-01 J-008692-12 PBRM1 55193 NM_181042 93102368 UGACAUGUAUUCUCGGAAA
Plate 2 A03 L-017017-00 J-017017-05 COPS6 10980 NM_006833 38027945 CGAAAUAUCGAGGUGAUGA
Plate 2 A03 L-017017-00 J-017017-06 COPS6 10980 NM_006833 38027945 UUUCUGAAGUUGAACCCUA
Plate 2 A03 L-017017-00 J-017017-07 COPS6 10980 NM_006833 38027945 CCACGUAGCCCGAAUGACA
Plate 2 A03 L-017017-00 J-017017-08 COPS6 10980 NM_006833 38027945 CAGACAAGUUCAAGACAGA
Plate 2 A04 L-012795-00 J-012795-05 PAXIP1 22976 NM_007349 40804749 UGUUUGCAAUUGCGGAUUA
Plate 2 A04 L-012795-00 J-012795-06 PAXIP1 22976 NM_007349 40804749 CAACUGGUUUAAAGUAUGA
Plate 2 A04 L-012795-00 J-012795-07 PAXIP1 22976 NM_007349 40804749 AGGCAUAGAUGUUCACAAU
Plate 2 A04 L-012795-00 J-012795-08 PAXIP1 22976 NM_007349 40804749 CAAAUAUACGGGUUAUCUA
Plate 2 A05 L-016177-01 J-016177-09 RAD9B 144715 NM_152442 41393615 GCACGAGUUUGCAUGUUUA
Plate 2 A05 L-016177-01 J-016177-10 RAD9B 144715 NM_152442 169234616 AGGAAGUGUUAACUGGCAA
Plate 2 A05 L-016177-01 J-016177-11 RAD9B 144715 NM_152442 169234616 CACAUUAGCUGAUGAACAA
Plate 2 A05 L-016177-01 J-016177-12 RAD9B 144715 NM_152442 169234616 GGCAAGAGCAAGUGACAGU
Plate 2 A06 L-019327-01 J-019327-09 INO80C 125476 NM_194281 42822883 UGAGGAAGGCCACGAGCAU
Plate 2 A06 L-019327-01 J-019327-10 INO80C 125476 NM_194281 42822883 GAAACAAAUCCUCGCUUCU
Plate 2 A06 L-019327-01 J-019327-11 INO80C 125476 NM_194281 42822883 CAGAGCAAACUGCGGUUCA
Plate 2 A06 L-019327-01 J-019327-12 INO80C 125476 NM_194281 42822883 GCGCAGUAGCUGGCAAGAA
Plate 2 A07 L-015648-00 J-015648-05 NFRKB 4798 NM_006165 23346419 CAUCAUGACUCGAGUAAAU
Plate 2 A07 L-015648-00 J-015648-06 NFRKB 4798 NM_006165 23346419 GGCAGGAAGUGUUAAGUGA
Plate 2 A07 L-015648-00 J-015648-07 NFRKB 4798 NM_006165 23346419 CAGGAGCGUUACAGGUAUA
Plate 2 A07 L-015648-00 J-015648-08 NFRKB 4798 NM_006165 23346419 GCUUAAGGACUCCCAGUUU
Plate 2 A08 L-013007-00 J-013007-05 PPP4R4 57718 NM_020958 17402883 CGACAGAAUCCCACUGAGA
Plate 2 A08 L-013007-00 J-013007-06 PPP4R4 57718 NM_020958 17402883 AUAGAAAGAUUGACAGUCG
Plate 2 A08 L-013007-00 J-013007-07 PPP4R4 57718 NM_020958 17402883 GCUCAGUGCUGGUCAAGAU
Plate 2 A08 L-013007-00 J-013007-08 PPP4R4 57718 NM_020958 17402883 GCGAUGGAUUUCAGUCAGA
Plate 2 A09 L-016186-01 J-016186-09 NCAPH2 29781 NM_014551 34303963 GGACUAACGUGGAUCUCAA
Plate 2 A09 L-016186-01 J-016186-10 NCAPH2 29781 NM_014551 34303963 AGGCAGCGUUGUUGAUCCA
Plate 2 A09 L-016186-01 J-016186-11 NCAPH2 29781 NM_014551 34303963 UGUACAGCCGUCAGGGUGA
Plate 2 A09 L-016186-01 J-016186-12 NCAPH2 29781 NM_014551 34303963 CGGAAGGAUUUCAGGAUGA
Plate 2 A10 L-032350-02 J-032350-19 SUMO4 387082 NM_001002255 50400080 CGAAAAGCCCACAGAAGAA
Plate 2 A10 L-032350-02 J-032350-20 SUMO4 387082 NM_001002255 50400080 GCAACCAAUCAGUGGAACA
Plate 2 A10 L-032350-02 J-032350-21 SUMO4 387082 NM_001002255 50400080 AGACCAAGAUUACUGCAUU
Plate 2 A10 L-032350-02 J-032350-22 SUMO4 387082 NM_001002255 50400080 GAAGUAACUGGUAUGUGUA
Plate 2 A11 L-026945-01 J-026945-09 ARID2 196528 NM_152641 56549667 CUAUACAUGCUCACGGAAA
Plate 2 A11 L-026945-01 J-026945-10 ARID2 196528 NM_152641 56549667 GCAAUUAGGCCUUGACACA
Plate 2 A11 L-026945-01 J-026945-11 ARID2 196528 NM_152641 56549667 CCAAAUAAAGUAGGAGUUA
Plate 2 A11 L-026945-01 J-026945-12 ARID2 196528 NM_152641 56549667 GCUGAAAUCAUGUGGGUAU
Plate 2 B02 L-027983-01 J-027983-09 RIF1 55183 NM_018151 56676334 CCUCAAAUGAAAUGCGAAA
Plate 2 B02 L-027983-01 J-027983-10 RIF1 55183 NM_018151 56676334 UCACGUAGCCCUAAAUUUA
Plate 2 B02 L-027983-01 J-027983-11 RIF1 55183 NM_018151 56676334 GAAUCAAAUCUAAGGACUA
Plate 2 B02 L-027983-01 J-027983-12 RIF1 55183 NM_018151 56676334 GCAAGUUCCUGAUGAUUUA
Plate 2 B03 L-027284-00 J-027284-05 SMEK2 57223 NM_020463 39930396 CCAUCUAUAUUGCGUAGUA
Plate 2 B03 L-027284-00 J-027284-06 SMEK2 57223 NM_020463 39930396 GCGGAUAAUUGGACUUAAA
Plate 2 B03 L-027284-00 J-027284-07 SMEK2 57223 NM_020463 39930396 CCACAUGUGAACUCAAUAA
Plate 2 B03 L-027284-00 J-027284-08 SMEK2 57223 NM_020463 39930396 UGAAACUAGUCAUCUGAUU
Plate 2 B04 L-031625-00 J-031625-05 UBE2NL 389898 NM_001012989 61175264 GGUCAUUGCUGGGGAAUCA
Plate 2 B04 L-031625-00 J-031625-06 UBE2NL 389898 NM_001012989 61175264 AAACGUGAACUAUUACUUG
Plate 2 B04 L-031625-00 J-031625-07 UBE2NL 389898 NM_001012989 61175264 GAUCCAAUCAUUAAGUGUG
Plate 2 B04 L-031625-00 J-031625-08 UBE2NL 389898 NM_001012989 61175264 AAUAUGCUCUCUAUCCAAG
Plate 2 B05 L-014646-01 J-014646-09 PPP6R3 55291 NM_018312 55925644 CCAAAGUAUUAGGCGGUUU
Plate 2 B05 L-014646-01 J-014646-10 PPP6R3 55291 NM_018312 55925644 GAGGAACACGGUAGAUCUA
Plate 2 B05 L-014646-01 J-014646-11 PPP6R3 55291 NM_018312 55925644 CCAUUCAGCUUGUUCAGUA
Plate 2 B05 L-014646-01 J-014646-12 PPP6R3 55291 NM_018312 55925644 GGGGAUUACUGGUAGAUAA
Plate 2 B06 L-020757-01 J-020757-09 INO80D 54891 NM_017759 38488717 CGGGCAGAAUCUCGUCAAA
Plate 2 B06 L-020757-01 J-020757-10 INO80D 54891 NM_017759 38488717 GCUAUUGAAUGGGCGUAUA
Plate 2 B06 L-020757-01 J-020757-11 INO80D 54891 NM_017759 38488717 CUGAUGAGUUGCCGGAUGA
Plate 2 B06 L-020757-01 J-020757-12 INO80D 54891 NM_017759 38488717 CGGCAUACGUUUAGGAAAG
Plate 2 B07 L-014151-01 J-014151-09 CRY2 1408 NM_021117 29789121 GGGACUACAUCAGGCGAUA
Plate 2 B07 L-014151-01 J-014151-10 CRY2 1408 NM_021117 29789121 GGGCAGAGAUAGAGCGAGC
Plate 2 B07 L-014151-01 J-014151-11 CRY2 1408 NM_021117 29789121 UGGAAGUAGUGACGGAGAA
Plate 2 B07 L-014151-01 J-014151-12 CRY2 1408 NM_021117 29789121 GGCUUAACAUUGAACGAAU
Plate 2 B08 L-024139-02 J-024139-21 UVSSA 57654 NM_020894 190358542 GAUAAUCAGUUGACCAAAA
Plate 2 B08 L-024139-02 J-024139-22 UVSSA 57654 NM_020894 190358542 GGCCAGGAGUUUAUAUGUA
Plate 2 B08 L-024139-02 J-024139-23 UVSSA 57654 NM_020894 190358542 GCUCGUGGAUCCAGCGCUU
Plate 2 B08 L-024139-02 J-024139-24 UVSSA 57654 NM_020894 190358542 GGUUCAGCACGGACGGAAU
Plate 2 B09 L-014585-01 J-014585-09 CTC1 80169 NM_025099 50055056 CCUCCUAGAUUUCGUCCAA
Plate 2 B09 L-014585-01 J-014585-10 CTC1 80169 NM_025099 50055056 CGGGACAGGUGUACCGACU
Plate 2 B09 L-014585-01 J-014585-11 CTC1 80169 NM_025099 50055056 UCAGAGGUGUGCAGCGAAA
Plate 2 B09 L-014585-01 J-014585-12 CTC1 80169 NM_025099 50055056 CAGAAAGUCUUGUCCGGUA
Plate 2 B10 L-014071-01 J-014071-09 PDS5A 23244 NM_015200 22094120 GAUAAACGGUGGCGAGUAA
Plate 2 B10 L-014071-01 J-014071-10 PDS5A 23244 NM_015200 22094120 CCAAUAAAGAUGUGCGUCU
Plate 2 B10 L-014071-01 J-014071-11 PDS5A 23244 NM_015200 22094120 GAACAGCAUUGACGACAAA
Plate 2 B10 L-014071-01 J-014071-12 PDS5A 23244 NM_015200 22094120 GAGAGAAAUAGCCCGGAAA
Plate 2 B11 L-015421-00 J-015421-05 CRY1 1407 NM_004075 19923246 CAGCAGCUUUCACGAUAUA
Plate 2 B11 L-015421-00 J-015421-06 CRY1 1407 NM_004075 19923246 GGAGUAGAAGUCAUUGUAA
Plate 2 B11 L-015421-00 J-015421-07 CRY1 1407 NM_004075 19923246 UAUAUGACCUAGACAAGAU
Plate 2 B11 L-015421-00 J-015421-08 CRY1 1407 NM_004075 19923246 CAACUGUUAUGGCGUGAAU
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Plate 2 B11 L-015421-00 J-015421-08 CRY1 1407 NM_004075 19923246 CAACUGUUAUGGCGUGAAU
Plate 2 C02 L-003546-00 J-003546-13 TERF2 7014 NM_005652 21536372 GAACAAGCGCAUGACAAUA
Plate 2 C02 L-003546-00 J-003546-14 TERF2 7014 NM_005652 21536372 GCAAGGCAGCUACGGAAUC
Plate 2 C02 L-003546-00 J-003546-15 TERF2 7014 NM_005652 21536372 GACAGUACAACCAAUAUAA
Plate 2 C02 L-003546-00 J-003546-16 TERF2 7014 NM_005652 21536372 CCGAACAGCUGUGAUGAUU
Plate 2 C03 L-012376-00 J-012376-08 TCEB2 6923 NM_207013 46276892 GCCAAGAGCAGAAACACAA
Plate 2 C03 L-012376-00 J-012376-09 TCEB2 6923 NM_207013 46276892 GAACUGAAGCGCAUCGUCG
Plate 2 C03 L-012376-00 J-012376-10 TCEB2 6923 NM_207013 46276892 GGGCAGAUGACACCUUUGA
Plate 2 C03 L-012376-00 J-012376-11 TCEB2 6923 NM_207013 46276892 CAUGUCCACUCCCAGACGA
Plate 2 C04 L-010541-00 J-010541-09 TCEB1 6921 NM_005648 16933562 GGCCAUGAAUUUAUUGUAA
Plate 2 C04 L-010541-00 J-010541-10 TCEB1 6921 NM_005648 16933562 GCUGCGAACUUCUUAGAUU
Plate 2 C04 L-010541-00 J-010541-11 TCEB1 6921 NM_005648 16933562 GUACAAGGUUCGCUACACU
Plate 2 C04 L-010541-00 J-010541-12 TCEB1 6921 NM_005648 16933562 CAUGUGCUAUCGAAAGUAU
Plate 2 C05 L-026692-01 J-026692-09 POLD3 10714 NM_006591 38492355 ACGAAAACGCGUACUAAAA
Plate 2 C05 L-026692-01 J-026692-10 POLD3 10714 NM_006591 38492355 GGCAUUAUGUCUAGGACUA
Plate 2 C05 L-026692-01 J-026692-11 POLD3 10714 NM_006591 38492355 CAAUUAGUGGUUAGGGAAA
Plate 2 C05 L-026692-01 J-026692-12 POLD3 10714 NM_006591 38492355 UGUAUAGCAAGCUGAGUAA
Plate 2 C06 L-021198-01 J-021198-09 NCAPD2 9918 NM_014865 41281520 GGUAAGAAAGCUCGGACCA
Plate 2 C06 L-021198-01 J-021198-10 NCAPD2 9918 NM_014865 41281520 GAAAAUUACAUGAUGCGUA
Plate 2 C06 L-021198-01 J-021198-11 NCAPD2 9918 NM_014865 41281520 AGUCAGUGCUAGUAUGUAA
Plate 2 C06 L-021198-01 J-021198-12 NCAPD2 9918 NM_014865 41281520 GAGCAUAGUGGGAGAGAUU
Plate 2 C07 L-012853-01 J-012853-09 NCAPH 23397 NM_015341 81295814 CUUUAGGCCUCGACGCAAA
Plate 2 C07 L-012853-01 J-012853-10 NCAPH 23397 NM_015341 81295814 GGGCAGAUCCCUCGUGAAU
Plate 2 C07 L-012853-01 J-012853-11 NCAPH 23397 NM_015341 81295814 UGACAGCGCUCUCCGGAAA
Plate 2 C07 L-012853-01 J-012853-12 NCAPH 23397 NM_015341 81295814 GCAAAAGGGCAGCCGGCAA
Plate 2 C08 L-007167-00 J-007167-05 SHPRH 257218 NM_173082 27436872 GCACAAAUCAGUCGUGUUA
Plate 2 C08 L-007167-00 J-007167-06 SHPRH 257218 NM_173082 27436872 AAAGAAAUCUCGUAUGUCU
Plate 2 C08 L-007167-00 J-007167-07 SHPRH 257218 NM_173082 27436872 GCCAGAAGCUAGUAAGAGA
Plate 2 C08 L-007167-00 J-007167-08 SHPRH 257218 NM_173082 27436872 GAAAUCACAUUAUCAAGGU
Plate 2 C09 L-004984-01 J-004984-09 MVP 9961 NM_005115 19913411 CCAUCGAAACGGCGGAUCA
Plate 2 C09 L-004984-01 J-004984-10 MVP 9961 NM_005115 19913411 GGAAGGAAGUGGAGGUCGU
Plate 2 C09 L-004984-01 J-004984-11 MVP 9961 NM_005115 19913411 CCACAACUACUGCGUGAUU
Plate 2 C09 L-004984-01 J-004984-12 MVP 9961 NM_005115 19913411 CAGGAUGUCAAGACCGGAA
Plate 2 C10 L-006448-00 J-006448-06 HLTF 6596 NM_139048 21071053 CCAGAUGACUUUCUAACUA
Plate 2 C10 L-006448-00 J-006448-07 HLTF 6596 NM_139048 21071053 GAUAGAGAAUGGUGGCAUA
Plate 2 C10 L-006448-00 J-006448-08 HLTF 6596 NM_139048 21071053 GCAGGAUCUUCUAAGGUUA
Plate 2 C10 L-006448-00 J-006448-09 HLTF 6596 NM_139048 21071053 GGAUUUGUGUUUACUCGUU
Plate 2 C11 L-007770-02 J-007770-21 HES1 3280 NM_005524 8400709 ACGAAGAGCAAGAAUAAAU
Plate 2 C11 L-007770-02 J-007770-22 HES1 3280 NM_005524 8400709 AGGCUGGAGAGGCGGCUAA
Plate 2 C11 L-007770-02 J-007770-23 HES1 3280 NM_005524 8400709 UCAACACGACACCGGAUAA
Plate 2 C11 L-007770-02 J-007770-24 HES1 3280 NM_005524 8400709 ACUGCAUGACCCAGAUCAA
Plate 2 D02 L-005143-00 J-005143-07 TCEB3 6924 NM_003198 4507388 GUAAAUAGCUUGCGAAAAC
Plate 2 D02 L-005143-00 J-005143-08 TCEB3 6924 NM_003198 4507388 AGAUGUACGUCGACCACUA
Plate 2 D02 L-005143-00 J-005143-09 TCEB3 6924 NM_003198 4507388 GAAAGGUGCCUGAUGUGUU
Plate 2 D02 L-005143-00 J-005143-10 TCEB3 6924 NM_003198 4507388 GACCAGGAGCCCAUUGUUU
Plate 2 D03 L-012610-00 J-012610-05 CUL4A 8451 NM_003589 57165422 GCACAGAUCCUUCCGUUUA
Plate 2 D03 L-012610-00 J-012610-06 CUL4A 8451 NM_003589 57165422 GAACAGCGAUCGUAAUCAA
Plate 2 D03 L-012610-00 J-012610-07 CUL4A 8451 NM_003589 57165422 GCAUGUGGAUUCAAAGUUA
Plate 2 D03 L-012610-00 J-012610-08 CUL4A 8451 NM_003589 57165422 GCGAGUACAUCAAGACUUU
Plate 2 D04 L-010224-00 J-010224-06 CUL3 8452 NM_003590 45827792 GAAGGAAUGUUUAGGGAUA
Plate 2 D04 L-010224-00 J-010224-07 CUL3 8452 NM_003590 45827792 GAGAUCAAGUUGUACGUUA
Plate 2 D04 L-010224-00 J-010224-08 CUL3 8452 NM_003590 45827792 GAAAGUAGACGACGACAGA
Plate 2 D04 L-010224-00 J-010224-09 CUL3 8452 NM_003590 45827792 GCACAUGAAGACUAUAGUA
Plate 2 D05 L-005279-00 J-005279-05 TOP3A 7156 NM_004618 52487034 UCGCCGACCUGCUGUCAAA
Plate 2 D05 L-005279-00 J-005279-06 TOP3A 7156 NM_004618 52487034 CCACACGGCUUGCCUAGUU
Plate 2 D05 L-005279-00 J-005279-07 TOP3A 7156 NM_004618 52487034 CAAAGAUGGUAUCGUAGAA
Plate 2 D05 L-005279-00 J-005279-08 TOP3A 7156 NM_004618 52487034 GAAACUAUCUGGAUGUGUA
Plate 2 D06 L-012272-00 J-012272-05 GPS1 2873 NM_004127 47078239 CCUUUAACGUGGACAUGUA
Plate 2 D06 L-012272-00 J-012272-06 GPS1 2873 NM_004127 47078239 GAAUGCACCUGACGUCAAC
Plate 2 D06 L-012272-00 J-012272-07 GPS1 2873 NM_004127 47078239 GAAUUGGUCUCAUGUGCUC
Plate 2 D06 L-012272-00 J-012272-08 GPS1 2873 NM_004127 47078239 UCACCAAGCUCAAGUGUGC
Plate 2 D07 L-010536-00 J-010536-05 SMARCB1 6598 NM_001007468 55956800 GUGACGAUCUGGAUUUGAA
Plate 2 D07 L-010536-00 J-010536-06 SMARCB1 6598 NM_001007468 55956800 GAAACUACCUCCGUAUGUU
Plate 2 D07 L-010536-00 J-010536-07 SMARCB1 6598 NM_001007468 55956800 GAUGACGCCUGAGAUGUUU
Plate 2 D07 L-010536-00 J-010536-08 SMARCB1 6598 NM_001007468 55956800 GGCAGAAGCCCGUGAAGUU
Plate 2 D08 L-017139-01 J-017139-09 C17orf70 80233 NM_025161 52851424 GCGGUUGACCAGCGGAACA
Plate 2 D08 L-017139-01 J-017139-10 C17orf70 80233 NM_025161 52851424 CCAUCAAGGUGUCGGCGGA
Plate 2 D08 L-017139-01 J-017139-11 C17orf70 80233 NM_025161 52851424 GAGAGGUGGCCAUGACCGA
Plate 2 D08 L-017139-01 J-017139-12 C17orf70 80233 NM_025161 52851424 GUGCAGUACCUCCGCCAGA
Plate 2 D09 L-004240-00 J-004240-07 TOP2B 7155 NM_001068 19913407 GAAGUUGUCUGUUGAGAGA
Plate 2 D09 L-004240-00 J-004240-08 TOP2B 7155 NM_001068 19913407 CGAAAGACCUAAAUACACA
Plate 2 D09 L-004240-00 J-004240-09 TOP2B 7155 NM_001068 19913407 GAUCAUAUGGGAUGUCUGA
Plate 2 D09 L-004240-00 J-004240-10 TOP2B 7155 NM_001068 19913407 GGUGUAUGAUGAAGAUGUA
Plate 2 D10 L-003279-00 J-003279-11 MDM2 4193 NM_006879 46488908 GCCAGUAUAUUAUGACUAA
Plate 2 D10 L-003279-00 J-003279-12 MDM2 4193 NM_006879 46488908 GAACAAGAGACCCUGGUUA
Plate 2 D10 L-003279-00 J-003279-13 MDM2 4193 NM_006879 46488908 GAAUUUAGACAACCUGAAA
Plate 2 D10 L-003279-00 J-003279-14 MDM2 4193 NM_006879 46488908 GAUGAGAAGCAACAACAUA
Plate 2 D11 L-003204-00 J-003204-09 CCNA1 8900 NM_003914 16306528 GAUAUAUCCUCCUGAAGUA
Plate 2 D11 L-003204-00 J-003204-10 CCNA1 8900 NM_003914 16306528 GGACUGAGAACCUGGCUAA
Plate 2 D11 L-003204-00 J-003204-11 CCNA1 8900 NM_003914 16306528 CAUAAAGCGUACCUUGAUA
Plate 2 D11 L-003204-00 J-003204-12 CCNA1 8900 NM_003914 16306528 UCCCGAUGCUUGUCAGAUA
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Plate 2 D11 L-003204-00 J-003204-12 CCNA1 8900 NM_003914 16306528 UCCCGAUGCUUGUCAGAUA
Plate 2 E02 L-006557-00 J-006557-07 RNF4 6047 NM_002938 34305289 GCUAAUACUUGCCCAACUU
Plate 2 E02 L-006557-00 J-006557-08 RNF4 6047 NM_002938 34305289 GAAUGGACGUCUCAUCGUU
Plate 2 E02 L-006557-00 J-006557-09 RNF4 6047 NM_002938 34305289 GACAGAGACGUAUAUGUGA
Plate 2 E02 L-006557-00 J-006557-10 RNF4 6047 NM_002938 34305289 GCAAUAAAUUCUAGACAAG
Plate 2 E03 L-004910-00 J-004910-05 UBE2I 7329 NM_194260 35493995 GGGAAGGAGGCUUGUUUAA
Plate 2 E03 L-004910-00 J-004910-06 UBE2I 7329 NM_194260 35493995 GAAGUUUGCGCCCUCAUAA
Plate 2 E03 L-004910-00 J-004910-07 UBE2I 7329 NM_194260 35493995 GGCCAGCCAUCACAAUCAA
Plate 2 E03 L-004910-00 J-004910-08 UBE2I 7329 NM_194260 35493995 GAACCACCAUUAUUUCACC
Plate 2 E04 L-016005-00 J-016005-07 SUMO1 7341 NM_001005781 54792064 GUGCAUAUAUGAUACAGUU
Plate 2 E04 L-016005-00 J-016005-08 SUMO1 7341 NM_001005781 54792064 GCACUGAAAGUUACUGAAG
Plate 2 E04 L-016005-00 J-016005-09 SUMO1 7341 NM_001005781 54792064 CAUAAAUACUGGAAAUUGC
Plate 2 E04 L-016005-00 J-016005-10 SUMO1 7341 NM_001005781 54792064 AAUACUCAGUGUUCUGUUU
Plate 2 E05 L-004087-00 J-004087-07 RBX1 9978 NM_014248 22091459 GAAGCGCUUUGAAGUGAAA
Plate 2 E05 L-004087-00 J-004087-08 RBX1 9978 NM_014248 22091459 GGGAUAUUGUGGUUGAUAA
Plate 2 E05 L-004087-00 J-004087-09 RBX1 9978 NM_014248 22091459 GGAACCACAUUAUGGAUCU
Plate 2 E05 L-004087-00 J-004087-10 RBX1 9978 NM_014248 22091459 CAUAGAAUGUCAAGCUAAC
Plate 2 E06 L-013133-01 J-013133-09 POLR2L 5441 NM_021128 45359860 GUGGCAAGAUCGUCGGCAA
Plate 2 E06 L-013133-01 J-013133-10 POLR2L 5441 NM_021128 45359860 UCGAGAAGCUGCUCAAUUA
Plate 2 E06 L-013133-01 J-013133-11 POLR2L 5441 NM_021128 45359860 GGAAGGAACCAUCCAGUAA
Plate 2 E06 L-013133-01 J-013133-12 POLR2L 5441 NM_021128 45359860 CGUAAUGCCUGGCCGCAGU
Plate 2 E07 L-011357-00 J-011357-05 POLR2G 5436 NM_002696 4505946 GGACCCGUGUGGACAAGAA
Plate 2 E07 L-011357-00 J-011357-06 POLR2G 5436 NM_002696 4505946 AGAUGGAGUUUGAUCCUAA
Plate 2 E07 L-011357-00 J-011357-07 POLR2G 5436 NM_002696 4505946 ACGAUGAGAUCCGCUUAAA
Plate 2 E07 L-011357-00 J-011357-08 POLR2G 5436 NM_002696 4505946 GCUCCCUGAUGGACGAUUA
Plate 2 E08 L-004723-01 J-004723-09 POLR2F 5435 NM_021974 14602451 AGGCCAACCAGAAGCGAAU
Plate 2 E08 L-004723-01 J-004723-10 POLR2F 5435 NM_021974 14602451 GCUCAUCAUCACCGACUGA
Plate 2 E08 L-004723-01 J-004723-11 POLR2F 5435 NM_021974 14602451 CAUACAUGACCAAGUACGA
Plate 2 E08 L-004723-01 J-004723-12 POLR2F 5435 NM_021974 14602451 GGCUAGAUGACUUGGAGAA
Plate 2 E09 L-012683-00 J-012683-05 COPS2 9318 NM_004236 4759263 GCAAUGACGAAUUUAGUAA
Plate 2 E09 L-012683-00 J-012683-06 COPS2 9318 NM_004236 4759263 GCAUUAAGCAGUUUCCAAA
Plate 2 E09 L-012683-00 J-012683-07 COPS2 9318 NM_004236 4759263 GGUACACAGUUAUUAGAAA
Plate 2 E09 L-012683-00 J-012683-08 COPS2 9318 NM_004236 4759263 CUAAGGAGUUAAACAUAGA
Plate 2 E10 L-008486-00 J-008486-06 PPP4C 5531 NM_002720 4506026 GCACUGAGAUCUUUGACUA
Plate 2 E10 L-008486-00 J-008486-07 PPP4C 5531 NM_002720 4506026 GACAAUCGACCGAAAGCAA
Plate 2 E10 L-008486-00 J-008486-08 PPP4C 5531 NM_002720 4506026 GCACUUAAGGUUCGCUAUC
Plate 2 E10 L-008486-00 J-008486-09 PPP4C 5531 NM_002720 4506026 GGAGCCGGCUACCUAUUUG
Plate 2 E11 L-011545-01 J-011545-09 PER3 8863 NM_016831 8567387 CGGCAUAAAGUUCGAACGA
Plate 2 E11 L-011545-01 J-011545-10 PER3 8863 NM_016831 8567387 CGGAAGAAUUUAAACACGU
Plate 2 E11 L-011545-01 J-011545-11 PER3 8863 NM_016831 8567387 CCAAAGAGCUGCACGGUAU
Plate 2 E11 L-011545-01 J-011545-12 PER3 8863 NM_016831 8567387 AAGGGAAGCACAAGCGGAA
Plate 2 F02 L-019730-00 J-019730-05 SUMO3 6612 NM_006936 48928057 GCAAGCUGAUGAAGGCCUA
Plate 2 F02 L-019730-00 J-019730-06 SUMO3 6612 NM_006936 48928057 GCAGGGCACAGUUUCUAGA
Plate 2 F02 L-019730-00 J-019730-07 SUMO3 6612 NM_006936 48928057 GUGGUGCAGUUCAAGAUCA
Plate 2 F02 L-019730-00 J-019730-08 SUMO3 6612 NM_006936 48928057 GGGAUGAAUCUGUAACUUA
Plate 2 F03 L-016450-00 J-016450-05 SUMO2 6613 NM_001005849 54792070 GUACGUAGCUGUUACAUGU
Plate 2 F03 L-016450-00 J-016450-06 SUMO2 6613 NM_001005849 54792070 GCGUCUUGUUGUUUAAAUA
Plate 2 F03 L-016450-00 J-016450-07 SUMO2 6613 NM_001005849 54792070 UUGCAUACCUUGUUCAAUU
Plate 2 F03 L-016450-00 J-016450-08 SUMO2 6613 NM_001005849 54792070 GCUCUUAUCUUUAUAUUCC
Plate 2 F04 L-010542-00 J-010542-05 TERF1 7013 NM_003218 189409139 CAAAUUCUCAUAUGCCUUU
Plate 2 F04 L-010542-00 J-010542-06 TERF1 7013 NM_003218 9257244 CAGUAGUAGUCCUUUGAUA
Plate 2 F04 L-010542-00 J-010542-07 TERF1 7013 NM_003218 189409139 AGAGUAACCUAUAAGCAUG
Plate 2 F04 L-010542-00 J-010542-08 TERF1 7013 NM_003218 189409139 UACCAGAGUUAAAGCAUAU
Plate 2 F05 L-011979-01 J-011979-09 POLR2K 5440 NM_005034 62422569 ACUAAAAGAUUGGUCGUUU
Plate 2 F05 L-011979-01 J-011979-10 POLR2K 5440 NM_005034 62422569 GUUGUAUAGCUUUCGAUUU
Plate 2 F05 L-011979-01 J-011979-11 POLR2K 5440 NM_005034 62422569 ACUACUGUACUUAGGAAUA
Plate 2 F05 L-011979-01 J-011979-12 POLR2K 5440 NM_005034 62422569 AUAUAUAUCUGUGGAGAGU
Plate 2 F06 L-012249-01 J-012249-09 POLR2J 5439 NM_006234 62422568 CUAAUAAAGUAUAGCGGGA
Plate 2 F06 L-012249-01 J-012249-10 POLR2J 5439 NM_006234 62422568 GCUUUCGGGUGGCCAUAAA
Plate 2 F06 L-012249-01 J-012249-11 POLR2J 5439 NM_006234 62422568 UGUCCACAGUAGAGUUUAA
Plate 2 F06 L-012249-01 J-012249-12 POLR2J 5439 NM_006234 62422568 GCGGUGACUUCGCAAGCAA
Plate 2 F07 L-012247-01 J-012247-09 POLR2H 5437 NM_006232 14589952 GAAGUUUGACCGAGUGUCU
Plate 2 F07 L-012247-01 J-012247-10 POLR2H 5437 NM_006232 14589952 CUGACCAGUUUGAGUAUGU
Plate 2 F07 L-012247-01 J-012247-11 POLR2H 5437 NM_006232 14589952 GAAACUGACUCGCCUGUGA
Plate 2 F07 L-012247-01 J-012247-12 POLR2H 5437 NM_006232 14589952 CUGCAUUGUGAGAGUGAAU
Plate 2 F08 L-010431-00 J-010431-05 SMARCA4 6597 NM_003072 21071055 GCACACCGCUGCAGAACAA
Plate 2 F08 L-010431-00 J-010431-06 SMARCA4 6597 NM_003072 21071055 CCAAGCCGGUCGUGAGUGA
Plate 2 F08 L-010431-00 J-010431-07 SMARCA4 6597 NM_003072 21071055 GCGACUCACUGACGGAGAA
Plate 2 F08 L-010431-00 J-010431-08 SMARCA4 6597 NM_003072 21071055 GACCAGCACUCCCAAGGUU
Plate 2 F09 L-017253-00 J-017253-05 SMARCA2 6595 NM_139045 48255897 CAAAGCAGAUGAACGCUAU
Plate 2 F09 L-017253-00 J-017253-06 SMARCA2 6595 NM_139045 48255897 GAAAGGAGGUGCUAAGACA
Plate 2 F09 L-017253-00 J-017253-07 SMARCA2 6595 NM_139045 48255897 CCGCAUAGCUCAUAGGAUA
Plate 2 F09 L-017253-00 J-017253-08 SMARCA2 6595 NM_139045 48255897 CAACUUGAACGGAAUCUUA
Plate 2 F10 L-020131-01 J-020131-09 POLD2 5425 NM_006230 5453923 CGUGAUGCCAGGCGAGUUU
Plate 2 F10 L-020131-01 J-020131-10 POLD2 5425 NM_006230 5453923 AAGAUGAACUGCAGCGUAU
Plate 2 F10 L-020131-01 J-020131-11 POLD2 5425 NM_006230 5453923 GGGUUAUCCUCGCUGGCAA
Plate 2 F10 L-020131-01 J-020131-12 POLD2 5425 NM_006230 5453923 GGACAGAACGUGAGUGACA
Plate 2 F11 L-011007-00 J-011007-08 CDKN2A 1029 NM_058195 47132605 GAUCAUCAGUCACCGAAGG
Plate 2 F11 L-011007-00 J-011007-09 CDKN2A 1029 NM_058195 47132605 AAACACCGCUUCUGCCUUU
Plate 2 F11 L-011007-00 J-011007-10 CDKN2A 1029 NM_058195 47132605 UAACGUAGAUAUAUGCCUU
Plate 2 F11 L-011007-00 J-011007-11 CDKN2A 1029 NM_058195 47132605 CAGAACCAAAGCUCAAAUA
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Plate 2 F11 L-011007-00 J-011007-11 CDKN2A 1029 NM_058195 47132605 CAGAACCAAAGCUCAAAUA
Plate 2 G02 L-026539-01 J-026539-09 NCAPD3 23310 NM_015261 76880473 GAUUAACAGUCCUACGUUU
Plate 2 G02 L-026539-01 J-026539-10 NCAPD3 23310 NM_015261 76880473 GAUGAGAAGACCAACGUUA
Plate 2 G02 L-026539-01 J-026539-11 NCAPD3 23310 NM_015261 76880473 CAGGGAAUAUGGACGAAGA
Plate 2 G02 L-026539-01 J-026539-12 NCAPD3 23310 NM_015261 76880473 GGGAAUACGCUAUGUUCAU
Plate 2 G03 L-019086-01 J-019086-09 RFC3 5983 NM_181558 31795537 CAGCAUGCCUUGCGAAGAA
Plate 2 G03 L-019086-01 J-019086-10 RFC3 5983 NM_181558 31795537 GGAAAUAGUGACCGAGUAG
Plate 2 G03 L-019086-01 J-019086-11 RFC3 5983 NM_181558 31795537 CCUUGGGACGGCUGGACUA
Plate 2 G03 L-019086-01 J-019086-12 RFC3 5983 NM_181558 31795537 AGACAGAUUGGGAGGUGUA
Plate 2 G04 L-009773-01 J-009773-09 RFC5 5985 NM_007370 31795541 GCUUCAGAUGACCGAGGAA
Plate 2 G04 L-009773-01 J-009773-10 RFC5 5985 NM_007370 31795541 GGCCGAAACUAUUAUACUU
Plate 2 G04 L-009773-01 J-009773-11 RFC5 5985 NM_007370 31795541 GCGUAGGGCUCUGAACAUU
Plate 2 G04 L-009773-01 J-009773-12 RFC5 5985 NM_007370 31795541 UUGCAGAGGCCUAGAUGCU
Plate 2 G05 L-003471-00 J-003471-09 CDKN1A 1026 NM_000389 17978496 CGACUGUGAUGCGCUAAUG
Plate 2 G05 L-003471-00 J-003471-10 CDKN1A 1026 NM_000389 17978496 CCUAAUCCGCCCACAGGAA
Plate 2 G05 L-003471-00 J-003471-11 CDKN1A 1026 NM_000389 17978496 CGUCAGAACCCAUGCGGCA
Plate 2 G05 L-003471-00 J-003471-12 CDKN1A 1026 NM_000389 17978496 AGACCAGCAUGACAGAUUU
Plate 2 G06 L-012248-01 J-012248-09 POLR2I 5438 NM_006233 47933390 CGCACGAAGUGGACGAACU
Plate 2 G06 L-012248-01 J-012248-10 POLR2I 5438 NM_006233 47933390 CCAGAUUCCAUGCGUGAAA
Plate 2 G06 L-012248-01 J-012248-11 POLR2I 5438 NM_006233 47933390 AAGACAAGGAGAACCGCAU
Plate 2 G06 L-012248-01 J-012248-12 POLR2I 5438 NM_006233 47933390 ACAAGGAGGCUGUGUUCUU
Plate 2 G07 L-009290-00 J-009290-05 RFC1 5981 NM_002913 32528305 GUAAAUAGCUCCCGUAAAG
Plate 2 G07 L-009290-00 J-009290-06 RFC1 5981 NM_002913 32528305 GGAAUUAAUUGGCCUGAUA
Plate 2 G07 L-009290-00 J-009290-07 RFC1 5981 NM_002913 32528305 GUCCAAAGAUCUAAUAAGA
Plate 2 G07 L-009290-00 J-009290-08 RFC1 5981 NM_002913 32528305 CAUAUGCGAUGGUGACCUA
Plate 2 G08 L-019061-00 J-019061-05 RFC2 5982 NM_002914 31563535 CUUGUAAUGCUUCGGAUAA
Plate 2 G08 L-019061-00 J-019061-06 RFC2 5982 NM_002914 31563535 GAACUGCCGUGGGUUGAAA
Plate 2 G08 L-019061-00 J-019061-07 RFC2 5982 NM_002914 31563535 CGGCAAGACCACAAGCAUU
Plate 2 G08 L-019061-00 J-019061-08 RFC2 5982 NM_002914 31563535 GCUGUGCAGUCCUCCGGUA
Plate 2 G09 L-008691-00 J-008691-06 RFC4 5984 NM_181573 31881686 UCAAAGCGCUACUCGAUUA
Plate 2 G09 L-008691-00 J-008691-07 RFC4 5984 NM_181573 31881686 GACCAAGGAUCGAGGAGUA
Plate 2 G09 L-008691-00 J-008691-08 RFC4 5984 NM_181573 31881686 CAGCAGUUAUCUCAGAAUU
Plate 2 G09 L-008691-00 J-008691-09 RFC4 5984 NM_181573 31881686 GAACGUGGAAUACAAGUAG
Plate 2 G10 L-011187-00 J-011187-05 POLR2B 5431 NM_000938 4505940 CCAAUUAUGUUGCGGUCAA
Plate 2 G10 L-011187-00 J-011187-06 POLR2B 5431 NM_000938 4505940 GAAAUGAGGUCCUGUACAA
Plate 2 G10 L-011187-00 J-011187-07 POLR2B 5431 NM_000938 4505940 GGAACGAGAUUGUCAGAUU
Plate 2 G10 L-011187-00 J-011187-08 POLR2B 5431 NM_000938 4505940 GAAGCAUGCUGGAUUGUAA
Plate 2 G11 L-003227-00 J-003227-10 CDC25B 994 NM_212530 47078254 GAGAUUACUCUAAGGCCUU
Plate 2 G11 L-003227-00 J-003227-11 CDC25B 994 NM_212530 47078254 GCAGAUACCCCUAUGAAUA
Plate 2 G11 L-003227-00 J-003227-12 CDC25B 994 NM_212530 47078254 UGGAUAAGUUUGUGAUUGU
Plate 2 G11 L-003227-00 J-003227-13 CDC25B 994 NM_212530 47078254 AGAGUGACUUAAAGGAUGA
Plate 2 H02 L-003226-00 J-003226-10 CDC25A 993 NM_201567 42490759 GGGCAGUGAUUAUGAGCAA
Plate 2 H02 L-003226-00 J-003226-11 CDC25A 993 NM_201567 42490759 UCAGGUUUCUGUCUAGAUU
Plate 2 H02 L-003226-00 J-003226-12 CDC25A 993 NM_201567 42490759 GCAAGCGUGUCAUUGUUGU
Plate 2 H02 L-003226-00 J-003226-13 CDC25A 993 NM_201567 42490759 CAUGACAUCUUUCAGCUCA
Plate 2 H03 L-005050-00 J-005050-05 WEE1 7465 NM_003390 19718775 AAUAGAACAUCUCGACUUA
Plate 2 H03 L-005050-00 J-005050-06 WEE1 7465 NM_003390 19718775 AAUAUGAAGUCCCGGUAUA
Plate 2 H03 L-005050-00 J-005050-07 WEE1 7465 NM_003390 19718775 GAUCAUAUGCUUAUACAGA
Plate 2 H03 L-005050-00 J-005050-08 WEE1 7465 NM_003390 19718775 CGACAGACUCCUCAAGUGA
Plate 2 H04 L-003212-00 J-003212-10 CCND3 896 NM_001760 16950657 GGACCUGGCUGCUGUGAUU
Plate 2 H04 L-003212-00 J-003212-11 CCND3 896 NM_001760 16950657 UGCGGAAGAUGCUGGCUUA
Plate 2 H04 L-003212-00 J-003212-12 CCND3 896 NM_001760 16950657 GAGCUGCUGUGUUGCGAAG
Plate 2 H04 L-003212-00 J-003212-13 CCND3 896 NM_001760 16950657 GAUCGAAGCUGCACUCAGG
Plate 2 H05 L-003211-00 J-003211-10 CCND2 894 NM_001759 16950656 GAUCGCAACUGGAAGUGUG
Plate 2 H05 L-003211-00 J-003211-11 CCND2 894 NM_001759 16950656 UGACUGAGCUGCUGGCUAA
Plate 2 H05 L-003211-00 J-003211-12 CCND2 894 NM_001759 16950656 GCUCAGACCUUCAUUGCUC
Plate 2 H05 L-003211-00 J-003211-13 CCND2 894 NM_001759 16950656 UCUCAAAGCUUGCCAGGAG
Plate 2 H06 L-003236-00 J-003236-11 CDK2 1017 NM_052827 16936529 GAGCUUAACCAUCCUAAUA
Plate 2 H06 L-003236-00 J-003236-12 CDK2 1017 NM_052827 16936529 GAAACAAGUUGACGGGAGA
Plate 2 H06 L-003236-00 J-003236-13 CDK2 1017 NM_052827 16936529 GGAGUUACUUCUAUGCCUG
Plate 2 H06 L-003236-00 J-003236-14 CDK2 1017 NM_052827 16936529 GGGCCUAGCUUUCUGCCAU
Plate 2 H07 L-011186-00 J-011186-06 POLR2A 5430 NM_000937 14589948 UAAUAGAGGUCAUCGAGAA
Plate 2 H07 L-011186-00 J-011186-07 POLR2A 5430 NM_000937 14589948 CAGGUGAACCGCAUUCUUA
Plate 2 H07 L-011186-00 J-011186-08 POLR2A 5430 NM_000937 14589948 GGGAUGAGAUGAACUUGCA
Plate 2 H07 L-011186-00 J-011186-09 POLR2A 5430 NM_000937 14589948 CAACUAUAGUCCCACAUCA
Plate 2 H08 L-003213-00 J-003213-10 CCNE1 898 NM_057182 17318560 GUACUGAGCUGGGCAAAUA
Plate 2 H08 L-003213-00 J-003213-11 CCNE1 898 NM_057182 17318560 UGUCCUGGCUGAAUGUAUA
Plate 2 H08 L-003213-00 J-003213-12 CCNE1 898 NM_057182 17318560 GGACAAUAAUGCAGUCUGU
Plate 2 H08 L-003213-00 J-003213-13 CCNE1 898 NM_057182 17318560 GGAGGUGUGUGAAGUCUAU
Plate 2 H09 L-003209-00 J-003209-09 CCNC 892 NM_001013399 61676092 GAUUGUUGCUUGAUAGUGU
Plate 2 H09 L-003209-00 J-003209-10 CCNC 892 NM_001013399 61676092 ACAUGUAGCCUGUGUUGUA
Plate 2 H09 L-003209-00 J-003209-11 CCNC 892 NM_001013399 61676092 GGAUAGUGAAUGAUACCUA
Plate 2 H09 L-003209-00 J-003209-12 CCNC 892 NM_001013399 61676092 GAAGUCAGAACUCUAGCUA
Plate 2 H10 L-003210-00 J-003210-15 CCND1 595 NM_053056 77628152 ACAACUUCCUGUCCUACUA
Plate 2 H10 L-003210-00 J-003210-16 CCND1 595 NM_053056 77628152 GUUCGUGGCCUCUAAGAUG
Plate 2 H10 L-003210-00 J-003210-17 CCND1 595 NM_053056 77628152 GCAUGUAGUCACUUUAUAA
Plate 2 H10 L-003210-00 J-003210-18 CCND1 595 NM_053056 77628152 GCGUGUAGCUAUGGAAGUU
Plate 2 H11 L-004270-00 J-004270-05 RRM1 6240 NM_001033 21071083 UAUGAGGGCUCUCCAGUUA
Plate 2 H11 L-004270-00 J-004270-06 RRM1 6240 NM_001033 21071083 UGAGAGAGGUGCUUUCAUU
Plate 2 H11 L-004270-00 J-004270-07 RRM1 6240 NM_001033 21071083 UGGAAGACCUCUAUAACUA
Plate 2 H11 L-004270-00 J-004270-08 RRM1 6240 NM_001033 21071083 CUACUAAGCACCCUGACUA
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Plate 3 A02 L-004509-00 J-004509-05 UBA1 7317 NM_153280 23510339 GCGUGGAGAUCGCUAAGAA
Plate 3 A02 L-004509-00 J-004509-06 UBA1 7317 NM_153280 23510339 CCUUAUACCUUUAGCAUCU
Plate 3 A02 L-004509-00 J-004509-07 UBA1 7317 NM_153280 23510339 CCACAUAUCCGGGUGACAA
Plate 3 A02 L-004509-00 J-004509-08 UBA1 7317 NM_153280 23510339 GAAGUCAAAUCUGAAUCGA
Plate 3 A03 L-003205-00 J-003205-10 CCNA2 890 NM_001237 16950653 GGAAAUGGAGGUUAAAUGU
Plate 3 A03 L-003205-00 J-003205-11 CCNA2 890 NM_001237 16950653 UAGCAGAGUUUGUGUACAU
Plate 3 A03 L-003205-00 J-003205-12 CCNA2 890 NM_001237 16950653 AUGAGGAUAUUCACACAUA
Plate 3 A03 L-003205-00 J-003205-13 CCNA2 890 NM_001237 16950653 UGAUAGAUGCUGACCCAUA
Plate 3 A04 L-004739-01 J-004739-09 POLR2E 5434 NM_002695 14589950 CGAUAUAAGCUCCGAGAGA
Plate 3 A04 L-004739-01 J-004739-10 POLR2E 5434 NM_002695 14589950 CAUCACGGAGCACGAGCUA
Plate 3 A04 L-004739-01 J-004739-11 POLR2E 5434 NM_002695 14589950 CCUGUGGAUUUGUGCGAGA
Plate 3 A04 L-004739-01 J-004739-12 POLR2E 5434 NM_002695 14589950 GAGGAGACGUACCGGCUCU
Plate 3 A05 L-009620-01 J-009620-09 POLR2C 5432 NM_032940 89276761 CAGCCUACCGUGCGGAUCA
Plate 3 A05 L-009620-01 J-009620-10 POLR2C 5432 NM_032940 89276761 UCAAUUAAGCCACGAGAUC
Plate 3 A05 L-009620-01 J-009620-11 POLR2C 5432 NM_032940 89276761 GGAGCUCACUGACGAGAAU
Plate 3 A05 L-009620-01 J-009620-12 POLR2C 5432 NM_032940 89276761 CCUAUGACCCCAACGGCAA
Plate 3 A06 L-003206-00 J-003206-09 CCNB1 891 NM_031966 34304372 CAACAUUACCUGUCAUAUA
Plate 3 A06 L-003206-00 J-003206-10 CCNB1 891 NM_031966 34304372 UGCACUAGUUCAAGAUUUA
Plate 3 A06 L-003206-00 J-003206-11 CCNB1 891 NM_031966 34304372 GAAUGUAGUCAUGGUAAAU
Plate 3 A06 L-003206-00 J-003206-12 CCNB1 891 NM_031966 34304372 CUAAUUGACUGGCUAGUAC
Plate 3 A07 L-003238-00 J-003238-12 CDK4 1019 NM_000075 16936531 CAAGGUAACCCUGGUGUUU
Plate 3 A07 L-003238-00 J-003238-13 CDK4 1019 NM_000075 16936531 GAGCUCUGCAGCACUCUUA
Plate 3 A07 L-003238-00 J-003238-14 CDK4 1019 NM_000075 16936531 CAGCACAGUUCGUGAGGUG
Plate 3 A07 L-003238-00 J-003238-15 CDK4 1019 NM_000075 16936531 GCACUUACACCCGUGGUUG
Plate 3 A08 L-005278-00 J-005278-05 TOP1 7150 NM_003286 19913404 GAAAAUGGCUUCUCUAGUC
Plate 3 A08 L-005278-00 J-005278-06 TOP1 7150 NM_003286 19913404 GAUUUCCGAUUGAAUGAUU
Plate 3 A08 L-005278-00 J-005278-07 TOP1 7150 NM_003286 19913404 GCACAUCAAUCUACACCCA
Plate 3 A08 L-005278-00 J-005278-08 TOP1 7150 NM_003286 19913404 CGAAGAAGGUAGUAGAGUC
Plate 3 A09 L-020381-00 J-020381-05 TFPT 29844 NM_013342 7019370 GGAAUUAAAUCGCAGAAAG
Plate 3 A09 L-020381-00 J-020381-06 TFPT 29844 NM_013342 7019370 AGACGGAAGUGGAGUUUGU
Plate 3 A09 L-020381-00 J-020381-07 TFPT 29844 NM_013342 7019370 GACUGACGCAUGCCCAAUA
Plate 3 A09 L-020381-00 J-020381-08 TFPT 29844 NM_013342 7019370 CGGUGCAGAUUAAGGUUGA
Plate 3 A10 L-009702-00 J-009702-05 DNTT 1791 NM_001017520 63054851 GCAGGAAGGUUGAUGCUUU
Plate 3 A10 L-009702-00 J-009702-06 DNTT 1791 NM_001017520 63054851 GGGAUUGGAUUAUAUUGAA
Plate 3 A10 L-009702-00 J-009702-07 DNTT 1791 NM_001017520 63054851 GUCAAAGAGUGGACAGUGA
Plate 3 A10 L-009702-00 J-009702-08 DNTT 1791 NM_001017520 63054851 CGGAAGAUGAUUCUGGAUA
Plate 3 A11 L-005282-00 J-005282-07 TOP3B 8940 NM_003935 34335290 UCACCAGGUUUCAGACUAA
Plate 3 A11 L-005282-00 J-005282-08 TOP3B 8940 NM_003935 34335290 GUGCACGGCUACUAUAAGA
Plate 3 A11 L-005282-00 J-005282-09 TOP3B 8940 NM_003935 34335290 CGAGUACACUGGGACCUUU
Plate 3 A11 L-005282-00 J-005282-10 TOP3B 8940 NM_003935 34335290 CGUGGCGGCUCUAUGAGUA
Plate 3 B02 L-006836-01 J-006836-09 SMC2 10592 NM_006444 5453590 GCAGAGGCUCAGCGAGUUA
Plate 3 B02 L-006836-01 J-006836-10 SMC2 10592 NM_006444 5453590 GGUUCGGGCUUCUAAUUUA
Plate 3 B02 L-006836-01 J-006836-11 SMC2 10592 NM_006444 5453590 CAGCAAAGCUCAUAUCACA
Plate 3 B02 L-006836-01 J-006836-12 SMC2 10592 NM_006444 5453590 CCCAAGACACUGUAAUUAA
Plate 3 B03 L-004740-00 J-004740-05 TNKS 8658 NM_003747 4507612 CUACAACAGAGUUCGAAUA
Plate 3 B03 L-004740-00 J-004740-06 TNKS 8658 NM_003747 4507612 GCAUGGAGCUUGUGUUAAU
Plate 3 B03 L-004740-00 J-004740-07 TNKS 8658 NM_003747 4507612 CGAAAGAGCCCAUAAUGAU
Plate 3 B03 L-004740-00 J-004740-08 TNKS 8658 NM_003747 4507612 GAGAGUACACCUAUACGUA
Plate 3 B04 L-003207-00 J-003207-09 CCNB2 9133 NM_004701 10938017 GUGACUACGUUAAGGAUAU
Plate 3 B04 L-003207-00 J-003207-10 CCNB2 9133 NM_004701 10938017 GUACAUGUGCGUUGGCAUU
Plate 3 B04 L-003207-00 J-003207-11 CCNB2 9133 NM_004701 10938017 CAAGUCCACUCCAAGUUUA
Plate 3 B04 L-003207-00 J-003207-12 CCNB2 9133 NM_004701 10938017 UAACGAAGAUUGGGAGAAC
Plate 3 B05 L-012708-00 J-012708-05 BCAS2 10286 NM_005872 49472833 GCAGAUACCGACCUACUAA
Plate 3 B05 L-012708-00 J-012708-06 BCAS2 10286 NM_005872 49472833 GCAUCAAGCAGUUAGAAUU
Plate 3 B05 L-012708-00 J-012708-07 BCAS2 10286 NM_005872 49472833 UGGAUGCGCUGCCGUAUUU
Plate 3 B05 L-012708-00 J-012708-08 BCAS2 10286 NM_005872 49472833 GAGAUUGAACGGACUAUUG
Plate 3 B06 L-021331-01 J-021331-09 PPP6R2 9701 NM_014678 55749632 CCGAACAGGUGAUUACGUU
Plate 3 B06 L-021331-01 J-021331-10 PPP6R2 9701 NM_014678 55749632 UGUCAGCAGCAGCGUACUA
Plate 3 B06 L-021331-01 J-021331-11 PPP6R2 9701 NM_014678 55749632 CAGUGACAAAGGACGGGAA
Plate 3 B06 L-021331-01 J-021331-12 PPP6R2 9701 NM_014678 55749632 CAAUAAAAGCCGUGACGUU
Plate 3 B07 L-013639-00 J-013639-05 DKC1 1736 NM_001363 15011921 CAAGGUGACUGGUUGUUUA
Plate 3 B07 L-013639-00 J-013639-06 DKC1 1736 NM_001363 15011921 GCAGGUAGUUGCCGAAGCA
Plate 3 B07 L-013639-00 J-013639-07 DKC1 1736 NM_001363 15011921 UCUCAUAAACGGCUGGUUA
Plate 3 B07 L-013639-00 J-013639-08 DKC1 1736 NM_001363 15011921 GGACAGGUUUCAUUAAUCU
Plate 3 B08 L-011478-00 J-011478-05 SMARCA5 8467 NM_003601 21071057 GGAAUGGUAUACUCGGAUA
Plate 3 B08 L-011478-00 J-011478-06 SMARCA5 8467 NM_003601 21071057 GGGCAAAUAGAUUCGAGUA
Plate 3 B08 L-011478-00 J-011478-07 SMARCA5 8467 NM_003601 21071057 GGAUUUACCAAUUGGAAUA
Plate 3 B08 L-011478-00 J-011478-08 SMARCA5 8467 NM_003601 21071057 GUUCUUUCCUCCACGUUUA
Plate 3 B09 L-019593-00 J-019593-05 PLRG1 5356 NM_002669 77404429 AUUAACACAUUGACGGUAA
Plate 3 B09 L-019593-00 J-019593-06 PLRG1 5356 NM_002669 77404429 CAGUGAAUCAGGAAUAUUU
Plate 3 B09 L-019593-00 J-019593-07 PLRG1 5356 NM_002669 77404429 UCUGAAAGUCGAUUACUAA
Plate 3 B09 L-019593-00 J-019593-08 PLRG1 5356 NM_002669 77404429 CAUCUUGGCUGGGUUCGAU
Plate 3 B10 L-011943-00 J-011943-05 POLR2D 5433 NM_004805 14589949 GUAUUAAUCUCCAAACAUC
Plate 3 B10 L-011943-00 J-011943-06 POLR2D 5433 NM_004805 14589949 GAGAGACCAUUGCCAGUGU
Plate 3 B10 L-011943-00 J-011943-07 POLR2D 5433 NM_004805 14589949 AGUUUGAGUUGGCCUGUUU
Plate 3 B10 L-011943-00 J-011943-08 POLR2D 5433 NM_004805 14589949 GAAUUAAACCGCUGUUAGU
Plate 3 B11 L-008266-00 J-008266-06 UBD 10537 NM_006398 222352095 GAACAUGUCCGGUCUAAGA
Plate 3 B11 L-008266-00 J-008266-07 UBD 10537 NM_006398 222352095 GCAAUGAUCGAGACUAAGA
Plate 3 B11 L-008266-00 J-008266-08 UBD 10537 NM_006398 50355987 CCUCUCAUCUUACGGCAUU
Plate 3 B11 L-008266-00 J-008266-09 UBD 10537 NM_006398 222352095 GAUCUUAAAGCCACGGAGA
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Plate 3 B11 L-008266-00 J-008266-09 UBD 10537 NM_006398 222352095 GAUCUUAAAGCCACGGAGA
Plate 3 C02 L-006536-00 J-006536-06 MDM4 4194 NM_002393 4505138 CGUCAGAGCUUCUCCGUAA
Plate 3 C02 L-006536-00 J-006536-07 MDM4 4194 NM_002393 323510635 CCACGAGACGGGAACAUUA
Plate 3 C02 L-006536-00 J-006536-08 MDM4 4194 NM_002393 323510635 AAGCAUGGGAGAACAGUUA
Plate 3 C02 L-006536-00 J-006536-09 MDM4 4194 NM_002393 323510635 CCUAAAGAUGCGUAUAUAA
Plate 3 C03 L-023451-00 J-023451-05 ANKRD28 23243 NM_015199 68131556 UCAGAAUGCUUACGGCUAU
Plate 3 C03 L-023451-00 J-023451-06 ANKRD28 23243 NM_015199 68131556 GGAAGGACAGCGUUGCAUA
Plate 3 C03 L-023451-00 J-023451-07 ANKRD28 23243 NM_015199 68131556 GUAGUGAAAUUGCUUGUGU
Plate 3 C03 L-023451-00 J-023451-08 ANKRD28 23243 NM_015199 68131556 GUAAUCGACUGUGAGGAUA
Plate 3 C04 L-012977-00 J-012977-05 PER2 8864 NM_003894 12707560 GAAUGGAUACGCGGAAUUU
Plate 3 C04 L-012977-00 J-012977-06 PER2 8864 NM_003894 12707560 CUUCAGCGAUGCCAAGUUU
Plate 3 C04 L-012977-00 J-012977-07 PER2 8864 NM_003894 12707560 GCAGUGGAGCAGAUUCUUU
Plate 3 C04 L-012977-00 J-012977-08 PER2 8864 NM_003894 12707560 CGACCAGUCUUCGAAAGUG
Plate 3 C05 L-003547-00 J-003547-06 TERT 7015 NM_198254 38201699 GAACGGGCCUGGAACCAUA
Plate 3 C05 L-003547-00 J-003547-07 TERT 7015 NM_198254 38201699 CGCCUGAGCUGUACUUUGU
Plate 3 C05 L-003547-00 J-003547-08 TERT 7015 NM_198254 38201699 GGUAUGCCGUGGUCCAGAA
Plate 3 C05 L-003547-00 J-003547-09 TERT 7015 NM_198254 38201699 GCGACGACGUGCUGGUUCA
Plate 3 C06 L-017263-00 J-017263-05 ARID1A 8289 NM_018450 21264568 GAAUAGGGCCUGAGGGAAA
Plate 3 C06 L-017263-00 J-017263-06 ARID1A 8289 NM_018450 21264568 AGAUGUGGGUGGACCGUUA
Plate 3 C06 L-017263-00 J-017263-07 ARID1A 8289 NM_018450 21264568 GCAACGACAUGAUUCCUAU
Plate 3 C06 L-017263-00 J-017263-08 ARID1A 8289 NM_018450 21264568 GGACCUCUAUCGCCUCUAU
Plate 3 C07 L-009935-00 J-009935-06 PPP6C 5537 NM_002721 20127429 CUAAAUGGCCUGAUCGUAU
Plate 3 C07 L-009935-00 J-009935-07 PPP6C 5537 NM_002721 20127429 CGCUAGACCUGGACAAGUA
Plate 3 C07 L-009935-00 J-009935-08 PPP6C 5537 NM_002721 20127429 GUUUGGAGACCUUCACUUA
Plate 3 C07 L-009935-00 J-009935-09 PPP6C 5537 NM_002721 20127429 CGAACGGAAUCAGGAAAUU
Plate 3 C08 L-016829-01 J-016829-09 STRA13 201254 NM_144998 71559138 CCUUUCCAGCCAUGCGAUA
Plate 3 C08 L-016829-01 J-016829-10 STRA13 201254 NM_144998 71559138 CAUCAAAGCUGGCGUGUGA
Plate 3 C08 L-016829-01 J-016829-11 STRA13 201254 NM_144998 71559138 ACGUGGACCAGCUGGAGAA
Plate 3 C08 L-016829-01 J-016829-12 STRA13 201254 NM_144998 71559138 GGAAGGACCUGAAGGAUUU
Plate 3 C09 L-021627-01 J-021627-09 HFM1 164045 NM_001017975 130484566 UCACAGAAAUUCCGGCAAA
Plate 3 C09 L-021627-01 J-021627-10 HFM1 164045 NM_001017975 130484566 GCACAUCAGUAUUCCGGAA
Plate 3 C09 L-021627-01 J-021627-11 HFM1 164045 NM_001017975 130484566 GAUAGCAUGACUAGGAAAU
Plate 3 C09 L-021627-01 J-021627-12 HFM1 164045 NM_001017975 63025209 AGCAAUAGUAAGCAGAAAU
Plate 3 C10 L-004164-00 J-004164-09 PIAS3 10401 NM_006099 31543399 GAGCCGACAUCCAAGGUUU
Plate 3 C10 L-004164-00 J-004164-10 PIAS3 10401 NM_006099 31543399 UAAGAAGAAGGUCGAAGUU
Plate 3 C10 L-004164-00 J-004164-11 PIAS3 10401 NM_006099 31543399 GGAAGCGCACUUUACCUUU
Plate 3 C10 L-004164-00 J-004164-12 PIAS3 10401 NM_006099 31543399 GACAGAGAGUCAGCACUAU
Plate 3 C11 L-020943-02 J-020943-17 PARPBP 55010 NM_017915 90819238 AGUAAAUACAACCGUGAUA
Plate 3 C11 L-020943-02 J-020943-18 PARPBP 55010 NM_017915 90819238 GAAUAGAUUGUACGGCAAA
Plate 3 C11 L-020943-02 J-020943-19 PARPBP 55010 NM_017915 90819238 CGAGAGAAACAAAUGUCUA
Plate 3 C11 L-020943-02 J-020943-20 PARPBP 55010 NM_017915 90819238 CAACAAUUGGAACGAGUUU
Plate 3 D02 L-013665-00 J-013665-05 TONSL 4796 NM_013432 34304357 CAAGGAAGGCUGUGCUCUA
Plate 3 D02 L-013665-00 J-013665-06 TONSL 4796 NM_013432 34304357 GUCAGAACCUCCAGCAUGU
Plate 3 D02 L-013665-00 J-013665-07 TONSL 4796 NM_013432 34304357 GACAACCGCAGGCCCAGUA
Plate 3 D02 L-013665-00 J-013665-08 TONSL 4796 NM_013432 34304357 GGACCCGCCUCUAUCUCAA
Plate 3 D03 L-017404-00 J-017404-05 FBXO18 84893 NM_178150 30795118 CCUCAACGCUGGUCAAGUA
Plate 3 D03 L-017404-00 J-017404-06 FBXO18 84893 NM_178150 30795118 AGGGAAGGGUGGAUUCAUA
Plate 3 D03 L-017404-00 J-017404-07 FBXO18 84893 NM_178150 30795118 GUGCCUAUUUGGUGUAAGA
Plate 3 D03 L-017404-00 J-017404-08 FBXO18 84893 NM_178150 30795118 AAACAAAACCUCGUCAUUA
Plate 3 D04 L-006445-00 J-006445-05 PIAS4 51588 NM_015897 24850132 GAAUUAGUCCCACAGAACA
Plate 3 D04 L-006445-00 J-006445-06 PIAS4 51588 NM_015897 24850132 GUACUUAAACGGACUGGGA
Plate 3 D04 L-006445-00 J-006445-07 PIAS4 51588 NM_015897 24850132 CAAGACAGGUGGAGUUGAU
Plate 3 D04 L-006445-00 J-006445-08 PIAS4 51588 NM_015897 24850132 GGAACUACGGCAAGAGCUA
Plate 3 D05 L-015697-01 J-015697-09 SFR1 119392 NM_001002759 50593525 AUACAAAUAGUUCCCGAAA
Plate 3 D05 L-015697-01 J-015697-10 SFR1 119392 NM_001002759 50593525 AAACAAAGAUUAAACGCUG
Plate 3 D05 L-015697-01 J-015697-11 SFR1 119392 NM_001002759 50593525 ACUAUGGGUUAGAUGAUAA
Plate 3 D05 L-015697-01 J-015697-12 SFR1 119392 NM_001002759 50593525 CUGAUAGUCUAGCAGGUAA
Plate 3 D06 L-027225-02 J-027225-19 MMS22L 253714 NM_198468 115583682 AAUCCUACCUUGAGUAUAA
Plate 3 D06 L-027225-02 J-027225-20 MMS22L 253714 NM_198468 115583682 GGAAUACCUUGGUGAAGUA
Plate 3 D06 L-027225-02 J-027225-21 MMS22L 253714 NM_198468 115583682 AAGACUUGCUGUUGCGAUA
Plate 3 D06 L-027225-02 J-027225-22 MMS22L 253714 NM_198468 115583682 GCUACUGAAUCAUGCUUUA
Plate 3 D07 L-014591-01 J-014591-09 TTI2 80185 NM_025115 13376690 GCACGACGAGGCAACGUAA
Plate 3 D07 L-014591-01 J-014591-10 TTI2 80185 NM_025115 387942386 CAAGAAACCUGCCGGCUUU
Plate 3 D07 L-014591-01 J-014591-11 TTI2 80185 NM_025115 387942386 GUGAUGAGGUCCUGCGGCU
Plate 3 D07 L-014591-01 J-014591-12 TTI2 80185 NM_025115 387942386 AGACCUCGGUGAUCUAAUA
Plate 3 D08 L-029596-02 J-029596-18 SWI5 375757 NM_001040011 148664191 CUGAAAUGUCGCAGUGAUA
Plate 3 D08 L-029596-02 J-029596-19 SWI5 375757 NM_001040011 148664191 GAACCAAGACUUACCCGAA
Plate 3 D08 L-029596-02 J-029596-20 SWI5 375757 NM_001040011 148664191 AGAGUUGUAUCCAGAGUUU
Plate 3 D08 L-029596-02 J-029596-21 SWI5 375757 NM_001040011 148664191 GUUCGUAUCUGAAGGCUAC
Plate 3 D09 L-184374-00 J-184374-09 ZSWIM7 125150 NM_001042698 111607458 GAUGAAGUUUCGACGAGUA
Plate 3 D09 L-184374-00 J-184374-10 ZSWIM7 125150 NM_001042698 111607458 UCUGAGACGCUUCGGUAAA
Plate 3 D09 L-184374-00 J-184374-11 ZSWIM7 125150 NM_001042698 111607458 GAGAGUUAGUAUCGAGAAC
Plate 3 D09 L-184374-00 J-184374-12 ZSWIM7 125150 NM_001042698 111607458 CAAAGAAGCAAUAAUACGU
Plate 3 D10 L-011683-00 J-011683-06 H2AFZ 3015 NM_002106 53759146 UCUAAAGGAUGCCUGGAUU
Plate 3 D10 L-011683-00 J-011683-07 H2AFZ 3015 NM_002106 53759146 GAUGCAGAAGUUAUAGUAA
Plate 3 D10 L-011683-00 J-011683-08 H2AFZ 3015 NM_002106 53759146 CAACCAAAUUUCUGCAUUC
Plate 3 D10 L-011683-00 J-011683-09 H2AFZ 3015 NM_002106 53759146 CAAUAAAGGUCAUAUCCCA
Plate 3 D11 L-008167-00 J-008167-06 PIAS1 8554 NM_016166 7706636 GAAUAAGGAAUCCGGAUCA
Plate 3 D11 L-008167-00 J-008167-07 PIAS1 8554 NM_016166 7706636 AAACAAGCACGGACGCAAA
Plate 3 D11 L-008167-00 J-008167-08 PIAS1 8554 NM_016166 7706636 GUUAUGAGCCUUAGAGUUU
Plate 3 D11 L-008167-00 J-008167-09 PIAS1 8554 NM_016166 7706636 CGACCCAGCCGACCAAUUA
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Plate 3 D11 L-008167-00 J-008167-09 PIAS1 8554 NM_016166 7706636 CGACCCAGCCGACCAAUUA
Plate 3 E02 L-009428-00 J-009428-06 PIAS2 9063 NM_173206 56699459 ACAACUAGCCUUCGGGUAU
Plate 3 E02 L-009428-00 J-009428-07 PIAS2 9063 NM_173206 56699459 UCGAAGAGUUGAGGAAUAU
Plate 3 E02 L-009428-00 J-009428-08 PIAS2 9063 NM_173206 56699459 UCAUCAAGCCCACGAGUUU
Plate 3 E02 L-009428-00 J-009428-09 PIAS2 9063 NM_173206 56699459 UGAGGGCGCUGCAUUUAUU
Plate 3 E03 L-014188-00 J-014188-05 TTI1 9675 NM_014657 24307960 GAACACACCUGCCAAGUUA
Plate 3 E03 L-014188-00 J-014188-06 TTI1 9675 NM_014657 24307960 AGGAUUUGCUGUAUCUUUA
Plate 3 E03 L-014188-00 J-014188-07 TTI1 9675 NM_014657 24307960 GUGAAUGGGAUCUCUUUAA
Plate 3 E03 L-014188-00 J-014188-08 TTI1 9675 NM_014657 24307960 GCACUGACCAGGCUUAUCA
Plate 3 E04 L-014237-01 J-014237-09 ACD 65057 NM_022914 12597658 GAUGAGAGUAAACGGGCCA
Plate 3 E04 L-014237-01 J-014237-10 ACD 65057 NM_022914 12597658 CCACAUGUCAUCCGAGGAA
Plate 3 E04 L-014237-01 J-014237-11 ACD 65057 NM_022914 12597658 UCAAGGAGUUUGUAGGGUU
Plate 3 E04 L-014237-01 J-014237-12 ACD 65057 NM_022914 12597658 ACGUCACGCAGGACAGAUA
Plate 3 E05 L-008243-00 J-008243-05 ACTL6A 86 NM_177989 30089996 GAACGGAGGUUUAGCUCAU
Plate 3 E05 L-008243-00 J-008243-06 ACTL6A 86 NM_177989 30089996 CCUACUACAUAGAUACUAA
Plate 3 E05 L-008243-00 J-008243-07 ACTL6A 86 NM_177989 30089996 GUAAAGGGGUUAUCAGGAA
Plate 3 E05 L-008243-00 J-008243-08 ACTL6A 86 NM_177989 30089996 UGGGAUAGUUUCCAAGCUA
Plate 3 E06 L-013382-00 J-013382-05 UBB 7314 NM_018955 22538474 GCUGUUAAUUCUUCAGUCA
Plate 3 E06 L-013382-00 J-013382-06 UBB 7314 NM_018955 22538474 GUAUGCAGAUCUUCGUGAA
Plate 3 E06 L-013382-00 J-013382-07 UBB 7314 NM_018955 22538474 UCGAAAAUGUGAAGGCCAA
Plate 3 E06 L-013382-00 J-013382-08 UBB 7314 NM_018955 22538474 CACCUGGUCCUGCGUCUGA
Plate 3 E07 L-019408-00 J-019408-05 UBC 7316 NM_021009 67191207 GUAAGACCAUCACUCUCGA
Plate 3 E07 L-019408-00 J-019408-06 UBC 7316 NM_021009 67191207 GUGAAGACCCUGACUGGUA
Plate 3 E07 L-019408-00 J-019408-07 UBC 7316 NM_021009 67191207 AAGCAAAGAUCCAGGACAA
Plate 3 E07 L-019408-00 J-019408-08 UBC 7316 NM_021009 67191207 GUGAAGACUCUGACUGGUA
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A.3 – Screen Data.  
A.3.1 – Raw data from first screen. 
Screen 1 – Plate 1. 
	
Table	A.6.	Percentages	from	screen	1	plate	1 
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/Red Numerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 46.4 43.7 100 46.4:43.7 1.0617849 0.96934613 1.09536198
2 A2 100 41.4 49.6 100 41.4:49.6 0.83467742 0.76201058
3 A3 100 42.3 47.8 100 42.3:47.8 0.88493724 0.80789479
4 A4 100 43 46.1 100 43:46.1 0.93275488 0.85154944
5 A5 100 42.7 48.1 100 7.11666666666667:8.016666666666670.88773389 0.81044796
6 A6 100 44.4 45.8 100 44.4:45.8 0.96943231 0.88503374
7 A7 100 41.9 45.4 100 41.9:45.4 0.92290749 0.84255936
8 A8 100 46 44.5 100 23:22.25 1.03370787 0.94371348
9 A9 100 43.7 47.5 100 43.7:47.5 0.92 0.839905
10 A10 100 48.2 42.5 100 8.03333333333333:7.083333333333331.13411765 1.0 5 8161
11 A11 100 41.9 47.8 100 41.9:47.8 0.87656904 0.80025512
12 A12 100 46.2 42.6 100 23.1:21.3 1.08450704 0.99009009
13 B1 100 48 40.9 100 6:5.1125 1.17359413 1.07142128
14 B2 100 42.7 50.7 100 21.35:25.35 0.84220907 0.76888653
15 B3 100 42.8 48.3 100 7.13333333333333:8.050.88612836 0.80898222
16 B4 100 46 44.9 100 23:22.45 1.02449889 0.93530623
17 B5 100 40.3 50.5 100 4.03:5.05 0.7980198 0.72854437
18 B6 100 45.1 44.2 100 45.1:44.2 1.02036199 0.93152949
19 B7 100 45.6 44.7 100 45.6:44.7 1.02013423 0.93132156
20 B8 100 43 47.6 100 43:47.6 0.90336134 0.8247149
21 B9 100 40.4 49 100 40.4:49 0.8244898 0.75270989
22 B10 100 47 42.8 100 47:42.8 1.09813084 1.0025278
23 B11 100 60.1 28.8 100 15.025:7.2 2.08680556 1.90512871
24 B12 100 46.7 42.9 100 23.35:21.45 1.08857809 0.99380671
25 C1 100 20.7 42.9 100 10.35:21.45 0.48251748 0.44050961
26 C2 100 57.1 31.5 100 57.1:31.5 1.81269841 1.65488527
27 C3 100 45 45.3 100 1:1.006666666666670.99337748 0.90689425
28 C4 100 44.2 47.9 100 44.2:47.9 0.92275574 0.84242082
29 C5 100 45.1 43 100 45.1:43 1.04883721 0.95752566
30 C6 100 45.1 46.4 100 45.1:46.4 0.97198276 0.88736215
31 C7 100 43.2 47.7 100 43.2:47.7 0.90566038 0.82681378
32 C8 100 46.5 42.4 100 23.25:21.2 1.09669811 1.00121981
33 C9 100 39.4 49.8 100 39.4:49.8 0.79116466 0.72228603
34 C10 100 45.4 45.3 100 1.00888888888889:1.006666666666671.0 220751 0.91495553
35 C11 100 48.1 41.8 100 48.1:41.8 1.1507177 1.05053646
36 C12 100 43.8 46.4 100 43.8:46.4 0.94396552 0.86178408
37 D1 100 46.3 42.6 100 23.15:21.3 1.08685446 0.99223314
38 D2 100 44.3 46.6 100 22.15:23.3 0.95064378 0.86788093
39 D3 100 43.6 45.7 100 43.6:45.7 0.95404814 0.87098891
40 D4 100 47.2 42.8 100 47.2:42.8 1.10280374 1.00679388
41 D5 100 46.6 45.4 100 46.6:45.4 1.02643172 0.93707079
42 D6 100 44.7 45.3 100 44.7:45.3 0.98675497 0.90084829
43 D7 100 49 39.5 100 49:39.5 1.24050633 1.13250811
44 D8 100 46.1 45 100 46.1:45 1.02444444 0.93525653
45 D9 100 44.8 45.9 100 44.8:45.9 0.97603486 0.89106147
46 D10 100 42.3 47.1 100 42.3:47.1 0.89808917 0.81990172
47 D11 100 45.5 45.5 100 1.01111111111111:1.011111111111110.9 294021
48 D12 100 50.5 39.1 100 50.5:39.1 1.2915601 1.17911715
49 E1 100 43.5 46.3 100 43.5:46.3 0.93952484 0.85773001
50 E2 100 47.1 43.9 100 47.1:43.9 1.07289294 0.97948711
51 E3 100 43.3 46.2 100 43.3:46.2 0.93722944 0.85563444
52 E4 100 47.9 41 100 47.9:41 1.16829268 1.06658137
53 E5 100 49.4 43.3 100 49.4:43.3 1.1408776 1.04155304
54 E6 100 41.1 48.5 100 41.1:48.5 0.84742268 0.77364624
55 E7 100 47 45 100 47:45 1.04444444 0.95351533
56 E8 100 45.3 46 100 45.3:46 0.98478261 0.89904764
57 E9 100 43.6 44.9 100 43.6:44.9 0.97104677 0.88650764
58 E10 100 49.1 43.6 100 49.1:43.6 1.12614679 1.02810469
59 E11 100 41.3 49.9 100 41.3:49.9 0.82765531 0.75559982
60 E12 100 22.1 39.7 100 22.1:39.7 0.55667506 0.50821105
61 F1 100 50.8 37.6 100 50.8:37.6 1.35106383 1.2334405
62 F2 100 39.8 48.2 100 13.2666666666667:16.06666666666670.82572 14 0.7538386
63 F3 100 44.2 44.4 100 1.00454545454545:1.009090909090910 9954 55 0. 882787
64 F4 100 46.7 41.8 100 46.7:41.8 1.11722488 1.01995952
65 F5 100 44.1 45.8 100 44.1:45.8 0.9628821 0.87905379
66 F6 100 44.6 44.6 100 1.01363636363636:1.013636363636361 0.91294021
67 F7 100 42.5 47.6 100 42.5:47.6 0.89285714 0.81512519
68 F8 100 44 48 100 11:12 0.91666667 0.83686186
69 F9 100 49.5 41.1 100 49.5:41.1 1.20437956 1.09952653
70 F10 100 42.3 47.5 100 42.3:47.5 0.89052632 0.81299728
71 F11 100 47.3 42.5 100 47.3:42.5 1.11294118 1.01604875
72 F12 100 46.2 41.9 100 46.2:41.9 1.1026253 1.00663097
73 G1 100 50.7 36.4 100 25.35:18.2 1.39285714 1.2715953
74 G2 100 46.2 43.8 100 46.2:43.8 1.05479452 0.96296433
75 G3 100 51.1 39.4 100 17.0333333333333:13.13333333333331.296954 1 1.18404175
76 G4 100 48.3 43 100 48.3:43 1.12325581 1.0254654
77 G5 100 46 42.6 100 23:21.3 1.07981221 0.98580399
78 G6 100 42 47.6 100 42:47.6 0.88235294 0.80553548
79 G7 100 42.5 47 100 42.5:47 0.90425532 0.82553104
80 G8 100 42 47.6 100 42:47.6 0.88235294 0.80553548
81 G9 100 46.4 48.8 100 23.2:24.4 0.95081967 0.86804151
82 G10 100 45.1 43.7 100 45.1:43.7 1.03203661 0.94218772
83 G11 100 46.9 42.9 100 23.45:21.45 1.09324009 0.99806284
84 G12 100 46.7 42 100 23.35:21 1.11190476 1.01510257
85 H1 100 47.6 40 100 47.6:40 1.19 1.08639885
86 H2 100 39.2 51 100 13.0666666666667:170.76862745 0.70171091
87 H3 100 43.8 46.5 100 43.8:46.5 0.94193548 0.85993078
88 H4 100 45.7 44.7 100 45.7:44.7 1.02237136 0.93336393
89 H5 100 43.7 45.2 100 43.7:45.2 0.96681416 0.88264352
90 H6 100 42.8 46 100 21.4:23 0.93043478 0.84943133
91 H7 100 45 44.2 100 45:44.2 1.01809955 0.92946402
92 H8 100 42.5 48.5 100 7.08333333333333:8.083333333333330.87628866 0.79999916
93 H9 100 45.7 45.9 100 1.01555555555556:1.020 9956427 0.90896226
94 H10 100 47.4 40.7 100 47.4:40.7 1.16461916 1.06322767
95 H11 100 50 41.9 100 50:41.9 1.19331742 1.08942746
96 H12 100 47.8 40.2 100 47.8:40.2 1.18905473 1.08553587
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Screen 1 – Plate 2. 
	
Table	A.7.	Percentages	from	screen	1	plate	2	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 48 41.1 100 48:41.1 1.16788321 1.04544673 1.11711403
2 A2 100 48.6 40.5 100 6.075:5.0625 1.2 1.07419651
3 A3 100 40.5 47.3 100 40.5:47.3 0.85623679 0.76647214
4 A4 100 47 43.6 100 47:43.6 1.07798165 0.96497011
5 A5 100 44.4 43 100 44.4:43 1.03255814 0.92430863
6 A6 100 44.4 46.2 100 22.2:23.1 0.96103896 0.86028725
7 A7 100 42.3 44.6 100 21.15:22.3 0.94843049 0.84900061
8 A8 100 44.7 45.5 100 44.7:45.5 0.98241758 0.87942462
9 A9 100 46 45.8 100 46:45.8 1.00436681 0.89907277
10 A10 100 43.6 43.6 100 1.01395348837209:1.013953488372091 0.89516376
11 A11 100 44.3 42.6 100 22.15:21.3 1.0399061 0.93088626
12 A12 100 44.3 43.7 100 44.3:43.7 1.01372998 0.90745434
13 B1 100 47.7 40.9 100 47.7:40.9 1.16625917 1.04399294
14 B2 100 43.8 47.3 100 43.8:47.3 0.92600423 0.82892543
15 B3 100 46.3 41.6 100 46.3:41.6 1.11298077 0.99630005
16 B4 100 46.3 44.7 100 23.15:22.35 1.03579418 0.92720542
17 B5 100 49.3 39.5 100 49.3:39.5 1.24810127 1.11725502
18 B6 100 41.8 46.8 100 41.8:46.8 0.89316239 0.79952661
19 B7 100 42.3 46.7 100 21.15:23.35 0.90578158 0.81082285
20 B8 100 43.7 44.9 100 43.7:44.9 0.97327394 0.87123956
21 B9 100 40.4 48.5 100 5.05:6.0625 0.83298969 0.74566218
22 B10 100 37.6 49.8 100 37.6:49.8 0.75502008 0.67586661
23 B11 100 38.1 51.4 100 38.1:51.4 0.74124514 0.66353578
24 B12 100 45.6 42.1 100 15.2:14.03333333333331.08 1 5 9 0.96958355
25 C1 100 23.1 43 100 23.1:43 0.5372093 0.4808903
26 C2 100 42.2 49.3 100 6.02857142857143:7.042857142857140.85598377 0.76624565
27 C3 100 45.4 45.3 100 1.00888888888889:1.006666666666671.00220751 0.89713984
28 C4 100 43.8 45.3 100 43.8:45.3 0.96688742 0.86552258
29 C5 100 45.7 42.8 100 15.2333333333333:14.26666666666671.06775701 0.95581738
30 C6 100 44.5 47.5 100 44.5:47.5 0.93684211 0.8386271
31 C7 100 40.4 48.1 100 5.05:6.0125 0.83991684 0.75186312
32 C8 100 43.9 47.7 100 43.9:47.7 0.92033543 0.82385092
33 C9 100 43 46.8 100 43:46.8 0.91880342 0.82247952
34 C10 100 48.8 41.8 100 48.8:41.8 1.16746411 1.04507157
35 C11 100 44.4 46.1 100 22.2:23.05 0.96312364 0.86215338
36 C12 100 46.4 38.6 100 23.2:19.3 1.20207254 1.07605177
37 D1 100 41.8 45.6 100 41.8:45.6 0.91666667 0.82056678
38 D2 100 42.6 43.2 100 42.6:43.2 0.98611111 0.88273093
39 D3 100 43.8 41.2 100 43.8:41.2 1.0631068 0.95165468
40 D4 100 41.8 47.5 100 41.8:47.5 0.88 0.78774411
41 D5 100 44.4 44.1 100 1.00909090909091:1.002272727272731. 068027 0.901 5331
42 D6 100 35.4 56.3 100 5.05714285714286:8.042857142857140.628774 0.56 608
43 D7 100 41.8 44.7 100 41.8:44.7 0.93512304 0.83708826
44 D8 100 40.2 48 100 5.025:6 0.8375 0.74969965
45 D9 100 44.2 44.3 100 1.00454545454545:1.006818181818180.9977426 0.8931430
46 D10 100 37.7 53.7 100 37.7:53.7 0.70204842 0.6284483
47 D11 100 46.8 43.6 100 46.8:43.6 1.0733945 0.96086385
48 D12 100 45.4 41.8 100 45.4:41.8 1.0861244 0.9722592
49 E1 100 44.8 39.6 100 44.8:39.6 1.13131313 1.01271052
50 E2 100 40.7 46.5 100 20.35:23.25 0.87526882 0.78350893
51 E3 100 43.7 46.5 100 43.7:46.5 0.93978495 0.84126143
52 E4 100 45.6 45.4 100 1.01333333333333:1.008888888888891.00440529 0. 9910721
53 E5 100 40.8 47.6 100 40.8:47.6 0.85714286 0.76728322
54 E6 100 42.8 49 100 6.11428571428571:70.8 346939 0.78189814
55 E7 100 40.4 47.9 100 40.4:47.9 0.8434238 0.75500242
56 E8 100 41.8 44.9 100 41.8:44.9 0.93095768 0.83335958
57 E9 100 41.7 47.7 100 41.7:47.7 0.87421384 0.78256455
58 E10 100 40.9 46.7 100 20.45:23.35 0.875803 0.78398711
59 E11 100 45 45.7 100 1:1.015555555555560.98468271 0.88145228
60 E12 100 22.7 38 100 11.35:19 0.59736842 0.53474256
61 F1 100 43.6 44 100 43.6:44 0.99090909 0.88702591
62 F2 100 42.4 44.9 100 21.2:22.45 0.94432071 0.84532168
63 F3 100 44.2 46.2 100 22.1:23.1 0.95670996 0.85641208
64 F4 100 40.2 48.7 100 5.025:6.0875 0.82546201 0.73892368
65 F5 100 45 43.7 100 45:43.7 1.02974828 0.92179335
66 F6 100 41.4 48 100 41.4:48 0.8625 0.77207874
67 F7 100 41.7 47.6 100 41.7:47.6 0.87605042 0.78420859
68 F8 100 41.8 48 100 41.8:48 0.87083333 0.77953844
69 F9 100 41.7 45.7 100 41.7:45.7 0.91247265 0.81681245
70 F10 100 41.2 49.2 100 41.2:49.2 0.83739837 0.74960868
71 F11 100 42.7 46.9 100 21.35:23.45 0.91044776 0.81499984
72 F12 100 42.7 43.6 100 42.7:43.6 0.9793578 0.87668561
73 G1 100 44.5 42.3 100 22.25:21.15 1.05200946 0.94172074
74 G2 100 45.4 43 100 45.4:43 1.05581395 0.94512639
75 G3 100 37.9 48.7 100 37.9:48.7 0.77823409 0.69664695
76 G4 100 43.2 48.7 100 43.2:48.7 0.88706366 0.79406724
77 G5 100 48.4 40.6 100 6.05:5.075 1.19211823 1.06714103
78 G6 100 41.4 47.9 100 41.4:47.9 0.86430063 0.7736906
79 G7 100 38.5 52.6 100 19.25:26.3 0.73193916 0.65520541
80 G8 100 41.1 49 100 41.1:49 0.83877551 0.75084144
81 G9 100 39.8 47.8 100 39.8:47.8 0.83263598 0.74534556
82 G10 100 40.8 46.7 100 20.4:23.35 0.87366167 0.78207027
83 G11 100 41.3 47.6 100 41.3:47.6 0.86764706 0.7766862
84 G12 100 46.2 41.5 100 46.2:41.5 1.11325301 0.99654375
85 H1 100 43.7 40.4 100 43.7:40.4 1.08168317 0.96828357
86 H2 100 42.7 43.7 100 42.7:43.7 0.9771167 0.87467946
87 H3 100 44.7 42.5 100 22.35:21.25 1.05176471 0.94150165
88 H4 100 44.1 45.5 100 44.1:45.5 0.96923077 0.86762026
89 H5 100 41.9 46.6 100 41.9:46.6 0.89914163 0.804879
90 H6 100 43.8 43.6 100 1.01860465116279:1.013953488372091.004587 6 0.8992 0 2
91 H7 100 32.8 53.4 100 32.8:53.4 0.61423221 0.54983841
92 H8 100 42.8 48.2 100 7.13333333333333:8.033333333333330.8879668 0.7948757
93 H9 100 41.9 46.2 100 41.9:46.2 0.90692641 0.81184765
94 H10 100 44.2 40.2 100 11.05:10.05 1.09950249 0.98423478
95 H11 100 34.5 53.3 100 34.5:53.3 0.64727955 0.5794212
96 H12 100 51.6 38.1 100 51.6:38.1 1.35433071 1.21234777
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Screen 1 – Plate 3. 
	
Table	A.8.	Percentages	from	screen	1	plate	3 
  
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 39.9 44.9 100 39.9:44.9 0.88864143 0.96867637 0.917377
2 A2 100 40.7 44.2 100 10.175:11.05 0.92081448 1.00374707
3 A3 100 45 39.2 100 15:13.06666666666671.14795918 1.25134943
4 A4 100 38.6 47.1 100 38.6:47.1 0.81953291 0.89334364
5 A5 100 37.8 50.8 100 37.8:50.8 0.74409449 0.8111109
6 A6 100 42 44 100 21:22 0.95454545 1.04051601
7 A7 100 43.1 44.9 100 43.1:44.9 0.95991091 1.0463647
8 A8 100 41.2 43.6 100 41.2:43.6 0.94495413 1.03006085
9 A9 100 41.2 44 100 41.2:44 0.93636364 1.02069666
10 A10 100 45 43 100 45:43 1.04651163 1.14076506
11 A11 100 37.8 42.5 100 37.8:42.5 0.88941176 0.96951609
12 A12 100 42.7 41.3 100 42.7:41.3 1.03389831 1.12701573
13 B1 100 40.8 44.1 100 10.2:11.025 0.92517007 1.00849495
14 B2 100 44.3 44.2 100 1.00681818181818:1.00454545454545.0022624 1.0925306
15 B3 100 38.3 50.9 100 19.15:25.45 0.7524558 0.82022527
16 B4 100 42.8 46.8 100 21.4:23.4 0.91452991 0.99689649
17 B5 100 40.2 50.6 100 4.02:5.06 0.7944664 0.86601954
18 B6 100 41.6 47.3 100 41.6:47.3 0.8794926 0.95870357
19 B7 100 37.6 50.8 100 37.6:50.8 0.74015748 0.80681931
20 B8 100 43.5 44.8 100 43.5:44.8 0.97098214 1.05843306
21 B9 100 41.7 46.3 100 41.7:46.3 0.90064795 0.98176426
22 B10 100 40 46.4 100 20:23.2 0.86206897 0.93971068
23 B11 100 43.7 42.2 100 43.7:42.2 1.03554502 1.12881076
24 B12 100 42 44.9 100 21:22.45 0.93541203 1.01965934
25 C1 100 21.7 45.1 100 7.23333333333333:15.03333333333330.48115299 0.52448774
26 C2 100 42.2 47 100 42.2:47 0.89787234 0.97873867
27 C3 100 47.1 43.7 100 47.1:43.7 1.0778032 1.17487489
28 C4 100 43 45.8 100 43:45.8 0.93886463 1.0234229
29 C5 100 43.3 45.2 100 43.3:45.2 0.9579646 1.0442431
30 C6 100 43.3 46.5 100 43.3:46.5 0.9311828 1.01504921
31 C7 100 43.3 48 100 43.3:48 0.90208333 0.98332892
32 C8 100 39.3 50.3 100 39.3:50.3 0.78131213 0.85168053
33 C9 100 42.1 46.8 100 21.05:23.4 0.89957265 0.98059211
34 C10 100 43.3 46.8 100 43.3:46.8 0.92521368 1.00854248
35 C11 100 41.7 47.7 100 41.7:47.7 0.87421384 0.95294937
36 C12 100 40.4 42.3 100 20.2:21.15 0.95508274 1.04110169
37 D1 100 43.4 40.5 100 43.4:40.5 1.07160494 1.16811838
38 D2 100 45.6 47 100 45.6:47 0.97021277 1.05759439
39 D3 100 44.6 45.6 100 44.6:45.6 0.97807018 1.06615947
40 D4 100 44.6 44.7 100 1.01363636363636:1.015909090909090.99776286 1. 8762577
41 D5 100 44.2 44.6 100 1.00454545454545:1.013636363636360.99103139 1.08028803
42 D6 100 46 42.7 100 23:21.35 1.07728337 1.17430824
43 D7 100 40.7 47.5 100 40.7:47.5 0.85684211 0.93401307
44 D8 100 44.1 45.1 100 44.1:45.1 0.97782705 1.06589445
45 D9 100 43.6 43.8 100 1.01395348837209:1.018604651162790.99543379 1.08508693
46 D10 100 44.4 44.4 100 1.00909090909091:1.009090909090911 1.090 6439
47 D11 100 46.6 39.5 100 46.6:39.5 1.17974684 1.28600002
48 D12 100 39 42.9 100 13:14.3 0.90909091 0.99096763
49 E1 100 41.2 44 100 41.2:44 0.93636364 1.02069666
50 E2 100 42.2 44.5 100 21.1:22.25 0.94831461 1.03372398
51 E3 100 43.8 44.4 100 43.8:44.4 0.98648649 1.07533379
52 E4 100 40.1 48.1 100 5.0125:6.01250.83367983 0.9087647
53 E5 100 41 46.5 100 41:46.5 0.88172043 0.96113204
54 E6 100 43.8 46.7 100 43.8:46.7 0.9379015 1.02237303
55 E7 100 41 48.1 100 41:48.1 0.85239085 0.92916092
56 E8 100 43.9 44.9 100 43.9:44.9 0.97772829 1.06578679
57 E9 100 41.2 44.8 100 41.2:44.8 0.91964286 1.00246993
58 E10 100 45.5 43.1 100 45.5:43.1 1.05568445 1.15076403
59 E11 100 42.1 47.1 100 42.1:47.1 0.89384289 0.9743463
60 E12 100 17 44 100 17:44 0.38636364 0.42116124
61 F1 100 39.1 44.4 100 39.1:44.4 0.88063063 0.95994409
62 F2 100 42.2 47.2 100 42.2:47.2 0.8940678 0.97459147
63 F3 100 41.6 45.5 100 41.6:45.5 0.91428571 0.9966303
64 F4 100 44 45.5 100 44:45.5 0.96703297 1.0541282
65 F5 100 42.5 47.3 100 42.5:47.3 0.89852008 0.97944475
66 F6 100 41 48.8 100 41:48.8 0.84016393 0.91583279
67 F7 100 40.7 47.6 100 40.7:47.6 0.85504202 0.93205086
68 F8 100 40.6 50.4 100 4.06:5.04 0.80555556 0.87810743
69 F9 100 42.7 44.2 100 21.35:22.1 0.96606335 1.05307126
70 F10 100 44.3 43.5 100 44.3:43.5 1.0183908 1.11011155
71 F11 100 45.7 42.7 100 15.2333333333333:14.23333333333331.07025761 1.16664971
72 F12 100 42.1 42.2 100 1.00238095238095:1.00476190476190.9 763 33 . 8 4813
73 G1 100 39.5 43.4 100 39.5:43.4 0.91013825 0.9921093
74 G2 100 41.7 48.4 100 41.7:48.4 0.86157025 0.93916705
75 G3 100 40.4 47.7 100 40.4:47.7 0.84696017 0.92324112
76 G4 100 39.6 50.1 100 39.6:50.1 0.79041916 0.86160778
77 G5 100 39.8 52.6 100 3.06153846153846:4.046153846153850.75 65399 0. 2480157
78 G6 100 40.7 49.7 100 40.7:49.7 0.81891348 0.89266842
79 G7 100 44.5 46.1 100 22.25:23.05 0.96529284 1.05223135
80 G8 100 45.7 46.5 100 45.7:46.5 0.9827957 1.07131059
81 G9 100 37.4 52.2 100 37.4:52.2 0.7164751 0.78100399
82 G10 100 46.6 43.3 100 46.6:43.3 1.07621247 1.17314089
83 G11 100 42.6 46.3 100 21.3:23.15 0.92008639 1.00295341
84 G12 100 41.8 43.7 100 41.8:43.7 0.95652174 1.04267029
85 H1 100 44.5 39.6 100 44.5:39.6 1.12373737 1.2249461
86 H2 100 44 42.4 100 22:21.2 1.03773585 1.1311989
87 H3 100 40.9 47.8 100 40.9:47.8 0.85564854 0.932712
88 H4 100 41.8 46.3 100 41.8:46.3 0.90280778 0.98411861
89 H5 100 42.9 47.9 100 42.9:47.9 0.89561587 0.97627896
90 H6 100 42.3 46.9 100 21.15:23.45 0.90191898 0.98314976
91 H7 100 40.9 46.9 100 20.45:23.45 0.87206823 0.95061052
92 H8 100 41 47.3 100 41:47.3 0.86680761 0.94487611
93 H9 100 39.9 46.1 100 39.9:46.1 0.86550976 0.94346137
94 H10 100 41.7 44.5 100 41.7:44.5 0.93707865 1.02147607
95 H11 100 38.3 48 100 19.15:24 0.79791667 0.86978055
96 H12 100 43.6 40.8 100 43.6:40.8 1.06862745 1.16487273
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Screen 1 – Plate 4 
	
Table	A.9.	Percentages	from	screen	1	plate	4 	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 44.7 44.8 100 1.01590909090909:1.01818181818182. 9776786 0.959 4911 1.04026355
2 A2 100 43 46.3 100 43:46.3 0.9287257 0.89277924
3 A3 100 42.7 47.5 100 42.7:47.5 0.89894737 0.86415348
4 A4 100 45.2 45.5 100 1.00444444444444:1.011111111111110.99340659 0.95495665
5 A5 100 44 48.7 100 11:12.175 0.90349076 0.86852102
6 A6 100 43.5 47.5 100 43.5:47.5 0.91578947 0.88034371
7 A7 100 39.6 49.5 100 39.6:49.5 0.8 0.76903589
8 A8 100 42.7 45 100 14.2333333333333:150.94888889 0.91216201
9 A9 100 44.5 44.3 100 1.01136363636364:1.006818181818181.00 51467 0.96563479
10 A10 100 46.7 43.9 100 46.7:43.9 1.06378132 1.02260751
11 A11 100 43.9 45.8 100 43.9:45.8 0.95851528 0.92141581
12 A12 100 44.7 45.1 100 44.7:45.1 0.99113082 0.95276896
13 B1 100 45.3 42.3 100 15.1:14.1 1.07092199 1.0294718
14 B2 100 47.8 43.9 100 47.8:43.9 1.08883827 1.04669463
15 B3 100 47.3 45 100 47.3:45 1.05111111 1.01042771
16 B4 100 42.6 48.7 100 7.1:8.116666666666670.87474333 0.84088626
17 B5 100 42.7 47.9 100 42.7:47.9 0.8914405 0.85693717
18 B6 100 41.2 50.7 100 41.2:50.7 0.81262327 0.78117057
19 B7 100 44.4 48.5 100 11.1:12.125 0.91546392 0.88003076
20 B8 100 43.2 48.4 100 43.2:48.4 0.89256198 0.85801524
21 B9 100 45.7 44.9 100 45.7:44.9 1.01781737 0.97842261
22 B10 100 46.8 42.9 100 23.4:21.45 1.09090909 1.0486853
23 B11 100 48.1 42.5 100 8.01666666666667:7.083333333333331.13176471 1.08795959
24 B12 100 45.6 42.4 100 15.2:14.13333333333331.0754717 1.03384541
25 C1 100 26 41.4 100 26:41.4 0.62801932 0.60371175
26 C2 100 45.8 46.8 100 45.8:46.8 0.97863248 0.94075437
27 C3 100 45.8 46.4 100 45.8:46.4 0.98706897 0.94886432
28 C4 100 43.5 50.1 100 43.5:50.1 0.86826347 0.83465721
29 C5 100 43.9 46.4 100 43.9:46.4 0.94612069 0.90950095
30 C6 100 41.1 50.1 100 41.1:50.1 0.82035928 0.78860716
31 C7 100 40.4 49.5 100 40.4:49.5 0.81616162 0.78457196
32 C8 100 41.1 51.1 100 41.1:51.1 0.80430528 0.77317453
33 C9 100 41.8 45.5 100 41.8:45.5 0.91868132 0.88312363
34 C10 100 47.3 43 100 47.3:43 1.1 1.05742434
35 C11 100 45.1 44.6 100 45.1:44.6 1.01121076 0.97207171
36 C12 100 44.5 42.6 100 22.25:21.3 1.04460094 1.00416951
37 D1 100 50.2 35.5 100 10.04:7.1 1.41408451 1.35935217
38 D2 100 43.6 46.9 100 43.6:46.9 0.92963753 0.89365577
39 D3 100 44.2 44.8 100 1.00454545454545:1.018181818181820.986607 4 0.94 42037
40 D4 100 45 44.8 100 45:44.8 1.00446429 0.96558635
41 D5 100 46.3 44.9 100 23.15:22.45 1.0311804 0.99126842
42 D6 100 38.6 52 100 19.3:26 0.74230769 0.71357657
43 D7 100 41 48.6 100 41:48.6 0.8436214 0.81096891
44 D8 100 46.1 44 100 23.05:22 1.04772727 1.00717484
45 D9 100 46.6 44.4 100 23.3:22.2 1.04954955 1.00892658
46 D10 100 40.2 50.7 100 4.02:5.07 0.79289941 0.76221012
47 D11 100 42.4 46.4 100 21.2:23.2 0.9137931 0.87842461
48 D12 100 43.3 45 100 43.3:45 0.96222222 0.92497927
49 E1 100 47.5 42.2 100 47.5:42.2 1.12559242 1.0820262
50 E2 100 42 49.9 100 6:7.128571428571430.84168337 0.80910589
51 E3 100 41.6 49.4 100 41.6:49.4 0.84210526 0.80951146
52 E4 100 44.9 48.7 100 11.225:12.1750.92197125 0.88628622
53 E5 100 43.2 47.3 100 43.2:47.3 0.91331924 0.87796909
54 E6 100 42 50.1 100 21:25.05 0.83832335 0.80587593
55 E7 100 38.5 48.6 100 19.25:24.3 0.79218107 0.76151959
56 E8 100 45.2 46.8 100 45.2:46.8 0.96581197 0.92843008
57 E9 100 37.8 51.4 100 37.8:51.4 0.73540856 0.70694447
58 E10 100 47 40 100 47:40 1.175 1.12952146
59 E11 100 47.3 43.3 100 47.3:43.3 1.09237875 1.05009808
60 E12 100 23.5 39.7 100 23.5:39.7 0.59193955 0.56902844
61 F1 100 44.6 44.3 100 1.01363636363636:1.006818181818181.00 772 1 0.967 0476
62 F2 100 45.3 43.4 100 45.3:43.4 1.0437788 1.00337919
63 F3 100 39.7 49.6 100 39.7:49.6 0.80040323 0.76942351
64 F4 100 42.8 43.4 100 42.8:43.4 0.98617512 0.94800507
65 F5 100 39.8 48.3 100 13.2666666666667:16.10.82401656 0.79212288
66 F6 100 37.6 53.6 100 37.6:53.6 0.70149254 0.67434117
67 F7 100 43.3 45.8 100 43.3:45.8 0.94541485 0.90882243
68 F8 100 39.5 47.9 100 39.5:47.9 0.82463466 0.79271705
69 F9 100 42.3 46.1 100 21.15:23.05 0.9175705 0.8820558
70 F10 100 45.1 46.2 100 45.1:46.2 0.97619048 0.93840688
71 F11 100 41.2 51.1 100 41.2:51.1 0.80626223 0.77505574
72 F12 100 45.5 45.7 100 1.01111111111111:1.015555555555560.99562363 0.9 708788
73 G1 100 44.8 46.7 100 22.4:23.35 0.95931478 0.92218436
74 G2 100 43.7 44.7 100 43.7:44.7 0.97762864 0.93978938
75 G3 100 44.4 46.2 100 22.2:23.1 0.96103896 0.92384181
76 G4 100 42.9 43 100 42.9:43 0.99767442 0.95905929
77 G5 100 41.4 49 100 41.4:49 0.84489796 0.81219606
78 G6 100 44.4 47.8 100 44.4:47.8 0.92887029 0.89291824
79 G7 100 46.1 40.6 100 23.05:20.3 1.13546798 1.09151953
80 G8 100 43 48.6 100 43:48.6 0.88477366 0.85052837
81 G9 100 47.5 43.5 100 47.5:43.5 1.09195402 1.04968979
82 G10 100 40.5 49 100 40.5:49 0.82653061 0.79453963
83 G11 100 46.5 44 100 23.25:22 1.05681818 1.01591388
84 G12 100 42.6 44.3 100 21.3:22.15 0.96162528 0.92440544
85 H1 100 41.8 44.8 100 41.8:44.8 0.93303571 0.89692243
86 H2 100 45.1 44.4 100 45.1:44.4 1.01576577 0.97645041
87 H3 100 44.9 41.8 100 44.9:41.8 1.07416268 1.03258706
88 H4 100 45 45.9 100 1:1.02 0.98039216 0.94244594
89 H5 100 48.1 41.4 100 48.1:41.4 1.16183575 1.11686673
90 H6 100 43.7 46.4 100 43.7:46.4 0.94181034 0.90535744
91 H7 100 47.1 45.1 100 47.1:45.1 1.0443459 1.00392434
92 H8 100 43.4 46.8 100 43.4:46.8 0.92735043 0.8914572
93 H9 100 45.6 45.3 100 1.01333333333333:1.006666666666671.00662252 0.9 7 105
94 H10 100 44 47.3 100 44:47.3 0.93023256 0.89422777
95 H11 100 41.8 47.9 100 41.8:47.9 0.87265136 0.83887526
96 H12 100 46.9 40.8 100 23.45:20.4 1.1495098 1.10501786
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Screen 1 – Plate 5. 
	
Table	A.10.	Percentages	from	screen	1	plate	5 	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 47.8 41.1 100 47.8:41.1 1.16301703 1.04739478 1.11039033
2 A2 100 48.4 40.5 100 6.05:5.0625 1.19506173 1.07625372
3 A3 100 40.4 47.3 100 40.4:47.3 0.85412262 0.76920935
4 A4 100 46.8 43.6 100 46.8:43.6 1.0733945 0.96668214
5 A5 100 44.2 43 100 44.2:43 1.02790698 0.92571679
6 A6 100 44.3 46.2 100 22.15:23.1 0.95887446 0.8635472
7 A7 100 42.2 44.6 100 21.1:22.3 0.94618834 0.85212228
8 A8 100 44.6 45.5 100 44.6:45.5 0.98021978 0.88277046
9 A9 100 45.8 45.8 100 1.01777777777778:1.017777777777781 0.90058421
10 A10 100 43.3 43.6 100 1.00697674418605:1.013953488372090.99311927 0.894 8753
11 A11 100 44.1 42.6 100 22.05:21.3 1.03521127 0.93229492
12 A12 100 44.1 43.7 100 44.1:43.7 1.00915332 0.90882755
13 B1 100 47.6 40.9 100 47.6:40.9 1.16381418 1.04811268
14 B2 100 43.7 47.3 100 43.7:47.3 0.92389006 0.8320408
15 B3 100 46.1 41.6 100 46.1:41.6 1.10817308 0.99800318
16 B4 100 46.2 44.7 100 23.1:22.35 1.03355705 0.93080516
17 B5 100 49.1 39.5 100 49.1:39.5 1.24303797 1.11946037
18 B6 100 41.7 46.8 100 41.7:46.8 0.89102564 0.80244362
19 B7 100 42.1 46.7 100 21.05:23.35 0.90149893 0.8118757
20 B8 100 43.4 44.9 100 43.4:44.9 0.96659243 0.87049788
21 B9 100 40.2 48.5 100 5.025:6.0625 0.82886598 0.74646361
22 B10 100 37.4 49.8 100 37.4:49.8 0.75100402 0.67634236
23 B11 100 38 51.4 100 38:51.4 0.73929961 0.66580156
24 B12 100 45.4 42.1 100 15.1333333333333:14.03333333333331.0783848 0.971176 2
25 C1 100 22.8 43 100 22.8:43 0.53023256 0.47751907
26 C2 100 42 49.3 100 6:7.042857142857140.85192698 0.76723199
27 C3 100 45.3 45.3 100 1.00666666666667:1.006666666666671 0.90058421
28 C4 100 43.6 45.3 100 43.6:45.3 0.96247241 0.86678745
29 C5 100 45.4 42.8 100 15.1333333333333:14.26666666666671.0607476 0.9552926
30 C6 100 44.3 47.5 100 44.3:47.5 0.93263158 0.83991328
31 C7 100 40.1 48.1 100 5.0125:6.01250.83367983 0.7507989
32 C8 100 43.8 47.7 100 43.8:47.7 0.91823899 0.82695154
33 C9 100 42.7 46.8 100 21.35:23.4 0.91239316 0.82168688
34 C10 100 48.6 41.8 100 48.6:41.8 1.16267943 1.04709073
35 C11 100 44.3 46.1 100 22.15:23.05 0.96095445 0.8654204
36 C12 100 46.1 38.6 100 23.05:19.3 1.19430052 1.07556819
37 D1 100 41.6 45.6 100 41.6:45.6 0.9122807 0.8215856
38 D2 100 42.3 43.2 100 42.3:43.2 0.97916667 0.88182204
39 D3 100 43.5 41.2 100 43.5:41.2 1.05582524 0.95085954
40 D4 100 41.5 47.5 100 41.5:47.5 0.87368421 0.78682621
41 D5 100 44.2 44.1 100 1.00454545454545:1.002272727272731.00226757 0.90262635
42 D6 100 35.2 56.3 100 5.02857142857143:8.042857142857140.6252220 0.56306508
43 D7 100 41.6 44.7 100 41.6:44.7 0.93064877 0.83812759
44 D8 100 39.9 48 100 13.3:16 0.83125 0.74861063
45 D9 100 44.1 44.3 100 1.00227272727273:1.006818181818180.99548533 0.8965 37
46 D10 100 37.6 53.7 100 37.6:53.7 0.70018622 0.63057665
47 D11 100 46.8 43.6 100 46.8:43.6 1.0733945 0.96668214
48 D12 100 45.1 41.8 100 45.1:41.8 1.07894737 0.97168297
49 E1 100 44.4 39.6 100 44.4:39.6 1.12121212 1.00974593
50 E2 100 40.6 46.5 100 20.3:23.25 0.87311828 0.78631654
51 E3 100 43.6 46.5 100 43.6:46.5 0.93763441 0.84441874
52 E4 100 45.5 45.4 100 1.01111111111111:1.00888888888889.00220264 0.902567 8
53 E5 100 40.3 47.6 100 40.3:47.6 0.84663866 0.76246941
54 E6 100 42.6 49 100 6.08571428571429:70.86 38776 0.78295689
55 E7 100 40.2 47.9 100 40.2:47.9 0.83924843 0.75581389
56 E8 100 41.7 44.9 100 41.7:44.9 0.92873051 0.83640004
57 E9 100 41.5 47.7 100 41.5:47.7 0.87002096 0.78352714
58 E10 100 40.7 46.7 100 20.35:23.35 0.87152034 0.78487746
59 E11 100 44.8 45.7 100 44.8:45.7 0.98030635 0.88284842
60 E12 100 22.4 38 100 11.2:19 0.58947368 0.53087069
61 F1 100 43.4 44 100 43.4:44 0.98636364 0.88830352
62 F2 100 42.2 44.9 100 21.1:22.45 0.93986637 0.84642881
63 F3 100 44 46.2 100 22:23.1 0.95238095 0.85769925
64 F4 100 40.1 48.7 100 5.0125:6.08750.82340862 0.74154881
65 F5 100 45 43.7 100 45:43.7 1.02974828 0.92737505
66 F6 100 41.3 48 100 41.3:48 0.86041667 0.77487767
67 F7 100 41.5 47.6 100 41.5:47.6 0.87184874 0.78517321
68 F8 100 41.7 48 100 41.7:48 0.86875 0.78238253
69 F9 100 41.6 45.7 100 41.6:45.7 0.91028446 0.81978782
70 F10 100 41.1 49.2 100 41.1:49.2 0.83536585 0.7523173
71 F11 100 42.5 46.9 100 21.25:23.45 0.90618337 0.81609444
72 F12 100 42.6 43.6 100 42.6:43.6 0.97706422 0.87992861
73 G1 100 44.4 42.3 100 22.2:21.15 1.04964539 0.94529407
74 G2 100 45.3 43 100 45.3:43 1.05348837 0.948755
75 G3 100 37.7 48.7 100 37.7:48.7 0.77412731 0.69716683
76 G4 100 43.2 48.7 100 43.2:48.7 0.88706366 0.79887552
77 G5 100 48.3 40.6 100 6.0375:5.075 1.18965517 1.07138467
78 G6 100 41.1 47.9 100 41.1:47.9 0.85803758 0.7727351
79 G7 100 38.3 52.6 100 19.15:26.3 0.72813688 0.65574858
80 G8 100 41 49 100 41:49 0.83673469 0.75355005
81 G9 100 39.7 47.8 100 39.7:47.8 0.83054393 0.74797475
82 G10 100 40.5 46.7 100 20.25:23.35 0.86723769 0.78102057
83 G11 100 41.3 47.6 100 41.3:47.6 0.86764706 0.78138924
84 G12 100 46 41.5 100 46:41.5 1.10843373 0.99823792
85 H1 100 43.5 40.4 100 43.5:40.4 1.07673267 0.96968845
86 H2 100 42.4 43.7 100 42.4:43.7 0.97025172 0.87379338
87 H3 100 44.6 42.5 100 22.3:21.25 1.04941176 0.94508367
88 H4 100 43.8 45.5 100 43.8:45.5 0.96263736 0.86693601
89 H5 100 41.5 46.6 100 41.5:46.6 0.89055794 0.80202242
90 H6 100 43.8 43.6 100 1.01860465116279:1.013953488372091.004587 6 0.90471533
91 H7 100 32.7 53.4 100 32.7:53.4 0.61235955 0.55148134
92 H8 100 42.7 48.2 100 7.11666666666667:8.033333333333330.88589212 0.79782045
93 H9 100 41.7 46.2 100 41.7:46.2 0.9025974 0.81286497
94 H10 100 43.9 40.2 100 43.9:40.2 1.0920398 0.9834738
95 H11 100 34.2 53.3 100 34.2:53.3 0.64165103 0.57786079
96 H12 100 51.4 38.1 100 51.4:38.1 1.34908136 1.21496138
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Screen 1 – Plate 6.  
	
Table	A.11.	Percentages	from	screen	1	plate	6 
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 39.9 44.9 100 39.9:44.9 0.88864143 0.96867637 0.917377
2 A2 100 40.7 44.2 100 10.175:11.05 0.92081448 1.00374707
3 A3 100 45 39.2 100 15:13.06666666666671.14795918 1.25134943
4 A4 100 38.6 47.1 100 38.6:47.1 0.81953291 0.89334364
5 A5 100 37.8 50.8 100 37.8:50.8 0.74409449 0.8111109
6 A6 100 42 44 100 21:22 0.95454545 1.04051601
7 A7 100 43.1 44.9 100 43.1:44.9 0.95991091 1.0463647
8 A8 100 41.2 43.6 100 41.2:43.6 0.94495413 1.03006085
9 A9 100 41.2 44 100 41.2:44 0.93636364 1.02069666
10 A10 100 45 43 100 45:43 1.04651163 1.14076506
11 A11 100 37.8 42.5 100 37.8:42.5 0.88941176 0.96951609
12 A12 100 42.7 41.3 100 42.7:41.3 1.03389831 1.12701573
13 B1 100 40.8 44.1 100 10.2:11.025 0.92517007 1.00849495
14 B2 100 44.3 44.2 100 1.00681818181818:1.00454545454545.0022624 1.0925306
15 B3 100 38.3 50.9 100 19.15:25.45 0.7524558 0.82022527
16 B4 100 42.8 46.8 100 21.4:23.4 0.91452991 0.99689649
17 B5 100 40.2 50.6 100 4.02:5.06 0.7944664 0.86601954
18 B6 100 41.6 47.3 100 41.6:47.3 0.8794926 0.95870357
19 B7 100 37.6 50.8 100 37.6:50.8 0.74015748 0.80681931
20 B8 100 43.5 44.8 100 43.5:44.8 0.97098214 1.05843306
21 B9 100 41.7 46.3 100 41.7:46.3 0.90064795 0.98176426
22 B10 100 40 46.4 100 20:23.2 0.86206897 0.93971068
23 B11 100 43.7 42.2 100 43.7:42.2 1.03554502 1.12881076
24 B12 100 42 44.9 100 21:22.45 0.93541203 1.01965934
25 C1 100 21.7 45.1 100 7.23333333333333:15.03333333333330.48115299 0.52448774
26 C2 100 42.2 47 100 42.2:47 0.89787234 0.97873867
27 C3 100 47.1 43.7 100 47.1:43.7 1.0778032 1.17487489
28 C4 100 43 45.8 100 43:45.8 0.93886463 1.0234229
29 C5 100 43.3 45.2 100 43.3:45.2 0.9579646 1.0442431
30 C6 100 43.3 46.5 100 43.3:46.5 0.9311828 1.01504921
31 C7 100 43.3 48 100 43.3:48 0.90208333 0.98332892
32 C8 100 39.3 50.3 100 39.3:50.3 0.78131213 0.85168053
33 C9 100 42.1 46.8 100 21.05:23.4 0.89957265 0.98059211
34 C10 100 43.3 46.8 100 43.3:46.8 0.92521368 1.00854248
35 C11 100 41.7 47.7 100 41.7:47.7 0.87421384 0.95294937
36 C12 100 40.4 42.3 100 20.2:21.15 0.95508274 1.04110169
37 D1 100 43.4 40.5 100 43.4:40.5 1.07160494 1.16811838
38 D2 100 45.6 47 100 45.6:47 0.97021277 1.05759439
39 D3 100 44.6 45.6 100 44.6:45.6 0.97807018 1.06615947
40 D4 100 44.6 44.7 100 1.01363636363636:1.015909090909090.99776286 1. 8762577
41 D5 100 44.2 44.6 100 1.00454545454545:1.013636363636360.99103139 1.08028803
42 D6 100 46 42.7 100 23:21.35 1.07728337 1.17430824
43 D7 100 40.7 47.5 100 40.7:47.5 0.85684211 0.93401307
44 D8 100 44.1 45.1 100 44.1:45.1 0.97782705 1.06589445
45 D9 100 43.6 43.8 100 1.01395348837209:1.018604651162790.99543379 1.08508693
46 D10 100 44.4 44.4 100 1.00909090909091:1.009090909090911 1.090 6439
47 D11 100 46.6 39.5 100 46.6:39.5 1.17974684 1.28600002
48 D12 100 39 42.9 100 13:14.3 0.90909091 0.99096763
49 E1 100 41.2 44 100 41.2:44 0.93636364 1.02069666
50 E2 100 42.2 44.5 100 21.1:22.25 0.94831461 1.03372398
51 E3 100 43.8 44.4 100 43.8:44.4 0.98648649 1.07533379
52 E4 100 40.1 48.1 100 5.0125:6.01250.83367983 0.9087647
53 E5 100 41 46.5 100 41:46.5 0.88172043 0.96113204
54 E6 100 43.8 46.7 100 43.8:46.7 0.9379015 1.02237303
55 E7 100 41 48.1 100 41:48.1 0.85239085 0.92916092
56 E8 100 43.9 44.9 100 43.9:44.9 0.97772829 1.06578679
57 E9 100 41.2 44.8 100 41.2:44.8 0.91964286 1.00246993
58 E10 100 45.5 43.1 100 45.5:43.1 1.05568445 1.15076403
59 E11 100 42.1 47.1 100 42.1:47.1 0.89384289 0.9743463
60 E12 100 17 44 100 17:44 0.38636364 0.42116124
61 F1 100 39.1 44.4 100 39.1:44.4 0.88063063 0.95994409
62 F2 100 42.2 47.2 100 42.2:47.2 0.8940678 0.97459147
63 F3 100 41.6 45.5 100 41.6:45.5 0.91428571 0.9966303
64 F4 100 44 45.5 100 44:45.5 0.96703297 1.0541282
65 F5 100 42.5 47.3 100 42.5:47.3 0.89852008 0.97944475
66 F6 100 41 48.8 100 41:48.8 0.84016393 0.91583279
67 F7 100 40.7 47.6 100 40.7:47.6 0.85504202 0.93205086
68 F8 100 40.6 50.4 100 4.06:5.04 0.80555556 0.87810743
69 F9 100 42.7 44.2 100 21.35:22.1 0.96606335 1.05307126
70 F10 100 44.3 43.5 100 44.3:43.5 1.0183908 1.11011155
71 F11 100 45.7 42.7 100 15.2333333333333:14.23333333333331.07025761 1.16664971
72 F12 100 42.1 42.2 100 1.00238095238095:1.00476190476190.9 763 33 . 8 4813
73 G1 100 39.5 43.4 100 39.5:43.4 0.91013825 0.9921093
74 G2 100 41.7 48.4 100 41.7:48.4 0.86157025 0.93916705
75 G3 100 40.4 47.7 100 40.4:47.7 0.84696017 0.92324112
76 G4 100 39.6 50.1 100 39.6:50.1 0.79041916 0.86160778
77 G5 100 39.8 52.6 100 3.06153846153846:4.046153846153850.75 65399 0. 2480157
78 G6 100 40.7 49.7 100 40.7:49.7 0.81891348 0.89266842
79 G7 100 44.5 46.1 100 22.25:23.05 0.96529284 1.05223135
80 G8 100 45.7 46.5 100 45.7:46.5 0.9827957 1.07131059
81 G9 100 37.4 52.2 100 37.4:52.2 0.7164751 0.78100399
82 G10 100 46.6 43.3 100 46.6:43.3 1.07621247 1.17314089
83 G11 100 42.6 46.3 100 21.3:23.15 0.92008639 1.00295341
84 G12 100 41.8 43.7 100 41.8:43.7 0.95652174 1.04267029
85 H1 100 44.5 39.6 100 44.5:39.6 1.12373737 1.2249461
86 H2 100 44 42.4 100 22:21.2 1.03773585 1.1311989
87 H3 100 40.9 47.8 100 40.9:47.8 0.85564854 0.932712
88 H4 100 41.8 46.3 100 41.8:46.3 0.90280778 0.98411861
89 H5 100 42.9 47.9 100 42.9:47.9 0.89561587 0.97627896
90 H6 100 42.3 46.9 100 21.15:23.45 0.90191898 0.98314976
91 H7 100 40.9 46.9 100 20.45:23.45 0.87206823 0.95061052
92 H8 100 41 47.3 100 41:47.3 0.86680761 0.94487611
93 H9 100 39.9 46.1 100 39.9:46.1 0.86550976 0.94346137
94 H10 100 41.7 44.5 100 41.7:44.5 0.93707865 1.02147607
95 H11 100 38.3 48 100 19.15:24 0.79791667 0.86978055
96 H12 100 43.6 40.8 100 43.6:40.8 1.06862745 1.16487273
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A.3.2 – Raw data from second screen 
Screen 2 – Plate 1.  
	
Table	A.12.	Percentages	from	screen	2	plate	1 
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/Red Numerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 44.2 49.8 100 44.2:49.8 0.8875502 0.99132611 0.89531608
2 A2 100 40.9 49.6 100 40.9:49.6 0.82459677 0.92101192
3 A3 100 40 54.2 100 20:27.1 0.73800738 0.82429815
4 A4 100 37.8 58.1 100 37.8:58.1 0.65060241 0.72667344
5 A5 100 37.5 54.2 100 37.5:54.2 0.69188192 0.77277951
6 A6 100 35.7 58.1 100 35.7:58.1 0.61445783 0.68630269
7 A7 100 41.1 49.4 100 41.1:49.4 0.83198381 0.92926267
8 A8 100 44.8 51.9 100 44.8:51.9 0.86319846 0.96412706
9 A9 100 46.2 48.3 100 23.1:24.15 0.95652174 1.06836207
10 A10 100 48 45.6 100 16:15.2 1.05263158 1.17570946
11 A11 100 40.1 53.1 100 40.1:53.1 0.75517891 0.84347744
12 A12 100 36.8 51.4 100 12.2666666666667:17.13333333333330.71595 1 0.79966542
13 B1 100 42.7 51.6 100 14.2333333333333:17.20.82751938 0.92427624
14 B2 100 43.6 46.8 100 43.6:46.8 0.93162393 1.04055312
15 B3 100 39 54 100 13:18 0.72222222 0.80666732
16 B4 100 39 52.1 100 3:4.007692307692310.74856046 0.83608513
17 B5 100 42.1 47.5 100 42.1:47.5 0.88631579 0.98994736
18 B6 100 41.2 53.7 100 41.2:53.7 0.76722533 0.85693237
19 B7 100 44.3 51.1 100 44.3:51.1 0.86692759 0.96829222
20 B8 100 39 56.3 100 39:56.3 0.69271758 0.77371289
21 B9 100 49.9 45.4 100 49.9:45.4 1.09911894 1.22763231
22 B10 100 38.6 56.5 100 19.3:28.25 0.68318584 0.76306665
23 B11 100 41.5 53.8 100 41.5:53.8 0.77137546 0.86156776
24 B12 100 47.3 48.5 100 47.3:48.5 0.97525773 1.08928875
25 C1 100 1.7 59.6 100 1.7:59.6 0.02852349 0.03185857
26 C2 100 45.9 46.6 100 45.9:46.6 0.98497854 1.10014616
27 C3 100 28.3 58.7 100 14.15:29.35 0.48211244 0.53848294
28 C4 100 44.6 49.7 100 44.6:49.7 0.89738431 1.00231006
29 C5 100 50.2 38 100 25.1:19 1.32105263 1.47551537
30 C6 100 40 54.4 100 20:27.2 0.73529412 0.82126764
31 C7 100 46.3 50.1 100 23.15:25.05 0.9241517 1.0322072
32 C8 100 39 54.7 100 13:18.23333333333330.71297989 0.79634434
33 C9 100 38.9 54.5 100 19.45:27.25 0.71376147 0.7972173
34 C10 100 43.1 52.3 100 43.1:52.3 0.82409178 0.92044787
35 C11 100 43.5 53.5 100 43.5:53.5 0.81308411 0.90815315
36 C12 100 38.8 56 100 19.4:28 0.69285714 0.77386876
37 D1 100 34.6 57.7 100 34.6:57.7 0.59965338 0.66976724
38 D2 100 38.2 56.5 100 19.1:28.25 0.67610619 0.75515923
39 D3 100 41.6 51.2 100 41.6:51.2 0.8125 0.90750074
40 D4 100 41.3 53.3 100 41.3:53.3 0.77485929 0.86545892
41 D5 100 42.3 50 100 21.15:25 0.846 0.94491769
42 D6 100 45.8 47.8 100 45.8:47.8 0.958159 1.07019077
43 D7 100 38.2 53.6 100 38.2:53.6 0.71268657 0.79601672
44 D8 100 43.7 48.2 100 43.7:48.2 0.906639 1.01264685
45 D9 100 48.7 43.7 100 48.7:43.7 1.11441648 1.24471849
46 D10 100 36.9 56.4 100 9.225:14.1 0.65425532 0.73075346
47 D11 100 37 56.8 100 37:56.8 0.65140845 0.72757372
48 D12 100 42.8 51.4 100 14.2666666666667:17.13333333333330.83268482 0.9 004565
49 E1 100 44.2 49.9 100 44.2:49.9 0.88577154 0.98933948
50 E2 100 40.8 52 100 10.2:13 0.78461538 0.87635574
51 E3 100 36.2 57.7 100 12.0666666666667:19.23333333333330.627 8 02 0.70073914
52 E4 100 38.5 50.9 100 19.25:25.45 0.75638507 0.84482463
53 E5 100 52.8 28.5 100 13.2:7.125 1.85263158 2.06924865
54 E6 100 43.8 48.4 100 43.8:48.4 0.90495868 1.01077005
55 E7 100 39.7 51.5 100 13.2333333333333:17.16666666666670.77087379 0.8 100742
56 E8 100 41.9 48.6 100 41.9:48.6 0.86213992 0.96294475
57 E9 100 43.8 47.8 100 43.8:47.8 0.91631799 1.02345754
58 E10 100 48.2 43.7 100 48.2:43.7 1.10297483 1.23193904
59 E11 100 38.4 58 100 19.2:29 0.66206897 0.73948071
60 E12 100 1.1 57.9 100 1.1:57.9 0.01899827 0.02121963
61 F1 100 38.8 48.9 100 19.4:24.45 0.79345603 0.88623008
62 F2 100 37.8 57.4 100 37.8:57.4 0.65853659 0.73553531
63 F3 100 43.8 50.6 100 43.8:50.6 0.86561265 0.96682353
64 F4 100 39.3 49.4 100 39.3:49.4 0.79554656 0.88856503
65 F5 100 40.9 50.3 100 4.09:5.03 0.81312127 0.90819465
66 F6 100 35.5 53.4 100 35.5:53.4 0.66479401 0.74252437
67 F7 100 44.8 49.8 100 44.8:49.8 0.89959839 1.00478302
68 F8 100 40.7 52.8 100 10.175:13.2 0.77083333 0.86096224
69 F9 100 39.9 52.1 100 3.06923076923077:4.007692307692310.7658349 0.85537941
70 F10 100 39 52.7 100 3:4.053846153846150.74003795 0.82656614
71 F11 100 47.4 46.5 100 47.4:46.5 1.01935484 1.13854187
72 F12 100 41.4 52.8 100 41.4:52.8 0.78409091 0.87576994
73 G1 100 36.9 52.5 100 9.225:13.125 0.70285714 0.785038
74 G2 100 42 49.7 100 6:7.1 0.84507042 0.94387943
75 G3 100 42.2 51.1 100 14.0666666666667:17.03333333333330.8258 17 0.922 9124
76 G4 100 36.4 56.1 100 9.1:14.025 0.64884135 0.72470647
77 G5 100 42.8 46.9 100 21.4:23.45 0.91257996 1.01928244
78 G6 100 44.2 47.1 100 44.2:47.1 0.93842887 1.04815372
79 G7 100 40.9 54.1 100 20.45:27.05 0.75600739 0.84440279
80 G8 100 43 51.1 100 43:51.1 0.84148728 0.93987733
81 G9 100 42.5 54.5 100 7.08333333333333:9.083333333333330.77981651 0.87099577
82 G10 100 41.1 51.6 100 41.1:51.6 0.79651163 0.88964294
83 G11 100 39.1 53.6 100 39.1:53.6 0.72947761 0.81477104
84 G12 100 41 46.7 100 41:46.7 0.87794433 0.98059708
85 H1 100 42.2 45.6 100 14.0666666666667:15.20.9 54386 1.03364457
86 H2 100 41.6 50.9 100 41.6:50.9 0.8172888 0.91284947
87 H3 100 38.5 55.5 100 38.5:55.5 0.69369369 0.77480313
88 H4 100 40.4 53.4 100 40.4:53.4 0.75655431 0.84501365
89 H5 100 39.5 53.1 100 39.5:53.1 0.74387947 0.83085683
90 H6 100 38.7 53.2 100 38.7:53.2 0.72744361 0.81249922
91 H7 100 42.6 51.8 100 14.2:17.26666666666670.82239382 0.91855139
92 H8 100 44.5 47.6 100 44.5:47.6 0.93487395 1.04418314
93 H9 100 41.4 49.7 100 41.4:49.7 0.83299799 0.93039543
94 H10 100 49.1 43.3 100 49.1:43.3 1.13394919 1.26653505
95 H11 100 41.3 51.9 100 41.3:51.9 0.79576108 0.88880464
96 H12 100 38 51.9 100 38:51.9 0.73217726 0.81778635
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Screen 2 – Plate 2. 
	
Table	A.13.	Percentages	from	screen	2	plate	2	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 42.4 47.2 100 42.4:47.2 0.89830508 0.97671339 0.9197223
2 A2 100 47.7 44.8 100 47.7:44.8 1.06473214 1.15766699
3 A3 100 38.4 55.5 100 38.4:55.5 0.69189189 0.75228348
4 A4 100 35 54.3 100 35:54.3 0.64456722 0.70082809
5 A5 100 41.6 53 100 41.6:53 0.78490566 0.85341593
6 A6 100 45.2 47.9 100 45.2:47.9 0.94363257 1.02599727
7 A7 100 40.2 53.4 100 40.2:53.4 0.75280899 0.81851771
8 A8 100 32.9 58.3 100 16.45:29.15 0.56432247 0.6135792
9 A9 100 40.8 53.1 100 40.8:53.1 0.76836158 0.83542781
10 A10 100 36.2 57.4 100 12.0666666666667:19.13333333333330. 3066202 0.68570918
11 A11 100 43.5 50.1 100 43.5:50.1 0.86826347 0.94404961
12 A12 100 40.6 36.5 100 10.15:9.125 1.11232877 1.20941807
13 B1 100 38.4 54.1 100 19.2:27.05 0.70979667 0.77175108
14 B2 100 42.1 50.8 100 21.05:25.4 0.82874016 0.90107651
15 B3 100 39 52.9 100 3:4.069230769230770.73724008 0.80158987
16 B4 100 45.6 47.4 100 45.6:47.4 0.96202532 1.04599543
17 B5 100 42.9 52.2 100 21.45:26.1 0.82183908 0.89357307
18 B6 100 42.5 47.3 100 42.5:47.3 0.89852008 0.97694716
19 B7 100 42 51.4 100 14:17.13333333333330.81712062 0.88844277
20 B8 100 41.7 49 100 41.7:49 0.85102041 0.92530149
21 B9 100 38.8 52 100 19.4:26 0.74615385 0.81128168
22 B10 100 25.5 65.5 100 5.1:13.1 0.38931298 0.42329405
23 B11 100 38.3 55.2 100 38.3:55.2 0.69384058 0.75440226
24 B12 100 47.1 46.2 100 47.1:46.2 1.01948052 1.10846559
25 C1 100 0.7 57.6 100 0.012280701754386:1.010526315789470.01215278 0.01321353
26 C2 100 42.9 50.3 100 21.45:25.15 0.8528827 0.92732633
27 C3 100 33.3 58.2 100 33.3:58.2 0.57216495 0.62210621
28 C4 100 37.1 48 100 37.1:48 0.77291667 0.84038048
29 C5 100 41.9 52.3 100 41.9:52.3 0.80114723 0.87107514
30 C6 100 47.9 41.1 100 47.9:41.1 1.16545012 1.26717611
31 C7 100 37 55 100 37:55 0.67272727 0.73144608
32 C8 100 44.6 49.4 100 44.6:49.4 0.90283401 0.98163762
33 C9 100 40.5 53.3 100 40.5:53.3 0.75984991 0.82617319
34 C10 100 42 51.3 100 14:17.1 0.81871345 0.89017462
35 C11 100 40.8 50.8 100 4.08:5.08 0.80314961 0.87325229
36 C12 100 40.1 53 100 40.1:53 0.75660377 0.82264372
37 D1 100 39.2 51.3 100 13.0666666666667:17.10.7 413255 0.83082965
38 D2 100 44.7 47.9 100 44.7:47.9 0.93319415 1.01464774
39 D3 100 37 50.3 100 37:50.3 0.73558648 0.79979194
40 D4 100 39.8 51 100 13.2666666666667:170.78039216 0.84850847
41 D5 100 40.7 51.2 100 40.7:51.2 0.79492188 0.86430641
42 D6 100 41.8 46.7 100 41.8:46.7 0.89507495 0.97320131
43 D7 100 40.2 50.3 100 4.02:5.03 0.79920477 0.86896314
44 D8 100 44.5 44.8 100 1.01136363636364:1.018181818181820.99330357 1.08000379
45 D9 100 37.6 54.7 100 37.6:54.7 0.68738574 0.74738401
46 D10 100 45.5 47.8 100 45.5:47.8 0.95188285 1.03496767
47 D11 100 38.7 47 100 38.7:47 0.82340426 0.89527486
48 D12 100 43.6 49.8 100 43.6:49.8 0.87550201 0.95191995
49 E1 100 44.9 50.7 100 22.45:25.35 0.88560158 0.96290106
50 E2 100 38.9 53.3 100 38.9:53.3 0.72983114 0.79353425
51 E3 100 40.5 48.9 100 5.0625:6.11250.82822086 0.90051188
52 E4 100 34.5 56.2 100 17.25:28.1 0.613879 0.66746126
53 E5 100 40.7 49.6 100 40.7:49.6 0.82056452 0.89218726
54 E6 100 40.4 49.9 100 40.4:49.9 0.80961924 0.88028663
55 E7 100 41.4 51.2 100 41.4:51.2 0.80859375 0.87917163
56 E8 100 40.8 46.5 100 20.4:23.25 0.87741935 0.95400466
57 E9 100 45.7 46.6 100 45.7:46.6 0.9806867 1.06628566
58 E10 100 41.9 47.8 100 41.9:47.8 0.87656904 0.95308012
59 E11 100 44.6 47.8 100 44.6:47.8 0.93305439 1.01449578
60 E12 100 2.8 55.5 100 2.8:55.5 0.05045045 0.054854
61 F1 100 37.5 45.6 100 37.5:45.6 0.82236842 0.89414862
62 F2 100 36.9 52.9 100 9.225:13.225 0.69754253 0.75842734
63 F3 100 38.7 51.7 100 38.7:51.7 0.74854932 0.81388624
64 F4 100 41.2 48.4 100 41.2:48.4 0.85123967 0.92553988
65 F5 100 38 52.8 100 19:26.4 0.71969697 0.78251552
66 F6 100 38.3 54.3 100 19.15:27.15 0.7053407 0.76690616
67 F7 100 41.3 48.6 100 41.3:48.6 0.84979424 0.92396829
68 F8 100 44.4 47 100 44.4:47 0.94468085 1.02713705
69 F9 100 44.3 45.8 100 44.3:45.8 0.96724891 1.05167496
70 F10 100 45 48.5 100 15:16.16666666666670.92783505 1.00882087
71 F11 100 42.6 49.1 100 6.08571428571429:7.014285714285710.867617 1 0.94334682
72 F12 100 45.5 44.7 100 45.5:44.7 1.01789709 1.10674395
73 G1 100 36.4 47.8 100 36.4:47.8 0.76150628 0.82797414
74 G2 100 40.3 47.8 100 40.3:47.8 0.84309623 0.91668565
75 G3 100 36.1 58.9 100 18.05:29.45 0.61290323 0.66640031
76 G4 100 38.5 52.9 100 19.25:26.45 0.72778828 0.79131308
77 G5 100 39.5 55.9 100 39.5:55.9 0.70661896 0.768296
78 G6 100 39.7 50.5 100 39.7:50.5 0.78613861 0.8547565
79 G7 100 37.3 55.7 100 37.3:55.7 0.66965889 0.72810987
80 G8 100 39.4 50.3 100 39.4:50.3 0.7833002 0.85167034
81 G9 100 40 47.7 100 40:47.7 0.83857442 0.91176916
82 G10 100 38.7 51.7 100 38.7:51.7 0.74854932 0.81388624
83 G11 100 43.3 48 100 43.3:48 0.90208333 0.98082142
84 G12 100 41.3 48.1 100 41.3:48.1 0.85862786 0.93357295
85 H1 100 37.9 46.2 100 37.9:46.2 0.82034632 0.89195002
86 H2 100 35 52.1 100 35:52.1 0.67178503 0.7304216
87 H3 100 43.7 42.5 100 43.7:42.5 1.02823529 1.11798452
88 H4 100 32.5 56.4 100 4.0625:7.05 0.57624113 0.62653818
89 H5 100 36.5 50.5 100 18.25:25.25 0.72277228 0.78585925
90 H6 100 39.7 50 100 39.7:50 0.794 0.86330407
91 H7 100 39.1 51.4 100 13.0333333333333:17.13333333333330.76070039 0.82709791
92 H8 100 39.2 54.9 100 13.0666666666667:18.30.7140255 0.77634902
93 H9 100 40 53.6 100 40:53.6 0.74626866 0.81140651
94 H10 100 39.4 52.4 100 3.03076923076923:4.030769230769230.7519 84 0.81753851
95 H11 100 43.8 49.7 100 43.8:49.7 0.88128773 0.95821068
96 H12 100 39.2 49.2 100 39.2:49.2 0.79674797 0.86629189
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Screen 2 – Plate 3. 
	
Table	A.14.	Percentages	from	screen	2	plate	3 	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 43.5 48.6 100 43.5:48.6 0.89506173 0.94921328 0.94295113
2 A2 100 38.8 50.6 100 19.4:25.3 0.76679842 0.81318999
3 A3 100 41.5 50.4 100 41.5:50.4 0.8234127 0.87322946
4 A4 100 39.1 52.7 100 3.00769230769231:4.053846153846150.74 93548 0.786 2284
5 A5 100 43.7 49.4 100 43.7:49.4 0.88461538 0.93813493
6 A6 100 37.5 51.8 100 37.5:51.8 0.72393822 0.76773674
7 A7 100 28.8 64.6 100 7.2:16.15 0.44582043 0.47279273
8 A8 100 35.8 54.6 100 35.8:54.6 0.65567766 0.69534638
9 A9 100 30.2 53 100 30.2:53 0.56981132 0.60428511
10 A10 100 39.9 52.7 100 3.06923076923077:4.053846153846150.75 11575 0.80292152
11 A11 100 40.8 53.5 100 40.8:53.5 0.76261682 0.80875541
12 A12 100 37.6 46.7 100 37.6:46.7 0.80513919 0.85385039
13 B1 100 37.6 50.7 100 37.6:50.7 0.74161736 0.78648547
14 B2 100 39.1 51.6 100 13.0333333333333:17.20.75775194 0.8035962
15 B3 100 44 46.7 100 22:23.35 0.94218415 0.99918663
16 B4 100 40.4 47.8 100 40.4:47.8 0.84518828 0.89632247
17 B5 100 40 51 100 40:51 0.78431373 0.83176498
18 B6 100 42.3 52.7 100 21.15:26.35 0.80265655 0.85121755
19 B7 100 36.4 55.2 100 36.4:55.2 0.65942029 0.69931545
20 B8 100 40.9 50.9 100 4.09:5.09 0.80353635 0.85215058
21 B9 100 42 47.5 100 42:47.5 0.88421053 0.93770557
22 B10 100 39.2 51.9 100 13.0666666666667:17.30.75529865 0.80099449
23 B11 100 42.4 48.4 100 7.06666666666667:8.066666666666670.8760330 0.9290333
24 B12 100 44.8 45.7 100 44.8:45.7 0.98030635 1.03961522
25 C1 100 2.7 57.2 100 2.7:57.2 0.0472028 0.05005858
26 C2 100 38 49.2 100 38:49.2 0.77235772 0.81908564
27 C3 100 36.8 52.5 100 9.2:13.125 0.70095238 0.74336025
28 C4 100 33.6 53.5 100 33.6:53.5 0.62803738 0.66603387
29 C5 100 43.1 43 100 1.00232558139535:11.00232558 1.06296663
30 C6 100 39.3 52.6 100 3.02307692307692:4.046153846153850.74714829 0.7923 102
31 C7 100 34 52.9 100 17:26.45 0.64272212 0.68160703
32 C8 100 40.5 45.9 100 8.1:9.18 0.88235294 0.9357356
33 C9 100 41.5 48.7 100 41.5:48.7 0.85215606 0.9037118
34 C10 100 37.9 51.7 100 37.9:51.7 0.73307544 0.77742676
35 C11 100 38.5 51.2 100 38.5:51.2 0.75195313 0.79744655
36 C12 100 37.1 52.9 100 37.1:52.9 0.70132325 0.74375355
37 D1 100 39.3 49.6 100 39.3:49.6 0.79233871 0.84027548
38 D2 100 42.5 47.9 100 42.5:47.9 0.88726514 0.94094499
39 D3 100 37.8 49.8 100 37.8:49.8 0.75903614 0.8049581
40 D4 100 37.2 47.7 100 37.2:47.7 0.77987421 0.82705688
41 D5 100 38.8 47 100 38.8:47 0.82553191 0.87547689
42 D6 100 38.7 49.3 100 38.7:49.3 0.78498986 0.83248202
43 D7 100 38.1 47.8 100 38.1:47.8 0.79707113 0.84529421
44 D8 100 39.1 45.6 100 13.0333333333333:15.20.85745614 0.90933254
45 D9 100 35.2 50.1 100 7.04:10.02 0.70259481 0.74510204
46 D10 100 39.6 50.1 100 39.6:50.1 0.79041916 0.8382398
47 D11 100 40.8 51.4 100 40.8:51.4 0.79377432 0.84179794
48 D12 100 45.7 46.4 100 45.7:46.4 0.98491379 1.04450142
49 E1 100 44.3 48.6 100 11.075:12.15 0.91152263 0.96667007
50 E2 100 40.6 47.7 100 40.6:47.7 0.85115304 0.9026481
51 E3 100 38.5 46.9 100 19.25:23.45 0.82089552 0.87055999
52 E4 100 36.7 48 100 3.05833333333333:40.76458333 0.81084089
53 E5 100 39.4 47.3 100 39.4:47.3 0.83298097 0.88337661
54 E6 100 36.9 46.4 100 18.45:23.2 0.79525862 0.84337205
55 E7 100 36.2 48.6 100 3.01666666666667:4.050.74485597 0.78992002
56 E8 100 15.3 70.7 100 3.06:14.14 0.21640736 0.22950008
57 E9 100 38.5 48.7 100 19.25:24.35 0.79055441 0.83838323
58 E10 100 37.9 49.7 100 37.9:49.7 0.76257545 0.80871154
59 E11 100 38.1 49 100 38.1:49 0.77755102 0.82459313
60 E12 100 3.7 55.7 100 3.7:55.7 0.06642729 0.07044616
61 F1 100 36.4 43 100 36.4:43 0.84651163 0.89772588
62 F2 100 39 47.5 100 39:47.5 0.82105263 0.8707266
63 F3 100 43.1 46.7 100 43.1:46.7 0.92291221 0.97874872
64 F4 100 39.5 46.3 100 39.5:46.3 0.85313175 0.90474652
65 F5 100 40.4 45.5 100 8.08:9.1 0.88791209 0.94163108
66 F6 100 38.7 48.6 100 19.35:24.3 0.7962963 0.8444725
67 F7 100 39.3 49.2 100 39.3:49.2 0.79878049 0.84710699
68 F8 100 37.8 49.8 100 37.8:49.8 0.75903614 0.8049581
69 F9 100 40.3 43.3 100 40.3:43.3 0.93071594 0.98702458
70 F10 100 36.9 46.5 100 18.45:23.25 0.79354839 0.84155834
71 F11 100 41 45.6 100 41:45.6 0.89912281 0.95352005
72 F12 100 43.4 48 100 43.4:48 0.90416667 0.95886907
73 G1 100 35 46.3 100 35:46.3 0.75593952 0.80167413
74 G2 100 38.9 47.1 100 38.9:47.1 0.82590234 0.87586972
75 G3 100 40.3 46.9 100 20.15:23.45 0.85927505 0.9112615
76 G4 100 40 46.2 100 20:23.1 0.86580087 0.91818212
77 G5 100 39.9 47.4 100 39.9:47.4 0.84177215 0.89269966
78 G6 100 34.2 52.6 100 17.1:26.3 0.65019011 0.68952684
79 G7 100 43 46.4 100 43:46.4 0.92672414 0.98279127
80 G8 100 36 51.8 100 12:17.26666666666670.69498069 0.73702727
81 G9 100 40.8 49.6 100 40.8:49.6 0.82258065 0.87234706
82 G10 100 41.3 49 100 41.3:49 0.84285714 0.8938503
83 G11 100 38.3 49.9 100 38.3:49.9 0.76753507 0.81397121
84 G12 100 39.2 45.8 100 13.0666666666667:15.26666666666670.8558952 0.907 7716
85 H1 100 39.1 42.9 100 13.0333333333333:14.30.91142191 0.96656326
86 H2 100 41.1 49 100 41.1:49 0.83877551 0.88952172
87 H3 100 38.2 51 100 38.2:51 0.74901961 0.79433556
88 H4 100 40.6 49 100 40.6:49 0.82857143 0.87870029
89 H5 100 33.8 56.3 100 33.8:56.3 0.60035524 0.63667694
90 H6 100 40.3 50 100 4.03:5 0.806 0.85476328
91 H7 100 39.3 52.2 100 3.02307692307692:4.015384615384620.75 87356 0.798422 8
92 H8 100 43.1 48 100 43.1:48 0.89791667 0.95224094
93 H9 100 40.7 52.4 100 10.175:13.1 0.77671756 0.82370924
94 H10 100 38.8 53.2 100 38.8:53.2 0.72932331 0.77344762
95 H11 100 27.6 59.5 100 27.6:59.5 0.46386555 0.49192957
96 H12 100 42.4 42.5 100 1.00952380952381:1.011904761904760.99764706 1.0580 50
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Table	A.15.	Percentages	from	screen	2	plate	4	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 42.1 48.8 100 7.01666666666667:8.133333333333330.8 270492 0.96695981 0.89218281
2 A2 100 38.1 52 100 19.05:26 0.73269231 0.82123563
3 A3 100 34.5 55.8 100 34.5:55.8 0.61827957 0.69299651
4 A4 100 33.5 56.9 100 33.5:56.9 0.5887522 0.65990085
5 A5 100 36.6 53.5 100 36.6:53.5 0.68411215 0.76678472
6 A6 100 39.5 48.9 100 13.1666666666667:16.30.80 77096 0.90538727
7 A7 100 41 49.1 100 41:49.1 0.83503055 0.93594109
8 A8 100 42.5 49.3 100 6.07142857142857:7.042857142857140. 6206897 0.966247
9 A9 100 39.9 50.1 100 39.9:50.1 0.79640719 0.89265023
10 A10 100 38.6 53 100 38.6:53 0.72830189 0.81631464
11 A11 100 41.9 50 100 41.9:50 0.838 0.93926939
12 A12 100 37.5 49.9 100 37.5:49.9 0.75150301 0.84231953
13 B1 100 38 51.6 100 38:51.6 0.73643411 0.82542961
14 B2 100 40.5 47 100 40.5:47 0.86170213 0.96583583
15 B3 100 37.3 51.5 100 37.3:51.5 0.72427184 0.81179758
16 B4 100 36.7 49.4 100 36.7:49.4 0.74291498 0.83269367
17 B5 100 18 70.3 100 9:35.15 0.25604552 0.28698773
18 B6 100 45.1 45.2 100 1.00222222222222:1.004444444444440.99778761 1.11836677
19 B7 100 41.4 48.9 100 41.4:48.9 0.84662577 0.94893755
20 B8 100 37.3 53.7 100 37.3:53.7 0.69459963 0.77853958
21 B9 100 42 47.9 100 42:47.9 0.87682672 0.98278818
22 B10 100 37.5 55.2 100 37.5:55.2 0.67934783 0.76144465
23 B11 100 42.8 46 100 21.4:23 0.93043478 1.04287459
24 B12 100 46.9 46.3 100 1.0195652173913:1.006521739130431.01295896 1.135 7153
25 C1 100 2.1 57.5 100 2.1:57.5 0.03652174 0.04093526
26 C2 100 40.2 50.4 100 4.02:5.04 0.79761905 0.89400854
27 C3 100 34.8 54.5 100 17.4:27.25 0.63853211 0.7156965
28 C4 100 25.4 61 100 25.4:61 0.41639344 0.46671314
29 C5 100 37.8 52.8 100 37.8:52.8 0.71590909 0.80242422
30 C6 100 34.2 53.1 100 34.2:53.1 0.6440678 0.72190115
31 C7 100 35.6 52 100 35.6:52 0.68461538 0.76734877
32 C8 100 37.8 53.8 100 37.8:53.8 0.70260223 0.78750927
33 C9 100 39.1 47.4 100 39.1:47.4 0.82489451 0.92458015
34 C10 100 36.7 52.4 100 9.175:13.1 0.70038168 0.78502037
35 C11 100 37.3 51.6 100 37.3:51.6 0.72286822 0.81022433
36 C12 100 40.4 50.6 100 4.04:5.06 0.79841897 0.89490513
37 D1 100 38.7 52.8 100 19.35:26.4 0.73295455 0.82152955
38 D2 100 41 47 100 41:47 0.87234043 0.97775973
39 D3 100 41.4 49.5 100 41.4:49.5 0.83636364 0.93743527
40 D4 100 41.7 46.1 100 41.7:46.1 0.90455531 1.01386768
41 D5 100 40.8 47 100 40.8:47 0.86808511 0.97299017
42 D6 100 40 47.3 100 40:47.3 0.84566596 0.94786175
43 D7 100 37.6 50.4 100 37.6:50.4 0.74603175 0.83618709
44 D8 100 36.8 49.2 100 36.8:49.2 0.74796748 0.83835675
45 D9 100 45.6 48.7 100 15.2:16.23333333333330.9 6 4497 1.049499
46 D10 100 37.7 51.9 100 37.7:51.9 0.72639692 0.81417946
47 D11 100 37.3 50.4 100 37.3:50.4 0.74007937 0.82951538
48 D12 100 44 48.5 100 11:12.125 0.90721649 1.01685045
49 E1 100 41.1 52.3 100 41.1:52.3 0.78585086 0.8808182
50 E2 100 38.7 50.7 100 19.35:25.35 0.76331361 0.85555741
51 E3 100 37.8 47.1 100 37.8:47.1 0.80254777 0.89953288
52 E4 100 36.6 51.2 100 12.2:17.06666666666670.714843 5 0.80123013
53 E5 100 38.2 47.7 100 38.2:47.7 0.80083857 0.89761713
54 E6 100 36.9 53.4 100 36.9:53.4 0.69101124 0.77451754
55 E7 100 39.5 48.4 100 13.1666666666667:16.13333333333330.8161157 0.91474045
56 E8 100 37.6 47.9 100 37.6:47.9 0.78496868 0.87982942
57 E9 100 32.1 55 100 32.1:55 0.58363636 0.65416679
58 E10 100 40.5 47.5 100 40.5:47.5 0.85263158 0.95566914
59 E11 100 40.1 51.4 100 40.1:51.4 0.78015564 0.87443474
60 E12 100 3.1 55.1 100 3.1:55.1 0.05626134 0.06306033
61 F1 100 35 47.1 100 35:47.1 0.74309979 0.83290081
62 F2 100 42.2 48.3 100 7.03333333333333:8.050.873706 0.97929034
63 F3 100 38.4 51.8 100 38.4:51.8 0.74131274 0.83089781
64 F4 100 37 52 100 37:52 0.71153846 0.79752541
65 F5 100 39.9 47.9 100 39.9:47.9 0.83298539 0.93364877
66 F6 100 47.3 37.7 100 47.3:37.7 1.25464191 1.40626102
67 F7 100 36.8 52 100 9.2:13 0.70769231 0.79321446
68 F8 100 42.4 48.7 100 7.06666666666667:8.116666666666670.87063655 0.97584995
69 F9 100 37.1 53.1 100 37.1:53.1 0.69868173 0.78311499
70 F10 100 39.5 50.2 100 39.5:50.2 0.78685259 0.88194099
71 F11 100 37.5 52.1 100 37.5:52.1 0.71976967 0.80675134
72 F12 100 34.6 57.1 100 34.6:57.1 0.60595447 0.67918196
73 G1 100 36.6 44.5 100 9.15:11.125 0.82247191 0.92186478
74 G2 100 20.2 68.9 100 5.05:17.225 0.29317852 0.32860812
75 G3 100 38.8 51.3 100 38.8:51.3 0.75633528 0.84773577
76 G4 100 39.8 48.2 100 13.2666666666667:16.06666666666670.82572614 0.9255122
77 G5 100 38.7 52.1 100 19.35:26.05 0.7428023 0.83256738
78 G6 100 38.3 51.1 100 38.3:51.1 0.74951076 0.84008653
79 G7 100 36.7 55.6 100 36.7:55.6 0.66007194 0.73983934
80 G8 100 42.3 47.7 100 42.3:47.7 0.88679245 0.99395824
81 G9 100 41.1 49.6 100 41.1:49.6 0.82862903 0.92876597
82 G10 100 37.7 51.2 100 37.7:51.2 0.73632813 0.82531082
83 G11 100 38.8 50.5 100 19.4:25.25 0.76831683 0.86116525
84 G12 100 38.5 47.9 100 38.5:47.9 0.80375783 0.90088917
85 H1 100 40.5 40.6 100 1.0125:1.015 0.99753695 1.11808582
86 H2 100 36.5 53.6 100 36.5:53.6 0.68097015 0.76326302
87 H3 100 38.3 51.7 100 38.3:51.7 0.74081238 0.83033698
88 H4 100 40.4 50.8 100 4.04:5.08 0.79527559 0.89138188
89 H5 100 38.5 54.2 100 19.25:27.1 0.7103321 0.79617327
90 H6 100 40.8 50.9 100 4.08:5.09 0.80157171 0.89843886
91 H7 100 39.8 52.7 100 3.06153846153846:4.053846153846150.75521822 0.84648371
92 H8 100 41.6 50.1 100 41.6:50.1 0.83033932 0.93068294
93 H9 100 37.7 55.8 100 37.7:55.8 0.67562724 0.75727444
94 H10 100 38.8 52.4 100 19.4:26.2 0.74045802 0.82993979
95 H11 100 39.8 50.1 100 39.8:50.1 0.79441118 0.89041301
96 H12 100 39.1 48.8 100 13.0333333333333:16.26666666666670.80122951 0.89805531
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Table	A.16.	Percentages	from	screen	2	plate	5 	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 42.6 53.6 100 42.6:53.6 0.79477612 0.87991321 0.90324376
2 A2 100 42 49 100 6:7 0.85714286 0.94896073
3 A3 100 35.7 56.1 100 5.1:8.014285714285710.63636364 0.70453145
4 A4 100 40.5 51.4 100 40.5:51.4 0.78793774 0.8723423
5 A5 100 40.3 51.3 100 40.3:51.3 0.78557505 0.86972652
6 A6 100 45.3 49.6 100 45.3:49.6 0.91330645 1.01114061
7 A7 100 40.5 52.3 100 10.125:13.0750.77437859 0.85733068
8 A8 100 41.1 50.3 100 41.1:50.3 0.81709742 0.90462558
9 A9 100 40.3 53.2 100 40.3:53.2 0.7575188 0.83866485
10 A10 100 37.7 55.7 100 37.7:55.7 0.67684022 0.74934391
11 A11 100 40.6 52.2 100 10.15:13.05 0.77777778 0.86109399
12 A12 100 42.3 44.9 100 21.15:22.45 0.94209354 1.0430114
13 B1 100 43.4 47.4 100 43.4:47.4 0.91561181 1.01369293
14 B2 100 44.5 47.6 100 44.5:47.6 0.93487395 1.03501844
15 B3 100 43.9 49.9 100 43.9:49.9 0.87975952 0.97400011
16 B4 100 41.1 49.4 100 41.1:49.4 0.83198381 0.92110662
17 B5 100 46.6 45.7 100 46.6:45.7 1.01969365 1.1289241
18 B6 100 42.7 49.6 100 6.1:7.085714285714290.8608871 0.95310605
19 B7 100 40.8 52.8 100 10.2:13.2 0.77272727 0.85550247
20 B8 100 45.1 48.1 100 15.0333333333333:16.03333333333330.9 762994 1.0 806965
21 B9 100 45.2 48.9 100 15.0666666666667:16.30.924335 8 1.02335097
22 B10 100 44.9 49.1 100 44.9:49.1 0.91446029 1.01241805
23 B11 100 41.1 51.1 100 41.1:51.1 0.80430528 0.89046315
24 B12 100 49.2 46 100 49.2:46 1.06956522 1.18413795
25 C1 100 1.7 62.5 100 1.7:62.5 0.0272 0.03011369
26 C2 100 37.4 56.2 100 37.4:56.2 0.66548043 0.73676726
27 C3 100 40.5 49.4 100 40.5:49.4 0.81983806 0.90765981
28 C4 100 45.8 43.3 100 45.8:43.3 1.05773672 1.17104238
29 C5 100 39.7 48.8 100 13.2333333333333:16.26666666666670.81 52459 0.900 7004
30 C6 100 40.7 48.7 100 5.0875:6.08750.83572895 0.92525295
31 C7 100 41.6 50.2 100 41.6:50.2 0.82868526 0.91745473
32 C8 100 44 49.7 100 44:49.7 0.88531187 0.98014723
33 C9 100 43.9 50.5 100 43.9:50.5 0.86930693 0.96242783
34 C10 100 39.2 53.8 100 39.2:53.8 0.72862454 0.80667541
35 C11 100 42.6 50.5 100 21.3:25.25 0.84356436 0.93392769
36 C12 100 38.3 54.7 100 19.15:27.35 0.70018282 0.77518699
37 D1 100 38.9 55.8 100 38.9:55.8 0.69713262 0.77181005
38 D2 100 45 46.9 100 45:46.9 0.95948827 1.06226947
39 D3 100 46.1 49 100 46.1:49 0.94081633 1.04159737
40 D4 100 44.8 43 100 44.8:43 1.04186047 1.15346544
41 D5 100 40.9 49.1 100 40.9:49.1 0.83299389 0.9222249
42 D6 100 40.6 48.2 100 5.075:6.025 0.84232365 0.93255408
43 D7 100 41.7 48.1 100 41.7:48.1 0.86694387 0.95981163
44 D8 100 46 45.7 100 46:45.7 1.00656455 1.1143886
45 D9 100 38.1 52.3 100 19.05:26.15 0.72848948 0.8065259
46 D10 100 44.3 48.7 100 11.075:12.1750.90965092 1.0070935
47 D11 100 40.5 52.5 100 10.125:13.1250.77142857 0.85406466
48 D12 100 44.7 48.7 100 11.175:12.1750.91786448 1.0161869
49 E1 100 43.2 52 100 43.2:52 0.83076923 0.91976194
50 E2 100 40.1 53.3 100 40.1:53.3 0.75234522 0.83293707
51 E3 100 41.9 49.5 100 41.9:49.5 0.84646465 0.93713866
52 E4 100 43.6 47.6 100 43.6:47.6 0.91596639 1.01408548
53 E5 100 38.2 50.9 100 19.1:25.45 0.75049116 0.83088441
54 E6 100 43 47.9 100 43:47.9 0.89770355 0.99386632
55 E7 100 45.1 44.7 100 45.1:44.7 1.00894855 1.11702797
56 E8 100 39.8 49.4 100 39.8:49.4 0.80566802 0.89197186
57 E9 100 38.4 51.2 100 38.4:51.2 0.75 0.83034064
58 E10 100 42.7 49.3 100 6.1:7.042857142857140.86612576 0.95890589
59 E11 100 44.7 49.1 100 44.7:49.1 0.91038697 1.00790839
60 E12 100 2.2 60.6 100 1.1:30.3 0.03630363 0.04019251
61 F1 100 43.7 44 100 43.7:44 0.99318182 1.0995723
62 F2 100 39.2 55.3 100 39.2:55.3 0.70886076 0.78479453
63 F3 100 43.3 50.8 100 43.3:50.8 0.8523622 0.94366797
64 F4 100 41.6 46.7 100 41.6:46.7 0.89079229 0.98621472
65 F5 100 41.5 49.2 100 41.5:49.2 0.84349593 0.93385194
66 F6 100 46.9 41.8 100 46.9:41.8 1.12200957 1.24220019
67 F7 100 45.7 45.9 100 1.01555555555556:1.020.99564 7 1.10229679
68 F8 100 42.9 47.6 100 42.9:47.6 0.9012605 0.9978043
69 F9 100 48.5 44.3 100 12.125:11.0751.09480813 1.2120849
70 F10 100 40.1 47.2 100 40.1:47.2 0.84957627 0.9405836
71 F11 100 45.1 49.8 100 45.1:49.8 0.90562249 1.00263354
72 F12 100 64.9 24.3 100 8.1125:3.03752.67078189 2.95687832
73 G1 100 38.1 47 100 38.1:47 0.8106383 0.89747456
74 G2 100 43.7 50 100 43.7:50 0.874 0.96762362
75 G3 100 43.7 51.5 100 43.7:51.5 0.84854369 0.93944041
76 G4 100 39.8 50.3 100 39.8:50.3 0.79125249 0.87601212
77 G5 100 44.1 46.7 100 22.05:23.35 0.94432548 1.04548243
78 G6 100 38.6 52.6 100 19.3:26.3 0.7338403 0.8124499
79 G7 100 40.2 53.3 100 40.2:53.3 0.75422139 0.83501422
80 G8 100 45.3 47.2 100 45.3:47.2 0.95974576 1.06255454
81 G9 100 38.3 55 100 38.3:55 0.69636364 0.7709587
82 G10 100 39.1 51.8 100 13.0333333333333:17.26666666666670.754826 5 0.835 8388
83 G11 100 40.5 52.1 100 10.125:13.0250.77735125 0.86062177
84 G12 100 42.5 47.8 100 42.5:47.8 0.88912134 0.98436477
85 H1 100 40.3 45.6 100 8.06:9.12 0.88377193 0.97844233
86 H2 100 42.4 51.3 100 14.1333333333333:17.10.82651072 0.91504725
87 H3 100 43.7 50.4 100 43.7:50.4 0.86706349 0.95994407
88 H4 100 41.4 49.6 100 41.4:49.6 0.83467742 0.92408877
89 H5 100 41.2 52.1 100 41.2:52.1 0.79078695 0.87549672
90 H6 100 36 56.7 100 9:14.175 0.63492063 0.70293387
91 H7 100 37.1 56.6 100 37.1:56.6 0.65547703 0.72569229
92 H8 100 42.9 50.7 100 21.45:25.35 0.84615385 0.93679456
93 H9 100 40.5 53.8 100 40.5:53.8 0.7527881 0.83342741
94 H10 100 39.7 53.5 100 39.7:53.5 0.74205607 0.82154575
95 H11 100 38.1 55.1 100 38.1:55.1 0.69147005 0.76554091
96 H12 100 43.6 46.7 100 43.6:46.7 0.93361884 1.03362889
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Table	A.17.	Percentages	from	screen	2	plate	6 
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 43.6 49.7 100 43.6:49.7 0.87726358 1.20457532 0.72827624
2 A2 100 47.3 36.7 100 47.3:36.7 1.28882834 1.76969709
3 A3 100 44.3 42.6 100 22.15:21.3 1.0399061 1.42790064
4 A4 100 38.1 45.1 100 38.1:45.1 0.84478936 1.15998479
5 A5 100 40.4 48.1 100 5.05:6.0125 0.83991684 1.15329431
6 A6 100 41.7 47.1 100 41.7:47.1 0.88535032 1.21567926
7 A7 100 42.9 48.7 100 7.15:8.116666666666670.88090349 1.2095733
8 A8 100 41.2 47.8 100 41.2:47.8 0.86192469 1.1835134
9 A9 100 34.7 56.7 100 17.35:28.35 0.61199295 0.84033079
10 A10 100 39.5 54 100 13.1666666666667:180.73148148 1.00440114
11 A11 100 37.5 54.6 100 37.5:54.6 0.68681319 0.94306686
12 A12 100 42.3 40.4 100 21.15:20.2 1.0470297 1.43768209
13 B1 100 38.8 51.5 100 38.8:51.5 0.75339806 1.03449491
14 B2 100 32.1 56.2 100 4.0125:7.025 0.57117438 0.78428259
15 B3 100 38.7 47.4 100 38.7:47.4 0.8164557 1.12107969
16 B4 100 38.6 50.2 100 19.3:25.1 0.7689243 1.05581408
17 B5 100 38.7 50.8 100 19.35:25.4 0.76181102 1.04604679
18 B6 100 39.9 45.1 100 13.3:15.03333333333330.88470067 1.21478722
19 B7 100 39.3 48.6 100 13.1:16.2 0.80864198 1.11035062
20 B8 100 41.1 46.1 100 41.1:46.1 0.89154013 1.22417852
21 B9 100 44.2 44.9 100 1.00454545454545:1.020454545454550.9844 98 1.35169836
22 B10 100 38.5 49.5 100 38.5:49.5 0.77777778 1.06797083
23 B11 100 41.7 49.4 100 41.7:49.4 0.84412955 1.15907881
24 B12 100 22.5 69.4 100 22.5:69.4 0.32420749 0.44517104
25 C1 100 1.6 63.4 100 1.6:63.4 0.02523659 0.0346525
26 C2 100 36.8 50.5 100 18.4:25.25 0.72871287 1.00059954
27 C3 100 40.5 47.6 100 40.5:47.6 0.85084034 1.16829342
28 C4 100 39.1 46.8 100 39.1:46.8 0.83547009 1.14718845
29 C5 100 39.5 47.9 100 39.5:47.9 0.82463466 1.13231026
30 C6 100 38.1 46 100 19.05:23 0.82826087 1.13728943
31 C7 100 40.2 43.8 100 40.2:43.8 0.91780822 1.26024738
32 C8 100 46 40 100 23:20 1.15 1.57907116
33 C9 100 39.5 47 100 39.5:47 0.84042553 1.1539928
34 C10 100 36.3 51.1 100 12.1:17.03333333333330.710 7182 0.97541535
35 C11 100 43.5 48.6 100 43.5:48.6 0.89506173 1.22901405
36 C12 100 36.9 53.5 100 36.9:53.5 0.68971963 0.94705771
37 D1 100 43.9 44.6 100 43.9:44.6 0.98430493 1.35155437
38 D2 100 41.3 45.9 100 41.3:45.9 0.89978214 1.23549567
39 D3 100 39.3 49.8 100 39.3:49.8 0.78915663 1.08359519
40 D4 100 41.9 44.7 100 41.9:44.7 0.93736018 1.28709428
41 D5 100 40.5 44.7 100 10.125:11.1750.90604027 1.24408874
42 D6 100 44 41.2 100 44:41.2 1.06796117 1.46642319
43 D7 100 37.4 45.9 100 37.4:45.9 0.81481481 1.11882658
44 D8 100 34.3 48.2 100 17.15:24.1 0.71161826 0.97712684
45 D9 100 38 51.1 100 38:51.1 0.74363992 1.02109596
46 D10 100 45.5 45.5 100 1.01111111111111:1.011111111111111.373 0535
47 D11 100 44 48.8 100 11:12.2 0.90163934 1.23804581
48 D12 100 46.3 45.8 100 46.3:45.8 1.01091703 1.38809559
49 E1 100 39.1 55.8 100 39.1:55.8 0.70071685 0.96215805
50 E2 100 43.8 45.8 100 43.8:45.8 0.95633188 1.31314442
51 E3 100 41.8 44.8 100 41.8:44.8 0.93303571 1.28115633
52 E4 100 42.2 45.5 100 14.0666666666667:15.16666666666670.92 47253 1.27351749
53 E5 100 42.2 41.8 100 42.2:41.8 1.00956938 1.38624512
54 E6 100 41.2 44.8 100 41.2:44.8 0.91964286 1.26276653
55 E7 100 37.2 49.1 100 37.2:49.1 0.75763747 1.04031607
56 E8 100 39 43.3 100 39:43.3 0.90069284 1.23674616
57 E9 100 39.8 46.2 100 39.8:46.2 0.86147186 1.18289162
58 E10 100 36.1 48.5 100 3.00833333333333:4.041666666666670.7443299 1.0220433
59 E11 100 38.4 48.3 100 19.2:24.15 0.79503106 1.0916614
60 E12 100 3.3 60 100 1.1:20 0.055 0.07552079
61 F1 100 38.2 46.2 100 19.1:23.1 0.82683983 1.13533819
62 F2 100 43.4 45.9 100 43.4:45.9 0.94553377 1.29831748
63 F3 100 40.9 45.5 100 8.18:9.1 0.8989011 1.23428591
64 F4 100 39.8 50.2 100 39.8:50.2 0.79282869 1.08863731
65 F5 100 39 43.3 100 39:43.3 0.90069284 1.23674616
66 F6 100 42.2 46.4 100 21.1:23.2 0.90948276 1.24881564
67 F7 100 40.5 45.3 100 8.1:9.06 0.89403974 1.22761075
68 F8 100 36.7 44.7 100 9.175:11.175 0.82102908 1.12735943
69 F9 100 41.9 48.8 100 41.9:48.8 0.85860656 1.17895726
70 F10 100 40.6 49.1 100 40.6:49.1 0.82688391 1.13539872
71 F11 100 39.7 50.1 100 39.7:50.1 0.79241517 1.08806951
72 F12 100 43.4 46.6 100 43.4:46.6 0.93133047 1.27881486
73 G1 100 37.5 45.5 100 37.5:45.5 0.82417582 1.13168024
74 G2 100 39.9 48.7 100 13.3:16.23333333333330.819 0185 1.12498775
75 G3 100 42.9 44.8 100 21.45:22.4 0.95758929 1.31487097
76 G4 100 41.4 47.1 100 41.4:47.1 0.87898089 1.20693337
77 G5 100 39.8 42 100 13.2666666666667:140.94 61905 1.30118079
78 G6 100 42.2 45.9 100 14.0666666666667:15.30.91938998 1.2624193
79 G7 100 41.8 47.2 100 41.8:47.2 0.88559322 1.21601279
80 G8 100 37.9 50.4 100 37.9:50.4 0.75198413 1.03255343
81 G9 100 43.8 49.2 100 43.8:49.2 0.8902439 1.22239867
82 G10 100 40 50.5 100 4:5.05 0.79207921 1.0876082
83 G11 100 44.9 46.5 100 22.45:23.25 0.9655914 1.32585872
84 G12 100 41.8 46.3 100 41.8:46.3 0.90280778 1.23965019
85 H1 100 38 42.4 100 19:21.2 0.89622642 1.23061329
86 H2 100 41.4 50.6 100 41.4:50.6 0.81818182 1.12344983
87 H3 100 37.9 51.2 100 37.9:51.2 0.74023438 1.01641978
88 H4 100 36.4 55.9 100 36.4:55.9 0.65116279 0.89411511
89 H5 100 39.8 40.8 100 39.8:40.8 0.9754902 1.33945081
90 H6 100 44.8 49.3 100 44.8:49.3 0.90872211 1.24777119
91 H7 100 35.6 58.7 100 35.6:58.7 0.60647359 0.83275214
92 H8 100 38.7 52.9 100 19.35:26.45 0.731569 1.00452131
93 H9 100 43.7 43.2 100 1.01627906976744:1.00465116279071.011574 7 1.3889 7 8
94 H10 100 44.2 49.2 100 44.2:49.2 0.89837398 1.23356213
95 H11 0 0 0 0 #DIV/0! #DIV/0! #DIV/0!
96 H12 100 38.5 51.5 100 38.5:51.5 0.74757282 1.02649623
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A.3.3 – Raw data from third screen.  
Screen 3 – Plate 1. 
	
Table	A.18.	Percentages	from	screen	3	plate	1	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/Red Numerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 46.5 47.5 100 46.5:47.5 0.97894737 1.07964148 0.90673375
2 A2 100 38 58.2 100 19:29.1 0.65292096 0.72008014
3 A3 100 43.3 47.6 100 43.3:47.6 0.90966387 1.00323151
4 A4 100 34.3 61.8 100 34.3:61.8 0.55501618 0.61210491
5 A5 100 38.7 56.7 100 19.35:28.35 0.68253968 0.75274543
6 A6 100 36.8 54.8 100 2.04444444444444:3.044444444444440.67153285 0.7 060643
7 A7 100 44.8 47.5 100 44.8:47.5 0.94315789 1.04017072
8 A8 100 35.1 61 100 35.1:61 0.57540984 0.63459625
9 A9 100 43.3 52 100 43.3:52 0.83269231 0.91834269
10 A10 100 44.9 47.4 100 44.9:47.4 0.94725738 1.04469188
11 A11 100 35.4 60.1 100 7.08:12.02 0.5890183 0.64960448
12 A12 100 45 47.9 100 45:47.9 0.9394572 1.03608938
13 B1 100 38.6 54.2 100 19.3:27.1 0.71217712 0.78543136
14 B2 100 37.6 56.4 100 37.6:56.4 0.66666667 0.73523972
15 B3 100 39.2 57.4 100 13.0666666666667:19.13333333333330.6829268 0.75 1724
16 B4 100 40.2 54.5 100 20.1:27.25 0.73761468 0.81348541
17 B5 100 33.8 58.1 100 33.8:58.1 0.58175559 0.64159473
18 B6 100 32.9 62.4 100 16.45:31.2 0.52724359 0.58147564
19 B7 100 33.9 60.3 100 11.3:20.1 0.56218905 0.62001558
20 B8 100 35.6 60.8 100 7.12:12.16 0.58552632 0.64575331
21 B9 100 35.7 57.9 100 35.7:57.9 0.61658031 0.6800015
22 B10 100 39.4 54.1 100 13.1333333333333:18.03333333333330.72828096 0.80 19163
23 B11 100 36.9 55.8 100 36.9:55.8 0.66129032 0.72931037
24 B12 100 43.8 52.4 100 43.8:52.4 0.83587786 0.92185591
25 C1 100 3.4 70.6 100 3.4:70.6 0.04815864 0.05311222
26 C2 100 38.7 56.5 100 19.35:28.25 0.68495575 0.75541001
27 C3 100 40.4 55.1 100 8.08:11.02 0.73321234 0.80863025
28 C4 100 39.4 56.3 100 39.4:56.3 0.69982238 0.77180582
29 C5 100 47.6 48.6 100 47.6:48.6 0.97942387 1.080167
30 C6 100 40.5 54.2 100 20.25:27.1 0.74723247 0.82409249
31 C7 100 42.8 52.6 100 21.4:26.3 0.81368821 0.89738384
32 C8 100 39.4 54.1 100 13.1333333333333:18.03333333333330.72828096 0.80 19163
33 C9 100 33.9 64 100 33.9:64 0.5296875 0.58417093
34 C10 100 35.4 60.3 100 7.08:12.06 0.58706468 0.6474499
35 C11 100 38.4 57.1 100 2.02105263157895:3.005263157894740.672 04 8 0.7416779
36 C12 100 41.8 51 100 41.8:51 0.81960784 0.90391236
37 D1 100 44.4 51.5 100 44.4:51.5 0.86213592 0.95081486
38 D2 100 34.7 58 100 17.35:29 0.59827586 0.65981427
39 D3 100 40.8 52 100 10.2:13 0.78461538 0.86532059
40 D4 100 41 52.5 100 41:52.5 0.78095238 0.86128081
41 D5 100 41.7 50.4 100 41.7:50.4 0.82738095 0.91248501
42 D6 100 39.3 54.4 100 13.1:18.13333333333330.72242647 0.79673495
43 D7 100 43.2 50.2 100 43.2:50.2 0.86055777 0.94907438
44 D8 100 41.9 53.3 100 41.9:53.3 0.78611632 0.86697592
45 D9 100 42.2 53.5 100 42.2:53.5 0.78878505 0.86991915
46 D10 100 45.1 46.8 100 45.1:46.8 0.96367521 1.06279844
47 D11 100 38.4 56.1 100 19.2:28.05 0.68449198 0.75489854
48 D12 100 46.9 47.6 100 46.9:47.6 0.98529412 1.08664106
49 E1 100 44.4 53.7 100 44.4:53.7 0.82681564 0.91186155
50 E2 100 41.9 53.8 100 41.9:53.8 0.77881041 0.85891852
51 E3 100 35.8 58.3 100 35.8:58.3 0.61406518 0.67722767
52 E4 100 39.7 54.5 100 13.2333333333333:18.16666666666670.72844037 0.80336744
53 E5 100 42 52.2 100 21:26.1 0.8045977 0.88735828
54 E6 100 43.6 51.3 100 43.6:51.3 0.84990253 0.93732315
55 E7 100 43 51.7 100 43:51.7 0.83172147 0.91727199
56 E8 100 38 57.1 100 2:3.005263157894740.66549912 0.73395208
57 E9 100 41.9 53.4 100 41.9:53.4 0.78464419 0.86535237
58 E10 100 36 57.7 100 12:19.23333333333330.62391681 0.68809263
59 E11 100 39.6 55.3 100 39.6:55.3 0.71609403 0.78975116
60 E12 100 4.4 63.6 100 4.4:63.6 0.06918239 0.07629846
61 F1 100 44.8 47.2 100 44.8:47.2 0.94915254 1.04678197
62 F2 100 37.4 57.9 100 37.4:57.9 0.64594128 0.71238253
63 F3 100 41.8 54.2 100 41.8:54.2 0.77121771 0.85054484
64 F4 100 37.3 58.1 100 37.3:58.1 0.64199656 0.70803205
65 F5 100 43.7 48.2 100 43.7:48.2 0.906639 0.99989551
66 F6 100 43.6 53 100 43.6:53 0.82264151 0.90725807
67 F7 100 39.8 56.8 100 39.8:56.8 0.70070423 0.77277837
68 F8 100 43.9 51.4 100 43.9:51.4 0.8540856 0.94193649
69 F9 100 36.7 59 100 36.7:59 0.6220339 0.68601604
70 F10 100 42.3 51.6 100 14.1:17.2 0.81976744 0.90408838
71 F11 100 37.4 58.2 100 37.4:58.2 0.64261168 0.70871045
72 F12 100 48.7 45.5 100 16.2333333333333:15.16666666666671.070329 7 1.18042333
73 G1 100 53.5 38 100 53.5:38 1.40789474 1.5527102
74 G2 100 38.6 55.2 100 38.6:55.2 0.69927536 0.77120253
75 G3 100 42.3 54.4 100 7.05:9.066666666666670.77 57353 0.85755442
76 G4 100 37.1 59.6 100 37.1:59.6 0.62248322 0.68651158
77 G5 100 40.4 54.1 100 20.2:27.05 0.74676525 0.82357721
78 G6 100 39.6 54.5 100 13.2:18.16666666666670.7266055 0.80134384
79 G7 100 41.1 54.3 100 41.1:54.3 0.75690608 0.83476112
80 G8 100 37.7 56.1 100 37.7:56.1 0.67201426 0.74113736
81 G9 100 37.1 60.4 100 37.1:60.4 0.61423841 0.67741872
82 G10 100 44.9 49.3 100 44.9:49.3 0.91075051 1.00442992
83 G11 100 47.7 46.9 100 47.7:46.9 1.01705757 1.12167168
84 G12 100 39.3 53.5 100 39.3:53.5 0.73457944 0.81013797
85 H1 100 42.1 47.4 100 42.1:47.4 0.88818565 0.97954406
86 H2 100 36.6 58.5 100 18.3:29.25 0.62564103 0.6899942
87 H3 100 39.4 56.4 100 39.4:56.4 0.69858156 0.77043737
88 H4 100 32.7 61.4 100 32.7:61.4 0.53257329 0.58735355
89 H5 100 47.3 48.4 100 47.3:48.4 0.97727273 1.07779459
90 H6 100 37.9 55.3 100 37.9:55.3 0.68535262 0.7558477
91 H7 100 41.6 50.8 100 41.6:50.8 0.81889764 0.9031291
92 H8 100 41.1 53 100 41.1:53 0.7754717 0.85523639
93 H9 100 42.6 49 100 6.08571428571429:70.86938776 0.95881261
94 H10 100 36.5 58.8 100 18.25:29.4 0.6207483 0.68459821
95 H11 100 46.6 49.9 100 46.6:49.9 0.93386774 1.02992498
96 H12 100 42.3 52.8 100 21.15:26.4 0.80113636 0.88354091
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Screen 3 – Plate 2.  
	
Table	A.19.	Percentages	from	screen	3	plate	2	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 49.2 47.7 100 49.2:47.7 1.03144654 1.05800744 0.97489536
2 A2 100 47.7 49.3 100 47.7:49.3 0.96754564 0.99246102
3 A3 100 48.1 48.8 100 1.00208333333333:1.016666666666670.98565574 1.0110374
4 A4 100 42.4 53.9 100 42.4:53.9 0.78664193 0.80689884
5 A5 100 50 48.6 100 25:24.3 1.02880658 1.0552995
6 A6 100 44.7 52.3 100 11.175:13.0750.85468451 0.87669359
7 A7 100 43.7 53.2 100 43.7:53.2 0.82142857 0.84258128
8 A8 100 40.5 55 100 8.1:11 0.73636364 0.75532582
9 A9 100 44.9 52.7 100 11.225:13.1750.85199241 0.87393217
10 A10 100 40.8 56.2 100 5.1:7.025 0.72597865 0.74467341
11 A11 100 47.4 50 100 47.4:50 0.948 0.97241206
12 A12 100 40.5 52.3 100 10.125:13.0750.77437859 0.7943197
13 B1 100 43.7 52.2 100 43.7:52.2 0.83716475 0.85872268
14 B2 100 48.8 48.4 100 1.01666666666667:1.008333333333331.00826446 1.0 42284
15 B3 100 46 51.1 100 46:51.1 0.90019569 0.92337674
16 B4 100 43.5 54.4 100 43.5:54.4 0.79963235 0.82022378
17 B5 100 45.2 52.8 100 45.2:52.8 0.85606061 0.87810512
18 B6 100 46.3 50.5 100 23.15:25.25 0.91683168 0.94044112
19 B7 100 39.1 57.7 100 13.0333333333333:19.23333333333330.67764298 0.69509 04
20 B8 100 42.6 53.3 100 42.6:53.3 0.79924953 0.8198311
21 B9 100 44 52.1 100 11:13.025 0.84452975 0.86627734
22 B10 100 44.1 50.7 100 22.05:25.35 0.86982249 0.89222139
23 B11 100 43 53.1 100 43:53.1 0.80979284 0.83064591
24 B12 100 48.5 48.6 100 1.01041666666667:1.01250.99 94239 1.02364052
25 C1 100 2.7 61.9 100 2.7:61.9 0.04361874 0.04474197
26 C2 100 42.3 53.3 100 42.3:53.3 0.79362101 0.81405764
27 C3 100 43.2 51.7 100 43.2:51.7 0.83558994 0.85710732
28 C4 100 46.9 48.8 100 23.45:24.4 0.96106557 0.98581409
29 C5 100 44 52.4 100 11:13.1 0.83969466 0.86131773
30 C6 100 45.3 51.8 100 15.1:17.26666666666670.87451737 0.89703717
31 C7 100 42.9 52.6 100 21.45:26.3 0.81558935 0.83659169
32 C8 100 43.1 53.1 100 43.1:53.1 0.81167608 0.83257765
33 C9 100 41 55.8 100 41:55.8 0.73476703 0.7536881
34 C10 100 45.2 51.3 100 15.0666666666667:17.10.88109162 0.90378071
35 C11 100 48.4 47.9 100 48.4:47.9 1.01043841 1.03645833
36 C12 100 45.9 51.4 100 15.3:17.13333333333330.89299611 0.91599176
37 D1 100 46.5 52.2 100 23.25:26.1 0.8908046 0.91374381
38 D2 100 43.7 51.7 100 43.7:51.7 0.84526112 0.86702754
39 D3 100 43.3 52.4 100 43.3:52.4 0.82633588 0.84761495
40 D4 100 43.3 54.1 100 43.3:54.1 0.80036969 0.8209801
41 D5 100 41.3 53.7 100 41.3:53.7 0.76908752 0.78889239
42 D6 100 46.3 49.4 100 46.3:49.4 0.93724696 0.96138212
43 D7 100 44.1 52 100 11.025:13 0.84807692 0.86991585
44 D8 100 45.5 51 100 15.1666666666667:170.89215686 0.9151309
45 D9 100 48.8 47.6 100 48.8:47.6 1.02521008 1.05161039
46 D10 100 40 56.2 100 5:7.025 0.71174377 0.73007197
47 D11 100 46.3 51.4 100 46.3:51.4 0.90077821 0.92397426
48 D12 100 44.7 53.8 100 44.7:53.8 0.83085502 0.85225046
49 E1 100 50.2 48.3 100 25.1:24.15 1.03933747 1.06610158
50 E2 100 41.1 56 100 41.1:56 0.73392857 0.75282805
51 E3 100 45.3 51.6 100 15.1:17.2 0.87790698 0.90051406
52 E4 100 40.3 56.5 100 5.0375:7.06250.71327434 0.73164195
53 E5 100 46.6 48.6 100 23.3:24.3 0.95884774 0.98353914
54 E6 100 45.7 49.7 100 45.7:49.7 0.9195171 0.9431957
55 E7 100 41.9 53.4 100 41.9:53.4 0.78464419 0.80484966
56 E8 100 43.2 52.1 100 43.2:52.1 0.82917466 0.85052684
57 E9 100 41.1 53.5 100 41.1:53.5 0.7682243 0.78800693
58 E10 100 40.7 55.9 100 8.14:11.18 0.72808587 0.74683489
59 E11 100 44.8 51.2 100 44.8:51.2 0.875 0.89753223
60 E12 100 7.2 54.5 100 7.2:54.5 0.13211009 0.13551207
61 F1 100 45.3 49.6 100 45.3:49.6 0.91330645 0.93682511
62 F2 100 40.8 56.5 100 5.1:7.0625 0.72212389 0.74071939
63 F3 100 45.9 50.4 100 9.18:10.08 0.91071429 0.9341662
64 F4 100 42.8 53.7 100 42.8:53.7 0.79702048 0.81754465
65 F5 100 44.1 52.4 100 11.025:13.1 0.84160305 0.86327527
66 F6 100 49.3 46.9 100 49.3:46.9 1.05117271 1.07824158
67 F7 100 50.3 45.6 100 10.06:9.12 1.10307018 1.13147547
68 F8 100 45.4 50.3 100 9.08:10.06 0.90258449 0.92582705
69 F9 100 41.7 54.2 100 41.7:54.2 0.76937269 0.7891849
70 F10 100 43.2 53.7 100 43.2:53.7 0.80446927 0.82518526
71 F11 100 44.2 53.5 100 44.2:53.5 0.82616822 0.84744298
72 F12 100 46.8 51.6 100 46.8:51.6 0.90697674 0.93033241
73 G1 100 48.3 47.7 100 48.3:47.7 1.01257862 1.03865365
74 G2 100 48 48.3 100 1:1.00625 0.99378882 1.01937999
75 G3 100 43.8 54.7 100 43.8:54.7 0.80073126 0.82135099
76 G4 100 43 55 100 43:55 0.78181818 0.80195087
77 G5 100 44 52.2 100 11:13.05 0.84291188 0.8646178
78 G6 100 42.1 54.3 100 7.01666666666667:9.050.77532228 0.7952877
79 G7 100 38.9 57.9 100 2.04736842105263:3.047368421052630.67184801 0.68914885
80 G8 100 44.3 53 100 44.3:53 0.83584906 0.8573731
81 G9 100 38.7 58.4 100 19.35:29.2 0.66267123 0.67973576
82 G10 100 40.6 56.3 100 5.075:7.0375 0.72113677 0.73970684
83 G11 100 43.6 53.2 100 43.6:53.2 0.81954887 0.84065317
84 G12 100 44.1 50.1 100 22.05:25.05 0.88023952 0.90290667
85 H1 100 44.3 49.7 100 44.3:49.7 0.89134809 0.9143013
86 H2 100 41.8 56 100 41.8:56 0.74642857 0.76564994
87 H3 100 49.7 47.1 100 49.7:47.1 1.0552017 1.08237432
88 H4 100 48.5 49 100 48.5:49 0.98979592 1.01528427
89 H5 100 44.8 51 100 44.8:51 0.87843137 0.90105196
90 H6 100 43.3 53.7 100 43.3:53.7 0.80633147 0.82709541
91 H7 100 48.1 48 100 1.00208333333333:11.00208333 1.0278881
92 H8 100 41.2 56 100 41.2:56 0.73571429 0.75465975
93 H9 100 42.4 55.4 100 42.4:55.4 0.76534296 0.7850514
94 H10 100 43.5 53.9 100 43.5:53.9 0.80705009 0.82783253
95 H11 100 39.3 57.6 100 13.1:19.2 0.68229167 0.69986144
96 H12 100 44.4 48.9 100 11.1:12.225 0.90797546 0.93135684
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Screen 3 – Plate 3.  
	
Table	A.20.	Percentages	from	screen	3	plate	3	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 51 44.7 100 51:44.7 1.1409396 1.19326096 0.95615263
2 A2 100 43.5 54.1 100 43.5:54.1 0.80406654 0.84093953
3 A3 100 40.8 56 100 5.1:7 0.72857143 0.76198235
4 A4 100 43.5 53.4 100 43.5:53.4 0.81460674 0.85196309
5 A5 100 49.4 47.6 100 49.4:47.6 1.03781513 1.08540739
6 A6 100 45.9 50.6 100 9.18:10.12 0.90711462 0.94871321
7 A7 100 38.1 59.4 100 38.1:59.4 0.64141414 0.6708282
8 A8 100 41.8 53.8 100 41.8:53.8 0.77695167 0.81258123
9 A9 100 39.1 56.4 100 39.1:56.4 0.69326241 0.72505413
10 A10 100 42.4 54.9 100 7.06666666666667:9.150.7 23 33 0.80773014
11 A11 100 39.7 57.7 100 13.2333333333333:19.23333333333330.68804159 0.71959 9
12 A12 100 41.4 50.2 100 41.4:50.2 0.8247012 0.86252045
13 B1 100 45.6 50.7 100 9.12:10.14 0.89940828 0.94065347
14 B2 100 49.2 48.3 100 49.2:48.3 1.01863354 1.06534617
15 B3 100 45.1 52.9 100 45.1:52.9 0.85255198 0.89164843
16 B4 100 47.2 49.3 100 47.2:49.3 0.95740365 1.00130839
17 B5 100 40.4 56.7 100 5.05:7.0875 0.71252205 0.74519698
18 B6 100 40.5 56.8 100 5.0625:7.1 0.71302817 0.74572631
19 B7 100 45 52.8 100 45:52.8 0.85227273 0.89135636
20 B8 100 44.1 54.2 100 22.05:27.1 0.81365314 0.85096575
21 B9 100 45.4 53 100 45.4:53 0.85660377 0.89588602
22 B10 100 43.5 53.5 100 43.5:53.5 0.81308411 0.85037063
23 B11 100 43.7 53.6 100 43.7:53.6 0.81529851 0.85268657
24 B12 100 45.7 51.1 100 15.2333333333333:17.03333333333330.89432485 0.9 5 692
25 C1 100 10.4 53.6 100 10.4:53.6 0.19402985 0.2029277
26 C2 100 42.9 55.4 100 42.9:55.4 0.77436823 0.80987931
27 C3 100 45.8 51.2 100 15.2666666666667:17.06666666666670.89453125 0.93555278
28 C4 100 42.9 54.2 100 7.15:9.033333333333330.79151292 0.82781022
29 C5 100 48.1 48.6 100 1.00208333333333:1.01250.98971193 1.03509828
30 C6 100 42.8 54.2 100 7.13333333333333:9.033333333333330.7896679 0.82588059
31 C7 100 35.4 62.2 100 35.4:62.2 0.56913183 0.59523116
32 C8 100 42.7 52.6 100 21.35:26.3 0.81178707 0.84901411
33 C9 100 43.1 53.6 100 43.1:53.6 0.80410448 0.84097921
34 C10 100 43.3 53.6 100 43.3:53.6 0.80783582 0.84488166
35 C11 100 49.6 47.4 100 49.6:47.4 1.0464135 1.09440007
36 C12 100 44.8 51.3 100 44.8:51.3 0.87329435 0.913342
37 D1 100 48.4 48.7 100 1.00833333333333:1.014583333333330.99 8398 1.0 941547
38 D2 100 48.2 48 100 1.00416666666667:11.00416667 1.05021588
39 D3 100 40.5 57 100 40.5:57 0.71052632 0.74310973
40 D4 100 40.7 55.5 100 8.14:11.1 0.73333333 0.76696263
41 D5 100 48.5 47.5 100 48.5:47.5 1.02105263 1.0678762
42 D6 100 43 54.3 100 43:54.3 0.79189687 0.82821178
43 D7 100 43.4 53.5 100 43.4:53.5 0.81121495 0.84841576
44 D8 100 40.9 55.7 100 8.18:11.14 0.73429084 0.76796405
45 D9 100 46.9 50.8 100 23.45:25.4 0.92322835 0.96556587
46 D10 100 48.5 47.9 100 48.5:47.9 1.0125261 1.05895865
47 D11 100 46.3 50.7 100 23.15:25.35 0.91321499 0.95509332
48 D12 100 41.4 54.3 100 41.4:54.3 0.76243094 0.7973946
49 E1 100 49.6 48.3 100 49.6:48.3 1.02691511 1.07400752
50 E2 100 47.2 49.8 100 47.2:49.8 0.94779116 0.9912551
51 E3 100 41.9 55.3 100 41.9:55.3 0.75768535 0.79243139
52 E4 100 45.5 51.5 100 15.1666666666667:17.16666666666670.883495 5 0.92401058
53 E5 100 46.6 49.3 100 46.6:49.3 0.94523327 0.9885799
54 E6 100 46 49.7 100 46:49.7 0.92555332 0.96799747
55 E7 100 43.9 51.3 100 43.9:51.3 0.85575049 0.89499361
56 E8 100 47.1 49.2 100 47.1:49.2 0.95731707 1.00121785
57 E9 100 48 49.1 100 48:49.1 0.97759674 1.0224275
58 E10 100 42.8 53.2 100 42.8:53.2 0.80451128 0.84140466
59 E11 100 43.5 53.6 100 43.5:53.6 0.81156716 0.84878412
60 E12 100 9 55 100 9:55 0.16363636 0.17114042
61 F1 100 46.3 49.2 100 46.3:49.2 0.94105691 0.98421202
62 F2 100 44.2 52.5 100 11.05:13.125 0.84190476 0.88051294
63 F3 100 47.1 50.5 100 47.1:50.5 0.93267327 0.97544392
64 F4 100 46.9 49.4 100 46.9:49.4 0.94939271 0.99293009
65 F5 100 49.5 47.3 100 49.5:47.3 1.04651163 1.0945027
66 F6 100 46.6 50.7 100 23.3:25.35 0.91913215 0.96128183
67 F7 100 45.7 50.8 100 9.14:10.16 0.8996063 0.94086056
68 F8 100 45.9 49.8 100 45.9:49.8 0.92168675 0.96395358
69 F9 100 42.7 54 100 7.11666666666667:90.79074074 0.82700263
70 F10 100 46.3 49.2 100 46.3:49.2 0.94105691 0.98421202
71 F11 100 40.4 56.7 100 5.05:7.0875 0.71252205 0.74519698
72 F12 100 40.7 56.7 100 5.0875:7.08750.71781305 0.75073062
73 G1 100 45.9 49.9 100 45.9:49.9 0.91983968 0.96202181
74 G2 100 42 56 100 3:4 0.75 0.7843936
75 G3 100 39.4 58.8 100 39.4:58.8 0.67006803 0.7007961
76 G4 100 40.8 57.1 100 40.8:57.1 0.7145359 0.74730318
77 G5 100 45.6 51.8 100 15.2:17.26666666666670.88030888 0.9206782
78 G6 100 20.4 76.2 100 5.1:19.05 0.26771654 0.27999352
79 G7 100 45.2 51.3 100 15.0666666666667:17.10.88109162 0.92149683
80 G8 100 44.6 51.6 100 44.6:51.6 0.86434109 0.90397815
81 G9 100 48.5 48.1 100 1.01041666666667:1.002083333333331.008316 1 1.0545555
82 G10 100 48 48.7 100 1:1.014583333333330.98562628 1.03082526
83 G11 100 42.8 54 100 7.13333333333333:90.79259259 0.82893941
84 G12 100 42.8 51.8 100 14.2666666666667:17.26666666666670.82625483 0.8 414533
85 H1 100 47.8 46.2 100 47.8:46.2 1.03463203 1.08207833
86 H2 100 47.1 50.8 100 47.1:50.8 0.92716535 0.96968343
87 H3 100 46 51.9 100 46:51.9 0.88631985 0.92696482
88 H4 100 45.4 50.7 100 9.08:10.14 0.89546351 0.9365278
89 H5 100 46 51.5 100 46:51.5 0.89320388 0.93416455
90 H6 100 47.7 49.2 100 47.7:49.2 0.9695122 1.01397221
91 H7 100 41.8 54.4 100 41.8:54.4 0.76838235 0.80361893
92 H8 100 47.8 49.8 100 47.8:49.8 0.95983936 1.0038558
93 H9 100 47.4 48.6 100 47.4:48.6 0.97530864 1.02003448
94 H10 100 40.5 56.3 100 5.0625:7.03750.71936057 0.7523491
95 H11 100 37.1 59.5 100 37.1:59.5 0.62352941 0.65212331
96 H12 100 39.9 52.8 100 3.06923076923077:4.061538461538460.75568182 0.7903 598
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Screen 3 – Plate 4. 
	
Table	A.21.	Percentages	from	screen	3	plate	4	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 45.5 52.1 100 45.5:52.1 0.87332054 0.94362724 0.92549314
2 A2 100 53.2 43.4 100 53.2:43.4 1.22580645 1.32449004
3 A3 100 39.5 58.3 100 39.5:58.3 0.67753002 0.73207459
4 A4 100 52.5 43.3 100 52.5:43.3 1.21247113 1.31008116
5 A5 100 45.1 50.6 100 9.02:10.12 0.89130435 0.96305883
6 A6 100 45.8 50.2 100 9.16:10.04 0.9123506 0.98579941
7 A7 100 49.7 46.7 100 49.7:46.7 1.06423983 1.14991649
8 A8 100 44.7 52.1 100 11.175:13.0250.85796545 0.92703599
9 A9 100 44.4 52.2 100 11.1:13.05 0.85057471 0.91905026
10 A10 100 43.9 51.9 100 43.9:51.9 0.84585742 0.9139532
11 A11 100 47.1 50 100 47.1:50 0.942 1.01783574
12 A12 100 42 50.9 100 21:25.45 0.82514735 0.89157586
13 B1 100 45 52.7 100 45:52.7 0.85388994 0.92263238
14 B2 100 47.8 50.6 100 47.8:50.6 0.94466403 1.02071424
15 B3 100 47.6 49.4 100 47.6:49.4 0.96356275 1.0411344
16 B4 100 46.9 51 100 46.9:51 0.91960784 0.9936409
17 B5 100 46.5 50.2 100 23.25:25.1 0.92629482 1.00086621
18 B6 100 45.2 51.4 100 15.0666666666667:17.13333333333330.8793774 0.95017174
19 B7 100 47.5 49.1 100 47.5:49.1 0.96741344 1.04529509
20 B8 100 48.7 48.3 100 1.01458333333333:1.006251.00828157 1.08945331
21 B9 100 44.2 52 100 11.05:13 0.85 0.91842928
22 B10 100 42.3 54.7 100 7.05:9.116666666666670.77330896 0.83556422
23 B11 100 41.9 55.5 100 41.9:55.5 0.75495495 0.81573263
24 B12 100 44.3 52.7 100 11.075:13.1750.84060721 0.90828032
25 C1 100 7.9 62.4 100 7.9:62.4 0.12660256 0.13679471
26 C2 100 50.8 47.1 100 50.8:47.1 1.07855626 1.16538547
27 C3 100 47.6 50.6 100 47.6:50.6 0.94071146 1.01644347
28 C4 100 47 51.1 100 47:51.1 0.91976517 0.99381089
29 C5 100 47.2 50.8 100 47.2:50.8 0.92913386 1.00393381
30 C6 100 48.4 47 100 48.4:47 1.02978723 1.11269029
31 C7 100 49.3 47.5 100 49.3:47.5 1.03789474 1.12145049
32 C8 100 41.5 56 100 41.5:56 0.74107143 0.80073141
33 C9 100 43.8 53.9 100 43.8:53.9 0.81261596 0.87803563
34 C10 100 47 48.6 100 47:48.6 0.96707819 1.04493285
35 C11 100 41.1 56.3 100 41.1:56.3 0.73001776 0.78878787
36 C12 100 42.3 53.2 100 42.3:53.2 0.79511278 0.85912336
37 D1 100 49.5 49 100 1.01020408163265:11.01020408 1.09153059
38 D2 100 47.4 50.4 100 47.4:50.4 0.94047619 1.01618926
39 D3 44.8 53.1 100 44.8:53.1 0.84369115 0.91161253
40 D4 100 47 49.8 100 47:49.8 0.9437751 1.01975375
41 D5 100 51.4 45.6 100 17.1333333333333:15.21.12719298 1.21793769
42 D6 100 44.8 51.8 100 44.8:51.8 0.86486486 0.93449084
43 D7 100 45.5 50.9 100 9.1:10.18 0.89390963 0.96587385
44 D8 100 45.4 51.6 100 15.1333333333333:17.20.87984496 0.95067691
45 D9 100 47.9 49.7 100 47.9:49.7 0.9637827 1.04137205
46 D10 100 41.3 54.4 100 41.3:54.4 0.75919118 0.82030989
47 D11 100 43.8 53.7 100 43.8:53.7 0.81564246 0.88130578
48 D12 100 47.3 50.1 100 47.3:50.1 0.94411178 1.02011753
49 E1 100 49.9 47.8 100 49.9:47.8 1.04393305 1.12797492
50 E2 100 41.5 57 100 41.5:57 0.72807018 0.78668349
51 E3 100 49.3 48.3 100 49.3:48.3 1.02070393 1.10287574
52 E4 100 50.5 46.7 100 25.25:23.35 1.08137045 1.16842621
53 E5 100 48.6 46.6 100 24.3:23.3 1.04291845 1.12687864
54 E6 100 49.2 47 100 49.2:47 1.04680851 1.13108186
55 E7 100 49.4 49.4 100 1.00816326530612:1.008163265306121 1.0805 503
56 E8 100 45.3 52.5 100 45.3:52.5 0.86285714 0.93232148
57 E9 100 46.5 51.3 100 46.5:51.3 0.90643275 0.97940515
58 E10 100 44.5 51.1 100 44.5:51.1 0.87084149 0.94094861
59 E11 100 41.4 55.1 100 41.4:55.1 0.75136116 0.81184952
60 E12 100 6.5 59.6 100 6.5:59.6 0.1090604 0.11784031
61 F1 100 48.4 47.9 100 48.4:47.9 1.01043841 1.09178379
62 F2 100 46 52.6 100 23:26.3 0.87452471 0.94492836
63 F3 100 47.5 50.2 100 47.5:50.2 0.94621514 1.02239022
64 F4 100 45.6 51.6 100 15.2:17.2 0.88372093 0.95486491
65 F5 100 50 48 100 25:24 1.04166667 1.12552608
66 F6 100 48.9 47 100 48.9:47 1.04042553 1.12418502
67 F7 100 46.5 50.3 100 23.25:25.15 0.92445328 0.99887642
68 F8 100 43.9 54.3 100 43.9:54.3 0.80847145 0.87355748
69 F9 100 42.8 55.8 100 42.8:55.8 0.76702509 0.82877447
70 F10 100 46.7 48.4 100 23.35:24.2 0.96487603 1.04255341
71 F11 100 44.4 53.2 100 44.4:53.2 0.83458647 0.90177488
72 F12 100 43.8 54.5 100 43.8:54.5 0.80366972 0.86836918
73 G1 100 43.8 51.6 100 43.8:51.6 0.84883721 0.91717288
74 G2 100 41.8 56.2 100 41.8:56.2 0.74377224 0.80364965
75 G3 100 47.8 49.3 100 47.8:49.3 0.96957404 1.04762963
76 G4 100 44.9 53.1 100 44.9:53.1 0.84557439 0.91364738
77 G5 100 43.9 54.3 100 43.9:54.3 0.80847145 0.87355748
78 G6 100 49 48.9 100 49:48.9 1.00204499 1.08271465
79 G7 100 46.8 50.8 100 23.4:25.4 0.92125984 0.9954259
80 G8 100 46.6 51.7 100 46.6:51.7 0.90135397 0.9739175
81 G9 100 44 54.3 100 22:27.15 0.81031308 0.87554736
82 G10 100 45.4 51.6 100 15.1333333333333:17.20.87984496 0.95067691
83 G11 100 38.5 59.3 100 38.5:59.3 0.64924115 0.70150833
84 G12 100 47.3 46.8 100 47.3:46.8 1.01068376 1.09204889
85 H1 100 41.7 53.2 100 41.7:53.2 0.78383459 0.84693721
86 H2 100 49.1 49.1 100 1.00204081632653:1.002040816326531 1.0805050
87 H3 100 42.7 55.3 100 42.7:55.3 0.7721519 0.83431401
88 H4 100 41 58 100 41:58 0.70689655 0.76380528
89 H5 100 44 52.3 100 11:13.075 0.84130019 0.90902909
90 H6 100 49.4 48.8 100 49.4:48.8 1.01229508 1.09378993
91 H7 100 48.6 48 100 1.0125:1 1.0125 1.09401134
92 H8 100 50.1 47.2 100 50.1:47.2 1.06144068 1.14689199
93 H9 100 44.9 51.6 100 44.9:51.6 0.87015504 0.9402069
94 H10 100 41.9 56.1 100 41.9:56.1 0.74688057 0.80700821
95 H11 100 43.3 55.3 100 43.3:55.3 0.78300181 0.84603739
96 H12 100 47.3 46.1 100 47.3:46.1 1.02603037 1.10863098
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Screen 3 – Plate 5. 
	
Table	A.22.	Percentages	from	screen	3	plate	5	
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 42.3 53.5 100 42.3:53.5 0.79065421 0.9705336 0.81465928
2 A2 100 49.9 48.7 100 49.9:48.7 1.02464066 1.25775362
3 A3 100 40.1 58.6 100 20.05:29.3 0.68430034 0.83998348
4 A4 100 50.4 47.1 100 50.4:47.1 1.07006369 1.31351071
5 A5 100 44 53.6 100 44:53.6 0.82089552 1.00765503
6 A6 100 46.2 52.6 100 23.1:26.3 0.878327 1.07815257
7 A7 100 49.2 48.4 100 49.2:48.4 1.01652893 1.24779641
8 A8 100 42 56.2 100 3:4.014285714285710.74733096 0.91735401
9 A9 100 39.7 56.7 100 39.7:56.7 0.70017637 0.85947142
10 A10 100 43.1 54.2 100 43.1:54.2 0.79520295 0.97611722
11 A11 100 37.9 60.6 100 37.9:60.6 0.62541254 0.7676983
12 A12 100 41.2 53 100 41.2:53 0.77735849 0.95421302
13 B1 100 45 53 100 45:53 0.8490566 1.04222296
14 B2 100 44.8 52.4 100 11.2:13.1 0.85496183 1.04947167
15 B3 100 43.3 53.5 100 43.3:53.5 0.80934579 0.99347766
16 B4 100 43.7 54.8 100 43.7:54.8 0.79744526 0.97886966
17 B5 100 40.6 57.5 100 40.6:57.5 0.70608696 0.86672671
18 B6 100 45.4 52.8 100 45.4:52.8 0.85984848 1.05547007
19 B7 100 51.1 46.2 100 51.1:46.2 1.10606061 1.35769718
20 B8 100 48.3 49.8 100 48.3:49.8 0.96987952 1.19053393
21 B9 100 44.2 53.4 100 44.2:53.4 0.82771536 1.01602642
22 B10 100 50.7 46.9 100 25.35:23.45 1.08102345 1.3269639
23 B11 100 46.3 51.5 100 46.3:51.5 0.89902913 1.10356458
24 B12 100 47.4 50.4 100 47.4:50.4 0.94047619 1.15444114
25 C1 100 6.8 51.2 100 2.26666666666667:17.06666666666670.1328125 0.1 302828
26 C2 100 46 51.2 100 46:51.2 0.8984375 1.10283835
27 C3 100 47.2 50.1 100 47.2:50.1 0.94211577 1.15645374
28 C4 100 44.6 52.8 100 11.15:13.2 0.84469697 1.03687147
29 C5 100 41.7 55.8 100 41.7:55.8 0.74731183 0.91733053
30 C6 100 51.2 46.8 100 51.2:46.8 1.09401709 1.34291368
31 C7 100 45.6 52.5 100 45.6:52.5 0.86857143 1.06617754
32 C8 100 46 52.4 100 23:26.2 0.8778626 1.07758251
33 C9 100 49.8 47.1 100 49.8:47.1 1.05732484 1.29787368
34 C10 100 43.3 52.6 100 43.3:52.6 0.82319392 1.01047633
35 C11 100 38.1 58.3 100 19.05:29.15 0.6535163 0.80219585
36 C12 100 45.1 52 100 45.1:52 0.86730769 1.0646263
37 D1 100 44.7 53.7 100 44.7:53.7 0.83240223 1.0217796
38 D2 100 44 53.7 100 44:53.7 0.81936685 1.00577858
39 D3 100 49.7 47.6 100 49.7:47.6 1.04411765 1.28166176
40 D4 100 46.8 49.2 100 46.8:49.2 0.95121951 1.16762865
41 D5 100 42.7 54.4 100 7.11666666666667:9.066666666666670.78492647 0.9 35027
42 D6 100 44.7 52.3 100 11.175:13.0750.85468451 1.04913125
43 D7 100 44.4 53.8 100 44.4:53.8 0.82527881 1.01303555
44 D8 100 43.8 54.8 100 43.8:54.8 0.79927007 0.98110964
45 D9 100 46.2 51.6 100 46.2:51.6 0.89534884 1.099047
46 D10 100 48 49.6 100 48:49.6 0.96774194 1.18791004
47 D11 100 46.8 51.1 100 46.8:51.1 0.91585127 1.12421388
48 D12 100 43 54.5 100 43:54.5 0.78899083 0.96849179
49 E1 100 41.8 56.6 100 41.8:56.6 0.7385159 0.90653347
50 E2 100 44.9 51.9 100 44.9:51.9 0.86512524 1.06194732
51 E3 100 48 50.8 100 24:25.4 0.94488189 1.15984917
52 E4 100 44.9 53.1 100 44.9:53.1 0.84557439 1.03794851
53 E5 100 45 52.5 100 45:52.5 0.85714286 1.05214889
54 E6 100 49.8 47.7 100 49.8:47.7 1.04402516 1.28154823
55 E7 100 48.2 48.9 100 1.00416666666667:1.018750.98568507 1.20993536
56 E8 100 44.2 53.8 100 44.2:53.8 0.82156134 1.00847232
57 E9 100 45.1 51.4 100 15.0333333333333:17.13333333333330.87743191 1.07705 84
58 E10 100 49 49.2 100 1:1.004081632653060.99593496 1.22251717
59 E11 100 42.6 56.2 100 3.04285714285714:4.014285714285710. 58007 2 0.93045907
60 E12 100 4.4 55.8 100 4.4:55.8 0.07885305 0.09679267
61 F1 100 46.1 49.2 100 46.1:49.2 0.93699187 1.15016411
62 F2 100 40.3 57.2 100 40.3:57.2 0.70454545 0.8648345
63 F3 100 50.6 47.9 100 50.6:47.9 1.05636743 1.29669846
64 F4 100 44.3 53.3 100 44.3:53.3 0.83114447 1.02023568
65 F5 100 36.8 61 100 36.8:61 0.60327869 0.74052884
66 F6 100 46.4 50.8 100 23.2:25.4 0.91338583 1.12118753
67 F7 100 47.3 49.5 100 47.3:49.5 0.95555556 1.17295117
68 F8 100 43.6 53.9 100 43.6:53.9 0.80890538 0.99293705
69 F9 100 40.2 57.6 100 40.2:57.6 0.69791667 0.85669762
70 F10 100 54 40.4 100 27:20.2 1.33663366 1.64072723
71 F11 100 41.1 56.2 100 41.1:56.2 0.73131673 0.89769643
72 F12 100 47.8 50.8 100 47.8:50.8 0.94094488 1.15501646
73 G1 100 43.8 52.4 100 43.8:52.4 0.83587786 1.02604596
74 G2 100 44.6 53.7 100 44.6:53.7 0.83054004 1.01949374
75 G3 100 48.7 47.6 100 48.7:47.6 1.02310924 1.2558738
76 G4 100 44.1 54.2 100 22.05:27.1 0.81365314 0.99876495
77 G5 100 50.5 47.5 100 50.5:47.5 1.06315789 1.3050338
78 G6 100 43.6 51 100 43.6:51 0.85490196 1.04939817
79 G7 100 38.7 57.9 100 2.03684210526316:3.047368421052630.66839378 0.8 04 807
80 G8 100 41.4 55.3 100 41.4:55.3 0.74864376 0.91896549
81 G9 100 44.6 53.3 100 44.6:53.3 0.83677298 1.02714473
82 G10 100 43.6 53.8 100 43.6:53.8 0.81040892 0.99478265
83 G11 100 43.6 53.2 100 43.6:53.2 0.81954887 1.00600201
84 G12 100 48.2 47.4 100 48.2:47.4 1.01687764 1.24822446
85 H1 100 46.3 48.7 100 23.15:24.35 0.95071869 1.16701388
86 H2 100 43.7 54.1 100 43.7:54.1 0.8077634 0.99153526
87 H3 100 45 51.3 100 15:17.1 0.87719298 1.07676056
88 H4 100 43.1 55.1 100 43.1:55.1 0.78221416 0.96017338
89 H5 100 41 56.8 100 41:56.8 0.72183099 0.88605261
90 H6 100 42.3 55.5 100 42.3:55.5 0.76216216 0.93555942
91 H7 100 41.5 55.8 100 41.5:55.8 0.7437276 0.91293086
92 H8 100 39.4 58.1 100 39.4:58.1 0.67814114 0.83242302
93 H9 100 39.5 59.5 100 39.5:59.5 0.66386555 0.81489963
94 H10 100 45.7 51.4 100 15.2333333333333:17.13333333333330.88910506 1.091 8272
95 H11 100 48.8 49.4 100 48.8:49.4 0.98785425 1.21259804
96 H12 100 45.3 49.8 100 45.3:49.8 0.90963855 1.11658773
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Screen 3 – Plate 6.  
	
Table	A.23.	Percentages	from	screen	3	plate	6 
Group Name	/	DescriptionAll Mean	GFP Mean	RFP R01 Ratio	Green/RedNumerical	RatioRatio/ScrambleAverage	scramble	average
1 A1 100 43.7 54.1 100 43.7:54.1 0.8077634 1.00554196 0.80331148
2 A2 100 46.2 52.3 100 23.1:26.15 0.8833652 1.09965465
3 A3 100 42.3 56.7 100 3.02142857142857:4.050.74603175 0.92869549
4 A4 100 45.2 53.8 100 45.2:53.8 0.8401487 1.04585671
5 A5 100 47.2 51.6 100 47.2:51.6 0.91472868 1.13869739
6 A6 100 38.1 57.5 100 2.00526315789474:3.026315789473680.6626 87 0.82484654
7 A7 100 34.1 61.9 100 34.1:61.9 0.55088853 0.68577201
8 A8 100 39.1 58.8 100 39.1:58.8 0.66496599 0.82778101
9 A9 100 44 54.3 100 22:27.15 0.81031308 1.00871592
10 A10 100 43.2 54.5 100 43.2:54.5 0.79266055 0.98674122
11 A11 100 37.8 60.1 100 37.8:60.1 0.62895175 0.78294879
12 A12 100 50.6 45.9 100 10.12:9.18 1.10239651 1.37231515
13 B1 100 42.9 55.4 100 42.9:55.4 0.77436823 0.96397008
14 B2 100 40.7 56.8 100 5.0875:7.1 0.7165493 0.89199434
15 B3 100 40.6 56.5 100 5.075:7.0625 0.71858407 0.89452733
16 B4 100 43.2 54.3 100 43.2:54.3 0.79558011 0.99037563
17 B5 100 43.4 54.2 100 43.4:54.2 0.80073801 0.99679642
18 B6 100 43.2 54.6 100 43.2:54.6 0.79120879 0.984934
19 B7 100 44.6 53.6 100 44.6:53.6 0.83208955 1.0358243
20 B8 100 40 57.5 100 40:57.5 0.69565217 0.86598062
21 B9 100 44.9 51.9 100 44.9:51.9 0.86512524 1.07694869
22 B10 100 42.8 54.7 100 7.13333333333333:9.116666666666670.78244973 0.97403031
23 B11 100 49.9 48.7 100 49.9:48.7 1.02464066 1.275521
24 B12 100 40.8 54.4 100 20.4:27.2 0.75 0.93363536
25 C1 100 7.3 60.1 100 7.3:60.1 0.12146423 0.1512044
26 C2 100 39.8 57.5 100 13.2666666666667:19.16666666666670. 9217391 0.8 1 5072
27 C3 100 51.7 43.5 100 51.7:43.5 1.18850575 1.47950799
28 C4 100 47.2 50.9 100 47.2:50.9 0.92730845 1.15435727
29 C5 100 49.3 48.2 100 49.3:48.2 1.02282158 1.27325652
30 C6 100 48.2 50.2 100 24.1:25.1 0.96015936 1.19525164
31 C7 100 44.2 53.7 100 44.2:53.7 0.82309125 1.02462279
32 C8 100 48.2 49.1 100 48.2:49.1 0.98167006 1.22202917
33 C9 100 46 51.6 100 46:51.6 0.89147287 1.10974745
34 C10 100 45.4 51.9 100 15.1333333333333:17.30.87475915 1.08894143
35 C11 100 39.3 58.2 100 39.3:58.2 0.67525773 0.84059266
36 C12 100 41.7 55.8 100 41.7:55.8 0.74731183 0.93028899
37 D1 100 50.3 47.7 100 50.3:47.7 1.05450734 1.31270045
38 D2 100 44.2 53.3 100 44.2:53.3 0.82926829 1.03231227
39 D3 100 48.7 49.7 100 48.7:49.7 0.97987928 1.21979992
40 D4 100 43.6 52.5 100 43.6:52.5 0.83047619 1.03381591
41 D5 100 46.6 51.5 100 46.6:51.5 0.90485437 1.12640538
42 D6 100 44.9 51.5 100 44.9:51.5 0.87184466 1.08531334
43 D7 100 47.1 50.8 100 47.1:50.8 0.92716535 1.15417914
44 D8 100 42.8 54.9 100 7.13333333333333:9.150.77959927 0.97048193
45 D9 100 41.9 55.2 100 41.9:55.2 0.75905797 0.94491115
46 D10 100 42.1 54.5 100 7.01666666666667:9.083333333333330.77247706 0.96161587
47 D11 100 40.9 56.6 100 5.1125:7.075 0.72261484 0.89954502
48 D12 100 40.7 55.2 100 8.14:11.04 0.73731884 0.91784925
49 E1 100 46 50.1 100 23:25.05 0.91816367 1.14297343
50 E2 100 40.5 56.9 100 5.0625:7.11250.71177504 0.88605113
51 E3 100 49.2 49.6 100 1.00408163265306:1.012244897959180.99193548 1.23480805
52 E4 100 50.3 48 100 25.15:24 1.04791667 1.30449607
53 E5 100 51.1 47.4 100 51.1:47.4 1.07805907 1.34201876
54 E6 100 47.9 49.7 100 47.9:49.7 0.9637827 1.19976214
55 E7 100 48.8 48.5 100 1.01666666666667:1.010416666666671.00618557 1.25254723
56 E8 100 46 51.9 100 46:51.9 0.88631985 1.10333273
57 E9 100 42.3 54.8 100 7.05:9.133333333333330.77189781 0.96089478
58 E10 100 44.4 52.8 100 11.1:13.2 0.84090909 1.04680328
59 E11 100 46.6 50.3 100 23.3:25.15 0.92644135 1.15327787
60 E12 100 3.5 65.2 100 3.5:65.2 0.05368098 0.06682462
61 F1 100 44.8 51.5 100 44.8:51.5 0.86990291 1.08289616
62 F2 100 41.5 56.1 100 41.5:56.1 0.73975045 0.92087623
63 F3 100 52.8 44.9 100 13.2:11.225 1.17594655 1.4638737
64 F4 100 47.9 49.5 100 47.9:49.5 0.96767677 1.20460966
65 F5 100 42.7 53.8 100 42.7:53.8 0.7936803 0.98801065
66 F6 100 45.5 52.2 100 45.5:52.2 0.87164751 1.08506791
67 F7 100 45.8 51.8 100 15.2666666666667:17.26666666666670.88416988 1.100 5 36
68 F8 100 43.7 53.3 100 43.7:53.3 0.81988743 1.02063453
69 F9 100 47.8 49.8 100 47.8:49.8 0.95983936 1.19485328
70 F10 100 46.4 49.5 100 46.4:49.5 0.93737374 1.16688702
71 F11 100 49.6 48.7 100 49.6:48.7 1.01848049 1.26785253
72 F12 100 31.7 66.3 100 31.7:66.3 0.47812971 0.59519841
73 G1 100 44.9 50 100 22.45:25 0.898 1.11787274
74 G2 100 42.3 56 100 3.02142857142857:40.7 535714 0.94030418
75 G3 100 51.6 45.5 100 17.2:15.16666666666671.1340 593 1.41173874
76 G4 100 44.1 53.2 100 44.1:53.2 0.82894737 1.03191276
77 G5 100 44.9 52.2 100 11.225:13.05 0.86015326 1.07075933
78 G6 100 52.6 45.3 100 52.6:45.3 1.1611479 1.44545165
79 G7 100 44.6 53.6 100 44.6:53.6 0.83208955 1.0358243
80 G8 100 54.3 44 100 27.15:22 1.23409091 1.53625454
81 G9 100 50.2 48.4 100 25.1:24.2 1.03719008 1.29114311
82 G10 100 51.4 47 100 51.4:47 1.09361702 1.36138603
83 G11 100 45 51.9 100 15:17.3 0.86705202 1.07934723
84 G12 100 39.2 55 100 39.2:55 0.71272727 0.88723651
85 H1 100 40.6 52.9 100 10.15:13.225 0.76748582 0.95540253
86 H2 100 45.1 53 100 45.1:53 0.8509434 1.05929446
87 H3 100 30.5 68 100 15.25:34 0.44852941 0.55835056
88 H4 100 42.9 55 100 42.9:55 0.78 0.97098077
89 H5 100 46.5 51.1 100 46.5:51.1 0.90998043 1.13278654
90 H6 100 35.6 62.3 100 35.6:62.3 0.57142857 0.71134123
91 H7 100 37 62.1 100 37:62.1 0.5958132 0.74169637
92 H8 100 36.9 60.6 100 3.075:5.05 0.60891089 0.75800098
93 H9 100 47.6 51.1 100 47.6:51.1 0.93150685 1.15958364
94 H10 100 51.6 46.8 100 51.6:46.8 1.1025641 1.37252377
95 H11 100 46.5 51 100 46.5:51 0.91176471 1.13500769
96 H12 100 47.9 45.3 100 47.9:45.3 1.05739514 1.31629532
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 A.3.4 – Combined Screen Z-Score Data. 
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Table	A.24.	Combination	of	average	Z-scores 
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A.3.5 – Counts from all three screens 
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Table	A.3.5	-	Tables	showing	how	many	cells	were	screened	throughout	the	screen	for	
each	individual	siRNA.	
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Table	 A.3.6.	 Top	 synthetic	 viable	 hits.	 This	 suggests	 a	 synthetic	 viable	 interaction	
between	NSMCE4a	shRNA	and	the	siRNA	target	listed	above.	  
	 225	
	
Table	A.3.7.	Results	from	the	middle	of	the	screen	These	indicate	no	preferential	growth	
advantage	or	disadvantage	on	NSMCE4a	or	Non-silencing	cells. 
	 	
	 226	
	
Table	A.3.8	–	RNR	Validation		
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Table	A.3.8.1	–	RNR	Validation	with	high	EdU	incorporation.		
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A.4.1	–	Western	Blot	Quantification.		
	
	
Table	A.4.1	–	Quantification	of	western	blotting.	A.	Quantification	of	initial	siRNA	
testing	using	SMC6	and	scramble	siRNA	in	osteosarcoma	cells.	B.	As	in	A	however	cells	
were	exposed	to	NSMCE4a	siRNA.	C.	Creation	of	cells	with	shRNA,	quantification	of	
SMC5/6	levels	after	incorporation	of	plasmid	expressing	shRNA.	D.	Quantification	of	
SMC5/6	levels	after	incorporation	of	plasmid	expressing	shRNA	expressing	either	non-
silencing	shRNA	with	NLS	GFP	and	RFP	and	two	constructs	targeting	NSMCE4a	and	NLS	
GFP.		
	
  
Scramble SMC6	siRNA
24 48 72 96 24 48 72 96
SMC6 0 34.99 170.24 61.58 0 0 0 0
SMC5 99.61 63.19 671.07 502.38 240.60 44.52 47.56 45.54
Tubublin 100 100 100 100 100 100 100 100
Scramble NSE4	siRNA
24 48 72 96 24 48 72 96
SMC6 50.6 45.85 161.97 241.70 0 0 0 0
SMC5 52.0 213.44 234.24 150.11 355.87 210.74 24.64 21.26
Tubulin 100 100 100 100 100 100 100 100
NS GAPDH EG5 C1 C2 C3
SMC6 60.73 456.27 39.06 28.16 167.30 122.76
SMC5 121.08 693.54 120.14 24.80 146.80 21.09
Ponceau 100 100 100 100 100 100
NS	RFP NS	GFP C1 C2
SMC6 47.13 89.55 10.27 36.29
SMC5 92.17 129.56 67.03 24.74
Tubulin 100 100 100 100
A
B
C
D
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Table	A.4.2	–	Quantification	of	western	blotting.	A.	Quantification	of	SMC5/6	levels	in	
cells	as	in	Table	A.4.1.D	after	screen	had	been	carried	out.	B.	Quantification	of	SMC5/6	
levels	 in	patient	 fibroblasts	after	 incorporation	of	NSMCE4a	 siRNA.	Right	hand	panel	
shows	quantification	of	SMC6	reduction	in	BRCA2	deficient	cells.	C.	As	in	B	however	with	
different	cell	lines.	D.	Quantification	of	BRCA1	knockdown	in	screen	cells	after	BRCA1	
siRNA	treatment.	 
NS C1
Smc6 53.05 34.43
Smc5 135.22 51.63
Tubulin 100 100
WT1
NSMCE3-
L264F Artemis
BRCA2	
deficient WT1
NSMCE3-
L264F Artemis
BRCA2	
deficient
Scramble Scramble Scramble Scramble NSMCE4a	 NSMCE4a	 NSMCE4a	 NSMCE4a	
SMC6 67.51 13.12 85.41 0.00 26.07 89.30 320.34 0.00
SMC5 70.93 0.00 137.45 31.70 0.00 0.00 0.00 0.00
Ponceau 100 100 100 100 100 100 100 100
BRCA2	
def
Scramble NSMCE4a	
SMC6 89.05 54.01
Ponceau 100 100
Scramble	siRNA BRCA1	siRNA	
Non-Silencing NSMCE4a	C1	 Non-Silencing NSMCE4a	C1	
BRCA1 83.07 42.07 69.05 35.68
Ponceau 100 100 100 100
WT1
NSMCE3-
L264F TDP1 XLF WT1
NSMCE3-
L264F TDP1 XLF
Scramble	
siRNA - + + + + - - - 
NSMCE4a	
siRNA + - - - - + + + 
SMC6	 72.43 186.71 249.88 531.03 313.38 303.95 332.42 183.20
Ponceau 100 100 100 100 100 100 100 100
A
B
C
D
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Table	A.4.3	–	A.	Quantification	of	western	blotting	of	SMC5/6	levels	using	cells	isolated	
from	two	sets	of	wild-type	patients	and	NSMCE3-L264F	patient	cells.		
  
WT1 NSMCE3-L264F WT2
SMC6 77.66 33.71 320.90
SMC5 107.28 41.65 200.91
Tubulin 100 100 100
A
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